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Millions of people across the world are affected by Chronic Obstructive Pulmonary
Disease (COPD). It is one of the most prevalent chronic health conditions in the world.
As a life-long condition that effects breathing, it has a huge physical and mental impact
on peoples’ lives every single day. COPD is characterised by periods of respiratory
exacerbations which, if are not managed swiftly, can result in hospitalisation for
emergency care. However, effective self-management and support can help people
with COPD to avoid the distress of requiring emergency care, while supporting their
quality of life and independence.
In addition to the difficulties that COPD introduces to a plethora of people, it
also presents a huge challenge for healthcare services around the world. In the UK,
COPD generates a high number of hospital admissions annually, with many of these
for emergency care. In this highly demanding and time-pressured context, healthcare
professionals are required to make timely and evidence-based decisions to effectively
care for patients. This is the challenging reality for all healthcare professionals that
collaborate in the ongoing management and support involved for COPD care.
Data supported decision-making (DSDM) technology holds potential to support
the ongoing care of people with COPD, through connecting them and their health-
care professionals with pertinent data that can inform decision-making around care.
Examples of such technologies include patient health monitoring apps that share data
with healthcare professionals for personalised care planning, and clinical dashboards
that interlink data from different sources to support decision-making about patient
treatment. However, there is currently limited research working in partnership with
people with COPD and respiratory healthcare professionals to truly understand how
these technologies might support care in its real-world context.
Specifically, there are three key gaps in knowledge which this thesis addresses.
First, there is a need to understand how DSDM technologies can be designed to
support healthcare professionals to provide COPD care, while considering the chal-
lenges of implementing technology into healthcare systems. Furthering this, there is
a need to understand how technology could support the self-management of COPD,
considering it is progressive and highly debilitating in nature. Finally, there is a need
to understand how technology could support the ongoing care collaboration between
healthcare professionals and patients through sharing patient-generated data about
COPD symptoms. Each of these three areas are important in developing an un-
derstanding about how technology could support the real-world context of COPD
care.
To advance our knowledge in this space, I conducted three novel pieces of re-
search working with people with COPD and healthcare professionals to understand
how DSDM technologies could support everyday challenges related to COPD care.
First, I worked with 11 healthcare professionals to co-design a DSDM dashboard by ex-
ploring their decision-making needs around COPD care. Then I conducted exploratory
research involving 171 people with chronic respiratory conditions to understand how
technology may support their self-care. Finally, I conducted a small exploratory case
study with eight participants to understand the patient experience of self-monitoring
their respiratory symptoms and the healthcare professionals’ experience of receiving
this data remotely.
The thesis concludes with a synthesis of the key novel findings across the three
research studies, providing overarching opportunities and nodes of caution when
designing and deploying DSDM technologies in this space. This discussion draws
attention to the ways that perceptions of data ‘trustworthiness’ affects how DSDM
technologies are used for decision-making, the tensions that occur when technology
does not align with the local context of care, the need for self-management technol-
ogy to support the personal and evolving condition journey of COPD, and how we





In early 2020, while I was writing this thesis, a sudden outbreak of COVID-19 (a novel
coronavirus) rapidly became a pandemic. It has claimed the lives of many people
around the world, including healthcare professionals who have fought hard to save
people. Though this thesis is being published during the pandemic, the research
described here occurred before the discovery of the virus.
The current outbreak of COVID-19 has put healthcare services around the world
under unprecedented strain, including the National Health Service in the United King-
dom. In addition to the strain on healthcare services, people with severe respiratory
conditions are at high risk of developing serious complications if they contract COVID-
19. It is a crucially important time for healthcare services to preserve their resources
as much as possible to respond to the pandemic, and for people with respiratory
conditions to self-isolate to avoid exposure to the virus. In turn, respiratory self-care
has become increasingly important.
As I submit this work during a respiratory pandemic, this thesis may raise im-
portant, yet unanticipated, questions about its applicability to COVID-19. However,
although COVID-19 is a respiratory disease, it is important to state that the findings
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We will all need healthcare at some point in our lives. For some people healthcare
is required more often than for others. This is particularly true for people with
chronic health conditions; which are long-term continuous or reoccurring health
problems (Bernell and Howard, 2016). Advancements in medicine mean that the
global population is now less prone to death from infection and infectious diseases, and
so on average, we live longer (Suzman and Beard, 2011; World Health Organization,
2017). Yet, as we live longer, we become more likely to develop chronic health
conditions like chronic respiratory conditions, cardiovascular diseases, cancers, and
diabetes (World Health Organization, 2018b). Chronic health conditions are by far the
leading causes of death globally (Vita-Finzi et al., 2005; World Health Organization,
2018a), resulting in tens of millions of deaths annually (Wang et al., 2016). These
conditions create a considerable challenge for millions of peoples’ lives and many
healthcare services around the world (National Institute of Health, 2017; Snell et al.,
2016a,b; World Health Organisation, 2018). For this reason, understanding how to
best support the lives of people with chronic health conditions is a pressing area for
research (Davis et al., 2000; Dixon, 2004).
Chronic respiratory conditions (CRCs) are among the most prominent chronic
health conditions in the world (Wang et al., 2016). Chronic Obstructive Pulmonary
1
2Disease (COPD) is one of the most common CRC. Risk factors which increase the
chance of developing COPD include cigarette smoking and various environmental
factors, such as smoke inhalation and air pollution (Mannino and Buist, 2007). The
term COPD describes a set of chronic and progressive lung conditions. These lung
conditions make it difficult to breathe, subsequently impacting everyday life for people
with the conditions and their families. There are an estimated 328 million people living
with COPD worldwide (Eisner et al., 2010; Quaderi and Hurst, 2018). Fortunately, the
condition can be effectively managed with the right ongoing support. Quality of life can
be supported through effective self-management of the condition, paired with support
from family, friends, and respiratory healthcare professionals (HCPs) (DiNicola et al.,
2013; Gadoury et al., 2005; Holman and Lorig, 2000; Russell et al., 2011). However,
COPD still remains a considerable challenge to so many lives and healthcare services
around the world (National Institute of Health, 2017; Snell et al., 2016a,b; World
Health Organisation, 2018). As such, understanding how we can support the lives
and care of the millions of people that have COPD is an important and worthwhile
area of study.
Lung diseases, like COPD, cost the United Kingdom’s (UK) National Health Ser-
vice (NHS) approximately £1.9 billion each year (British Lung Foundation, 2014). In
the UK, COPD generates a high number of emergency hospital admissions annually,
with 97% of COPD admissions being for emergency care (Snell et al., 2016b). Un-
planned hospital admissions are a distressing experience for patients and their families.
They also put tremendous pressure on HCPs who are responsible for making timely,
life-saving decisions each day. When caring for patients with chronic health condi-
tions like COPD, HCPs often rely on information from a range of different sources
and HCPs to make ongoing decisions about care (Casas et al., 2006; Dobler, 2016;
Nolte et al., 2012; Smith, 1996). The prompt retrieval of relevant health information
about patients is important to support the time-pressured HCP to make informed and
effective decisions about care.
Technology has had an important role in transforming healthcare over the past
century (Hatcher and Heetebry, 2004; Spekowius and Wendler, 2006; Thimbleby,
32013; Timmermann and Anderson, 2006; Wright et al., 2012), which has led to
the field of ‘digital health’ as an area of interest for research (DePasse et al., 2014;
Lupton, 2014a). The introduction of Electronic Health Records is a notable example
of how technology has transformed healthcare, enabling patient data to be stored
digitally and thus being potentially more accessible than paper records (Evans, 2016).
Electronic Health Records enable data supported decision-making (DSDM), in that they
provide pertinent data that can support and inform decisions about healthcare. The
concept of DSDM is central to healthcare; HCPs will aim for optimal care outcomes by
considering a collage of medical information and evidence (Smith, 1996). Likewise,
people with chronic health conditions may collect data about their symptoms and
experiences to craft effective self-care practices. Digital health technologies which
provide data that supports and informs decision-making in this way can be considered
DSDM technologies. Examples of DSDM technologies used across healthcare include
clinical dashboards that visualise data to support the delivery of patient care (Dowding
et al., 2015), and technologies that support people to collect data about their health
through the practice of self-monitoring (Lupton, 2017). Both of these technologies
present data that can help to inform care at different points and in different ways.
To that end, we can then begin to envision how DSDM technologies could
be designed to provide timely and data-driven support for COPD care. This could
positively impact the lives of people with the condition and the work of HCPs who care
for them. However, to truly understand where potential opportunities lie in this space,
it is crucial to first develop a rich understanding of the needs of those involved with
COPD care. This can be achieved through actively engaging HCPs and people with
COPD within computer science research, using participatory methods for technology
design and development (Sanders and Stappers, 2008). By doing so we can ensure
what is created is driven by real-world needs faced by those directly impacted by
COPD, instead of developing pre-conceived technical solutions (Liu et al., 2006). For
this reason, my research involves working with people with COPD and respiratory
HCPs to explore the potential role of DSDM technologies to support care.
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1.1 Research Context
The field of Human-Computer Interaction (HCI) takes an interdisciplinary approach to
understand the interplay between people and technology (Dix, 2009). The aim of HCI
research is to observe how technology influences human work and activities (Dix,
2009; Preece et al., 1994). Previous HCI research has documented the different
ways in which digital technologies can support healthcare (Fitzpatrick and Ellingsen,
2013). The goals of these HCI studies are to understand how engaging with these
technologies may provide support, and in some instances improvement, to healthcare
and how it is delivered. This thesis aims to add to this body of HCI research in
healthcare, by working directly with those impacted by COPD to explore the role
that DSDM technologies may have for supporting care. It is important to note that
decisions about care are not just made by HCPs in clinic settings, they are also made
by people with COPD as they practice self-care in their everyday lives. As such this
thesis actively seeks to explore how DSDM technologies can support the ongoing
decisions about care made by both respiratory HCPs and people with COPD.
There is a relatively limited amount of digital health research that explores how
technology can support the self-care of people with COPD. Most studies in this space
focus on the creation of novel technical systems that aim to support COPD care. For
example, there are numerous studies about using novel machine learning techniques
to detect declines in health for people with COPD (Anastasiou et al., 2018; Chatterjee
et al., 2019; Fernandez-Granero et al., 2018; Gokalp and Clarke; Hofer et al., 2015;
Merone et al., 2016; Nathan et al., 2019b; Sanchez-Morillo et al., 2015). While these
studies demonstrate the impressive technical capabilities of digital health technologies,
there is a strong need to work with people with COPD to understand how technology
can address their real needs and fit into their everyday lives.
In fact, within the limited number of studies that explore technologies for COPD
self-care, even fewer studies have involved people with the condition in their re-
search (Dahl et al., 2018; Johnston et al., 2009; Nadarajah et al., 2019; Pereira et al.,
2016; Spina et al., 2013). Considering COPD is a complex chronic health condition
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that introduces many mental and physical challenges into people’s lives (Cicutto et al.,
2004; Cicutto and Brooks, 2006), there is much to learn about their experiences and
needs which will shape the support that is created. This rich perspective is generally
missing from HCI research, which represents a prominent gap in current knowledge.
Enhancing this knowledge is an essential research pursuit that would help to under-
stand if, and how, technology might support the lives of people with COPD.
Technologies that aim to support HCPs’ decision-making are generally better re-
searched. Though not specific to respiratory care, there has been a wealth of previous
work about clinical decision-support systems and dashboards (Dowding et al., 2015;
Iftikhar et al., 2019). These technologies have been created to support reductions in
hospital admissions (Alluhaidan et al., 2015), best practice adherence (McMenamin
et al., 2011), identifying patients that require follow up care (Croon et al., 2015), and
medication monitoring (Waitman et al., 2011). Most previous work in this space
details the technical creation of these systems, or the quantitative evaluation of their
clinical effectiveness. While these technologies demonstrate great potential to support
decision-making, there is a lack of rich understanding about how HCPs may engage
with these technologies in practice to support their work.
Moreover, previous work has shown that there is difficulty integrating digital
health technologies into clinical practice. Some of the reasons for this are: poor
cultural fit; failing to meet user demand; or lack of integration with other key clinical
systems (Fitzpatrick and Ellingsen, 2013; Grimson et al., 2000; Liu et al., 2006).
This presents a strong case for the need to involve HCPs in the design of DSDM
technologies to unpack, and address, these challenges in greater detail. There is
limited HCI research that details the complex cultural and technical challenges that
arise when designing DSDM technologies for healthcare. A stronger understanding of
this process can help to form a deeper appreciation of the challenges and opportunities
in this space. This brings the field of HCI a step closer to understanding how DSDM
technologies can be designed to integrate into real-world clinical practice. It is at this
point where the benefits of using these technologies can truly be realised.
Given the gaps evident in previous HCI research, there is still much to learn about
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the role of DSDM technologies for respiratory care. This thesis takes an interpretivist
and pragmatist approach to deepen our understanding of this role. I build a body
of empirical evidence about the experiences and needs of those involved in COPD
care, with a view to understanding the opportunities for DSDM technologies. To do
this, I conduct three pieces of novel research that engage both respiratory HCPs and
people with COPD to understand the context of care. Within these studies, I carefully
uncover the opportunities and challenges in this space from these key perspectives. I
also outline opportunities for future work that can advance this area of research.
1.2 Research Questions and Setting
This section outlines the research questions that this thesis addresses, followed by an
overview of the research setting.
1.2.1 Research Questions
This thesis aims to contribute an exploration of the potential role of DSDM technolo-
gies for respiratory care. To explore this in detail from the perspectives of HCPs and
people with COPD, I have chosen to focus on three main research questions:
1. How can technology support healthcare professionals in their decision-making
for COPD care?
2. What is the lived experience of COPD, and how can technology support this
experience?
3. What is the lived experience of using self-monitoring technology to share symp-
tom data between COPD patients and healthcare professionals?
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1.2.2 Overview of Research Setting
This research was conducted with participants from two collaborating healthcare
organisations, and members of the CRC community, in North West England. The aim
was to explore the potential role of DSDM technologies for COPD care, both in clinical
settings and everyday life as motivated above. I briefly summarise the research setting
below, providing more detail in later chapters.
To explore DSDM from the HCPs’ perspective, I worked with two collaborating
NHS organisations. The NHS is the UK’s publicly funded national healthcare sys-
tem. The two organisations operated, respectively, a hospital respiratory service and
a community care service. Both organisations work together to provide respiratory
care services to COPD patients in their region. The hospital respiratory service pro-
vides urgent, specialised, and emergency care services to patients. Community care
provides diverse support services for that promote self-management, independence,
and hospital admission avoidance through home visits. The organisations collaborate
through provision of care: once a COPD patient has been discharged from the hos-
pital service, they usually receive follow-up care from the community care service.
COPD represents a high demand on their joint services, and so they were motivated
to explore how DSDM technology could support their work.
Specifically, they were motivated to explore how the aggregation and presen-
tation of pertinent data about their COPD patients and services could help inform
their decision-making (Chapter 4). It was thought that this information, displayed on
a joint dashboard, could help them to make timely data-supported decisions. This
could improve the care offered to patients and subsequently help to reduce service
demand. In addition to this, the community care service were interested to explore
how technology could support and educate their COPD patients (Chapter 6). Partic-
ularly, they wanted to explore how self-monitoring technology might fit in with their
service and assist patients to self-manage their condition through better awareness of
their symptoms. It was thought that this could help to improve patients’ quality of
life, while reducing the pressure on their service.
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To explore DSDM technology with people with COPD, I engaged the wider CRC
community by largely working with respiratory support groups (Chapter 5). These
groups, called Breathe Easy groups, are supported by a UK charity organisation called
the British Lung Foundation. The groups are self-organised and run by members of
the respiratory community, including friends and carers. I focused on participants’
experiences of care, self-care and self-management, and technology. While my re-
search activities with HCPs focused on specific types of technology (a dashboard
and self-monitoring technology), my research with the CRC community took a more
open-ended and exploratory approach about the possibilities for digital support.
Figure 1.1 provides a visual depiction of how each of my research chapters
(Chapter 4, 5, and 6) contribute to my three research questions. Note that each
research chapter contributes to more than one research question.
Research Question 3:
What is the lived experience of using self-monitoring
technology to share symptom data between COPD 
patients and healthcare professionals?
Research Question 2:
What is the lived experience of COPD, and
how can technology support this experience?
Research Question 1:
How can technology support healthcare
professionals in their decision-making for COPD 
care?
Chapter 4 (Data Supported Decision-Making)
Understanding Data Supported Decision-Making
in Respiratory Care
Chapter 5 (Technology and the Lived Experience)
The Role of Technology in Supporting the Lived
Experience of Chronic Respiratory Conditions
Chapter 6 (Self-Monitoring and Collaboration)
Exploring the Lived Experiences of 
Self-Monitoring for Chronic Respiratory Care
Figure 1.1: How each research chapter contributes to each research question.
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1.3 Contribution Statement
Through exploring the three research questions outlined in the previous section, my
thesis provides a number of contributions to the fields of HCI and Health Informatics.
The primary contribution is about growing our understanding of the role that DSDM
technologies could have for COPD care. I contribute this understanding from the
key perspectives of both people with the condition and respiratory HCPs. More
specifically, this thesis considers how DSDM technologies can be designed to take
into consideration the specific needs and complexities of COPD care. However in
addition to this primary contribution, I also make six further contributions:
1. I have identified prominent gaps in knowledge about DSDM technologies in
healthcare, through interweaving research from HCI, computer science, health
informatics, and social science literature (Chapter 2). In addition to motivating
this thesis through the literature synthesis, Chapter 2 lays the foundation for
future research avenues beyond this thesis.
2. I take the reader on a previously unexplored journey to understand how real-
world DSDM occurs for COPD care (Chapter 4). I explore how technology could
feasibly support this process. Through involving diverse stakeholders, I provide
novel empirical contributions in addition to specific conceptual contributions
about how trust in data impacts DSDM. I conclude with insights about how we
may begin to design DSDM technologies for respiratory care that account for
the real-world challenging nature of clinical practice.
3. Through my research engagements with the CRC community in Chapter 5, I
have detailed a rich account of the salient challenges and experiences of liv-
ing with COPD. This has allowed me to identify novel opportunities for self-care
technologies to support this experience. Particularly, I contribute an understand-
ing of where DSDM technologies may be most needed to support the COPD
journey. I conclude with important recommendations, grounded in the lived
experience of COPD, for those designing self-care technologies in this space.
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4. From the viewpoints of both patients and HCPs, Chapter 6 provides real-world
insights into the COPD self-monitoring process and remote sharing of this data.
This case study provides a recognition of the values placed in the self-monitoring
and data sharing process. It also explores the concerns and challenges involved
with recording and remotely sharing personal health data about COPD, including
the conceptual challenge of accountability. I conclude by identifying opportuni-
ties and nodes of caution for designers of COPD self-monitoring technologies.
5. I synthesise my key contributions in Chapter 7 (Discussion), drawing on the
findings from each research chapter (4, 5, and 6). I clearly outline my overall
contributions to knowledge, situating them within previous work in this space.
Overall, this shows how this thesis has advanced understanding about the po-
tential role of DSDM technologies for respiratory care.
6. When concluding this thesis in Chapter 8, I outline opportunities for future work
to directly build on this thesis. This contributes a clear understanding of the next
steps that are required to further knowledge in this space.
1.4 Thesis Structure
This thesis is structured into eight chapters, which sequentially take the reader through
the journey of this PhD research. The structure of this thesis is discussed below, with
a summary of the contents of each chapter.
To gain a deeper understanding of COPD, Chapter 2 (Background and Related
Work) begins by introducing COPD in more detail by describing its prevalence, causes,
diagnosis, and the importance of self-management and self-care. This prepares the
reader with enough foundation knowledge about the condition to appreciate the
challenges raised throughout the thesis. It also explains the overlap between COPD
and CRCs more generally, justifying my inclusion of the CRC community more widely
in this research. Following on from this, I critically examine the current literature
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around DSDM in healthcare, the challenges when innovating in the healthcare space,
technologies for COPD self-management, and sharing personal health data about
COPD. This chapter draws on literature from various relevant disciplines, including
medical sciences, computer science, HCI, and social sciences. It identifies prominent
gaps in this space, which motivates my three research questions.
Following on from the critical examination of the literature and the identification
of knowledge gaps, Chapter 3 (Methodology) discusses the methodological approach
for this thesis. I begin by introducing and justifying my mixed methods approach,
which includes a discussion of my chosen frameworks. Then I introduce my specific
research methods, approach to data analysis, the healthcare setting for this research,
and participant recruitment. I conclude by discussing the various important practical,
ethical, and methodological considerations which shaped this research.
My first research study is Chapter 4 (Understanding Data Supported Decision-
Making in Respiratory Care). It explores DSDM in respiratory care from the experi-
ences of HCPs. This chapter documents the design and evaluation of a DSDM proto-
type that aims to support decision-making about COPD care and services. Through
uncovering HCPs’ data needs that could be supported by technology, this study also
uncovers the real-world challenges and complexities of designing DSDM technologies
for healthcare. This chapter contributes a rich understanding about the experiences,
opportunities, and limitations of DSDM in respiratory care — directly demonstrating
how this impacts how these technologies should be designed and deployed.
To truly understand how technology might support people with CRCs, Chapter
5 (The Role of Technology in Supporting the Lived Experience of Chronic Respiratory
Conditions) details a series of research engagements with the CRC community to
understand their lived experiences. This chapter provides a rich understanding of
people’s experiences living with CRCs, how they self-manage and self-care, and how
technology could support these practices. It identifies opportunities for technology
to support the needs of people with CRCs, followed by challenges which arise in this
design space that require careful consideration.
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To unite HCPs and COPD patients together as part of ongoing care, Chapter 6
(Exploring the Lived Experiences of Self-Monitoring for Chronic Respiratory Care) ex-
plores the experiences of self-monitoring COPD symptoms and sharing the resulting
data with HCPs. This chapter took an exploratory case study approach. It involved
patients self-monitoring their COPD symptoms using a mobile health app, which re-
motely sends the data to their HCPs. It reports on the experiences and perspectives
of both patients and HCPs during the case study. I conclude by providing an under-
standing of the needs that patients and HCPs have in relation to the self-monitoring
process, and the challenges that arise when sharing data remotely in this way.
Synthesising the overall contributions of the thesis, Chapter 7 (Discussion)
revisits my research questions and discusses the contributions from all three research
chapters. It incorporates key literature in the discussion to show how this thesis has
advanced understanding of this space. This chapter aims to demonstrate how each
research study has contributed to the overall story about ‘The Role of Data Supported
Decision-Making in Respiratory Care’. It concludes by briefly summarising how my
thesis can be positioned among previous research in this space.
Finally, Chapter 8 concludes the thesis, presenting clear opportunities for future
work which expand on my research. The chapter ends with my concluding remarks
about this research as a whole.
1.5 Chapter Summary
This chapter has inaugurated the thesis by motivating its importance and relevance
in today’s world and potential future worlds. I have explored the concept of DSDM
in healthcare through the lens of HCI, laying the foundation for its focus within the
remainder of the thesis. Then, I outlined the three research questions which shape
this thesis and introduced the research setting. Following this I provided summary
statements on my contributions to knowledge. This chapter concluded with a clear




Background and Related Work
This chapter is divided into four main topics which provide an understanding of
the background and related work on data supported decision-making (DSDM) and
Chronic Obstructive Pulmonary Disease (COPD) (self-)care. Within the review of
related work, I identify the areas in which this thesis aims to contribute. The first
topic of this chapter explains the prevalence, cause(s), symptoms, diagnosis, and
ongoing management of COPD. This exploration is important for understanding the
context and unique challenges that are involved with COPD care as encountered
in the research chapters. The second topic of this chapter explores the concept of
DSDM in healthcare and the challenges when innovating in this space, reviewing
previous work spanning Human-Computer Interaction (HCI), Computer-Supported
Cooperative Work (CSCW), and Health Informatics. The third topic presents a review
of previous digital health literature about COPD self-management technologies. The
final topic then discusses literature on self-monitoring technologies for COPD and
experiences surrounding their use, followed by how personal health data can be used
by healthcare professionals (HCPs) to inform care.
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2.1 Understanding Chronic Obstructive Pulmonary Dis-
ease
COPD is one of the most common chronic respiratory conditions1 in the world (World
Health Organisation, 2018). There are an estimated 16 million people living with
COPD in the United States (US) and 1.2 million in the United Kingdom (UK) (National
Institute of Health, 2017; Snell et al., 2016b). In the UK, COPD generates over 140,000
hospital admissions annually, accounting for over one million bed days2 — with 97%
of these admissions being for emergency care (Price et al., 2006; Snell et al., 2016a).
COPD is characterised by non-reversible chronic obstruction of the airways which
results in breathlessness (Elkington et al., 2004; Miravitlles et al., 2006; Wedzicha
and Seemungal, 2007). COPD describes conditions such as emphysema and chronic
bronchitis (Madison and Irwin, 1998; Petty, 2006).
Emphysema and chronic bronchitis are chronic respiratory conditions which
make breathing challenging for different biological reasons. Emphysema is a lung
disease which progressively destroys the alveoli (the tiny air sacs) of the lungs (British
Lung Foundation, 2016; Thurlbeck, 1984). It causes the inner walls of the single
alveoli to rupture, ultimately creating larger air sacs which reduces the surface area of
the lungs (National Emphysema Foundation, 2005; Thurlbeck, 1984). This leads to a
decrease in the amount of gases exchanged in the lungs, making breathing difficult.
Chronic bronchitis is caused by the overproduction of mucus, which causes airflow
obstruction and difficulty breathing (Kim and Criner, 2013). It is not the same as acute
bronchitis, which is usually temporary and caused by a viral infection.
1Chronic health conditions are long-term continuous or reoccurring health problems (Bernell and
Howard, 2016).
2Bed days refer to the number of days that a hospital bed has been allocated to a patient with a
particular condition. If COPD accounts for over one million bed days a year, that means that COPD
patients spent over one million combined days a year occupying hospital beds.
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Research suggests that nearly all patients with COPD experience the effects
of both emphysema and chronic bronchitis (Niewoehner, 2012). The terminology
associated with COPD has been raised as challenging for patients to understand,
with some patients expressing a lack of knowledge about what COPD means (Powell
et al., 2013). Adding to this, it is possible to have more than one respiratory condition
simultaneously (Miravitlles et al., 2012). For example, having both asthma and COPD,
referred to as Asthma COPD Overlap Syndrome (Barnes, 2016; Barrecheguren et al.,
2020; Bujarski et al., 2015). Asthma is also a common chronic respiratory condition,
causing the lining of the airways to become inflamed and narrowed (Hargreave and
Nair, 2009). Asthma COPD Overlap Syndrome describes instances where a patient
has clinical features of both COPD and asthma simultaneously. It is important to note
that COPD and asthma differ in the nature of their inflammation, and as a result, require
different respiratory medication (Murphy, 2019). However, characteristics of COPD
and asthma can be similar, leading to misdiagnosis in practice due to uncertainty
(i.e. people with COPD being diagnosed as having asthma and vice-versa) (Arne
et al., 2007; Bellia et al., 2003; Buist, 2003; Fletcher and Pride, 1984; Murphy, 2019;
Tinkelman et al., 2006).
The main cause of COPD is cigarette smoking, although second-hand smoke in-
halation, air pollution, breathing noxious materials, and having an alpha-1-antitrypsin3
deficiency are also causes of COPD (British Lung Foundation, 2016; Goldklang et al.,
2013; Hu et al., 2010; Mannino and Buist, 2007; National Heart, Lung, and Blood
Institute, 2019; Viegi et al., 2001). People that develop COPD usually begin to ex-
perience symptoms after the age of 40 or 50 (Jarad, 2011; Marcus et al., 2015;
Shavelle et al., 2009; World Health Organisation, 2016) or when their condition has
advanced (Gulsvik, 2001), but people can develop COPD at any age (Morice et al.,
2010). People with COPD will experience breathlessness, frequent chest infections,
3Alpha-1-antitrypsin is a protective enzyme inhibitor produced by your liver. When you have
a deficiency of alpha-1-antitrypsin, you are more vulnerable when inhaling certain substances like
cigarette smoke.
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wheezing, and fatigue. These symptoms may be experienced on a regular basis or
exacerbated by specific triggers. Triggers make it difficult for individuals to engage in
everyday life such as leaving their home, socialising, and dressing or washing oneself.
Triggers can include respiratory viral infections, common colds, physical exertion,
smoke inhalation, and environmental factors such as high pollen counts and air pollu-
tion (British Lung Foundation, 2018; Hu et al., 2010; Johnston et al., 2017; McManus
et al., 2008; Sama et al., 2017).
Triggers can cause an ’exacerbation’ of the condition. An exacerbation is a
health event that is characterised by a change in a person’s baseline breathlessness,
cough, or sputum (phlegm) that is considered unusual for that person (i.e. outside
of their normal day to day symptom variations) (Hurst and Wedzicha, 2007). An
exacerbation is usually acute in nature and may warrant a change in the person’s
medication (Calverley et al., 2003; Hurst and Wedzicha, 2007). For example, they
may be prescribed antibiotics or steroids to manage the exacerbation or require a
change in their daily medication. Exacerbations can be infective (caused by bacterial
infection and treated with antibiotics) or non-infective (caused by factors such as the
environment and comorbidities, which are not treated with antibiotics) (Ko et al.,
2016; National Institute for Health and Care Excellence, 2019; Qureshi et al., 2014;
Sapey and Stockley, 2006).
The symptoms of COPD can place restrictions on people’s lives. For example,
physical and social restrictions introduced by the condition can cause people to feel
depressed and anxious (Cicutto et al., 2004; Clari et al., 2017; Maurer et al., 2008;
Stage et al., 2006; van Manen et al., 2002; Yohannes and Alexopoulos, 2014). Similarly,
feelings of constant breathlessness can cause people to feel fearful of being alone in
case exacerbations occur (Powell et al., 2013). As such, the condition journey is one
that can involve severe social and emotional challenges.
17 2.1. Understanding Chronic Obstructive Pulmonary Disease
2.1.1 Diagnosis
The three main criteria to consider when deciding whether to test a patient for COPD
are outlined by National Institute for Health and Care Excellence (2010a) as follows:
(1) the patient is a smoker or has been in the past; (2) the patient is over 35 years
of age; and (3) the patient presents with at least one of the following symptoms:
exertional breathlessness, chronic cough, regular sputum production, frequent winter
bronchitis, and wheeze. The diagnosis of COPD usually occurs by the patient taking a
spirometry test (Derom et al., 2008). This is achieved by the patient performing three
forced blows into a spirometer device, which is a medical device that measures lung
function. It does so by calculating the volume, flow, and speed of air that is exhaled by
the patient (Moore, 2012). The results of the test can indicate if the patient’s airways
are obstructed. As part of the diagnosis process, the HCP may also order a chest
radiograph (a technique that uses X-rays to create an image of an internal structure),
a full blood count (measuring the number and types of cells that are in a person’s
blood (NHS, 2016)), and calculate the patient’s body mass index (which calculates if
a person’s weight is healthy in relation to their height) (National Institute for Health
and Care Excellence, 2010a). If there is diagnostic uncertainty, the HCP may refer
the patient to see a respiratory specialist for clarification (Conway et al., 2015). This
referral is also made if the patient is found to be very severe and needs specialist
input (Conway et al., 2015).
If a diagnosis of COPD is confirmed then the patient will be prescribed medi-
cation to help manage their symptoms and daily life. The prescribed medication will
depend on the patient’s needs, but usually includes steroid inhalers which are used to
prevent symptoms and bronchodilator inhalers (‘rescue inhalers’) which are used to
manage flare ups (British Lung Foundation, 2019). To assist the intake of medication,
patients may use a spacer or a nebuliser. Spacers are plastic containers which sit
between the inhaler and the patient’s mouth, by spraying the inhaler into the spacer
the medication can be inhaled at an easier pace. A nebuliser is a device which admin-
isters the inhaler medication in the form of a mist, connected to the patient’s mouth
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through a mask, which makes it easier to inhale. In more severe cases, patients may
be prescribed oxygen to use at home for a certain number of hours each day to assist
with breathing (Rous, 2008). A ‘rescue pack’ may also be given to patients, which
contains emergency antibiotics and steroid tablets to take at the onset of an exacerba-
tion (Schomberg et al., 2011). It is thought that by issuing rescue packs, patients can
treat themselves at home in a timely way to avoid hospital admissions (Schomberg
et al., 2011).
The timely treatment of exacerbations is important, as delaying treatment can
lead to worse health outcomes for patients (Wilkinson et al., 2004). However, pre-
scribing a rescue pack is at the discretion of the HCP. For example, some HCPs are
concerned whether patients are educated enough about when they should use their
rescue pack, with some HCPs holding the belief that antibiotics should only be taken
under their explicit instruction (Davies et al., 2014; Robinson, 2018). Whereas other
HCPs have discussed that rescue packs can help patients to quickly manage their
condition on their own without needing to wait for an appointment to see a doctor
during an exacerbation (Davies et al., 2014).
Previous work has noted how patients with COPD generally have a low adher-
ence to their prescribed medication by underusing it (Arnold et al., 2011; Rand, 2005;
Restrepo et al., 2008). Studies that track medication adherence have shown that some
patients ‘dump’ their medication to appear to HCPs that they are adhering (Dolce et al.,
1991). Non-adherence to medication is thought to be influenced by numerous factors
including patients’ understanding of their condition, disagreement with physicians’
prescribing choices, and lack of confidence in prescribed medication with a prefer-
ence for natural remedies to treat symptoms (Antonelli et al., 2001; Dowson et al.,
2004b; George et al., 2005; Restrepo et al., 2008; Turner et al., 1995).
After a confirmed diagnosis of COPD, patients will receive information about
how to manage their condition by their HCP. This information will centre mostly on
how to avoid exacerbations, which can lead to emergency hospital admissions and
worsening of the condition (Rennard and Farmer, 2004; Wedzicha et al., 2014).
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2.1.2 Ongoing Management
Following diagnosis, patients will be encouraged to effectively self-manage their con-
dition at home as part of everyday life. As COPD is a progressive chronic condition,
it requires ongoing management from the patient themselves, carers, and HCPs. Self-
management and self-care can help improve the quality of life for the patient, and
potentially save healthcare costs significantly (Bourbeau et al., 2006; Cannon et al.,
2016; Department of Health, 2011; Zwerink et al., 2014). ‘Self-management’ focuses
on managing a specific health condition, defined as an ‘individual’s ability to man-
age the symptoms, treatments, physical and psychosocial consequences, and lifestyle
changes inherent in living with a chronic condition’ (Barlow et al., 2002). ‘Self-care’
takes a more holistic approach that considers the person’s life beyond their health
condition, being defined as ‘activities performed by individuals or communities to
achieve, maintain, or promote maximum health’ (Richard and Shea, 2011). Effective
self-management and self-care is an important part of living with COPD. Education
about self-management can help individuals to improve their quality of life, physical
function, and avoid hospitalisation (Gadoury et al., 2005; Yu et al., 2014).
Carers, such as family members and friends, can support daily life for people with
COPD by providing emotional and physical support (Gardiner et al., 2010; Seamark
et al., 2004). For self-management, people with COPD will carry out actions and
activities such as avoiding triggers, taking medication as prescribed, smoking cessation
(if the patient is a current smoker), annual influenza vaccinations, using their inhaler
correctly, and daily exercise (AL-Jahdali et al., 2013; Bekkat-Berkani et al., 2017;
Cicutto and Brooks, 2006; Effing et al., 2011, 2012; Pesek and Lockey, 2011; Pothirat
et al., 2015; Tønnesen, 2013). However, there are more subtle and unique challenges
that individuals with COPD will have to address as part of the ongoing experience
of their condition. For example, learning to adjust to the physical limitations that
COPD introduces, and dealing with perceptions of ‘dying’ that impact emotional
health (Cicutto et al., 2004; Giacomini et al., 2012; Seamark et al., 2004). These
challenges extend beyond what can be learnt from the HCP, and instead are learnt
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through the unique lived experience of the condition.
In some instances people may be advised to keep track of their symptoms
to support their self-management. For example, by taking regular readings on a
peak flow meter (a mechanical device that measures expiration speed) or keeping a
diary of their symptoms to discuss during periodic reviews with HCPs (In ’t Veen
et al., 2014; Kulich et al., 2015; van Kruijssen et al., 2015; Walters et al., 2012;
Worth, 1997). During annual reviews with their General Practitioner (GP) or practice
nurse, patients will usually undertake a spirometry test to compare and monitor lung
function over time. If the patient is having difficulties managing their condition, they
may be referred to healthcare services or professionals that can help; for example:
smoking cessation services (services that help patients to stop smoking); pulmonary
rehabilitation classes (exercise and education classes aimed at supporting patients
with respiratory conditions); or an appointment with a respiratory specialist. The HCP
may ask the patient to rate their breathlessness using the Medical Research Council
Dyspnoea Scale during these appointments, to understand the patient’s perceived
respiratory disability in daily life. The Medical Research Council Dyspnoea Scale is
a scale from one (representing ‘not troubled by breathlessness except on strenuous
exercise’) to five (representing ‘too breathless to leave the house, or breathless when
dressing or undressing’) (Bestall et al., 1999; Paladini et al., 2010; Stenton, 2008).
This rating may be used to complement the annual spirometry result, and may be
compared each year or after certain interventions (Elkhateeb et al., 2015).
Between annual reviews, if the patient becomes unwell or exacerbates, they may
make an appointment to be reviewed by their GP. In emergency situations, such as
when the patient is experiencing a severe exacerbation, this process may be bypassed
altogether and the patient will be admitted to hospital for emergency care.
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2.1.3 Summarising Understanding
This section provided an overview of COPD. I discussed its prevalence, symptoms and
causes, the complexities surrounding diagnosis and medication adherence, and the
activities carried out, and challenges experienced, as part of the condition journey. The
following sections review the literature around DSDM in healthcare and the challenges
innovating in the healthcare space, technologies for COPD self-management, and
self-monitoring technologies for COPD and the experiences of their use. Within the
literature review, I identify the relevant gaps in knowledge where my thesis aims to
contribute through my research questions.
2.2 Data Supported Decision-Making in Healthcare
Many academic disciplines are interested in the process of how decisions are made,
including psychology, philosophy, economics, and computer science (Beach and
Connolly, 2005; Boos and Jacquemart, 2000; Bruch and Feinberg, 2017; Herbert,
2000; L. Martin, 2003; Roberts, 2008; Szaniawski, 1980; Turpin and Marais, 2004).
Decision-making describes the cognitive process of considering a set of actions in
a particular context, and choosing the action that will align best with the decision-
maker’s goals and values (Beach and Connolly, 2005; Mill and Bentham, 1987; Sza-
niawski, 1980). Specific to healthcare, clinical decision-making is a complex process
that involves utilising an ensemble of medical knowledge and evidence to make deci-
sions about a patient’s care (Smith et al., 2008). This involves weighing outcomes and
probabilities, while equally trying to assess and balance risks (Hajjaj et al., 2010).
Evidence based medicine is an example of an approach taken for clinical decision-
making whereby the clinician uses their empirical experience, paired with evidence
from clinical research, to optimise their decisions about patient care (Rosenberg and
Donald, 1995; Sackett, 1997). Patients are also actively involved in making decisions
about their own health in their everyday lives, such as when to seek professional
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help, adhering to agreed treatment, and how to adapt their lifestyle to living with
their condition (Broadstock and Michie, 2000; Stacey et al., 2008). ‘Patient em-
powerment’ is a core topic among medical literature, encouraging patients to think
critically about their health and make autonomous informed decisions that improve
self-efficacy (Anderson and Funnell, 2010). In addition to the ways that clinicians
and patients make different types of decisions about care, shared decision-making is
becoming an increasingly common concept to promote patient-centered care (Barry
and Edgman-Levitan, 2012). Shared decision-making is the process whereby clinicians
and patients collaborate during decision-making to aim for outcomes that align with
the patient’s informed preferences (Elwyn et al., 2010, 2012).
In this thesis, I use the term DSDM to refer to the use of pertinent data that
can support and inform decision-making about healthcare. The use of the term ‘data’
here is broad, encompassing any form of data that is pertinent to healthcare decisions.
This is not necessarily limited to digital data, it may include data such as handwritten
notes made by a patient about their symptoms, which can then be used to inform
their care. Using this definition of DSDM, numerous digital health technologies can
be considered DSDM technologies.
For patients, DSDM technologies can be self-management technologies that gen-
erate data which assists the everyday decisions they make about their health (Nunes
and Fitzpatrick, 2015; Nunes et al., 2015). For example, self-monitoring technologies
that provide data support by allowing people to track their health for self-reflection, to
support behaviour change or health goals, and for sharing with others as part of their
care (McBain et al., 2015; Nunes et al., 2015; Schroeder et al., 2019). Nunes et al.
(2015) conducted a detailed review of the different types of technologies that exist
for self-care of chronic conditions, many of which provide DSDM capabilities. For
example, medical devices that provide health readings and apps that use self-tracking
data to provide suggestions about care activities are both types of DSDM (Nunes et al.,
2015).
Numerous digital health technologies provide DSDM support to clinicians, such
as Electronic Health Records, clinical dashboards, clinical decision support systems,
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and computer aided detection systems. Clinicians can also use data generated by
patients to aid the decision-making process (Demiris et al., 2019), such as data about
their symptoms. Clinical decision support systems are a prominent example of how
technology has been explicitly designed to assist clinical decision-making in prac-
tice (Alter, 1977; Berner and La Lande, 2007). Clinical decision support systems are
defined as ‘any computer system that is designed to help a healthcare professional
make a clinical decision’ (Shortliffe, 1987). These support systems can be active or
passive systems (Shortliffe, 1987). Active decision support systems explicitly sug-
gest courses of action for clinicians to undertake (Jimison et al., 2007; Lee et al.,
2018), which are less common due to growing concerns about technology driving
the decision-making process (Jimison et al., 2007; Miller, 1990). Whereas passive
systems offer advice to a clinician only when explicitly sought (Shortliffe, 1987).
An example of a passive clinical decision support system was shown in Cai et al.’s
(2019) study on designing a deep learning system to assist pathologists. The system
helped pathologists to query medical images for possible cancer. In their study, a
pathologist could query the system with a specific medical image and view previous
cases of similar images and their respective diagnoses. Using this information, they
can compare the image at hand with previous images — before making a decision
about diagnosis. Similarly, computer aided detection systems are also being used to
support clinicians with the visual detection of tumours (Litjens et al., 2014; Sampat
et al., 2005; Tang et al., 2009). These systems typically work by using machine
learning techniques to identify potential abnormalities in imaging scans of the human
body, after having been previously trained on a vast number of medical images (Tang
et al., 2009). Computer aided detection systems enable DSDM by assisting clinicians
in the tumour identification process, by presenting its findings to the clinician who
can then further assess the area called into question.
As shown, DSDM technologies feature strongly as part of digital health research
to support patients and clinicians in making decisions about care. This thesis focuses
on DSDM technologies, specifically understanding their potential role for providing
support for respiratory care.
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2.3 Clinical Dashboards for Data Supported Decision-
Making
Dashboards are another form of DSDM technology, which are widely used across
the healthcare domain (Dowding et al., 2015; Iftikhar et al., 2019). Dashboards are
visualisation displays, which in the context of healthcare, aggregate health data in
particular ways to produce insights for users. In literature reviews on dashboards
used to support patient care and decision-making, Dowding et al. (2015) and Iftikhar
et al. (2019) have shown that dashboards have been used to provide DSDM support
for a variety of activities and stakeholders. For example, dashboards have featured
in the healthcare domain for service planning around health insurance costs (Reese
et al., 2013); optimising service administration by reminding healthcare services to
follow up with patients (Croon et al., 2015); business intelligence uses for hospital
logistics and resources (Mahendrawathi et al., 2010); tracking in-patients on mental
health wards (Daley et al., 2013); performance and benchmarking for acute respiratory
infections (Linder et al., 2010); identifying and alerting HCPs about potentially high
risk medication combinations for patients (Waitman et al., 2011); and sharing patient
reported outcome data with HCPs (Hartzler et al., 2016; Iott et al., 2019). As shown,
dashboards are a common tool used to enable DSDM for healthcare delivery.
Previous work has shown how DSDM dashboards have led to positive outcomes
in clinical practice and can be used to manage a range of medical conditions. For exam-
ple, McMenamin et al. (2011) described a dashboard that is linked to electronic medi-
cal records, which provided reminders about health screening targets agreed between
patients and clinicians. The screening targets related to smoking, alcohol consump-
tion, and breast cancer screening. They reported a higher recording of screening tests
about smoking status and alcohol consumption through its use. Whereas Waitman
et al. (2011) created an adverse drug event dashboard combining data from multiple
clinical systems to identify possible high-risk medication prescribing scenarios. They
reported that the dashboard successfully intercepted possible high-risk scenarios. Fi-
nally, Daley et al. (2013) created a dashboard to track in-patients on mental health
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wards. The dashboard tracked features such as length of stay, readmissions, and
available beds. When evaluating the dashboard, they found HCPs felt they had better
access to required information, improved awareness, and improved communication.
These studies serve as examples of how DSDM technologies hold potential to facilitate
improvement in patient care and support the work of HCPs.
However, most research on DSDM dashboards have focused on evaluating the
clinical effectiveness or clinical outcomes achieved using the technology4 (Daley et al.,
2013; Dolan et al., 2013; Dowding et al., 2015; Faiola et al., 2015; Iftikhar et al., 2019;
Linder et al., 2010; Waitman et al., 2011). Though this type of evaluation is important
for understanding the effectiveness of the technology, there is a lack of rich qualitative
insight from users about the technology during these evaluations. That is, these stud-
ies do not contribute an understanding of what makes these technologies effective
(or not) from a qualitative, user-centered perspective (Kaplan, 2001a,b; Kaplan and
Maxwell, 2005). Moreover there is a lack of understanding about how these effective
DSDM technologies have been designed in the first place. This understanding can
reveal important procedural, cultural, and technical challenges (or sociotechnical chal-
lenges5) that arise behind the scenes when creating DSDM technologies for clinical
practice. Uncovering these insights can inform how we approach the design of these
technologies, which is important to support their integration in real-world complex
healthcare settings. I plan to widen our understanding of this area when answering
my first research question: ‘how can technology support healthcare professionals in
their decision-making for COPD care?’
4See Dowding et al.’s (2015) comprehensive review on the evaluation outcomes of dashboards that
are designed to improve patient care.
5Ackerman et al. (2017) describes sociotechnical considerations for healthcare as those which
‘investigate the analysis, design, implementation, and adaptation of systems that incorporate both the
technical and the social’.
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2.4 Exploring the Challenges of Designing Technology
for Healthcare
Designing DSDM technologies for healthcare is a challenging task due to the complex
nature of how clinical work is carried out. There are notable challenges with collecting
and accessing data within the healthcare domain, which makes designing DSDM
technologies particularly complex. For instance, clinical data can be incomplete and
recorded inconsistently (Axelrod et al., 2011; Rowlands and Callen, 2013). An example
of this is coded6 data. Typical issues with coded data are the use of multiple codes
to demarcate the same condition, or coding too generally (for example that a doctor
chatted with a patient instead of coding for the actual condition) (Axelrod et al., 2011;
Campbell et al., 2001; de Lusignan, 2005; O’Malley et al., 2005; Santos et al., 2008;
Sunderland, 1985). This makes extracting data for analysis in new systems challenging,
as it can be difficult to rely on this data to correctly identify patients being treated for
a certain condition.
Another prominent challenge when designing technology for healthcare is that
healthcare services may still use a combination of paper and handwritten notes to
record data (Fitzpatrick and Ellingsen, 2013). The benefits of paper notes include their
communicative flexibility, portability, and availability to clinicians (Fitzpatrick and
Ellingsen, 2013; Heath and Luff, 1996; Luff and Heath, 1998). However, handwritten
notes are difficult to analyse due to their unstructured nature, illegibility of handwriting,
and the cost of anonymising data in free-text format (Axelrod et al., 2011; Collard and
Royal, 2015; Long, 2003; Xu et al., 2007). As paper notes exist outside of digital
systems, it can be challenging both practically and financially to integrate this large
volume of information onto DSDM technologies. This potentially excludes key data
6Coded data is produced by a coding professional or a HCP, who will assign a code relating to the
assumed condition as described in the patient’s clinical documentation. These codes are then used to
describe a patient’s health event and for insurance purposes (Clayton and van Mulligen, 1996).
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from being collated within systems, ultimately impacting the type and quality of
support that is offered.
Additionally, sharing patient information between HCPs and between health-
care organisations can be particularly difficult. Interoperability7 challenges between
clinical systems remains a key issue that can limit HCPs from sharing and access-
ing data they require to effectively treat a patient (Atasoy et al., 2019; Azarm-Daigle
et al., 2015; Benham-Hutchins, 2009; Brailer, 2005; Chong et al., 2013; Everson and
Adler-Milstein, 2018; Fisher et al.; Fitzpatrick and Ellingsen, 2013; Holen-Rabbersvik
et al., 2018; Holmgren AJ, 2017; Musen et al., 2014; Olaronke et al., 2013). Adding
to this, the increasing digitisation of healthcare information within different clinical
systems, which lack interoperability, introduces significant ‘data work’8 for healthcare
staff (Bossen et al., 2019). This requires the active reorganising of work practices to
support the creation and use of healthcare information — which is exacerbated by
data intensive clinical systems (e.g. electronic health records) (Bossen, 2020; Bossen
et al., 2019; Møller et al., 2020; Piras, 2011). This demonstrates how the introduction
of new technology into clinical practice can have unintended negative consequences
for healthcare staff.
Previous research has documented the dissatisfaction that HCPs have when
engaging with existing clinical systems, such as systems being hard to use and be-
ing poorly developed (Weimar, 2009); difficulty searching for key information within
patient records and notes (Christensen and Grimsmo, 2008); and not supporting
clinical tasks effectively (i.e. treating medical work as a straighforward, linear pro-
cess) (Benham-Hutchins, 2009). These areas of dissatisfaction stem from how these
technologies are designed. In some cases, these pain points can lead to HCPs creat-
7Interoperability is related to the ability of distributed systems to work together (Gortzis, 2010).
8Bossen et al. (2019) defines data work as ‘any human activity related to creating, collecting,
managing, curating, analysing, interpreting, and communicating data’.
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ing workarounds to achieve the work which the system hinders, leading to the data
within the clinical systems being inaccurate or flawed (Beerepoot and Van de Weerd,
2018; Hartswood et al., 2003a; Pine and Mazmanian, 2014). On a similar note, the
complexity of organisational work in clinic settings means that records may appear in-
accurate and require contextual interpretation to make sense of the data (Clarke et al.,
2006). Though this is not the result of a workaround, it further highlights important
challenges for DSDM technologies which aggregate and visualise this data.
The challenges with data quality, format, access, and accuracy are all examples
of the complexities involved when designing technology for healthcare. Moreover,
the introduction of new clinical systems can cause significant additional work for
healthcare staff. This has direct implications for how DSDM technologies are designed
and deployed from a sociotechnical perspective. As such, it is crucial to take these
challenges into account when designing DSDM technologies for healthcare. This
can be achieved through taking a user-centered design approach to understand the
needs of HCPs and their work environment. Indeed, a small number of studies
have documented the process of working in partnership with HCPs to design DSDM
dashboards which consider their needs (Bardram and Nørskov, 2008; Hartzler et al.,
2016; Iott et al., 2019; Sarcevic et al., 2018; Swartz et al., 2014). However, fewer
studies appear to have examined the complexities of the clinical context which the
DSDM tool is being designed to support (Bardram and Nørskov, 2008; Sarcevic et al.,
2018). These insights and experiences are important to document and share across
the HCI community to inform how we approach the design and real-world deployment
of DSDM technologies for healthcare.
Bardram and Nørskov (2008) involved a team of HCPs and hospital managers
when designing a context-aware dashboard for patient safety in operating theatres.
They worked with HCPs to understand their daily challenges and data needs, before
creating initial designs and iteratively evaluating them in-situ together. From this
collaborative process and the in-situ evaluation, they were able to revise the design
of the dashboard to take into account the complexities and real-world environment of
operating theatre work. For example, excluding audio warnings from the system (as
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trauma patients may be awake); requiring limited user feedback (as not to be obtrusive
and impair the team’s focus); supporting the immediate correction of high-risk errors
(as to keep up with the fast-paced environment); and the use of a large display (which
limited the need for user interaction and supported easy viewing of information).
Sarcevic et al. (2012, 2018) also actively involved HCPs during the design of a
dashboard that combines and displays emerging information about patients in trauma
resuscitation. The aim of the DSDM dashboard was to support timely information
access and promote team awareness. During the collaborative design process, they
defined data needs and how paper-based information should be captured and visu-
alised. However, they also placed a strong emphasis on understanding the wider
context of how trauma resuscitation work is carried out. To do this they conducted
observations, followed by simulations of the system in the trauma room to evalu-
ate their designs. From this, they developed a stronger understanding about how
decision-making is achieved in fast-paced trauma settings. This was reflected in their
adapted system design, for example: avoiding the use of an additional interface for
data entry (which would be too time-consuming and distracting for the team); sup-
porting dynamic information visualisation (as the trauma team learn more information
about the patient’s situation); and working with HCPs to understand the most re-
quired information for visualisation rather than including all the data needs (as this
could cause information overload during resuscitation).
The studies by Bardram and Nørskov (2008) and Sarcevic et al. (2012, 2018) are
important examples which highlight the value obtained by examining the wider work
practices and environments that DSDM technologies are designed for. This involves
taking into account the challenges using and responding to data during decision-
making, which include the data quality, format, access, and accuracy concerns dis-
cussed earlier. Working in partnership with healthcare staff can help to explore these
factors in more detail and understand their subsequent implications for DSDM tech-
nology design and use. However as it stands, limited HCI work has examined the
multifaceted complexities specific to the design of DSDM technologies for healthcare.
Studies have noted the complexities of designing technology for healthcare settings
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more generally (Ackerman et al., 2017; Thieme et al., 2016). For example, Thieme
et al. (2016) discussed the difficulties of integrating research into hospital services and
the cultural changes needed to introduce research projects onto hospital wards. They
stressed the need for healthcare staff to be appropriately trained to effectively engage
with new technology interventions.
Ackerman et al. (2017) emphasised the importance of taking a sociotechni-
cal approach when designing healthcare technologies to ensure they are suitable
for real-world contexts. They highlighted four important considerations for effec-
tive healthcare technology design. The first consideration advocates that designers
and researchers dedicate time to understand the meaning, value, and logic behind
healthcare practices. The second consideration focuses on understanding the social
relationships, interactions, and processes that occur between patients and HCPs, to
understand how technology may make these processes more effective. The third in-
volves the identification of the multiple real-world stakeholders involved in healthcare
work (HCPs, patients, family, carers, volunteers), and how their different perspectives
can be considered in the design process. The forth and final consideration is about the
importance of taking a participatory design approach to ensure the clear identification
of stakeholder needs, experiences, and barriers.
As shown, the work by Thieme et al. (2016) and Ackerman et al. (2017) provide
valuable lessons for navigating the challenges involved when designing technology for
clinical practice. However, there is a requirement to further understand the challenges
when designing DSDM technologies specifically. With the wealth of growing research
on DSDM technologies in healthcare, this insight is increasingly needed to advance
our understanding of how to effectively design and develop these technologies (Liu
et al., 2006; Smith, 1996). This thesis aims to contribute this insight by working in
partnership with healthcare staff to understand how DSDM technology can feasibly
support COPD care. This will be explored while answering my first research question:
‘how can technology support healthcare professionals in their decision-making for
COPD care?’
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2.5 Technologies for COPD Self-Management in Digital
Health Literature
While the previous sections focused on DSDM in clinical settings, this section focuses
on technologies that support self-management and self-care of people with COPD.
There is an abundance of HCI research about how technology can be used to support
self-management and self-care for a variety of chronic health conditions (Fitzpatrick
and Ellingsen, 2013; Nunes et al., 2015). Effective self-management is a crucial part
of chronic condition care (Grady and Gough, 2014), and the rise in personal device
ownership presents numerous opportunities for technology to support healthcare
delivery and management (Klasnja and Pratt, 2014; Ofcom, UK, 2013; World Health
Organization, 2011b).
Nunes et al.’s (2015) review of 29 HCI papers about self-care demonstrated
how digital health technologies have been designed for a range of chronic condi-
tions. They reviewed many technologies designed to support reflection on symp-
toms; suggest and share information about self-care activities; promote collaboration
between patients and their care network; and provide opportunities to learn from oth-
ers with the same condition. These technologies include mobile health technologies
(or mHealth, which is the use of mobile devices to support a health practice (World
Health Organization, 2011a)), telemonitoring technologies (transmitting data about
health between geographically separated individuals (Maric et al., 2009)), and wear-
able technologies (devices worn on the body that produce data about the wearer or
their surroundings (Piwek et al., 2016)). In short, how technology can be used to
support self-management and self-care has been a prominent area of interest within
HCI research.
Understanding how technology can support the everyday self-management and
self-care practices of people with COPD is an area which has been relatively unex-
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plored in previous research9. When research on COPD has been explored in this area,
machine learning research studies have dominated. These machine learning studies
have largely involved using techniques to predict exacerbations or deterioration of
chronic respiratory conditions at home through sensor technology (Anastasiou et al.,
2018; Chatterjee et al., 2019; Fernandez-Granero et al., 2018; Gokalp and Clarke;
Hofer et al., 2015; Larson et al., 2012; Merone et al., 2014, 2016; Nathan et al.,
2019a,b). For example, these studies have accurately predicted exacerbations or res-
piratory difficulty using pulse oximeter10 and heart rate readings (Gokalp and Clarke;
Merone et al., 2014, 2016), home-based spirometry readings (Anastasiou et al., 2018;
Larson et al., 2012), and voice and respiratory acoustics (such as wheezing, breathing,
and talking) (Chatterjee et al., 2019; Fernandez-Granero et al., 2018; Nathan et al.,
2019a,b).
For example, Anastasiou et al. (2018) created an mHealth system for monitoring
and predicting asthma exacerbations seven days in advance through machine learn-
ing. The system provides a way for HCPs to passively monitor the patient’s status
during an exacerbation period, using parameters such as medication usage, peak flow
readings, and daily responses to a clinical questionnaire. A different approach was
taken by Chatterjee et al. (2019) to detect respiratory deterioration, as they created a
wearable device to monitor COPD and asthma patients’ abnormal lung sounds, such
as wheezing. Their system used machine learning techniques to characterise patients’
wheezing as either ‘high severity’ or ‘low severity’, which can be used to indicate the
severity of their condition. Though these techniques demonstrate clear potential for
supporting the detection of condition decline in COPD, these studies focus on the
9Nunes et al.’s (2015) review of 29 HCI papers on self-care only included two papers on COPD
self-management.
10A pulse oximeter is a small digital device that non-invasively measures your oxygen saturation
levels (i.e. the oxygen levels in your blood). The result is indicated as a percentage, with a healthy
person’s reading usually being between 95-100% (British Lung Foundation, 2020).
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technical feasibility and accuracy of algorithms compared to understanding patients’
needs in the first instance.
The HCI studies that have focused on designing technology for COPD have
looked to support patients in practicing rehabilitative and breathing exercises (Pereira
et al., 2016), some of which have included HCPs in the process where they can directly
support the patient (Spina et al., 2013; Taylor et al., 2011). For example, Taylor et al.
(2011) examined how people with moderate to severe COPD who live far from clinics
can participate in pulmonary rehabilitation (PR) classes at home. They developed a
home-based PR programme using video conferencing technology, reporting clinical
improvements for all four participants enrolled onto the study (compared to traditional
PR programmes). This intervention addresses an important challenge about the acces-
sibility of essential interventions for people with COPD. However, the study focused
on the creation of a therapist-supported tool to make existing rehabilitation classes
more accessible; it does not widen our understanding about COPD self-management
outside of supervised support.
Similarly, Spina et al. (2013) created an mHealth app that uses sensors to sup-
port people with COPD (and cardiovascular disease) to exercise, by providing real
time corrective feedback on performance. They tested the system with seven COPD
patients under supervision of a therapist, asking them to conduct exercises while using
the system. They found that patients were often able to correct their exercises as a
result of the system’s feedback. The study provided a proof of concept about the fea-
sibility of using smartphone sensors to support exercise in COPD patients. However,
it did not evaluate how this technology is being used in practice by patients and how
it may be supporting COPD self-management more widely.
Pereira et al. (2016) designed an exercise mHealth app that could be used by
people with COPD without supervised support. The app created rehabilitative exercise
sessions and allowed patients to share their exercise data with caregivers and on social
networking websites. The app was evaluated by 10 participants in terms of how well
they could navigate the app, complete tasks, and their overall experience of using it.
Participants noted the app’s features were useful. However, the study only collected
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basic data on user experience, which lacks insight into how participants could envisage
using the app beyond the study to support their self-management. Moreover, it does
not explore the acceptability of sharing exercise data or where this design decision
came from.
A limited number of computer science studies (within and outside of HCI re-
search) have explored other types of technologies to support COPD self-management.
For example, improving air quality in the home for people with chronic respiratory
conditions (Kim and Paulos, 2009), and tracking parameters such as their symp-
toms, activity levels, and environment (Beattie et al., 2014; Brunschwiler et al., 2017;
Johnston et al., 2009). However, even fewer of these studies appear to have actively
involved people with COPD to understand their needs in a capacity beyond testing the
technical validity of the technology (Beattie et al., 2014; Johnston et al., 2009).
For example, Kim and Paulos (2009) created the inAir tool to measure, visualise,
and educate people with chronic respiratory conditions about the air quality in their
homes. They used an air quality sensor, iPod Touch, and a microcontroller to count
the particles in the air which creates visualisations on the iPod Touch. They conducted
a user study involving five households for a two week period to engage with the inAir
tool. They found the visualisations improved participants’ awareness of air quality in
their homes, and motivated them to improve the air quality. Though the tool helped
participants to learn about, and reflect on, air quality, they did not appear to recruit
people with chronic respiratory conditions in the user study to understand how this
may benefit or impact their health.
Brunschwiler et al. (2017) created an mHealth intervention tool to track numer-
ous parameters that can inform COPD patients about their health. For example, they
used the camera and microphone on a smartphone to detect sputum colour changes
and coughing; a smart inhaler to track medication adherence; a smart spirometry to
track lung function; an activity and vital sign monitor to capture data on the patient’s
vital signs and energy expenditure; and environmental sensors to detect characteris-
tics about the room the patient is in. The system uses a virtual assistant to provide the
patient with information on their condition and reminders to track their symptoms.
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They noted the parameters that they chose to track have been grounded in previous
work, such as physical activity being a predictor for COPD exacerbations. However,
to date, the system has not been trialled with any patients and there is no feedback
about the effectiveness of the system for enhancing self-management.
Beattie et al. (2014) created the COPD Activity Lifestyle Support (CALS) system.
The system collects and displays a variety of information relevant for self-management.
CALS collects how the patient is feeling through a questionnaire, physiological data,
sleep data, and has features to support activity goal setting and provide educational
material about COPD. The design of CALS was based on patients’ needs which were
identified through a secondary analysis of existing literature. They included HCPs in
the design of the tool, and feedback from patients during trials of the tool. However,
the design process involving HCPs and patients is underreported in their work, with
no explicit mention of how they were involved and their feedback (Beattie et al., 2014).
Moreover, follow up studies detailing how the CALS system has been used by patients
have not yet been published.
Finally, Johnston et al. (2009) involved COPD patients in the design of a tool to
support collaborative monitoring of respiratory symptoms and exercises. They first
interviewed eight COPD patients to understand their experience having used tech-
nology to manage their breathlessness through education, exercise, peer interaction,
and nurse support. The researchers then used this perspective to create prototypes
of their monitoring tool before conducting usability testing with three COPD patients.
They found that patients responded positively to the tool, though visualising symptom
data prompted a negative reaction from one participant, who preferred not to think
about their symptoms each day. Though the study took a user-centered design ap-
proach that considered the perspectives of COPD patients, the paper mainly focused
on usability of the system and did not discuss user needs in detail. However, they
did note that their tool was designed for an ‘average user’ and future work should
consider tools that are more reflective of the heterogeneous COPD population.
As shown, some studies have focused on designing and building technology
to support COPD by enabling the detection of exacerbations, rehabilitative exercises,
36 2.6. Personal Health Data for Data Supported Decision-Making
awareness of air quality in the home, and tracking numerous physiological and environ-
mental parameters. Most of the examined literature focused on testing the feasibility
and validity of a pre-conceived intervention tool, or have designed tools that have a
clinical focus. However, there is a need to understand the wider context of COPD
self-care as a starting point so that technology can be designed with people’s specific
needs at the forefront. Self-care is not a passive activity, but an active combination
of important processes that the individual will undertake to improve their wellbe-
ing (Nunes and Fitzpatrick, 2018). COPD self-care is rooted in the social, physical,
and emotional difficulties faced by the individual, which can affect their desire and
motivation to fulfill certain self-care practices (Cicutto et al., 2004).
It is important to understand what technologies individuals may find valuable to
support daily living with COPD, and how they may integrate these technologies into
their lives. In their review of self-care technologies in HCI, Nunes et al. (2015) high-
lighted the importance of focusing on non-medical aspects of a person’s condition,
to consider a more holistic picture of what self-care looks like in reality. This thesis
aims to address these limitations in the literature by underpinning the lived challenges
that people with COPD face, through actively collaborating with them to answer my
research questions. Ultimately this will answer my second research question: ‘what
is the lived experience of COPD, and how can technology support this experience?’
Once this is better understood through involving people with COPD directly in re-
search, researchers and designers will be more knowledgeable about how technology
could support their real needs.
2.6 Personal Health Data for Data Supported Decision-
Making
While the previous sections focused on DSDM technologies for clinical decision-
making and technologies to support COPD self-management, this section focuses on
uniting these activities to enable DSDM for ongoing COPD care. Technology can
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enable DSDM by supporting patients to track and monitor their symptoms outside of
clinic settings, which they can then share with people in their care circle (such as their
HCPs or caregivers) (Cohen et al., 2016; Pang et al., 2013). ‘Self-monitoring’ or ‘self-
tracking’ refers to the conscious recording of specific features in a person’s life (such
as features about their health) (Lupton, 2014b). The self-monitoring process may be
a patient or clinician initiated process (Zhu et al., 2016), meaning that the patient
may decide themselves that they wish to self-monitor their symptoms or may so do
at the advice of a clinician. The data can then be used to support decision-making
about care, such as by personalising self-management plans; considering specific
interventions; goal setting; or changing medications (Chung et al., 2016; Mentis et al.,
2017; Schroeder et al., 2017; Zhu et al., 2016). Though this data can be shared with
different people in the patient’s care circle, this section focuses specifically on sharing
this data with HCPs for DSDM (Holman and Lorig, 2000).
Personal health data is collected by individuals so they can understand, and
reflect on, characteristics about their health (Li et al., 2010; Rapp and Cena, 2016).
When this data is shared and used within clinical contexts, it is described as ‘patient-
generated data’ (Shapiro et al., 2012). This data can be viewed collaboratively in clinic
settings, such as when patients bring paper-based or digitally self-tracked data about
their condition to appointments with their HCPs (Chung et al., 2016; Mentis et al.,
2017; Schroeder et al., 2017; West et al., 2016, 2018). It can also be shared remotely
with HCPs through practices such as telemonitoring. During the telemonitoring
process, patients will use equipment provided by their healthcare provider to monitor
predetermined variables about their health, which are sent to the HCP. The HCP will
then view and interpret the data, making contact with the patient in instances where
there are outliers. In both instances of sharing patient-generated data (in clinic settings
and remotely), HCPs have an active role in viewing the data to consider its meaning
in context to the patient and their management.
Understanding the self-monitoring process as experienced by patients them-
selves is important for exploring how technology may support and enhance this prac-
tice. In-the-wild studies are a particularly valuable way to explore this, as they provide
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organic insights into the patients’ experiences of engaging with the self-monitoring
process (Klasnja et al., 2011; Mamykina et al., 2015; Rogers et al., 2013). When
patient-generated data is shared with HCPs for decision-making, it is additionally im-
portant to explore their experiences of receiving this data. Incorporating the HCPs’
perspective alongside the patients’ is key for understanding how patient-generated
data could be feasibly used in practice to support collaborative self-management and
DSDM. This full picture understanding can help researchers consider the potentially
different requirements that patients and HCPs will have for this process.
The practice of self-monitoring health conditions has been of strong interest to
the HCI community (Bardram et al., 2012; Ferrario et al., 2017; Gronvall and Verde-
zoto, 2013; Kim et al., 2019; Lupton, 2013; Mishra et al., 2019; Nunes et al., 2015;
Schroeder et al., 2017; Vega et al., 2018). However, studies reporting the experiences
of self-monitoring COPD symptoms specifically is fairly scant within previous work
(both within and outside of HCI research) (Brunton et al., 2015; Dahl et al., 2018;
Huniche et al., 2013; Nadarajah et al., 2019). Some studies in this space have focused
on the creation of novel technologies that can support self-monitoring of COPD, rather
than exploring how these technologies are used and experienced by people with the
condition (Hofer et al., 2015; Larson et al., 2012; Xu et al., 2013).
The studies that do explore patient experiences of self-monitoring their COPD
have focused primarily on telemonitoring contexts (Brunton et al., 2015; Dahl et al.,
2018; Huniche et al., 2013; Nadarajah et al., 2019). For example, Nadarajah et al.
(2019) explored self-tracking needs and concerns of six COPD patients in a telemoni-
toring context. Patients participated in telemonitoring to track objective and subjective
data three times a week for at least three months, including: pulse rate, oxygen sat-
uration levels, weight, and questions about symptoms. Hospital staff made contact
with patients on occasions where data deviated from patients’ normal range. The
study reported that patients were motivated to track their symptoms as they felt a
sense of security that HCPs were connected in the process. However, they noted
that patients opted to under-report their symptoms when they were unsure how their
symptoms compared to their usual baseline. Moreover, patients could not report
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what they learnt from self-monitoring their symptoms as they did not have access to
their own data throughout the study. Though the study provided valuable insights
into the patient experience of self-monitoring (as a process), the study was limited
in that the patients were not able to use the data to enhance their self-management.
Moreover, the HCPs’ perspectives were not explored in the study.
Dahl et al. (2018) uncovered similar findings to Nadarajah et al. (2019), their
study focused on the values and tensions that emerge through the process of tele-
monitoring – with an emphasis on patient safety. They interviewed both COPD
patients and HCPs about their experiences participating in a telemonitoring interven-
tion. Patients used a web-based questionnaire where they rated their symptoms for
10 weeks, and if their symptoms appeared aggravated they received a call from a HCP.
The study reported that patients felt positive about the intervention, and placed value
in the added safety of the HCPs’ involvement. However, they also found that patients
under-reported their symptoms to avoid ‘burdening’ the HCPs. The HCPs thought
the telemonitoring process was beneficial as patients had become more active in their
own management. However, HCPs were concerned about how to interpret irregu-
lar or underreported data, and highlighted the additional work involved in providing
support to patients over the phone during the study. This study takes a full picture
perspective by exploring the experiences of both patients and HCPs. However, the
study focused on patient safety, and while this is an important perspective, there is
an opportunity to extend this research by considering broader factors outside of this
lens. This can help to build a stronger understanding of the COPD self-monitoring
process, and how patient-generated data may contribute to DSDM in practice.
Brunton et al. (2015) reviewed 10 papers (relating to seven studies, five of
which were randomised control trials11) which qualitatively evaluated the patient and
11Randomised control trials of technology in this context usually involves assigning participants to
one of two groups, one exposing the participant to the intervention (in this case, the clinical system)
or the second ‘control group’ (utilising conventional care without the system). The system’s impact is
then studied (Liu and Wyatt, 2011).
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HCP experience of COPD telemonitoring studies (only three studies explored both
perspectives). They reported three prevailing themes relating to user experience across
the seven studies. The first was how telemonitoring helped to validate patients’ health
concerns which encouraged them to seek help when needed. Though one study
reported concerns from HCPs that telemonitoring may promote patients to become
fixated on the data and dependent on HCPs during periods of ill health (Fairbrother
et al., 2013). Some studies reported that patients used the data that they had generated
to enhance their self-care independently.
The second theme related to the change in interactions between the patient and
HCP, as telemonitoring changed the type of contact (face-to-face to remote) and the
frequency (periodically to daily). Patients reported feeling reassured by having more
regular contact with HCPs, and a ‘sense of security’ knowing their data was being
viewed remotely. Though patients viewed the change in interactions positively, three
of the seven studies showed that HCPs had a less favourable experience as they lost
the social and physical context required for a holistic view of care.
The third and final theme related to how telemonitoring transformed the nature
of care work. Patients felt empowered, and welcomed taking a more active role in their
care by conducting monitoring activities typically undertaken by their HCP. Whereas
HCPs reported how telemonitoring increased their workload, due to additional contact
with patients and expectations to install, and deal with, study equipment.
The review by Brunton et al. (2015) synthesised important conceptual insights
into the positive and negative experiences of COPD telemonitoring. They called on
future work to expand on this limited body of literature by qualitatively exploring
how positive experiences are inhibited through telemonitoring. They also discussed
the value of focusing on how specific types of technology interventions may increase
patient self-management and user acceptance. This was raised as they acknowledged
that their study focused on experiences, without considering the specific technologies
used within the studies they had evaluated.
Overall, there are limited studies that explore the experiences of COPD self-
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monitoring. The majority of studies have focused on telemonitoring, and have not anal-
ysed findings about the self-monitoring experience in light of technology (re)design.
From a HCI standpoint, there is a need to explore the experiences of the COPD
self-monitoring from the perspectives of both HCPs and patients to understand how
this can inform design. This exploration allows for a stronger understanding of ex-
periences specific to COPD care, a prevalent chronic condition that requires ongoing
collaborative management (Barton et al., 2015; Kuzma et al., 2008). This thesis aims
to address this gap in the literature by answering the third research question: ‘what
is the lived experience of using self-monitoring technology to share symptom data
between COPD patients and healthcare professionals?’ Once this is better under-
stood, it will inform how self-monitoring technologies should be designed, ensuring
that both perspectives are accounted for. This will support future solutions that aim
to be integrated as part of COPD care in practice.
2.7 Chapter Summary
This chapter has provided a contextual understanding of COPD, including the com-
plexities of diagnosis, ongoing management of the condition, followed by experiences
of living with the condition. Then, I explored the concept of DSDM in healthcare,
which sets the tone for the remainder of this thesis. I reviewed the current literature
around DSDM technologies for clinical decision-making (with a focus on dashboards),
technologies for supporting self-management of COPD, and self-monitoring of COPD
symptoms. The gaps identified in the literature provided motivation for the three
research studies (Chapter 4, 5, and 6). Before introducing these studies, the next




This chapter provides a description and justification of the research methodology
for this thesis. It begins by describing the methodological approach that this thesis
follows. Then I introduce and discuss my qualitative research method and data analysis
approach. Following this I introduce the healthcare setting that research chapters 4
and 6 took place in. This leads to a discussion of the research participants and their
recruitment, including the challenges faced with recruitment. Next, I move on to
discuss the ethical considerations of this thesis. Finally, I conclude this chapter by
discussing the salient limitations arising from this research methodology.
3.1 Methodological Approach
This thesis takes a mixed methods approach. Mixed methods research involves a
combination of different research methods. For example, it can include the use of
both qualitative and quantitative methods (Doyle et al., 2009), or a combination of
methods within one specific methodological paradigm (Johnson et al., 2007b). The
research in this thesis is mostly qualitative, mainly incorporating multiple qualitative
methods and approaches for data collection. Before moving onto the specific data
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collection methods, it is important to first discuss the underpinnings of the main
methodological approaches used for this research.
The aim of this thesis is to understand the role that data supported decision-
making (DSDM) technology could have for Chronic Obstructive Pulmonary Disease
(COPD) care. I take an exploratory design-oriented research approach to achieve this.
Design-oriented research seeks to produce new knowledge by involving design activi-
ties within the research process (Fallman, 2003, 2007). What is primarily contributed
from the process is knowledge arising from studying artifacts and ideas, rather than
producing ‘final’ products (Fallman, 2007). The research in this thesis follows a num-
ber of different user-focused frameworks and processes to produce new knowledge.
The goal is to explore the different contexts, experiences, and needs involved with
COPD care. Therefore, it is appropriate to utilise different methodological frameworks
and techniques to explore these diverse areas of focus. I discuss and compare the
different frameworks and approaches used throughout this thesis below. These are:
user-centred design, human-centred design, and participatory design.
User-centred design (UCD) is a framework used in Human-Computer Interac-
tion (HCI) research that emphasises the importance of focusing on the target user’s
needs at each stage of the design process. Its principles are drawn from numerous di-
verse fields, including computer science, engineering, psychology, anthropology, and
sociology (Ritter et al., 2014). The key to designing user-centred systems is possessing
not only knowledge of technology, but knowledge of people. Norman and Draper’s
seminal work in 1986 helped change thinking about system design. They proposed a
pluralistic approach to designing computer systems, with a focus on the target user as
a starting point of systems design. This contrasted with prior approaches that solely
focused on designing systems that achieved their functional purpose as the goal.
Specifically, Norman and Draper (1986) discussed the importance of design-
ing systems that consider how psychological goals and user intentions can map onto
physical variables of a task on a system. In doing so, systems can be designed that cre-
ate ‘pleasurable engagement’ (p.32) in their use (Norman and Draper, 1986). These
discussions by Norman and Draper (1986) laid the foundations for UCD. What distin-
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guishes UCD from other user-focused frameworks is that it has defined boundaries
between the designer and the user (Sanders and Stappers, 2008). The focus is on the
user whose needs must be understood and satisfied by the designer. However, there
are still a plethora of opportunities in which end users can collaborate with design-
ers in the UCD process. Collaboration can occur during requirements engineering,
prototyping, user testing, and evaluation (Noyes and Baber, 1999).
Human-centred design (HCD) is a user-focused framework that focuses more
explicitly on how systems can have a direct impact on people’s contexts and capabili-
ties (Ritter et al., 2014). Compared to UCD, HCD takes a more holistic consideration
of people’s needs. Gould and Lewis (1985) outlined three core principles of HCD.
The first involves focusing on users and tasks. That is not just identifying their needs,
but understanding the nature of their work, behaviour, and attitudes. The second
principle involves empirical measurement, emphasising the importance of user test-
ing of prototypes for observation and tuning. The third principle involves adopting an
iterative design approach which repeats the previous principles as often as needed.
The emphasis of HCD is on the ways in which technology can change contexts and
activities both within and outside of its use (Ritter et al., 2014). Although elements of
HCD apply to UCD and vice-versa, their key focuses subtly differ.
Participatory design approaches describe methods that promote collaboration
between end users and designers (Carroll and Rosson, 2007). These methods can be
used within UCD and HCD frameworks. Participatory design emerged initially as an
approach to explore how technology could impact the day-to-day activities of workers.
The focus on the workplace arose from the desire to build emancipatory technological
solutions that could support workers to carry out their duties (Bødker et al., 2000; Kraft
and Bansler, 1994). A narrative was then introduced that workers should be involved
in decision-making about how technology is used in the workplace. One notable
participatory design project in healthcare was project Florence, an empowering feat
providing nurses with the ability to influence the design of computer systems that form
part of their daily work (Bjerknes and Bratteteig, 1987). Of relevance to the discussion
on participatory design and empowerment are the tensions observed in recent years
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about the role of technology in healthcare. Specifically the advancing role of artificial
intelligence in clinical care (particularly decision support systems), with concerns
about the prospect of technology ‘replacing’ clinicians through automation (Foley,
2016; Hannah Devlin, 2018; Mazoue`, 1990; Shortliffe, 1993).
Participatory design is similar to co-design, which is also an approach that in-
volves users being embedded in the design process. In fact, Sanders and Stappers
(2008) have argued that participatory design is the same as co-design. However, some
scholars have argued that there are subtle differences between the two (Cantu and Sel-
loni, 2013; Langley, 2016; Spagnoli et al., 2019). For example, Langley (2016) argued
that although co-design enables the involvement of others to contribute to the design
process, the researcher ultimately holds an ‘expert’ role as they manage and own the
process. This is in contrast to participatory design, which Langley (2016) described as
offering more power, democracy, and ownership to participants in the design process
(i.e. rooted in the origins of the approach described previously). When discussing the
approaches used in this thesis, I subscribe to the distinction that participatory design
affords participants a stronger sense of ownership in the design process (Cantu and
Selloni, 2013; Langley, 2016; Spagnoli et al., 2019).
Table 3.1 summarises the approaches used within each research chapter.
Research Chapter
and Short Title
Aim Description of Approaches
UCD Study followed a UCD process to design a DSDM pro-
totype, overall led and managed by me (researcher)
HCD Broader effort employed to understand the nature of
healthcare work and context of care (beyond the spe-




Exploring DSDM for COPD
in clinic settings, realised
through the design of a DSDM
prototype. Participatory
design





Exploring the lived experience
of CRCs and how technology
could support this experience
HCD Sought to explore the lived experience of CRCs, by
understanding the context of self-care, and perspec-




Exploring the lived experience
of self-monitoring symptoms
and sharing this data with HCPs
HCD Sought to examine the organic experiences of self-
monitoring and sharing symptom data. A particular
focus on how this relates to the wider context of self-
management and patient management.
Table 3.1: An overview of each research chapter and approaches used.
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3.2 Research Method
The research presented in this thesis largely takes an inductive qualitative approach,
an exploratory approach that aims to seek meaning from collected data. Qualitative
research is a method in which the researcher actively engages in naturalistic inquiry
of real-world settings to collect and interpret data (Lincoln, 2007). By doing so,
the researcher becomes integrated into the research process in a similar way as the
participants (Corbin et al., 2015; Jackson et al., 2007; Lincoln, 2007; Patton, 2005).
Qualitative research is usually employed as a method to explore research questions
that seek to understand the rich human experiences of some phenomena, process, or
perspective (Caelli et al., 2003; Corbin et al., 2015). It does not involve the collection of
data with the intention to test some predetermined hypothesis. Rather, the researcher
analyses the raw data to understand the prominent themes which are generated from
it, building an understanding of the studied phenomena (Thomas, 2006).
I took an inductive approach as my research questions were exploratory in nature
and were not centred around a set of assumptions. More specifically I was interested
to explore how DSDM technologies could support COPD care from the perspectives of
healthcare professionals (HCPs) and people with the condition. These investigations
were designed to be open and exploratory. To identify opportunities for technology
to support both participant groups, I had to explore their different contexts and care
practices. The very nature of this inquiry was exploratory and interpretive, and as such
warranted an inductive approach to the research.
Given this approach, the epistemological position of this thesis aligns with inter-
pretivism, but also draws on pragmatism. Interpretivism focuses on how knowledge
is socially constructed by individuals based on their lived experiences (Abdul Rehman
and Alharthi, 2016; Doyle et al., 2009; Gray, 2014). This is appropriate for exploring
the lived experiences of COPD and how technology can support this experience. In-
terpretive approaches seek to capture the rich, subjective, and situated experiences
of a particular phenomenon from the perspective of the research participants (Doyle
et al., 2009; Duarte and Baranauskas, 2016; Saks and Allsop, 2012). This contrasts
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with positivist paradigms, which typically dominate health research, which focus on
the generation of objective scientific facts and patterns through quantification (Doyle
et al., 2009; Saks and Allsop, 2012). Pragmatism, however, employs a mixed methods
approach by blending qualitative and quantitative paradigms to strengthen research
findings (Johnson and Onwuegbuzie, 2004). A mixed methods approach is impor-
tant for this research, enabling me to contextualise the subjective lived experiences
of COPD with the objective quantifiable ‘facts’ about the condition. Therefore, this
thesis aligns with both interpretivism and pragmatism paradigms.
Table 3.2 presents an overview of the individual research chapters, their research
question, frameworks used, participants, and specific methods. The specific methods
used are discussed in detail within each research chapter. Note that although this the-
sis is largely qualitative, there are also quantitative data collection methods employed
(e.g. quantitative data captured within surveys and questionnaires). Quantitative data
was mainly used to supplement the richer qualitative findings. A timeline of each
research study and its methods is presented in Figure 3.1.
Research Chapter and
Short Title




How can technology support
healthcare professionals in their
















What is the lived experience of
COPD, and how can technology
support this experience?






What is the lived experience of
using self-monitoring technology
to share symptom data between






Case study, focus group,
interviews, phone calls
Note: healthcare professional (HCP), information technology (IT), business intelligence (BI), chronic
respiratory conditions (CRCs).
Although each chapter is shown to primarily investigate one research question, as shown in Chapter 1
(Introduction), each research chapter contributes to multiple research questions.
Table 3.2: An overview of the research chapters, research questions, frameworks,
participants, and methods.
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Chapter 4 - Data Supported Decision-Making 
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Chapter 6 - Self-Monitoring and Collaboration
~10 month research study
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Phone calls
to check in with COPD
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Note: healthcare professional (HCP), information technology (IT), business intelligence (BI).
Blue boxes represent activities undertaken with the chronic respiratory conditions community / COPD
patients. Orange boxes represent activities undertaken with HCPs.
Figure 3.1: A timeline of each research study.
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3.3 Data Analysis
Interviews, focus groups, and workshops were all audio recorded using a dictation
device (with written or verbal consent from the participants). I transcribed each audio
recording verbatim, and created memos of early concepts which seemed interesting
to explore through future research activities or when analysing the dataset (Birks et al.,
2008; Braun and Clarke, 2006). Observations, however, were not audio recorded.
Instead I made detailed notes either during or after the observation activity. Tran-
scribing audio recordings myself helped contribute to the early analysis of the data,
as I was able to capture and interpret the relevant features of talk which contributed
to the later stages of analysis (Bailey, 2008; Bird, 2005). I would estimate that I spent
over 150 hours overall transcribing data for this thesis1.
I mainly used an inductive thematic analysis approach to analyse the datasets,
which is a common approach for analysing inductive qualitative data (Braun and
Clarke, 2006). This involved carefully reading each data item in the dataset in its
entirety before conducting any coding, allowing me to gather initial thoughts about
any patterns that could be reviewed during later analysis (Braun and Clarke, 2006).
After completing a first reading, I approached each data item again and conducted
bottom-up open coding of the data at sentence level by hand. I did not use any
specialised software to support this process, except for the survey data in Chapter 5
(Technology and the Lived Experience), where I used NVivo to manage the volume of
data (Lakeman, 2009). The coding process involved carefully and iteratively reviewing
each line of the data item, then assigning individual codes that describe the data to
create broader themes describing the entire dataset (Corbin and Strauss, 2014).
When analysing the survey data for Chapter 5, I analysed the free-text responses
using an inductive content analysis approach by hand (Hsiu-Fang and Shannon, 2005;
1Researchers have estimated that one hour of audio can take around four hours to tran-
scribe (Stuckey, 2014).
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Vaismoradi et al., 2013). This involved first reading through the survey responses,
question by question, to familiarise myself with the data. Then, for each question,
I identified themes and patterns within the responses, starting at sentence level and
analysing them in context to the question. I kept note of the themes which occurred
most frequently in the dataset, creating a strong case for their inclusion in the sub-
sequent analysis (Vaismoradi et al., 2013). Additionally, I used case classifications in
NVivo to make comparisons in the survey dataset, comparing attributes such as age,
chronic respiratory condition (CRC), and length of time living with the condition, to
explore any notable differences in responses. Case classifications describe groups (or
categories) and their attributes (Bazeley and Jackson, 2013). For example, I explored
the potential relationship between age groups and devices owned. Note that this
was an exploratory step, there were no predetermined hypotheses regarding how
demographic or contextual information may map to particular response types.
The data was analysed throughout the research. To validate the themes created
from the data, I discussed them with my supervisors (Dr Maria Angela Ferrario and Dr
Roisin McNaney). I also carried out member checking of early themes and findings
with the participants throughout the research. I carefully judged whether I had reached
data saturation by considering the richness (quality) and thickness (quantity) of the
dataset (Fusch and Ness, 2015). I tried to strike a balance between collecting data
that was both rich and thick, with a priority for the former (Saunders et al., 2018). In
instances where data saturation was not yet reached, I undertook further research to
collect more data on areas which required saturation. I achieved data saturation for
all three research studies, which indicated that I could cease data collection.
3.4 Healthcare Setting
Before describing the participant recruitment process in the section below, it is use-
ful to briefly describe the healthcare setting which the research for Data Supported
Decision-Making (Chapter 4) and Self-Monitoring and Collaboration (Chapter 6) took
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place in. All HCP participants recruited for this thesis worked within this setting.
Further details about their work practices are included in the research chapters.
This research involved participants from two collaborating National Health Ser-
vice (NHS) organisations. In England, where this research took place, many healthcare
services are managed by types of NHS Trusts. Trusts are organisations which typi-
cally provide healthcare services to patients in their region. This can include primary
and secondary care services, and sometimes community care services (Department
of Health, 2005). Primary care services are the first point of contact for patients,
such as General Practitioner (GP) practices, pharmacies, or dentists. Secondary care
services are carried out within specialised clinics and hospitals (for example, for in-
patient care, where a patient is admitted to hospital for a health related incident).
Community care services are diverse and often involve services that help people with
complex health needs (though the specific services offered are organisation depen-
dent) (Charles, 2019). For example, community care services may provide support for
managing long-term health conditions or services aimed at preventing certain health
conditions, such as smoking cessation services (Charles, 2019).
The healthcare staff in this research were either part of a hospital respiratory
service or community care respiratory service. The hospital respiratory service is made
up of respiratory consultants (senior doctors who have completed specialised training
in respiratory health) and COPD nurses (nurses specialised in respiratory health). The
hospital team work within a respiratory ward at a hospital. The community care service
is made up of COPD nurses, physiotherapists (who specialise in physical methods to
treat injuries or diseases), and assistant practitioners (who are trained to assist and
deliver health and social care in a specific condition domain). The community team
operate in shared office spaces across two healthcare centres located a few miles from
the hospital. Both organisations work together to provide respiratory care services
to patients in their region, as well as other (non-respiratory) services. How they
collaborate to deliver care to COPD patients is discussed in further detail in Chapter
4 (Data Supported Decision-Making).
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3.5 Participants and Recruitment
This thesis involved a diverse range of participants. Most participants were people
with CRCs or HCPs. However, in Data Supported Decision-Making (Chapter 4), there
were also business intelligence (BI) representatives (who direct business strategy),
and information technology (IT) representatives (who build, maintain, and train on
information technology systems). Their diversity of expertise and perspectives were
key for the UCD approach taken in Chapter 4. Likewise there were two carers who
participated in Technology and the Lived Experience (Chapter 5) and Self-Monitoring
and Collaboration (Chapter 6) respectively. An overview of the research participants
included across this thesis, along with the recruitment channels, is shown in Table
3.3. The breakdown of participants are discussed in further detail within each research
chapter. There were no monetary incentives offered for research participation.
The remainder of this section discusses my approach to recruiting the main two
participant groups: people with CRCs and HCPs. I also discuss the challenges involved
with recruiting people with chronic health conditions and HCPs for research.







All participants from this study were staff members of
the two collaborating healthcare organisations (the hos-
pital respiratory service and community care respiratory






Workshop (n=11, inc. 1 carer)








The HCPs from this study were staff members of the
community care respiratory service. The COPD patients
were patients of that community care service
Note that three of the HCP participants in Chapter 6 were also participants in Chapter 4.
Table 3.3: Overview of research participants and recruitment channels.
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3.5.1 Recruiting Patients and People with Chronic Conditions
Recruiting people as participants in healthcare research has historically been challeng-
ing for a number of reasons; mistrust in health research (Corbie-Smith et al., 1999)
and limited accessibility due to poor health (Patel et al., 2003) are among some of the
reasons. As such, when embarking on this research I anticipated facing difficulty in
recruiting people with CRCs. Although I recruited 171 participants from the CRC com-
munity in total, the process was challenging for different reasons depending on which
research question I was answering. I describe the challenges faced when recruiting
participants for Technology and the Lived Experience (Chapter 5) and Self-Monitoring
and Collaboration (Chapter 6) below.
3.5.1.1 Recruiting for Technology and the Lived Experience (Chapter 5)
Technology and the Lived Experience (Chapter 5) is made up of a survey (147 partic-
ipants), one-to-one interviews (13 participants), and one workshop (11 participants).
To recruit participants for interviews and the workshop in this chapter, I relied heavily
on support from respiratory support groups in North West England. By attending
these groups and keeping in contact with them, I was able to build trust with this
community and familiarise them with my research. This helped facilitate recruitment.
It is important to note that recruiting from support groups can bias research findings.
Support group members may have different condition experiences compared to those
who do not attend support groups (Hewison and Haines, 2006). For example, people
who do not attend support groups may lack social support or face significant symp-
tom related challenges inhibiting them from attending groups — which influences the
perspectives captured in the data.
In addition to attending the support groups, I published recruitment material
online for interviews through Lancaster University’s website and social networking
websites. However I was not able to recruit any participants this way. It was clear
that building trust with the respiratory community was key to recruitment for face-to-
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face research activities, and this resonates with the trust challenges raised in previous
healthcare research (Becker et al., 2004; Corbie-Smith et al., 1999; Renert et al., 2013;
Silvestre et al., 2006; Sutton et al., 2003).
Trust was also key for recruiting participants to undertake the survey for Tech-
nology and the Lived Experience (Chapter 5). The survey was open for 70 days. When
advertising the survey, I posted paper versions to four respiratory support groups in
North West England (three of which I had been visiting). I provided them with stamps
to return the completed surveys to me. I also advertised the survey through email
and online using Facebook, Reddit’s COPD forum, and the British Lung Foundation
channel on HealthUnlocked2. Recruiting from specific online communities can be an
effective way to reach a large audience, particularly hard to reach populations (Shatz,
2017; Topolovec-Vranic and Natarajan, 2016). However it can also bias research
findings as it is likely that people actively engaging in online communities are more
computer literate and feel technology has benefits, which is relevant to my inves-
tigation of technology use and perspectives among the CRC community (Hamilton
and Bowers, 2006). Likewise the responses may reflect individuals who feel more
supported as they are connected with others within online communities (similar to
those who attend physical support groups).
When I advertised my research on Reddit and HealthUnlocked (which had res-
piratory communities which I could approach directly), I had to introduce myself, my
research, my prior publications, and my current request for participants3. Whereas
posting my survey link on Facebook (a less community specific social networking
medium) required no approvals process and the use of different language. I was
not entering a specific online community as such, rather I was making an open call
2HealthUnlocked is an online forum made up of individual channels where members can offer and
request advice about living with a health condition.
3In fact, before I was allowed to post my research on HealthUnlocked, I was required to have my
survey participation request approved by a moderator before posting.
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for survey participation and for people to share the survey link to their networks. I
used unique survey links to track responses across each medium and observed two
responses from Facebook, 23 from Reddit, and 89 from HealthUnlocked. There were
33 paper responses sent back from four respiratory support groups.
3.5.1.2 Recruiting for Self-Monitoring and Collaboration (Chapter 6)
Recruiting patients as participants for Self-Monitoring and Collaboration (Chapter 6)
was far more challenging. This study involved four patients who used an mHealth
app for four weeks as part of a case study. The HCPs had to undertake recruitment
for this study as patients needed to meet a set of clinical criteria to participate (that
they were clinically well enough to self-monitor their condition independently). Pre-
vious work has noted that collaborating with different HCPs can be an accelerator
for recruitment (Newington and Metcalfe, 2014). However, for Self-Monitoring and
Collaboration, it was still very difficult to recruit participants. One notable reason
that recruitment was slow and difficult for this study was that participants were being
recruited as ‘patients’ in the healthcare system (rather than just as ‘members of the
public with a CRC’ as was the case for Chapter 5). Participants had to be recruited this
way to explore the lived experience of self-monitoring COPD symptoms and sharing
this data with their HCPs. This approach to recruitment required additional ethical
approvals (Health Research Authority) before recruitment could commence. I provide
further detail on the ethical approval processes in the next section.
During the recruitment process for Self-Monitoring and Collaboration, I asked
HCPs to keep a short record of the demographics of patients who declined partic-
ipation. This record included their gender, age, and reason for decline. I believed
this would help to appreciate the barriers to participation. In total 57 COPD patients
were approached by four HCPs during clinics or pulmonary rehabilitation classes at
the community care site. Only four patients decided to participate. The reasons for
53 patients deciding against participation were:
• Not interested in the study and no further explanation offered (36);
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• No smartphone to access the mHealth app (8);
• Reluctant to record health information on the mHealth app (4);
• No internet connection to download and use mHealth app (4);
• No desire to use the internet (1).
Recruitment was open from May 2018 to November 2018. The HCPs provided
feedback iteratively throughout the recruitment process about the observed barriers.
Once I had learnt that smartphones and lack of internet access was a barrier, I provided
the option for patients to borrow a smartphone with a SIM card that had 5GB of
cellular data4. This change to the study (providing smartphones and SIM cards to
patients) required me to submit an amendment to my study protocol to the Health
Research Authority. I had to wait for approvals again before the study could continue.
Recruitment was therefore on hold for 40 days (June 14th — July 23rd 2018). On July
24th 2018, after the amendment was approved, four participants were recruited. One
participant who was recruited was lent a smartphone and SIM card, the other three
participants had devices and internet access of their own.
3.5.1.3 Comparing Recruitment Approaches
Technology and the Lived Experience (Chapter 5) and Self-Monitoring and Collab-
oration (Chapter 6) explored different contexts and required different recruitment
approaches. Technology and the Lived Experience sought to explore the lived expe-
rience of CRCs and the potential role of technology to support this. The aim was to
explore the diverse experiences of the CRC community. This required participants to
either participate in a survey, interview, or workshop. I led the recruitment for this
4The smartphones and SIM cards were provided by Lancaster University’s School of Computing and
Communications department.
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study, and was able to embed myself in the CRC community to build trust among
participants, which facilitated recruitment.
Whereas Self-Monitoring and Collaboration explored a specific context where
patients were required to monitor their COPD symptoms. This required ongoing effort
and time investment from patients (e.g. compared to an interview). Additionally, HCPs
were the study recruiters for Self-Monitoring and Collaboration. They were tasked
with identifying potential participants, explaining the study to them, and answering
any immediate questions (among their usual clinical duties). The recruitment for
Technology and the Lived Experience was undertaken by me and was driven by my
motivation to complete the study. The HCPs leading recruitment for Self-Monitoring
and Collaboration were understandably not driven by this same motivation.
The different recruitment approaches, required participation level, and barriers
to access yielded very different sample sizes for both studies (Technology and the
Lived Experience: 171 participants versus Self-Monitoring and Collaboration: four
patient participants). Although I do not claim these to be the only reasons for sample
size differences, I argue they are strong contributing factors.
3.5.2 Recruiting Healthcare Professionals
Recruiting HCPs as participants has a different set of associated challenges compared
to patient participants. It is widely understood that HCPs are extremely time pressured
in their day-to-day work, and previous work has shown that HCPs can perceive
research participation as being a time burden (Asch et al., 2000; Broyles et al., 2011;
Solberg, 2006). There were a total of 12 HCP participants involved this research,
11 participating in Data Supported Decision-Making (Chapter 4) and four in Self-
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Monitoring and Collaboration (Chapter 6)5. All HCP participants within this study
were recruited from the two collaborating NHS organisations described earlier. All
participants specialised in respiratory care.
I used snowball sampling to recruit HCPs for both studies (Faugier and Sargeant,
1997; Noy, 2008). Snowball sampling has been shown to be a successful method
of recruitment for traditionally hard to reach populations (Asch et al., 2000; Bonevski
et al., 2014; Faugier and Sargeant, 1997). Here, I found snowball sampling pro-
vided an effective way to identify and approach key staff whose participation would
help advance the research aims. For Data Supported Decision-Making, once I had
recruited a core group of interested HCPs, they were able to identify and approach po-
tentially interested colleagues to participate. Through being introduced to the HCPs
in Data Supported Decision-Making, I learnt about their motivations and interests.
This enabled me to directly approach and recruit three HCPs for Self-Monitoring and
Collaboration from the same participant pool.
The most challenging part of involving HCPs as participants was not necessarily
recruitment itself, but retaining their involvement throughout the research process.
As HCPs participated in a UCD process in Data Supported Decision-Making, their
consistent involvement was important throughout. All research activities occurred at
their place of work. However, I often faced difficulty arranging to meet participants
to undertake the various research activities, as they had very limited availability (and
were often tired when we did meet). This was particularly challenging from September
to March each year, when it was ‘flu season’ and staff were overwhelmed looking
after respiratory patients. Moreover, there were some instances where last minute
demands on HCPs’ schedules resulted in a no-show to research activities (Broyles
et al., 2011; Ingersoll, 1995). Not only did this impact the immediate data collection,
5Three of the four HCPs in Self-Monitoring and Collaboration were also participants in Data Sup-
ported Decision-Making. The fourth HCP was newly recruited for Self-Monitoring and Collaboration
through invitation from the other HCPs.
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but introduced delays in the overall research trajectory, as the next opportunity to
reschedule the activity was often weeks away. In addition to the challenge of sustaining
involvement, some participants were promoted to different roles (and no longer had
time to participate in the study) or moved to different organisations. This created
challenges for this research, which had to be completed within a limited time frame
and relied on long-term engagement.
3.6 Ethical Considerations
Rooted in healthcare research is the long tradition of institutionalised bioethics, arising
from various human rights violations that occurred in the twentieth century to advance
medicine. As such, it is a requirement that all human subject research undergoes
independent ethical review, with an emphasis on obtaining informed consent from
participants. Ethical review is usually obtained through an institutional review board
of some kind. For the research presented in this thesis, all research chapters were
naturally subject to an internal and independent review process at Lancaster University.
However, in addition to this, Data Supported Decision-Making (Chapter 4) and Self-
Monitoring and Collaboration (Chapter 6) were subject to an extra layer of review by
the Health Research Authority (HRA) (Whitburn et al., 2017).
The HRA are a national body that reviews and regulates health and social care
research carried out with an NHS service in the United Kingdom. Depending on
the categorisation of the research, there may be further layers of approval required
beyond standard HRA approval. For example, there is an additional layer of ethical
approval that must be obtained by the Research Ethics Committee (REC) for any
studies which involve patients as participants. The responsibility of the REC is to
decide if the research is ethical from the perspective of domain experts and members
of the public (the committee vote on the outcome of the application). Self-Monitoring
and Collaboration was subject to a review by the REC due to the involvement of NHS
patients as participants. Data Supported Decision-Making only required standard HRA
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approval as there were no patients as participants.
Obtaining approvals from the HRA and REC introduced significant delays for
starting these studies. It is acknowledged among the health research community that
these processes are lengthy and complex (Fur; Fistein and Quilligan, 2012; Page and
Nyeboer, 2017; Thompson and France, 2010). It is worth noting that these review
processes require the submission of information from both the researcher (myself, at
Lancaster University) and the research site (the collaborating NHS organisations). This
dependency introduced unanticipated delays for beginning Data Supported Decision-
Making and Self-Monitoring and Collaboration. I found the approvals process to be
heavily geared towards clinical trials or intervention studies, which made writing and
navigating the application challenging for my small-scale qualitative research.
After the relevant approvals were secured, the final step was to obtain a research
passport. A research passport is an additional process that must be granted before
you can enter an NHS premises to conduct any research. This approval is organised
by the NHS organisations which are participating in your research, and accounts for
your presence on-site to conduct research. Once HRA approval is obtained, and a
research passport is secured, the study can commence. It is important to document the
ethical review processes for two reasons. First, to demonstrate that this research was
independently assessed as being ethical according to its design and aims. Second, to
allow the reader of this thesis to appreciate the limitations that these lengthy processes
place onto a three and a half year PhD.
3.7 Limitations
This section discusses the limitations which arise from my research design. This
includes a discussion on generalisability, validity, and reflexivity.
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3.7.1 Generalisability
I argue that this thesis primarily has the potential to generalise through transferability.
That is, how the findings of this research can resonate with different settings outside
of the original study’s contextual confines (Firestone, 1993; Guba and Lincoln, 1989;
Hayes, 2011; Polit and Beck, 2010; Smith, 2018). Generalisation based on trans-
ferability has been described as a ‘collaborative’ activity between the researcher and
the audience of the work, it is not something the researcher can simply claim with
certainty (Polit and Beck, 2010; Smith, 2018). The reader of the research must decide
how, and if, the experiential account can be extrapolated elsewhere (both to similar
or different contexts) (Hellstrom, 2008; Polit and Beck, 2010).
For example, the reader of this research may find that the concept of how trust
effects how HCPs engage with data in Data Supported Decision-Making (Chapter 4)
can be seen in health domains outside of respiratory care, or exists when engaging
with technology other than a dashboard (Chapter 4, section 4.5.1, pg. 130). It could
be the case that the reader identifies transferability across non-healthcare related
domains that have similar patterns of work in collaborative teams. I reflect on specific
implications for generalisability at the end of each research chapter, though I share
my overarching arguments for the thesis as a whole below.
In qualitative research, generalisability is not discussed in the statistical prob-
abilistic sense (Baskerville and Lee, 1999; Crabtree et al., 2013; Guba and Lincoln,
1989; Lincoln, 2007; Yardley, 2000; Yin, 1994) and thus does not equate general-
isability with large sample sizes (Crabtree et al., 2013). Instead, generalisability in
qualitative research can be achieved providing that the data is rich, meaningful, and
thick to facilitate transferability and analytical generalisation (Firestone, 1993; Polit
and Beck, 2010; Smith, 2018). Below I describe the steps that I have taken to ensure
that my data is rich, thick, and meaningful.
I achieved data richness through data and methodological triangulation (Fusch
and Ness, 2015). For data triangulation, I involved different types of participants to
investigate my research questions (consultants, nurses, assistant practitioners, phys-
62 3.7. Limitations
iotherapists, IT representatives, BI representatives, people with CRCs, and carers). For
methodological triangulation, I have used an array of research methods to capture my
findings (interviews, focus groups, surveys, observations, questionnaires, phone calls,
workshops, user stories, scenario-based design, and a case study). I have collected
meaningful data through building my findings from a series of long-term encounters
with my participants. I argue this has led to nuanced and detailed findings. I reflect
on my relationship with the participants, which has been central to capturing rich and
meaningful data, later in this chapter. Finally, through involving a range of research
methods and participants, I have collected a thick qualitative dataset consisting of 228
individual data items. As such, I argue my findings are grounded in data that is both
rich, meaningful, and thick. Therefore, I have provided a solid foundation for the
readers of this work to participate in the collaborate activity of generalising.
It is important to acknowledge the difficulty of predicting and quantifying the
degree of generalisability of this research. Nevertheless, I do not believe that qualita-
tive research must generalise to a specific number of contexts to be considered useful
scientific knowledge. For example, my findings may only resonate with a subset of
people with COPD or other chronic conditions. I strongly argue that this still con-
tributes valuable scientific knowledge, as it informs our understanding of the different
lived experiences of health conditions which can be supported with technology.
3.7.2 Validity
Qualitative research builds a case for validity and reliability of results through the
process of triangulation (Fusch and Ness, 2015; Hayes, 2011; Thurmond, 2001).
That is, the careful consideration of the methods used to collect and understand data,
followed by an assessment of when data saturation has been reached (Fusch and Ness,
2015). This does not necessarily relate to the quantity of data collected, but considers
its richness and depth (Fusch and Ness, 2015). I have taken a conscious effort to
employ methodological and data triangulation to capture different perspectives that
strengthen my conclusions (and I acknowledge their respective limitations).
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To further validate qualitative findings, Hayes (2011) and Guba and Lincoln
(1989) argued that prolonged engagements with a participant group adds layers of
trustworthiness to the study’s scientific rigor. This is because the researcher de-
velops a deep understanding of the group, which cannot be built through a single
encounter (Guba and Lincoln, 1989). Each study involved engaging more than once
with the same participant6, whether through a series of research engagements, mem-
ber checking, or by updating participants about the research (Guba and Lincoln,
1989).
Data Supported Decision-Making (Chapter 4) involved a prolonged engagement
with my HCP participants over three years. Technology and the Lived Experience
(Chapter 5) involved a prolonged engagement with the wider CRC community over
approximately two years. Though Self-Monitoring and Collaboration (Chapter 6) was
comparatively shorter (10 months), I was engaging with three of the same HCP partic-
ipants from Data Supported Decision-Making. Likewise, for that study, I engaged with
the patient participants on three separate occasions throughout the study. Overall, for
this thesis I had the opportunity to engage with participants multiple times to clarify
aspects of the data during early analysis. I argue this adds to the trustworthiness of
my results.
3.7.3 Reflexivity
It is crucial to acknowledge the influence that I had on this research as I became
part of the social world that I studied (Berger, 2015; Jootun et al., 2009). There
are undoubtedly many subtle biases that I have introduced into the research process,
which influence the quality of the data — just by being my self (e.g. how I communicate
verbally and non verbally, how I look, and who I am) (Berger, 2015; Blandford, 2013).
6Except data collected through the anonymous survey in Technology and the Lived Experience
(Chapter 5).
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I have taken care to reflect on factors which I think have been particularly important
for my data collection, and ultimately, the outcomes of my research. I describe these
factors in the following sections, dividing them by participant groups.
3.7.3.1 People with Chronic Respiratory Conditions
While explaining my research to my participants who had COPD, I consciously dis-
closed to them that I was the daughter of somebody with COPD. I believe disclosing
this information helped to break down perceived participant-researcher power struc-
tures (Karnieli-Miller et al., 2009). As participants understood that I believed my
research was not just interesting, but something I deeply cared about and was affected
by (as a relative of somebody with the condition), they were more willing to ‘accept’
me into the respiratory community. When I attended support groups for Technology
and the Lived Experience (Chapter 5), I was not there just as a curious researcher,
I was also there as a member of the community. When I had planned visits to the
groups, the group leaders would announce in their newsletters that ‘our friend Helena’
would be attending. It was clear that I was not viewed as an outsider who was simply
there to collect data and leave. As such, I believe my personal relationship with COPD
helped facilitate the collection of rich and meaningful data for this research.
I believe that my participants’ knowledge of my personal relationship with COPD
also impacted one-to-one interview dynamics. I argue that participants felt more
comfortable sharing their personal experiences with me, knowing that I may be less
judgemental of them, compared to somebody who did not have experience of what
COPD is like. This was particularly important when discussing stigma and potentially
embarrassing and sensitive topics, like soiling oneself from coughing too hard and fear
of dying. This is where my partial7 insider status within the community enabled me to
collect the true and raw experiences of living with COPD (Merriam et al., 2001).
7Being a healthy woman in my early twenties meant I was not a complete ‘insider’.
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Though I was a partial insider, I made it clear that participants should recall
their experiences to me in their own words, describing them as the very individual
experiences that they are. This helped to avoid participants making assumptions about
my knowledge, thus avoiding exploring experiences in depth (Allen, 2004). Though
this did not stop the odd comment to the effect of ‘but surely you know what that’s
like, with your mum and all’. There were even times where participants were giving
me self-management advice to share with my mother, or requesting advice based
on what my mother does to manage her own symptoms. Dealing with this was
sometimes challenging, as I had built a rapport with my participants based on trust,
but as a researcher I felt anxious to give healthcare ‘advice’ to my participants even if
it seemed trivial. Instead I always emphasised that each person is different and that it
was best to ask their HCP if they were struggling with something in particular.
3.7.3.2 Healthcare Professionals
My experience with participants that had COPD can be contrasted with my experience
engaging with HCPs. The power dynamics between myself and HCPs seemed more
evident, particularly between myself and the respiratory consultants. They were highly
trained professionals with plenty of experience with respiratory care, while I was a
young computer science student with only a growing knowledge of their domain.
Disclosing that my mother had COPD at the start of my research did not seem to
effect the relationships I built, or the dialogue I had, with the HCPs. Though it could
have been the case that they phrased their language more sensitively when talking
about how the condition progresses and what happens to the most unwell patients.
However, this is something which I would suspect a HCP is already accustomed to
doing when talking to patients and their relatives or carers.
I felt far more like an outsider with this participant group. I largely conducted
research activities with them on my own. During my first encounters with HCPs, I
was often asked if I was a ‘student nurse’ conducting some research. When answering
that I was a computer science student, I believe HCPs then oriented themselves to
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account for the fact that I was an outsider to their domain. For example, there
was common understanding which had to be collaboratively built over time, unlike
the understanding I shared with my participants with COPD (which partially pre-
existed). One instance of this was learning the roles and responsibilities of the
different HCPs and how their organisations worked. As the research progressed, this
common understanding was built, and HCPs became more familiar and trusting of me.
Through building this familiarity and trust, they became more confident to honestly
reflect on their experiences and needs in relation to COPD care.
Overall my relationship with the HCPs developed and strengthened over time
due to the fact I was an outsider. Whereas my partial insider status with the respiratory
community meant my relationship with them was stronger from the beginning.
3.8 Chapter Summary
This chapter introduced the methodological approach for this research. Following this,
I presented inductive qualitative research as the main method for this thesis. Then I
discussed my inductive thematic analysis approach for data analysis. Next I described
the healthcare setting that Chapter 4 (Data Supported Decision-Making) and Chapter 6
(Self-Monitoring and Collaboration) took place in, introducing the hospital respiratory
service and community care respiratory service. Then I discussed the participants
within this thesis, the recruitment process, and challenges. I moved on to discuss
the ethical considerations of this work in relation to the area of healthcare. Finally







The final phases of this project were worked on collaboratively between myself and
Dr Adrian Gradinar (a research associate at the time). Although I solely undertook
this research, Adrian contributed to this work by building a digital prototype of the
dashboard based on my work. However, the research activities, coding and analysis
of data, material, and conclusions of this chapter are all my own work. Some of
the data and findings from this chapter have been published as a full paper in the
2018 EAI International Conference on Pervasive Computing Technologies for Healthcare
(Tendedez et al., 2018)
4.1 Introduction
This chapter explores the concept of data supported care for Chronic Obstructive
Pulmonary Disease (COPD) patients. It investigates how a data supported decision-
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making (DSDM) dashboard could support healthcare professionals (HCPs) with COPD
care. The DSDM dashboard aims to unite HCPs with data that they believe will inform
their decision-making about their COPD patients and service. This chapter documents
the design and evaluation of a DSDM prototype. The focus is on exploring the
opportunities and challenges that DSDM technologies could introduce for everyday
clinical decision-making about COPD care. This chapter aims to answer the first
research question: ‘how can technology support healthcare professionals in their
decision-making for COPD care?’
The key contributions of this chapter can be summarised as follows:
1. A detailed account of the real-world daily challenges faced by HCPs relating to
their decision-making about COPD care.
2. The concept of trusting data is particularly relevant for DSDM technologies, and
influences how willing HCPs are to engage with the data for decision-making.
Data must be perceived as originating from reliable ‘sources’ and ‘authors’ for
it to be considered trustworthy.
3. Integrating DSDM technologies into healthcare settings requires a careful con-
sideration of the relevant protocols and resources which must accommodate
how HCPs can respond to the data. Without these protocols and resources, the
technology may not be able to positively influence decision-making.
4. Training HCPs on clinical systems is a time-consuming process and there may
be reluctance towards formal training. However, training HCPs on DSDM
technologies is important to ensure they can confidently draw safe and correct
inferences from the data.
5. A scenario-based evaluation is an effective way to conduct early evaluations of
DSDM technologies, without requiring a fully integrated system. However, how
we adapt evaluation techniques and methods for DSDM technologies, such as
the Technology Acceptance Model, requires careful consideration.
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4.2 Study Setting
A brief description of the National Health Service (NHS) and the study setting is
described in the methodology chapter (Chapter 3, section 3.4, pg. 50). The following
sections describe the everyday work of the hospital respiratory service and community
care respiratory service, how they collaborate, and their motivation for a DSDM
dashboard.
4.2.1 Hospital Respiratory Service
The hospital respiratory service, referred to as the ‘Hospital’ henceforth, has a dedi-
cated respiratory ward usually occupied by COPD patients. The ward has 32 beds,
including non-invasive ventilation beds which provide breathing support to patients.
Respiratory consultants, staff nurses, student nurses, healthcare assistants, specialist
nurses, and assistant nurse practitioners work on the ward. Each morning, the con-
sultants undertake a ward round, during which they check on each in-patient. During
the ward round, consultants are accompanied by a registrar (a trainee consultant), a
nurse, and a doctor. They use mobile computers and paper medical notes to facilitate
discussions about each patient before visiting them at their bed. Once the ward round
is complete, a second ward round is conducted for patients on an ‘outlier list’. The
outlier list consists of patients admitted to hospital for a respiratory condition but are
located on non-respiratory wards. This usually occurs due to capacity constraints on
the ward or to treat a patient before breaching specific national targets1.
Once the ward rounds are completed, the consultants discuss the tasks to be
completed for the day with the rest of the healthcare staff. This occurs in a room
called the Doctors’ Office located on the ward. A whiteboard, which has a list of
1In the United Kingdom (UK), this refers to the time frame in which a patient should be seen to,
admitted, treated, or discharged, which is within four hours (UK Government, 2017).
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the in-patients, is annotated to reflect the discussions between the healthcare staff.
During these discussions, the team will address which patients can be discharged that
day and which require further investigations. After this meeting, the COPD specialist
nurses will then spend the afternoon carrying out these tasks and providing care to the
COPD patients. Consultants and doctors will then attend clinic appointments with
respiratory out-patients. These out-patients may be referred to them for a respiratory
diagnosis or a review after being discharged from hospital.
To conduct their post-meeting duties, the HCPs will access paper and digital sys-
tems to find relevant information about the patients to inform their decision-making.
This may involve interacting with any of the five hospital systems (depicted in Figure
4.3 later in the chapter). The most used systems are Quadramed (the electronic
medical records system used across the entire hospital), a prescription management
system (to request and view patients’ prescriptions and medication), and Evolve (a
digital document archive system that archives patient documents such as hospital dis-
charge letters or general practitioner letters). The challenge with these systems is that
they are not interoperable, and the Hospital staff often switch between each system
to obtain the combination of information that they need to make decisions about a
patient’s care.
4.2.2 Community Care Service
The community care service, referred to as ‘Community Care’ henceforth, is made up
of COPD nurses, physiotherapists, and assistant practitioners. The nurses start the
day by providing telephone support to COPD patients on their caseload. These may
be patients who have just been discharged from hospital after a COPD exacerbation,
acutely unwell patients on their intensive home support service, or patients who are
being managed by the service for other reasons. During these calls, the nurses check
on the patients’ COPD and general wellbeing, providing support and encouragement.
They then input a summary of each call onto their electronic care record system (which
is a system only accessible by their organisation). In the late morning, the nurses will
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Figure 4.1: One of Community Care’s shared offices.
also prepare for, and then conduct, home visits to patients that are on their intensive
home support service. These are the most acutely unwell patients and require frequent
contact from HCPs. Patients may be on this service for a short period after a severe
exacerbation, or for longer periods if they are palliative or very severe.
Community Care also run clinics and classes, which are usually led by the
healthcare team in the afternoon. There are three types of clinics: (1) spirometry
clinics, where a HCP has referred a suspected COPD patient to the service for a
certified diagnosis; (2) nurse clinics, where a HCP has referred a confirmed COPD
patient to the service for further specialised management; or (3) physiotherapy clinics
that help a patient with breathing and mobility. There are also pulmonary rehabilitation
(PR) classes which run for eight weeks at a time. These are a series of education and
exercise classes for people with chronic respiratory conditions. The classes help
patients to learn about their condition, how to manage it, and receive encouragement
to remain physically active.
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4.2.3 Cross-Organisational Collaboration
As both the Hospital and Community Care operate across the same locality, they
often care for the same COPD patients. One of the main ways that both organisations
collaborate is through provision of care. That is, once a COPD patient has been
discharged from the Hospital after an exacerbation, they usually receive follow-up
care and support from Community Care. This follow up care may include PR classes
or an intensive home support referral. PR would be recommended if the patient needs
support to self-manage their condition to prevent future exacerbations. Intensive
home support would be recommended if the patient is acutely unwell and can be
cared for at home. Similarly, Community Care will liaise with the Hospital if a patient
on their caseload has a severe exacerbation and must be referred into hospital.
The organisations also collaborate through documentation. When a patient is
discharged from the Hospital and into Community Care, the nurses receive documen-
tation which explain details of the hospitalisation. The nurses will use this information
to understand the patient’s context so they can manage them accordingly. Likewise,
the Hospital may request a patient’s notes from Community Care to paint a picture of
their history and context for decision-making. Both organisations may also collabo-
rate with the patient’s General Practitioner (GP). This includes requesting patient data
recorded by the GP, such as spirometry test results or details about COPD related
appointments. This is obtained through letters or phone calls to the patient’s GP.
As shown, both organisations’ role in the care of patients with COPD is collab-
orative. This collaborative approach is important for the ongoing care and informed
management of COPD patients.
4.2.4 Data Supported Decision-Making Dashboard
This research involved engaging with the Hospital and Community Care to design
a joint dashboard to support their decision-making about their COPD patients and
services. A dashboard is a type of visualisation software, which aggregates data in
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personalised ways to produce knowledge and insights for users. In the healthcare
domain, for example, dashboards can turn raw data about Emergency Department
visits into visualisations that provide an easy understanding about which times the
department is busiest. A dashboard was initially chosen for this study as they were
familiar to the HCPs and are commonly used across healthcare settings (Dowding
et al., 2015). For example, at the Hospital, there is a dashboard used in the cardiac
department that visualises basic departmental data about cardiac appointments and
admissions. However, this simple dashboard visualises limited data and does not
collate data from different organisations. Thus, it is different to the type of dashboard
this study will explore.
The organisations were motivated to explore how the aggregation and presenta-
tion of pertinent COPD data could support their decision-making. As described above,
the HCPs are required to engage with different clinical systems, paper-based records,
and other HCPs to obtain needed information. To that end, this study explores how
technology could support this process.
4.3 Study Design and Methods
This chapter reports on a four stage study involving participants from both organ-
isations (see Figure 4.2). Data was collected through semi-structured one-to-one
interviews, workshops, observations, questionnaires, and focus groups with the par-
ticipants. The first stage focused on understanding the problem space and motivations
for a DSDM dashboard. The second stage aimed to explore and prioritise HCPs’ data
needs that should be included on the dashboard. The third stage involved wireframing
the interface and creating scenarios for the prototype. The fourth stage involved the
qualitative evaluation of the prototype with HCPs.
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Figure 4.2: The research process within this chapter.
4.3.1 Participants
This study involved 17 participants across both organisations at different parts of the
study (Table 4.1). This included 11 respiratory HCPs, 3 Community Care business
intelligence (BI) representatives, and 3 Hospital information technology (IT) represen-
tatives. Participants were provided with an information sheet and consent form to
consider before study participation (provided in Appendix A).
BI staff work within a team of analysts and are responsible for the operational
management of services. They use data collected within their organisation to make
strategic business decisions about the funding and improvement of services. They have
a broad understanding of the types of data that are collected within the organisation. IT
staff are responsible for the development, maintenance, and training of the IT systems
within their organisation. They assist staff if there is difficulty using a particular
system or if a system fails. They have in-depth knowledge of the different systems,
what data is collected in them, and what technical solutions could be feasible within
the organisation’s current technology ecosystem.
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Identifier Role Organisation
H1 COPD Nurse Hospital
H2 COPD Nurse Hospital
H3* Respiratory Consultant Hospital
H4* Respiratory Consultant Hospital
H5 Respiratory Consultant Hospital
C6 Lead Respiratory Nurse / Respiratory Service Manager Community Care
C7* Lead COPD Nurse Community Care
C8 COPD Nurse Community Care
C9* Lead Physiotherapist Community Care
C10 Assistant Practitioner Community Care
C11 COPD Nurse Community Care
BI1 Business Intelligence and Analytics Manager Community Care
BI2 Care Group Manager Community Care
BI3 Business Intelligence Representative Community Care
IT1 Information Technology Representative Hospital
IT2 Head of Information and Technology Hospital
IT3 Clinical Applications Trainer Hospital
Those prefixed with H are Hospital HCPs, those with C are Community Care HCPs.
Numbers depict participant number, grouped by professional role.
Identifiers with an asterisk (*) represent study leads.
Note that C6 was promoted during the study hence the dual roles listed.
Table 4.1: Chapter 4 participants.
Including different participants groups permits a more inclusive consideration
of different levels of expertise, knowledge, and skills which are valuable for exploring
this area (Bowen et al., 2011). Moreover, previous work has highlighted that involving
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IT staff within the innovation process can help scope technical feasibility and improve
dialogue around user needs (Hartswood et al., 2000). Involving BI and IT staff enabled
insights into the technical and work-flow feasibility of emerging dashboard designs.
They could also contribute unique knowledge about the different types of data and
systems across the organisations. This information could not have been effectively
obtained through solely involving the HCPs. Therefore, the diversity of participants
equipped me with a better understanding of the possibilities and challenges involved
with designing and implementing a DSDM dashboard for clinical practice.
At the start of the study, two HCPs from both organisations volunteered to be
the study leads (denoted with an asterisk in Table 4.1). The leads were my main point
of contact throughout the study, acting as the clinical champion for their organisation.
They were committed to being involved in each study stage, and activities were
arranged around their schedule. They also helped to schedule sessions with the
remainder of the participants.
4.3.2 Stage 1: Scoping the Design Space
The first stage focused on working with participants to understand the problem space
and to uncover their motivations for a DSDM dashboard. Three initial one-to-one
interviews, each lasting between 30 and 60 minutes, were conducted with the HCPs
(H3, H4, and C6) at both clinical sites. The duration of the interviews was dictated
by the HCPs’ work schedules. The interviews aimed to gain an initial insight into
their everyday challenges, and to discuss how they felt a DSDM dashboard could
help to address this. The questions revolved around topics such as ‘what are your
day to day challenges when accessing data in your role?’, ‘how do you interact with
current clinical systems?’ and ‘how do you believe a dashboard could help to alleviate
these challenges?’ During the interviews, they discussed challenges with their current
clinical systems and high-level key data that they believed having access to would
improve the delivery of care and services. These high-level data needs were then
77 4.3. Study Design and Methods
collated into a requirements document2 (see Appendix B), that was used to stimulate
further discussions around data requirements later in this stage.
To gain a better understanding of the main clinical system that was referenced
in the interviews, a two-hour interview was conducted with two IT representatives
(IT1 and IT2). During this interview, IT2 led a walkthrough of the main clinical system
used by the Hospital and Community Care to view a patient’s clinical information.
This walkthrough was carried out on a testing account which the IT representatives
use to train HCPs. An overview of the types of data that the system collects was
explored, followed by the process that HCPs would undertake to find certain data
about a patient. For example, how to access a patient’s latest blood test results and
their current hospital admission reason. I was also provided with the IT department’s
user guide for the main clinical system to deepen my understanding. The interview
discussion was focused on sharing the data needs that the HCPs outlined in the prior
interviews. We then talked briefly about where this data sits in the main clinical
system, followed by data which would be more challenging to obtain as it is not
recorded in the system.
The final phase was a focus group at the Community Care site with the broader
stakeholder team, including two HCPs (H3 and H4) and three BI representatives (BI1,
BI2, and BI3). The objective of the focus group was two-fold: to update the rest of
the group about the previous activities (the interview with the HCPs and IT staff) and
discuss the initial data needs outlined from the HCPs in more detail, drawing on the
insight and expertise of the BI representatives.
The findings from this stage are presented in section 4.4.1 (pg. 94).
2Note that the requirements document was not intended to outline a definitive list of data require-
ments that would be implemented. At this stage, it was simply used fluidly as a tool to structure early
requirements and ideas to probe further discussions.
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4.3.3 Stage 2: Priorities and Implementation Challenges
The second stage aimed to understand and prioritise HCPs’ data needs, followed by
exploring challenges that may arise when implementing a DSDM dashboard. As part
of this, it was important to learn more about the different clinical systems outside of
the main hospital system. It was also necessary to understand how the main system is
used in practice. Although an observation of the main clinical system was conducted
in Stage 1, this was in a controlled and quiet environment which does not reflect how
the system is used in practice by HCPs. Therefore, I conducted a one day observation
at the Hospital with IT3. The day began by IT3 carrying out a walkthrough of the
remaining four clinical systems within the technical ecosystem (with a discussion
on the sixth, EMIS3, which was not accessible by IT3). I made handwritten notes
throughout the observation. I also drew how each of the different systems linked
together based on my understanding, which was reviewed and amended by IT3 until
it accurately depicted the technical ecosystem (Figure 4.3).
Following the demonstration of the wider systems infrastructure guided by IT3,
I spent one hour visiting two wards to learn about the general ward environment.
During this time, I unobtrusively observed different HCPs using the main clinical
system on the wards. I visited the respiratory ward and gynaecology ward. The
gynaecology ward was a completely paperless ward, and IT3 wanted me to compare
this to the respiratory ward, which used both paper and digital records. Data was
captured through handwritten notes made immediately after the observations, as I
was advised by IT3 not to bring my notebook onto the wards for hygiene control. The
aim of the observations was to develop an appreciation for how systems are used in
their real-world clinic contexts, enabling more informed discussions during the later
design of the dashboard.
3EMIS is an electronic patient record system used in many primary care services in the UK, such as
GP practices.
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Figure 4.3: The technology ecosystem at the Hospital.
After my engagements with IT3, the next step was to explore HCPs’ data needs
in more detail to understand their core priorities. I conducted two 2-hour workshops
with HCPs, BI, and IT at the Community Care site. H3 and IT1 were in one workshop,
while in the other was H4, C9, BI1 and BI2. Two workshops were required due to the
difficulty coordinating a time suitable for all participants. To manage this, I ensured
there was at least one BI or IT representative present with a HCP in each workshop. It
was important to include BI and IT staff to draw on their expertise about how feasible
it would be to collect, and visualise, the discussed data on a dashboard.
During the workshops, HCPs were tasked with thinking about their top three data
priorities, which would best support their work. They were asked to rank each priority
by level of importance in relation to the timescale of delivery. For example, orange
post-it notes represented ‘things I would like to access right now’, fuchsia represented
‘things I would like to access in the next 2-5 years’ and blue represented ‘blue-sky
thinking; if I could have access to any data without limitation’. The blue-sky thinking
approach allowed HCPs to think freely about their needs without limits, ensuring they
did not fixate only on the requirements that they believed were possible (which may
underestimate what could be achieved). HCPs justified their data needs by discussing
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the current challenges that occur without having that data for support. While the HCPs
were working on this, BI and IT were tasked with assessing each of the data priorities
and deciding whether the data was readily available, or if there were any barriers to
accessing it (see Figure 4.4). This activity sparked thoughtful discussion between both
participants groups about the challenges faced in practice and the potential role of a
dashboard. After the sessions, I created a priorities document that summarised the
workshops to use in the final phase of this stage (see Appendix C).
Figure 4.4: Participants’ data priorities mapped onto post-it notes.
The final phase of Stage 2 involved updating the wider stakeholder team about
the workshop activities. To do this, a focus group was held with BI1, H4, C7, and
C9. During this focus group, it was established that the different data priorities for
both organisations warranted the dashboard to have two separate views (one view for
the Hospital and one view for Community Care). Within these views, the dashboard
would be split into a service view (which observes the overall performance of their
respiratory service), and a patient view (which shows an overview of an individual
patient) (see Figure 4.5). This would allow the data needs to be individualised to each
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organisation. For example, there may be data that is a priority for Community Care to
access, but is not a priority for the Hospital. Therefore, splitting the views allows for
the most pertinent data to each organisation to be visualised. However, we discussed
the importance of having access to both organisations’ view for the purpose of their
collaborative work.
Dashboard
Hospital View Community Care View
Service View Patient View Service View Patient View
Figure 4.5: Dashboard split as proposed by participants.
The findings from this stage are presented in section 4.4.2 (pg. 96).
4.3.4 Reflections on Stage 1 and 2
The multi-stakeholder approach taken throughout the first two stages of the study
allowed a number of multifaceted challenges to be uncovered. The key challenges
were: (1) how a cross-organisational dashboard could implemented, managed, and
maintained; (2) how the appropriate time and resources could be allocated to the
project; (3) how the required data would be pulled from all systems and physical
locations for collation on a dashboard; and (4) how the governance around data
sharing and access would be managed. And finally, a challenge more relevant to me:
(5) how this could all be addressed and achieved within the duration of a PhD.
I concluded that the above challenges meant that it would be difficult to end
the design process with a fully functioning dashboard for evaluation. Instead, I opted
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for the creation of a high-fidelity prototype that focused on fewer — but key —
functionality that the original dashboard was designed to provide.
4.3.4.1 Moving Forward with Scenario-Based Design
I decided to proceed the study using a scenario-based design approach. Scenario-
based design is centred around a set of ‘scenarios’, which are defined as task-driven
descriptions of particular work instances (Carroll, 1995). They are use-oriented,
focusing on how the system can support human activities (Carroll, 1995). Scenarios
are effective for qualitatively evaluating usability, suitability, and user experience of a
system (Bardram, 2000; Carroll, 1995; Dahl et al., 2010; Favela et al., 2010). This
involves users completing a set of work-related tasks using the proposed system and
evaluating their experiences. Scenarios have been used in previous Human-Computer
Interaction (HCI) and Computer-Supported Cooperative Work (CSCW) research to
evaluate healthcare systems and prototypes (Bardram, 2000; Favela et al., 2010). They
are particularly effective for eliciting detailed feedback from users without deploying
a fully functioning system into clinical practice (Favela et al., 2010). This inspired me
to gear the design process towards creating a scenario-based prototype instead of a
fully functioning dashboard.
4.3.5 Stage 3: Wireframing and Scenario Creation
The third stage focused on making paper prototypes to create tangible designs that
could explore the HCPs’ needs in more detail. A total of five workshops were con-
ducted with the HCPs (H1, H3, H4, C7, C8, C9, and C11). They were tasked with
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wireframing4 the dashboard5. The first two sessions involved the Hospital and Com-
munity Care HCPs separately. This consisted of two sessions with each group (totalling
four workshops), before uniting them in the last session (workshop five). Sessions
lasted between 60 and 90 minutes. The focus for the first session was to explore
the key data the dashboard should present (and how) within the different sub-views
(patient and service level, see Figure 4.5). The subsequent sessions followed on from
the first session, focusing on discussing the sketches and initial ideas in further detail.
I describe the sessions in more detail below.
4.3.5.1 Wireframing
During the first sessions, HCPs were provided with A3 sheets of blank paper and
pencils. They were asked to sketch out initial interface designs that centred around
visualising their data needs (see Figure 4.6 and 4.7). The aim was not to create perfect
interface designs. Rather this activity was aimed at creating tangible representations of
their data needs depicted within an early interface plan. This allowed the exploration
of not just data needs, but data representation and visualisation.
HCPs were asked to divide the time between sketching designs for the service
overview and the patient overview respectively. They were first asked to consider what
the prototype should look like when the patient and service view were first opened
(i.e. demonstrating what their respective ‘homepages’ would look like). They were
then individually asked to sketch one sub-view within both patient and service views
which represented a task they believed the dashboard should support. To facilitate
the sessions, I asked questions such as ‘once opening the service level view of the
4Wireframes are technical design ‘blueprints’ (Marsh, 2015). Wireframing is the process of creating
wireframes.
5Although we were creating a scenario-based prototype, myself and participants still used the term
‘dashboard’ to describe what we were creating, for simplicity and out of habit.
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dashboard, what would be the first thing you would want to see about the service?’,
‘what data would be included within that?’, and ‘how would you want to interact with
that?’ After the first session, for both groups, I collated the sketches and created digital
wireframes that captured the discussed concepts. These were then provided in paper
format in the subsequent sessions to follow on from the first session.
Figure 4.6: Participant H3’s initial sketches of the service view.
The subsequent sessions were focused on revisiting and refining the wireframes
created in the prior sessions, further exploring the ideas in more detail. Instead of
expanding the designs with new ideas, I asked HCPs to focus specifically on fewer
impactful tasks the dashboard should support. These tasks became known as ‘sce-
narios’. For example, Figure 4.8 shows two panels, which would be two distinct
scenarios: (1) accessing the patient’s spirometry result test history; and (2) accessing
the patient’s hospital admissions history. I asked for HCPs’ thoughts on the collated
wireframes which I had produced after the first session, encouraging them to amend
and discuss them. For example, for some parts of the wireframes, HCPs amended
the way certain data was visualised (such as requesting to supplement tables with
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graphs or changing graph types). They also refined the types of data displayed on
certain views (such as removing data items they felt were not important to include on
reflection: see Figure 4.8).
Figure 4.7: Participant H1’s initial sketches of the patient view.
After each group had their second workshop (when a total of four workshops had
been completed overall), I revised the wireframes a final time to reflect their suggested
changes. The output of the sessions were 11 Hospital scenarios and 10 Community
Care scenarios that the dashboard should support (Table 4.2). I presented the final
wireframes in the joint session to stimulate discussion (workshop 5). This workshop
brought together H3, C7, C8 and BI2 and lasted 30 minutes. The aim was to share
the wireframes and ideas with both groups of HCPs (Hospital and Community Care)
for discussion and comparison. This was an important step to allow HCPs to identify
areas of shared interest across both organisations. BI2 was included in the workshop
to gather their thoughts on what had been designed.
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Figure 4.8: Edits to the wireframes made by participants.
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4.3.5.2 Shortlisting Scenarios
After the wireframing sessions, it was time to create a digital scenario-based prototype.
A digital prototype would create a realistic interactive experience for the HCPs, which
would be important for the evaluation. I decided to prioritise and shortlist the number
of scenarios to include in the prototype (from the current list of 21 collective scenarios).
Shortlisting scenarios meant that I could focus on capturing a rich and meaningful
understanding of how a subset of scenarios would support HCPs’ work. This compares
to covering more scenarios in less detail. I aimed for each evaluation session to last
for one hour (which was the typical time on average I was able to meet HCPs for).
Therefore I decided to limit the number of scenarios to five, which would allow at
least ten minutes to discuss each one.
To decide which scenarios to shortlist, I thematically analysed the wireframing
workshop transcripts to determine which scenarios featured most prominently in
discussion. From this I identified the types of discussions about each scenario and how
often the scenario was referred to. It would have been ideal to conduct this shortlisting
activity with HCPs, but due to their busy schedules I had to forgo this activity myself.
However, I had enough knowledge to make an informed judgement about which
scenarios to shortlist from being embedded in the process. Additionally, I aimed
to prioritise scenarios which overlapped between both the Hospital and Community
Care (i.e. scenarios which they both discussed). For example, scenario number
one (accessing a patient’s spirometry test results) listed under both the Hospital and
Community Care in Table 4.2. Choosing overlapping scenarios would mean all HCPs
would be presented with the same scenarios in the evaluation. This would aid data
analysis by comparing and contrasting the feedback on the same scenarios.
After I had chosen the five scenarios to shortlist, I wanted to validate my choices
with the HCPs before moving forward with the digital prototype. I met with one HCP
from both organisations (H4 and C7) to discuss the scenarios and approve the final
versions of the wireframes from Stage 3 (which the upcoming digital prototype would
89 4.3. Study Design and Methods
be based upon). I used these discussions to create user stories6 about each scenario.
Creating user stories helped to gain a clear, structured focus of why each scenario
was important to the HCPs. This would help to create the discussion prompts for the
evaluation in Stage 4. The five scenarios shortlisted and validated for inclusion in the






An overview of COPD in-patients at the Hospital, including their ward
location, length of stay, and their number of previous COPD related ad-
missions. The overview is split by patients who are in hospital with COPD
as their primary admission reason, and those in hospital with COPD as





Live reports of COPD related hospital admissions and exacerbations on
a population level. The exacerbation data is reported by the Hospital,
Community Care, and GP practices in the locality
3 Patient-GeneratedData Overview
Overview of patient-generated data about COPD symptoms recorded by
patients via a hypothetical mobile app. Clicking on an individual patient’s
reports opens up their individual data entries which can be viewed as a
time series
4 Example Patient’sExacerbation History
A view of a patient’s history of clinically reported exacerbations, reported
by the Hospital, Community Car, and the patient’s GP practice
5 Example Patient’sSpirometry Results
A view of a patient’s spirometry test result history, reported by Hospital,
Community Care, and the patient’s GP
Table 4.3: The five shortlisted scenarios to include in the digital prototype.
4.3.5.3 Creating the Digital Scenario-Based Prototype
After creating the user stories based on discussions with the HCPs, I worked with a
research associate, Dr Adrian Gradinar, who developed the scenario-based prototype
base from the designs. The prototype was built as an Angular web app. Adrian and I
worked iteratively during the development phase: I provided him with the annotated
6User stories capture users’ goals relating to carrying out a task using a system (Cohn, 2004).
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wireframes and specifications for the development (Appendix D). I also shared the user
stories with Adrian to ensure a shared understanding of the value that each scenario
should deliver. I created a series of dummy datasets, with advice from a biostatistician
researcher, Dr Olatunji Johnson. These were used to populate the prototype so it could
support interaction during the evaluation with the HCPs (Appendix E).
After the first version of the prototype had been developed, I met individually
with a group of HCPs for feedback (H2, H3, H4, C7, C8 and C9). This was an
important step to ensure that the designs translated well across mediums (paper to
digital). I brought a laptop to the meetings to demonstrate the prototype, and asked
participants to comment on each scenario in its first-version form. I emphasised that,
at this stage, the feedback should be focused on any slight alterations to the interface,
wording of labels, or dummy data, rather than the addition or subtraction of any
features. Following the feedback from the HCPs, the prototype was minorly amended
and finalised for evaluation (Appendix H shows each finalised scenario).
The findings from this stage are presented in section 4.4.3. (pg. 102).
4.3.6 Stage 4: Evaluation
The final stage was the evaluation of the prototype with HCPs. The aim was to
collect feedback about the prototype. This was facilitated by walking through each
scenario and exploring how HCPs believed (or did not) the prototype could support
their decision-making about COPD care. The evaluation would provide HCPs with the
ability to interact with the prototype as if it were a real system. This would stimulate
meaningful and realistic discussions compared to utilising paper prototypes.
Evaluations were held at quiet rooms at both clinical sites, each lasting between
60 and 90 minutes. They were conducted one-to-one between myself and each
HCP (11 in total, detailed in Table 4.1). The HCP was first asked to answer basic
demographic information (age, gender, years in current role, and experience in years
using clinical systems) to provide additional context for data analysis. I provided
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participants with a laptop with the prototype loaded, and asked them to navigate
through each scenario sequentially (Figure 4.9).
Before moving to the next scenario, they were asked rate (on a 7-point Likert
scale) how realistic they perceived the scenario to be (‘does this scenario respond
in a way that you would expect when using a system to complete this task?’) and
its relevance to their job (‘is this scenario something you would use in your role?)7.
Understanding the HCPs’ perceptions on realism and relevance would complement
the analysis of the scenario discussions. For example, a high rating would provide
some confidence that the HCPs could engage with the prototype meaningfully (i.e. it
supported their mental model of that task and they could envisage how the scenario
could be used to support their work). Moreover, I was aware that each scenario may
have different levels of relevance for each HCPs and this was important to consider
when analysing the feedback8.
When walking through each scenario, HCPs were asked to interact with the
prototype freely by exploring different tabs, reviewing the visualisations, and exam-
ining the data. They were encouraged to think aloud9 while exploring each scenario
(Fonteyn et al., 1993). I prompted discussion by asking open-ended questions such
as ‘do you feel that the data presented to you in this format could influence your
decision-making?’, ‘are there any challenges that you could envisage when using this
scenario to undertake a task?’ and ‘who do you think needs to be involved in the
collection and maintenance of this data to ensure it is useful?’
To conclude the evaluation, I asked the HCPs to complete two short question-
7I referred to this as the Realism and Relevance questionnaire.
8Shortlisting five scenarios from the total of 21 that were generated in Stage 3 meant that some
scenarios would be more relevant to some HCPs than others.
9This involves participants verbally sharing their thoughts out loud while undertaking a task.
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The prototype’s homepage is loaded on the laptop screen, with buttons to select a specific scenario.
Figure 4.9: The evaluation set up at one of the clinical sites.
naires. The first asked them to rank the usefulness of the scenario from one to five
(with one being the most useful to them in their role)10. The second questionnaire was
a Technology Acceptance Model (TAM) questionnaire (Davis et al., 1989; Hornbæk
and Hertzum, 2017) which is intended to predict if a user will accept a new technol-
ogy11. TAM was primarily designed as a theoretical tool to quantifiably measure user
acceptance of a technology in information systems research. However, my intention
was not to use TAM as a form of theoretical predictor that the prototype would be
accepted by the HCPs in practice. Instead, the intention was to use the data generated
from the TAM questionnaire to supplement the richer qualitative insights from the
10I called this the Usefulness questionnaire.
11Technology acceptance can be defined as ‘an individual’s psychological state with regard to his or
her voluntary or intended use of a particular technology’ (Hendrick et al., 1984; Hu et al., 1999).
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evaluation. The TAM data would provide an indicator about how the experience of the
prototype mapped to theoretical components central to technology acceptance (which
are ‘perceived usefulness’ and ‘perceived ease of use’ in standard TAM by Davis et al.
(1989)). TAM has been used this way in HCI and CSCW research by Knowles and
Hanson (2018a) and Favela et al. (2010).
The TAM questionnaire was created in collaboration with a Professor of Respi-
ratory Medicine, Professor Mike Pearson12, to ensure the questions were clinically
meaningful and relevant to healthcare contexts (see Appendix G). I used the TAM
questionnaire provided in Davis and Venkatesh (1995) as an initial starting point13 to
adapt core questions which were grounded in previous TAM literature. As I revised
the questions to make them specific to the prototype and healthcare context (which
Holden and Karsh (2010) and Bardram (2018) encouraged when using TAM in health-
care research), I iteratively received feedback from Professor Pearson to ensure the
questions were applicable to clinical decision-making.
The findings from this stage are presented in sections 4.4.5 (pg. 110) and 4.4.6
(pg. 113).
4.4 Findings
This section presents the findings from all stages of the study (Stage 1: Scoping the
Design Space, Stage 2: Priorities and Implementation Challenges, Stage 3: Wirefram-
ing and Scenario Creation, and Stage 4: Evaluation). Findings from each stage have
been separated into distinct sections.
12Professor Mike Pearson was independent from the study and both NHS organisations.
13 Davis and Venkatesh (1995) used TAM to evaluate a word processing software.
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4.4.1 Stage 1 Findings: Scoping the Design Space
The following sections describe the findings from Stage 1, involving three one-to-one
interviews with HCPs (H3, H4, C6), a two-hour interview with IT staff (IT, IT2), and
focus group with HCPs (H3 and H4) and BI staff (BI1, BI2, BI3). Five themes arose
from the thematic analysis, which were refined into two key themes: (1) ‘lack of data
for daily decision-making’ and (2) ‘lack of data for strategic planning’. Both key themes
are discussed in detail below.
4.4.1.1 Lack of Data for Daily Decision-Making
HCPs were asked to discuss areas where they felt a dashboard would alleviate some
of the challenges they faced in their everyday work. They highlighted the difficultly of
making informed decisions about the care of individual patients, as data about their
full care journey is captured and stored in different digital systems and formats across
care organisations (such paper notes, digital notes, and spreadsheets). The problem
was further intensified by the fact that they did not have access to each system where
digital data was held, which made it difficult for them to decide the next steps to
take when planning care for a patient. H3 described care services as “fragmented”,
whereas having access to “a real patient story” would allow for HCPs to “compare
and contrast [information about the patient] in order to make a case for change, and
lead [their care] with that change.” Though BI1 agreed that “systems don’t necessarily
talk that well together”, they justified the use of multiple systems as providing the
technical ability to “capture more detail” through the use of systems that are specific
to a certain aspect of patient care. The overall challenge in accessing data about a
patient’s care was summarised by BI2 as follows: “the key thing is there’s the Hospital
and the Community [Care], and patients will move to one place to another. So when
they’re at the Hospital, I guess it’s the systems the Hospital are using and then when
they’re in Community [Care] it’s the IT systems we use”. The fact that patient data is
held across different systems, organisations, and formats, created difficulty for HCPs
to fully inform themselves about a patient’s care journey, particularly when different
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care organisations are involved in that patient journey.
When probing HCPs further to understand what processes they undertake to
obtain some of the data that they need, they described having to call or write to other
HCPs from “acute services, community services, [and] general practice” (H3) to request
the required data. For example, C6 described having to phone the emergency depart-
ment of the Hospital to understand if any Community Care patients were admitted
to hospital, and that “[it was] very difficult to either get through or speak to anyone
who knew what was happening.” Likewise, H4 discussed needing to “physically ask
the GP to fax [spirometry test results]” and how they felt frustrated that they could
not “see the investigation [test result] on my [computer] screen”. In some cases, C6
noted that a lack of data sharing caused HCPs to spend time on redundant tasks: “the
Community [Care] team would have referrals sent in, and when they went to ring or
visit the patient, they were already in the Emergency Department, so knowing they
were in the Emergency Department would save wasted activity.” BI1 explained that the
lack of data sharing is due to “information governance agreements” which need to be
established between collaborating organisations to share data about their patients14.
This meant that although HCPs could share data about their mutual patient verbally
and through letters, it could not be digitally shared through their IT systems.
4.4.1.2 Lack of Data for Strategic Planning
The lack of access to data useful for the strategic planning of services and resources
was another challenge that HCPs faced in practice. They were concerned that they
were working under “unpredictable” (H3) conditions that are not supported by any
“live data” (H3). One key area discussed was the number of hospital admissions
14In this case, the Hospital and Community Care needed agreed policies and processes around data
sharing for the purposes of direct patient care. Different healthcare organisations may have different
approaches for sharing patient data across collaborating organisations.
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relating to COPD, particularly relating to sudden spikes, which makes their services
“vulnerable” (H3). H3 discussed that it is commonly understood that more COPD
admissions occur in winter months “because patients tend to flare up with their COPD
with viral infections and stuff like that”, but sudden spikes within those months are
challenging to deal with and “we [HCPs] need to understand what is going on” (H4) to
effectively deal with increased service use. One method that was highlighted as a way
to deal with increased service use is to “allocate our resources slightly differently to be
able to deal with that [spikes]” (H3), for example, through allocating “a community
nurse or somebody in the hospital to go around and look at all these patients” (H3).
As such, accessing service level data could allow HCPs and service managers to better
adapt to increases in service usage.
It was further discussed by the wider stakeholder group that insights into what
causes spikes in admissions and referrals could potentially be identified if data was
linked across care organisations. Understanding “what is resulting in them [patients]
coming into hospital in the first place” (H4) could act as a first step in working towards
decreasing admission and referral rates. For example, BI2 highlighted a specific
instance of this: “if you suddenly saw an increase in activity from a particular GP
practice and you could see there’s a spike [in referrals for diagnosis or admissions],
then you could go and do some further investigations and there might be that there’s a
locum in for 6 months” and that “it’s being able to visualise it and easily see where the
connections might be”. The linking of data in this way was thought to be a possibility
to not only improve the Hospital and Community Care COPD services, but service
usage across all COPD care organisations including GP practices.
4.4.2 Stage 2 Findings: Priorities and Implementation Challenges
The following sections detail the findings from Stage 2, involving an observation of
the clinical systems (IT3), two workshops with HCPs (H3, H4, C9), BI (BI1, BI2), and
IT staff (IT1), and a focus group updating the stakeholder team jointly (BI1, H4, C7,
C9). Eight themes arose from the thematic analysis, which were refined into five main
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themes: (1) ‘integrating new systems into workflow’; (2) ‘need for quality data’; (3)
‘need for meaningful data’; (4) ‘the future of patient-generated data’; and (5) ‘digitally
supporting data needs’. These five main themes are described in detail below.
4.4.2.1 Integrating New Systems into Workflow
A challenge to integrating a new piece of software for use by the Hospital and Com-
munity Care HCPs was related to training staff. Training was highlighted by IT3 as a
challenge for HCPs due to the limited time that they could dedicate away from clinical
practice to be trained on new systems. It was noted that staff tend to be trained
“gradually” (IT3) at different time periods to help avoid many staff from being absent
from clinical practice at once. However, this gradual approach meant that there were
often staff, and locum staff, that were not trained on the system that they were using.
In addition to the gradual approach meaning that some staff were not trained, IT3
reflected on their experiences of staff believing that their, often fallible, intuition was
sufficient enough to mean that they did not require official training on systems. This
led to two challenges: data entry errors and inefficient task execution. Data entry
errors were not always immediately flagged as some systems did not have certain val-
idation checks (e.g. the HCP may use the wrong prescription units or amounts, and
the request would get sent back to them to be re-written, causing delays). Inefficient
task execution referred to HCPs not learning the most efficient way to undertake a
task on the system, and would therefore carry out a task using a path that they have
taught themselves, which may be more time-consuming (e.g. ordering a combination
of medications for a COPD patient individually, when the combination is available to
order as a set on the system). In some cases, not being trained on systems led to HCPs
not knowing about certain functionality that the system can provide, which meant that
HCPs were not aware of shortcuts or functionality that could save time.
In addition to being trained on how to use the system, it was highlighted that
there would need to be protocols established for responding to the data visualised
on the dashboard. When implementing a dashboard that indicates, or forecasts, an
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increase in service usage, it was acknowledged that there must be procedures put in
place to enable appropriate (re)action to those indications. For example, H3 described
the need for “agreements with other Trusts about how we respond to these spikes in
admissions” which would be “complex” as they would need to discuss how they
“re-deploy staff” and other resources in response to what the data suggests. This
was seen as a necessary step if the dashboard were to visualise admissions in real
time, as without arrangements around resources, HCPs would simply have to continue
responding to admissions in the same way which they did before using the dashboard.
Without these agreed arrangements (e.g. redeployment of staff), services would not
become more “proactive” (BI2, H3) as a result of using the dashboard, which was
seen as counterproductive to what the dashboard aimed to deliver.
To support building a dashboard that collates data that HCPs need, it was ac-
knowledged that some paper data would need to be collected digitally for use on the
dashboard, which would create “some change in the way we [HCPs] work” (H3). The
organisational change from recording on paper to recording data digitally was another
challenge area identified in discussions with participants. It was highlighted that one
of the main organisational challenges would be “transforming people’s ideas about
how they put information into systems” (H3) when shifting from paper to digital, as
there “there may be some resistance to that” (H3) due to the way it changes how work
is carried out. This resonated with findings from the ward observation, in which a
HCP highlighted that their team were initially against the digitisation of prescription
services due to change in work flow and their perceived lack of technical competence
to use a new system. However, IT2 noted that there is a gradual transition from
paper records to digital across care services in light of the UK government’s push for a
paperless healthcare system (Honeyman et al., 2016), and this may act as a motivator
for HCPs to persevere with digital data input. The technical challenge associated with
transitioning from paper to digital, highlighted by IT2, related to how adding additional
data into their existing systems would “change the way that the current data is held
in there”. Changing the way that data is held in the current system would take “time
and constraint” (IT2) to adapt the system, which was highlighted as being technically
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feasible but challenging to carry out.
4.4.2.2 Need for Quality Data
The reliability and trustworthiness of some data that would be used for the dashboard
was identified as a challenge area. This particular point related to the diagnosis of
COPD through spirometry tests. The wider stakeholder group acknowledged that
there were some “issues around diagnosis [of COPD]” (H3) which meant that some
patients were being improperly diagnosed with COPD (i.e. misdiagnosed) and referred
into clinics held at the Hospital and Community Care. The misdiagnosis of patients
created an increase in service usage and “puts the patient on the pathway that they
might not need to be on” (BI2) which can cause additional work for HCPs and undue
stress for the patients. For H4, misdiagnosis occurred for two reasons: (1) improper
investigation of symptoms and (2) HCPs being poorly trained to undertake spirometry
tests. For improper investigation of symptoms, H4 and H3 were concerned that some
HCPs believe “they’ve [the patient] smoked for a bit, they’ve been a bit breathless,
this could be COPD” (H4) and then proceed to diagnose the patient with COPD
without taking a spirometry reading. For poor spirometry training, H4 and the wider
stakeholder group agreed “the quality of spirometry depends on where the patient has
attended that test” (BI2), as HCPs in primary care organisations may not be properly
trained in delivering the tests. As a result of the quality concerns, H3 noted that they
“can’t really be sure that it [the diagnosis] is correct”, and would have to re-do the tests
themselves. H4 expressed frustration at this, mentioning that re-doing spirometry
tests to ensure they are accurate caused “duplication for the patient” and that they
feel they are “forgetting the patient in the middle of doing all these things”.
Although there were quality concerns about spirometry tests, and the dashboard
would “only [be] as good as the data you put into it” (H3), HCPs highlighted having
access to this data as one of their top priorities for the dashboard. H4 remarked
that this would put an end to needing to “beg, borrow, and ask somebody” for their
patients’ spirometry test results. There was an acknowledgement that viewing this data
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could also allow services to identify “the number of inappropriate referrals” (BI2) which
would make “a massive difference” (BI2) in being “able to track it back” (BI2) and target
those services with support and training to “ensure that there is accurate spirometry
across the entire patch” (H3). However, there was an acknowledgement from BI staff
that creating visibility around the individual practices which make incorrect referrals
could be considered “political” (BI2), and as such, there would need to be a thorough
consideration of the granularity of the listed source of the spirometry test alongside
“who has visibility of that” (BI2).
4.4.2.3 Need for Meaningful Data
The process of obtaining “meaningful” (H3, IT2) data was highlighted as a challenge
when using the current systems. HCPs illustrated this point by discussing the process
they undertook to access a list of patients who are in hospital with a COPD related
admission, which they carried out daily. H3 described having to log onto the main
Hospital system and would “bring up a list of patients who have got this flag [as having
COPD] but it won’t say whether the particular admission is because of their COPD” or a
“nose bleed”. For the HCPs, being able to access this list easily and meaningfully was
a priority. However, they found they had to either “ring the ward” (H3) or physically
click into each individual patient profile on the list to clarify what their admission was,
which H3 stated was “a waste of time” and they did not “have the capacity to do
this for every COPD patient”. Currently, the main system makes use of ‘data flags’
on a marker system, which are tags that link patients to certain conditions or codes
(such as a ‘Do Not Resuscitate’ Code). Patients that have been diagnosed with COPD
(whether correctly or incorrectly) will have a COPD flag associated with their profile,
as a way to easily link them to different system functionality. IT2 sympathised with the
concern, and stated that more meaningful flags would differentiate between patients
that are in Hospital for a “COPD patient problem” and those where they are in hospital
for another reason, such as “a broken leg”, so that staff members can prioritise which
patients they need to attend to.
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4.4.2.4 The Future of Patient-Generated Data
As a form of blue-sky thinking, HCPs discussed their desire for patients to record their
own health data at home. They were especially excited at the prospect of being able
to view patient-generated data around symptoms “using an app” (H3) or otherwise
“electronically” (H3) to help in identifying patients that are struggling to cope as “we
[HCPs] know patients do delay and put off seeing their doctor in case they go to
hospital” (H3) and “see if there’s particular flare ups in particular areas on a population
level” (H3). The reason that this was not seen as something immediately feasible
was because, as H3 discussed, they believed they had a “long way to go to be able
to get patients to record the data” because “the cohort of patients that we deal with
are generally not very electronically savvy” but they believed that this will “change” as
older adults become more comfortable with technology. However, H3 highlighted it
would be important to first understand “how can we [HCPs] practically interact with it
[patient-generated data]” for patient care.
The type of data they discussed as being most useful was “subjective reports
of symptoms” (H3) as “two people with the same spirometry [history] might show
quite different levels of symptoms” (C9). While discussing how patients currently self-
manage their symptoms, C9 reflected on patients’ use of a paper self-management
booklet currently used at their organisation, citing its “poor” adoption as there are “lots
of colours and lots of ticks, and people just look at them and go I’ll never be able to do
that”. However, C9 believed that a simpler system could have a “better response” that
would give patients “autonomy and the empowerment to manage their condition”.
In response to this priority being highlighted, IT2 stated that the sharing of patient-
generated data would require a “patient portal” being built, which is feasible, but is
not currently supported in their systems. In addition to building a patient portal would
be the organisation of “patients giving permission” (IT2) for their data to be shared,
which would need to be arranged from an information governance standpoint. One
of IT2’s concerns around building a patient portal to share data was about potential
cyberattacks, as a portal could become a gateway for exploitation.
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4.4.2.5 Digitally Supporting Data Needs
One of the most prominent challenges for creating the dashboard was around the
lack of flexibility that the current systems offer, meaning it would be challenging
for systems to be adapted to start recording data required for the dashboard. BI2
described the main system at the Hospital as being “a very old system”, and that
they hold a long contract meaning “it’s essentially is as it is” and “our hands are kind
of tied in terms of what we can do”. This would make it difficult to incorporate all
of the HCPs’ data needs, as the design of the system would become bound to the
possibilities within current systems (unless systems were altered and updated, which
would require lots of “time and resource” (IT2)). For example, C9 discussed using a
spreadsheet as a workaround to capture the number of assessments, referrals and the
outcomes of pulmonary rehabilitation, which was very “manual” and “doesn’t work
properly”. In response to this, BI2 noted that this data was “not really something at the
moment that current system are able to record” but if it were, visualising it would be
“dead easy” (BI2). The use of workarounds was justified by BI1, who stated: “having
a system across the Trust that fulfils everyone’s demand in services that operate very
differently is very challenging, and this is why you have these things like spreadsheets
and recording things in this way because there’s no alternative bespoke system . . . it’s
basically because we can’t have the flexibility to have it in the main system.”
4.4.3 Stage 3 Findings: Wireframing and Scenario Creation
The sections below discuss the key findings arising from the five workshops, four of
which were wireframing and scenario creation activities with the HCPs, and the fifth
workshop bringing HCPs together and BI1 for feedback. The workshops aimed to
uncover and visualise data needs. The findings from this stage relate to three types of
information needs (resulting in three key themes): (1) ‘understanding patient severity’;
(2) ‘understanding quality of life’; and (3) ‘understanding demand’. The three themes
are discussed in detail below.
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4.4.3.1 Understanding Patient Severity
Understanding the severity of a patient’s condition was a central discussion point
which dominated the wireframing sessions with both the Hospital and Community
Care. Hospital HCPs were keen to discuss scenarios that would help them to better
understand a patient’s condition when they were first admitted to hospital, such as
knowing “the number of admissions they’ve had that are COPD related” (H1), “how
many exacerbations they’ve had, when those have been” (H3), “who’s managing the
exacerbations [in terms of the GP, Community Care, or the Hospital]”, and “have they
ever been on non-invasive ventilation15 before” (H4) as that will help HCPs understand
“the severity” (H4) of the patient. Understanding the severity of the patient in a way
which “could be viewed by everyone who’s looking after the patient” (H3) would
help HCPs to collaboratively decide the next steps in the patients’ management. For
example, they might look at the patient’s exacerbation history and then ask:
“This patient has had two to three admissions needing non-invasive venti-
lation, have you thought about domiciliary ventilation16? Or, they’ve not
done pulmonary rehabilitation in over a year - or over a few years - could
they do that?” (H3)
H3 discussed that seeing this information in “some kind of graphical represen-
tation” over time could help support the easy identification of trends, and how the
patient’s condition may have changed, as “when you see patients from admission to
admission you might not necessarily join everything together” (H3) so having access to
a cohesive story of the patient’s condition history “would be helpful” (H3) for decision-
making. Adding to this, H4 described the importance that exacerbation and data on
a patient’s past exacerbations is “merged” (H4) with data from “whoever they’ve [the
15Non-invasive ventilation is a method of providing ventilation support to a patient, usually through
a mask worn over their mouth and nose.
16Domiciliary ventilation is support that the patient can use at home.
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patient] met in their pathway” (H3) so that it provides a true inclusive picture of their
condition and experience. This would directly support their work, in contrast to their
current method of “literally look[ing] through the letters [from the GP and Community
Care]” (H4) and “reading in between the lines” (H4) to try and piece together the
patient’s history.
For Community Care HCPs, accessing COPD hospital admission data for each
patient was “definitely needed” (C11) to better understand the individual patient’s care
journey. Knowing the patient’s exacerbation history and when they have had “acute
medication” (C7) was “really lacking for us in Community Care, and we really like the
idea of being able to see [that]” in a shared Community Care and Hospital “view” (C7).
This sharing of exacerbation history data was seen as crucial to supporting patients
and the collaborative work of both services as they are “trying to get away from the
‘Hospital’ and ‘Community Care’ and make it more joined” (H3).
It was further highlighted that collating exacerbation data from the Hospital,
Community Care, and GP practices would be viewable “in an ideal world” (C9) to un-
derstand the severity of the patient, but to also discover potential patients whose care
could be managed by a specific, more appropriate, service. For example, viewing a
patient’s exacerbation data which demonstrated many GP visits could allow Commu-
nity Care to be “more proactive around our management [of that patient] and making
sure patients aren’t missed by the [Community Care] service”. This type of data could
also facilitate support to other HCPs that offer care to the patient, as explained by
C7:
“If patients have had three admissions by the GP, and they weren’t known
to us, do we need to do some education around that [GP] practice around
what’s available [service wise] in Community Care [for COPD patients]?”
Being able to easily access and compare a patient’s annual spirometry test results
in “chronological order” (C7) was also seen as a useful way to understand condition
severity. Particularly, knowing if the patient has had a diagnostic spirometry test,
which forms one of the pillars for ensuring diagnosis has been carried out “accurately”
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(C11) in accordance with clinical guidelines17. This referred back to the concerns that
HCPs had that some patients they encounter have not been properly diagnosed. Hav-
ing access to a collated list of results “per patient as a comparable” (C7) was discussed
as being useful for understanding how the patient’s lung function has improved or
deteriorated over time (particularly in context of assessing how interventions, medi-
cation, and management techniques may have helped). Alongside having results in
comparable formats, it was highlighted that HCPs tend to have access to only the
numerical results of the test, which does not give adequate reassurance of the test’s
quality18. C9 and C11 shared the ways in which the spirometry trace can provide
additional meaning to spirometry test results:
“It’s the shape basically, it’s the shape of the curve, it will tell you potentially
a bit more about their airways. We generally just have the numbers but you
look at it together, that would be useful.” (C9)
“I like the idea that you can actually see the trace as well ... because you
can get a good idea of the technique and how they actually performed, it
tells you a lot of information really” (C11)
Having complete information about a patient’s exacerbations (recorded by all
healthcare services), followed by a complete history of spirometry results (a result
which demonstrates both the numerical results and trace results) was seen as an
effective way to better understand the severity of the patient. Completeness of infor-
mation was raised as essential for capturing a true understanding of patients’ condition
severity.
17According to National Institute for Health and Care Excellence (2010b), a spirometry test should
be undertaken as part of COPD diagnosis.
18Spirometry test results are usually made up of numerical results about lung function performance
and a graphical depiction of this as a trace.
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4.4.3.2 Understanding Quality of Life
An important area discussed with HCPs was related to understanding patients’ quality
of life, specifically their perspective on their condition and how they are self-managing.
This was particularly relevant to patients that are reaching the end stages of their life
or those who are acutely unwell. It was discussed that at the Hospital, quality of
life information is “sometimes” (H4) discussed in clinics, however “it’s physically
not possible to address it every time in clinic” (H4) with every patient due to the
time allocated to clinics and the number of topics the HCP must cover with each
patient. However, patients’ quality of life was something that H4 was “very conscious
about” and H3 thought was “a very useful perspective” for helping patients manage
their condition. In addition to using this information to help patients to manage
their condition, this information was thought to help HCPs have more constructive
discussions with patients to help manage any “unrealistic expectations” (H4) about
the patient’s future based on, for example, the prescription of a new medication. H4
discussed that some patients may believe “everything will get back to how they were
before” after new interventions, which is not always possible with acutely unwell
patients. One method discussed as being able to support this understanding around
patient quality of life was through the patient tracking a “semi-objective measure of
quality of life” (H3) over time that the HCP could discuss with the patient in clinic.
It was also raised that accessing patient-generated data about COPD symptoms
for “capturing exacerbations and deterioration earlier” would be useful to help patients
to “avoid potential hospital admissions and potential deterioration” (C7). This concept
was of interest to both the Hospital and Community Care HCPs. C7 raised that
patients tracking their own symptoms can help them to become better “aware of their
symptoms” as patients often only became aware of their symptoms once “things are
getting worse”. It was further highlighted that patients recording data about their
symptoms could aid with their self-management, and could be supported by HCPs
as “we can go back and look at that” (C9) patient-generated data if a patient called
the Community Service with concerns. Whereas H3 believed there was additional
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potential for patients “adding their own data particularly related to symptoms” which
would be “really powerful data” that could be used for “predicting exacerbations in a
totally different way that’s ever been done before” using predictive modelling, which
they believed would benefit on a patient level and also population level.
4.4.3.3 Understanding Demand
Understanding and predicting the demand on the Hospital and Community Care
services was also discussed as an effective way to adapt resources, but additionally,
to ensure that patients are being signposted to services effectively. HCPs agreed that
seeing the COPD hospital admission rate at the Hospital on a “day by day” (C7) basis
would be useful as a way to understand the number of acute exacerbations that are
leading to hospital admissions. In addition to hospital admissions data, H3 described
the desire to view the “number of patients that have been seen over a particular time
[for exacerbations]” (H3) across all services, including the number of patients which
have been seen by Community Care and GP services “so that we can see when the
dips, troughs, and the peaks are” (H3). Community Care HCPs also believed this data
was important, as seeing “the number of patients accessing their GP [service] but not
our service is really useful” (C8) in understanding “how many patients we’re missing”
(C7) and could divert to Community Care services to manage demand and provision
specialised care.
Furthermore, H1 and H3 highlighted that it could be useful to know if exac-
erbations were either infective or non-infective, as infective exacerbation data could
be mapped to “environmental data, prevalence of flu as well, especially in the winter
months” (H3) to help forecast service usage as “in flu season, we see a huge surge
in admissions and exacerbations” (H3). However, H3 pointed out that the clinical
method currently used to differentiate between an infective and non-infective exac-
erbations are not particularly effective, and so understanding this distinction may be
blue-sky thinking. At present, H3 described that HCPs often have to “ask patients if
they cough up phlegm, and if its changed colour, and if it has, we deem it as infective
108 4.4. Findings
and give them antibiotics” as sputum culture test results are not always immediately
available (and such tests are not usually undertaken at GP practice level). Therefore,
being able to distinguish between infective and non-infective exacerbations was seen
as something which held more exploratory potential in better understanding patterns
of exacerbations, and how these may relate to service demand.














HCPs must click an individual
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Figure 4.10: A conceptual representation of the Hospital marker system and how an
admission reason is determined.
Understanding day to day service demand was also discussed as being an effec-
tive way to prioritise immediate work. Particularly, Hospital HCPs discussed needing
to differentiate between admissions that are COPD related or admissions which relate
to patients that have a diagnosis of COPD. This related back to the ineffective marker
system that highlighted when COPD patients were in hospital, without explicitly spec-
ifying the admission reason. H3 described that this was an area that“we really struggle
with at the moment” as the HCPs need to “address them [patients who have come in
with a COPD related admission] first” but the process to differentiate them from un-
related admissions was laborious. For H1 and H2, being able to distinguish between
admission reasons was thought to save time and allow HCPs to “direct your resources
and time to the people who need us from a COPD exacerbation point of view” (H2)
109 4.4. Findings
and currently they had to make “our own list” on paper of patients that were showing
up on the COPD list as in hospital, but not having a COPD related admission, to
then remove the flag from them (which removes them from the in-patient list, but
not the original marker list, Figure 4.10). Whereas Community Care HCPs described
accessing the same marker system to “look at discharge summaries” to find out which
patients they should offer follow up care to, and having to undergo the same process
for understanding COPD in-patient’s admission reason.
4.4.4 Recap on Scenarios
To follow the findings presented from Stage 4 (11 interviews evaluating the prototype
with HCPs) in sections 4.4.5 and 4.4.6, it is important to be reminded of the five
scenarios that were involved in the evaluation. These have been described in Table
4.3 (pg. 89), and the interfaces presented to HCPs on the digital prototype are shown
in Appendix H (pg. 397 onwards). However, they are also summarised below:
• Scenario 1 provides an overview of COPD patients that are currently in hospital
with a COPD related hospital admission.
• Scenario 2 provides live reports of COPD related hospital admissions and exac-
erbations on a population level.
• Scenario 3 provides an overview of patient-generated data about COPD symp-
toms, with the option to view an individual patient’s data.
• Scenario 4 provides an overview of an individual patient’s previous exacerba-
tions reported by the Hospital, Community Care, and the patient’s GP.
• Scenario 5 provides a history of an individual patient’s spirometry test results,
undertaken by the Hospital, Community Care, and the patient’s GP.
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4.4.5 Stage 4 Questionnaire Findings: Evaluation
The following sections outline findings from the two questionnaires from Stage 4
(Evaluation). These questionnaires were given to the 11 HCPs that took part in the
qualitative evaluation of the prototype. This included the Realism and Relevance
questionnaire (that aimed to understand how realistic each scenario appeared, and
how relevant it was to the HCP’s role) and the TAM questionnaire (used to supplement
the qualitative insights by providing an understanding of what acceptance may be
according to theory). The Likert data was interpreted as interval data.
4.4.5.1 Realism and Relevance Questionnaire Results
After calculating the realism scores, results showed on average19 that all HCPs rated the
scenarios as appearing realistic. Likewise, on average20 each HCP rated the scenarios
as being relevant to their job. Overall, the least realistic scenario was Scenario 3
(Patient-Generated Data Overview) and the most realistic scenario was Scenario 1
(Respiratory Ward Overview). The scenario most relevant to participants’ job role was
Scenario 4 (Example Patient’s Exacerbation History) and the scenario least relevant
was Scenario 2 (Admissions and Exacerbation Reports). A full breakdown of results
from the Realism and Relevance questionnaire is provided below in Table ??.
On average across all scenarios, C10 provided the lowest rating for relevance,
and participant C6 provided the lowest rating for realism. C10 noted that in their
role as an Assistant Practitioner, they would not be expected to engage with the
five scenarios, hence their low relevance rating across all scenarios. Whereas C6
gave their lowest ratings for Scenario 2 (Admissions and Exacerbation Reports) and
19After calculating the mean of each participant’s realism scores across all five scenarios.
20After calculating the mean of each HCP’s relevance scores across all five scenarios.
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ParticipantScenario H1 H2 H3 H4 H5 C6 C7 C8 C9 C10 C11 Average
Realism 3 3 3 3 2 2 3 2 3 3 2 2.641. Respiratory Ward
Overview Relevance 3 3 -2 3 2 2 3 3 3 -3 3 1.82
Realism 2 2 3 3 3 -1 2 1 2 3 1 1.912. Admissions and
Exacerbation Reports Relevance 3 1 2 3 3 -1 1 2 3 -3 2 1.45
Realism 1 2 2 3 3 -1 0 3 3 3 1 1.823. Patient-Generated
Data Relevance 1 2 2 3 3 -1 2 3 3 -1 2 1.73
Realism 3 3 3 3 3 1 0 3 3 1 2 2.274. Example Patient’s
Exacerbation History Relevance 3 3 3 3 3 1 2 3 3 -2 2 2.18
Realism 3 3 3 1 2 0 1 1 3 2 2 1.915. Example Patient’s
Spirometry History Relevance 3 3 3 2 3 1 2 2 3 -3 3 2
Realism 2.4 2.6 2.8 2.6 2.6 0.2 1.2 2 2.8 2.4 1.6Participant Average Relevance 2.6 2.4 1.6 2.8 2.8 0.4 2 2.6 3 -2.4 2.4
A score of 3 indicates ‘strongly agree’, 0 indicates ‘neither agree nor disagree’, and -3 indicates
‘strongly disagree’.
Table 4.4: Realism and relevance survey results.
Scenario 3 (Patient-Generated Data), rating them as ‘slightly unrealistic’ and ‘slightly
irrelevant’. During the evaluation with C6, they discussed how they felt sceptical that
accurate data could be collected for visualisation in Scenario 2, as some healthcare
services do not include all COPD patients in their national audits, where they felt this
data would likely be sourced from. Therefore, they believed the data cannot be truly
representative of hospital admissions. When discussing Scenario 3, they described
their experience of being involved in a number of patient remote monitoring research
studies, which were not sustained due to lack of patient engagement. They believed
this would be the case for Scenario 3 also. They also believed that Scenario 3 would
be difficult to scale to many patients, which would potentially compromise how useful
it was in practice. These reasons had impacted how realistic and relevant C6 believed
the scenarios to be during the evaluation.
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4.4.5.2 TAM Questionnaire Results
The results from the TAM questionnaire indicated that all participants’ perceptions
of using dashboards to support their work and patient care were positive. A full
breakdown of results from the TAM questionnaire is detailed in Table ?? below.
The participant with the least positive perception of dashboards was C10, who still
‘moderately agreed’ that using dashboards could positively support their work and
patient care. All remaining participants ‘completely agreed’ on both questions aimed
at scoping their perceptions of using dashboards to support their work and for patient
care.
Likewise, on average, all participants found the prototype easy to use and useful.
The participant who gave the lowest rating for both usefulness and ease of use was
C10 (who on average still ‘slightly agreed’ that the prototype was easy to use and
useful). C10 cited their reasoning as a perceived lack of technical competency in
using technology and difficulty distinguishing the colours on the graphs due to an eye
condition (though, I did not look at the scores in front of the participants nor did I
ask them to justify their scores). Moreover, C10 is the same participant who had
scored among the lowest for average ‘relevance’ of all scenarios in the Realism and
Relevance questionnaire, as they acknowledged that they do not need access to most
of the data within the prototype in their day to day work, as they were an Assistant
Practitioner. This could explain why C10 gave the lowest score for ‘usefulness’ of the
prototype.
According to TAM literature, the positive ratings for ‘ease of use’ and ‘usability’
of the prototype would be indicative of participants’ motivation to use the prototype
in practice, leading to eventual acceptance of the prototype (Davis et al., 1989).
However, this finding was not the focus of issuing a TAM questionnaire to participants,
and I do not use it to argue for the prototype’s acceptability. As discussed previously
in section 4.3.6, TAM was used to supplement the richer qualitative findings from




Question Topic H1 H2 H3 H4 H5 C6 C7 C8 C9 C10 C11 Average
Perceptions of Dashboards 3 3 3 3 3 3 3 3 3 2 3 2.90
Usefulness 3 2.75 3 3 2.75 1.75 3 3 3 1.75 2.5 2.68
Ease of Use 3 3 3 3 3 1.75 2.25 3 3 1.5 2.5 2.63
Participant average refers to their average score across each topic.
A score of 3 indicates ‘strongly agree’, 0 indicates ‘neither agree nor disagree’, and -3 indicates
‘strongly disagree’.
Table 4.5: Results from the TAM survey.
4.4.6 Stage 4 Qualitative Findings: Evaluation
The following sections provide the findings from the discussions during the scenario
walkthroughs, which were part of the one-to-one qualitative evaluations with 11 HCPs.
Each section is organised in chronological order by scenario number, incorporating
the results from the Usefulness questionnaire undertaken in the evaluation. The
Usefulness questionnaire was presented to the 11 HCPs at the end of the evaluation,
where they were asked to rank the scenarios in order of usefulness to them in their
role (a full breakdown of these results are provided in Appendix F).
4.4.6.1 Scenario 1: Respiratory Ward Overview Feedback
Scenario 1 received a joint ranking of first place in the Usefulness questionnaire (along-
side Scenario 4: Example Patient’s Exacerbation History). Hospital HCPs believed that
overall, this scenario would help them to prioritise their day to day workload. For
example, the length of stay indicator would help them to understand which patients
to target first during ward rounds, with patients with longer lengths of stay being
targeted first (Figure 4.11(B)). It would also help them to organise which HCPs should
tend to which patients, as H4 described that junior staff and registrar staff could be
allocated to help in accordance with each patient’s needs (with patients that have a
longer length of stay having more complex needs, and more senior staff could tend to
them). Similarly, the number of previous COPD related hospital admissions (Figure
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4.11(C)) would allow Hospital HCPs to target patients in specific ways. For exam-
ple, patients with no previous admissions may benefit from education on managing
their condition to prevent future admissions. Patients with many previous admissions
could suggest that they are reaching palliative stages of their condition, and may not
be receiving effective treatment, or have limited support in managing their condition
(hence multiple admissions).
(A) lists the ward that the patient is on
(B) details each patients’ current length of stay
(C) details the number of COPD hospital admissions each patient has had in the past 12 months
Figure 4.11: Scenario 1: Respiratory Ward Overview annotated.
In addition to this, the easy identification of patients on outlier wards (Figure
4.11(A)) was raised as another way workload could be prioritised, allowing HCPs to
become more “proactive” (C6) in finding these patients compared to waiting for the
outlier wards to call the respiratory ward to inform them that a COPD patient is on
their ward.
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Community Care HCPs agreed that Scenario 1 could enable them to identify
discharged Hospital patients quicker to provide them with follow up care. This con-
trasted with current practice, where they have to “trawl” (C7) through a list of flagged
COPD patients on the marker system to understand why patients have been admitted
to hospital, to decide if it was necessary to follow up with the patient on hospital
discharge (i.e. if the admission was not related to COPD, there would be no need
to follow up with specialised COPD care). C7 suggested that the prototype could be
improved by providing Community Care with a view which listed discharged COPD
patients, so that they had an organised list which they could work from (this compared
to the current list which had patients that were still in Hospital and are not ready to
receive follow up support from Community Care).
However, a notable challenge highlighted by HCPs was that data generated in
clinical settings can often be incomplete and unspecific, which can affect how they
engage with it and use it for decision-making. Knowing which data source would be
used to facilitate Scenario 1 was important for HCPs so that they could acknowledge
the respective drawbacks when making decisions based upon it. When discussing
viewing patients listed in Scenario 1, it was highlighted that the existing data sources
that could feasibly facilitate the scenario both have noteworthy inaccuracies. For
example, there were two methods that could identify if a patient has come into
hospital due to COPD that could facilitate Scenario 1. The first is through the Hospital
COPD marker system, which keeps a list of patients flagged as having COPD. The
list was first populated by data from local GP practices, where patients who were
diagnosed with COPD at their GP practice were then added to the marker system.
The list is then shared with the Hospital and Community Care, who can add patients
(as a result of a COPD diagnosis) or remove patients (if they are shown not to have
COPD). However, it was noted that there are three main reasons why this was not a
“true list” (C7). The first was that patients on the list sometimes “have other respiratory
conditions” (C11) instead of COPD. The second related to how there are “patients
within the Hospital that haven’t had the flag added [to their name]” (C7) as the marker
system is not “utilised very well” (C7) in how it is operationalised, as it is a manual
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process, and “there will be patients that probably slip through the net” (C7). The third
related to uncertainty around the validity of the original diagnosis of COPD at GP
practice level. These factors each made the marker system seem appear an unreliable
data source for Scenario 1.
The second data source that could facilitate Scenario 1 was data from the clinical
coding department at the Hospital, but this was thought to be unspecific and often
initially inaccurate. For example, the initial coding of the patient’s admission reason
is based on what senior decision-makers in the emergency department write, who
are “generalists” (C6) and can only devise a working diagnosis for the patient that is
not intended as the finalised admission reason. Clinical coding involves assigning a
code describing diagnoses according to a classification system such as ICD-10 (World
Health Organisation, 2019). It was also acknowledged that there are “very umbrella
type codes” (C6) within current classifications systems, that mean that there are
multiple codes that are used to describe a single hospital admission, which has “has
been an issue, always” (C6) and is not a problem that is specific to COPD. To illustrate,
COPD can be clinically coded both as ‘COPD’ and ‘breathlessness’ separately, which
means that there may be COPD patients who do not receive a ‘COPD’ code. In this
case, they may be missed from the dataset used to populate Scenario 1. However, it
was highlighted that the data produced from the coding department generally becomes
more accurate as a patient’s admission progresses, as HCPs “get more information
during the course of somebody’s admission” (C6) and can amend the code to reflect
a more accurate reason for admission.
4.4.6.2 Scenario 2: Admissions and Exacerbation Reports Feedback
Scenario 2 was ranked as the least useful scenario in the Usefulness questionnaire.
When explaining the decision for a low ranking, participants mentioned that the
scenario had less impact in their day to day work and was less meaningful for individual
patient care (though the scenario was still useful to them). They discussed that they
would not access this scenario on a daily basis in their role, and it would be checked
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on more of a “monthly” (H4) or “six-monthly basis” (H2). The main perceived benefit
for this scenario was the ability to support strategic planning, such as “what [resources]
do we need, how do we improve services, where do we plan our service, how do we
improve our pathway to get more staff in and more services” (H4) and forecasting
admissions as “GP spikes normally occur slightly before admission spikes so if there is
starting to be a GP spike then you can follow the trend” (H5). For Community Care
HCPs, this scenario had most potential to see “where people are referring themselves
into, where they are ending up, that first presentation, and does work need to be done
to meet particular needs, so do we need to be promoting this service more” (C9) and
“looking at winter trends and things like that” (C7) so that if there are spikes Community
Care could “issue business continuity plans and things like that” (C7).
Though all participants agreed the scenario was useful, C8 highlighted that they
believed that themselves and colleagues would require training to understand the
data that was being presented in order to incorporate it into strategic decision-making
(Figure 4.12). They noted that they were “not used to seeing data like this” (C8),
expressing that the volume of the data across all three services (Hospital, Community
Care, and GP services) looked “a bit frightening” (C8).
A major challenged raised regarding this scenario was the belief that the Hospital,
Community Care, and GP practices do not have a shared, consistent understanding
of what constituted a COPD exacerbation. HCPs strongly believed that this affected
the quality of exacerbation reporting, as some patients were labelled as having an
exacerbation “too easily” (C9). For example, H4 and C11 discussed their concerns
over the way that exacerbations are currently labelled and how this impacts how they
would engage with this data in practice:
“It’s easy to label them as [having] an exacerbation and give them a little bit
of steroids and a little bit of antibiotics ... that’s why it comes back to how
much do you trust the person who is saying they have taken it seriously and
taken it to say this is an actual [COPD] exacerbation?” (H4)
“I also do feel like from a professional side that medics are like well we’ll
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The current view is set to a graph indicating the reported exacerbation frequency over time reported
by the Hospital, Community Care, and GP practices.
Figure 4.12: Scenario 2: Exacerbation Reports tab.
give you this because it’ll move you on through and out the system.” (C11)
One explanation offered for the discrepancies in labelling exacerbations was
that not all HCPs involved in patients’ care will be specialised in COPD. As such,
the Hospital and Community Care HCPs’ specialism in COPD is what made their
identification of exacerbations most reliable, compared to GP practices and emergency
department staff who “aren’t specialised in every condition” (H1). C11 discussed the
ways in which a patient’s symptoms may be classified as an exacerbation by some
HCPs but not others, which can lead to differences in how they are reported:
“People tend to be treated unnecessarily we do find. Patients that we are
monitoring at home, that we don’t feel are clinically exacerbating, but they
want something treatment wise, and then they will present at the GP or
Emergency Department and get that treatment so I do think there’s a bit of
discrepancy [of what exacerbations are] there.” (C11)
Whereas H1 described that some HCPs who have less “expertise” with COPD
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may assume the patient “knows their condition best”. As a result of this, H1 ex-
plained that some HCPs will prescribe exacerbation medication to the patient when
the medication may not have been necessary. This would in turn be incorporated
as exacerbation data within the scenario, which may not be an accurate reflection of
what the patient experienced.
For the HCPs, not knowing if an exacerbation has been accurately identified
meant that they were not confident in relying on this data for decision-making. They
felt that inaccurate exacerbation reports could project an overestimation of the number
of exacerbations occurring in their region, which could lead to “overspending” (C7)
on resources to adjust. However, they did agree that the visualisations provided by
Scenario 2 could be used to help HCPs across the different healthcare services to
educate one another as to why a consistent terminology is needed, and the impact
that inaccurate data can have on the services and patients.
Another notable challenge with Scenario 2 was that it collated data from different
collaborating organisations (the Hospital, Community Care, and GP practices), which
led to concerns over potential duplication of certain data that could render misleading
visualisations. While discussing the graph that depicts population level exacerbation
reports in Scenario 2 (Figure 4.12), C6 noted that “you could have the same patient in
three datasets there”, as patients could visit their GP and be treated for an exacerbation,
deteriorate, and end up being treated by Community Care, and then be referred to
Hospital. This would create three separate data points for the patient for one single
exacerbation, which would then be visualised thrice on the scenario.
4.4.6.3 Scenario 3: Patient-Generated Data
Scenario 3 was ranked second most useful in the Usefulness questionnaire. Most
participants believed that this scenario would be very valuable in providing an under-
standing of the whole patient experience of living with COPD, followed by the early
identification of patients that are struggling to manage their condition. They particu-
larly liked the way that the traffic light system could provide a quick review of patients’
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symptoms, allowing them to quickly identify and focus on patients who seem to be
experiencing difficulties (Figure 4.13).
There was discussion among participants about how this scenario could help to
avoid hospital admissions through the early identification of flare ups, and even be
used as an educational tool to help patients self-manage their condition better. For
example, the log of individual patient entries can facilitate discussions between the
HCPs and the patient as to what actions to take when the patient is experiencing a
specific symptom. While looking at the dummy data of a patient’s entry (Figure 4.14),
H4 saw an example of a hypothetical patient that contacted their healthcare team
without experiencing any symptoms. They discussed how they believed the patient
may be experiencing anxiety and as a result required “assurance” from a HCP, and
that they could use this data to probe discussions in clinic with the patient. Similarly,
C6 described value in using the patient-generated data in the same way as H4:
“You could use it [patient-generated data] to talk to them and educate them,
and say, well you’re reporting that you are terrible, why is that? And if they
say well I’m reporting that I’m feeling terrible because I’ve had an argument
with my husband, then you can say well that’s interesting and I’m sure that
does make you feel unwell, but here’s some breathing techniques to help
when you’re anxious, but it’s not an exacerbation... So yeah you could use
it as an entry to a conversation.”
HCPs discussed that it would be important to identify the correct patient group
to be enrolled onto self-monitoring set ups as in Scenario 3, as HCPs agreed that the
scenario could not scale to all patients on their service as it would lead to “unmanage-
able numbers” (C9). The types of patient groups that were believe would benefit most
from self-monitoring were mainly severely ill patients that have had several hospital
admissions. It was also raised that patients could be enrolled on the system for a
specific period of time as encouragement, rather than participating for an indefinite
amount of time. For example, C9 suggested that Scenario 3 could be “practical” if
patients “could be put on it for a month and monitored by the Community Care team”
to combat 30 day hospital re-admissions rates that occur with COPD (Rezaee et al.,
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Highlighted is the traffic light system which depicts each patient’s seven day status. Red indicates
symptomatic, green indicates asymptomatic, and grey indicates no data has been entered by the
patient.
Figure 4.13: Scenario 3: Patient-Generated Data Overview.
Highlighted is an example patient’s day type on 20/04/2019, followed by the action the patient took
on that day as a result of their symptoms.
Figure 4.14: Scenario 3: Individual Patient Log.
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2017). There was also potential identified for newly diagnosed patients to use this
system to become familiar with their symptoms. However, all HCPs agreed that they
would be most willing to enroll severely unwell patients onto a system like Scenario
3, compared to the average patient who can manage their condition on their own.
There was a notable concern raised by H5 and C6 that recording this type of data may
be “medicalising their condition” (C6). This may not be “constructive” (C6) for some
patients, as “some don’t want to be reminded that they are ill” (H5).
This directly leads to the second challenge about expectations around monitoring
the patient-generated data in Scenario 3. Though HCPs identified that one of the
benefits of Scenario 3 would be the early identification of patients that were unwell,
HCPs had concerns about how they could realistically allocate time to review each
patient on the system each day. C6 highlighted that set ups like Scenario 3 are
“implying somebody is monitoring it” and patients “may become dependent upon”
the idea that a HCP is monitoring their health and “looking at that [data] and acting”.
C6 expanded on this:
“Self-management sounds great, in reality it means a clinician managing
them. That isn’t self-management, is it? *pointing to the screen at Scenario
3*. A clinician is looking, or supposed to be looking at that and acting.
Mmm. I mean you can make an argument well the patient is looking at it
too, and it would hopefully prompt them to take action, yeah fair enough
I get that, but fundamentally they aren’t fully self-managing under this sort
of scenario.”
Both C6 and H2 suggested that the scenario could incorporate filters that alert
them when patients have “gone from green to red” (C6) or based on “an agreed
parameter where there was three days of red or five days of red” (H2), as this would
provide a proactive way of “highlighting an issue” to HCPs, rather than relying them
to check themselves. However, C6 noted that this could still lead to “unmanageable
numbers” and hence ensuring that the right target population used the app at the right
time was crucial. Similarly, the potential time required to investigate a patient who
was not compliant with data entry was another concern. C7 felt concerned that a
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patient that was no longer inputting data could “potentially be home isolated, and be
dead potentially”. Following on from this, C6 described the labour intensive process
that would be required to reach the patient in these instances:
“Say somebody has three grey days [no data input] one after the other,
they have to have a phone call, otherwise it’s meaningless, you’ve got to
do something with this data. So, fine alright. You ring them up and they
don’t answer. Really common, patients often particularly in the days of
mobile phones, it used to be better when people had landlines, but now
with mobile phones, people just block you or don’t answer if they don’t
see your number. So you try, and you try, and you maybe try every day for
a month. At some point, you are gonna have to send them a letter or do
something else. So you generating a whole heap of work, and then what
will tend to happen is you’ll get through to the patient who will say ‘ah
yeah I didn’t bother I’m not bothered about it anymore.’ ... as a service
manager, you’ve got to decide where’s the most appropriate use of your
resources, so the issue with telemonitoring or telehealth is that it can be
very monitoring heavy for very little beneficial outcomes.”
On a related note, HCPs discussed the differences in using sporadic data versus
consistent data entered by the patient for decision-making. While patient compliance
in engaging with data reporting was described as the “denominator of success” (H5),
some HCPs believed consistent data entry was key for a “true overall reflection”
(C10) of how the patient is doing, while others felt sporadic entries were acceptable
so long as the patient inputs data when they are symptomatic. The boundary of
acceptability differed depending on what the patient-generated data would be used
for. For example, for the purpose of remotely monitoring a patient and intervening
where necessary, sporadic data was seen as acceptable so long as the symptomatic
days were consistently reported by the patient:
“If you have loads of grey [no input] and then three red, you know you need
to phone them ... but there will also be patients who just don’t put data
in until they are unwell. What you don’t want is patients who put greens
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[days] but don’t put the red.” (H5)
Community Care HCPs also reported that for the purpose of monitoring a patient
from the clinic, asymptomatic days (green days) could be “hidden” (C9) from the
Scenario 3 (Patient-Reported Data) view, as “there’s no need to worry about them” (C9)
and the priority was to see the patients reporting symptomatic days (red days) as those
are the “patients that needs to be viewed” (C7) and contacted. This further supported
the notion that consistent reporting of symptomatic days was important for decision-
making in this context, without necessarily requiring consistent reporting overall. For
the purpose of reviewing a patient in a clinic setting, consistent reporting overall was
seen as more important compared to sporadic data entry. It was acknowledged that
COPD is a “variable” (C8) condition and without daily input, HCPs “couldn’t be so sure
about the day to day changes” to the patient’s condition. These day to day changes
were important for the HCPs to build a picture of how patients are managing their
condition to better understand their quality of life. They also noted that encouraging
the patient to record green days can allow them to collaboratively review the data with
the patient and emphasise the positive periods of their life.
There were also trust concerns around using the patient-generated data for
decision-making, particularly the difference between self-assessed data (based on
patient judgement) and physiological data (backed by quantitative measurements).
Although self-assessed data was initially outlined as a need from the HCPs in Stage 2
(Priorities and Implementation Challenges, section 4.4.2.4, pg. 101), HCPs perceived
self-assessed data as less reliable for clinical decision-making due to the fact that
patients’ perceptions of their condition can affect the data that they record. For
example, HCPs discussed the variability and subjectivity that arises with self-assessed
data around factors such as rating breathlessness and fatigue. H6 voiced concerns
that data within Scenario 3 would require some form of standardisation to account
for this variability as “some patients will over-report their symptoms, and some will
under-report their symptoms.” Whereas C8 discussed the challenges in identifying
individual patient symptom thresholds and the organisational guidelines which would
effect how the data is used for decision-making purposes:
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“What is drastic to somebody is nothing to somebody else. It’s so variable.
Whereas you know physiological data, you’ve got a guidance that you can
say ‘that’s acceptable, that’s not acceptable”’
It was further raised that self-assessed patient-generated data “doesn’t filter
out things like depression” (C6) and the “huge psychological element” (H2) which
“some people struggle with” (C6) and thus can impact how patients assess their
symptoms. HCPs noted that readings which are affected by factors outside of the
patients’ COPD “doesn’t mean they don’t have a genuine need”. Rather, it becomes
a challenge for what respiratory HCPs “can draw out from the data” in regards to
the patient’s COPD. In a remote monitoring context, it would make it challenging
to understand which patients require attention from a respiratory perspective or a
social care perspective. Although HCPs felt they could not rely on self-assessed data
alone for decision-making, they did note that there was significant value in viewing
self-assessed data. They discussed the importance of understanding the patient’s own
perception of their condition, noting that without self-assessed data the “emotional
value” (H4) and what the patient is “experiencing” (H4) is lost, an aspect that still
must be understood as part of chronic care management. However, the psychological
factors resulting from COPD required different management support compared to
clinical exacerbations, thus knowing which data could be influenced by psychological
aspects of the condition is important for decision-making.
One way in which HCPs felt patient-generated data could be more reliable for
decision-making was through pairing self-assessed data with physiological readings
from the patient. Physiological readings, such as pulse oximeter readings (which
measure oxygen saturation) were seen as being able to provide a “baseline” (C11) to
compare a patient’s perceived breathlessness against, which can help to differentiate
the type of support the patient needs. H2 elaborated on this concept:
“If someone was telling me they feel absolutely awful and are scoring reds
(pointing to screen), but actually their physiological parameters were fine,
I’d feel more reassured that perhaps they aren’t clinically deteriorating, but
obviously I still need to address the fact that the patient feels like they are.”
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Some HCPs believed that the pairing of self-assessed and physiological readings
could create a more “meaningful” (H4) dataset from the patient, as both aspects of
this data cover the experience of living with COPD and “you want to merge both what
they feel or experience to what is actually happening” (H4). Likewise, H2 agreed that
pairing both types of data together would provide a “more of a well-rounded picture”
of the patient’s condition that could help to decide how to proceed with their care
and which type of support the patient should receive (e.g. exacerbation management
support, psychological support, or social support).
4.4.6.4 Scenario 4: Example Patient’s Exacerbation History Feedback
Scenario 4 was also the highest ranked scenario in the Usefulness questionnaire. The
positive feedback centred mostly around being able to better understand the patient’s
journey “and how patients’ quality of life and clinical health has been affected across
all sectors of care” (H5) as HCPs tend to see the patient at specific intervals and
“what you don’t see is what’s been happening, and how many times” (H5). This was
particularly valuable given that COPD is a chronic condition that is managed by a
diverse team of HCPs at different stages, and having “the overall picture rather than
just snippets of information” (C8) was seen as important for effective care planning and
patient management. Scenario 4 was thought to provide an easier way to identify the
patient’s previous exacerbations, which was a direct improvement over the current
method of asking the patient for their history and shuffling through “thousands of
records” (C6) about the patient which contains detail that is too “heavy” (H5) and
“stuff [that] is not relevant for what we [respiratory HCPs] are interested in” (C6).
A further benefit of Scenario 4 was the ability to identify which patients are
severely struggling with their condition and may require a referral to secondary care
(C9) or “are heading towards more palliative end stage disease” (H4) and need “advance
care planning” (H3). The collation of exacerbations in this way was thought to be “very,
very useful” (H4) in supporting decisions around the next steps for the patient’s care,
but also for better understanding the patient’s story of living with the condition. H4
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envisioned using Scenario 4 when engaging with patients within clinics, whereby “you
sit with them to say tell me what happened there” to learn their story. This was seen
as a valuable tool, as patients often “forget” (C7) and their “recall isn’t always great”
(H3), which impacts how well they can articulate their experiences. H4 described
using the data in a way that promotes the collaborative detangling of the patient story
to identify specific actions (or inactions) that impacted their COPD:
“[The patient may say] I went away on holiday, and was in the bus or
the coach, and this other person was coughing next to me... so you
can understand ok what happened there? Did you forget to take your
inhalers is that how you ended up having a non-infective exacerbation,
what happened there? ... [or] ... if they are only breathless because
they have seen something on the television that upset them, that may not
physiologically be there, but that has been there on their mind and that has
affected the way that they are feeling, but physiologically they don’t need
steroids.”
A notable concern with Scenario 4 related to misinterpreting the number of
exacerbations a patient has had within a time period. As the data within this scenario
was collated from the Hospital, Community Care, and GP practices, there were similar
concerns as with Scenario 2 (Admissions and Exacerbation Reports), whereby one
exacerbation could be mistaken for multiple exacerbations. HCPs described that the
list in Scenario 4 presented each entry as an isolated exacerbation, yet multiple could
be “the same exacerbation” (C6). For example, a patient may visit their GP about an
exacerbation, receive medication, and end up in hospital for that same exacerbation,
leading to two separate data entries in the scenario. However, this concern was
thought to have less severe consequences than those associated with Scenario 2, as
HCPs felt they could use their judgement to sieve through the entries and “say well two
of them or three of them were really close together so we’d actually say that’s probably
part of the same exacerbation that we just weren’t treating effectively” (C9).
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4.4.6.5 Scenario 5: Example Patient’s Spirometry Results Feedback
Spirometry results were seen as the third most useful scenario according to the
Usefulness questionnaire results. Discussions with HCPs revealed that the reason for
a lower rating was due to the lack of impact the scenario could have to the patient,
as “it’s not a functional tool” (H5). Though HCPs still described the scenario as being
“really useful” (H5) and time saving, just comparatively less impactful than Scenario
1 (Respiratory Ward Overview), Scenario 4 (Example Patient’s Exacerbation History),
and Scenario 3 (Patient-Generated Data). All participants agreed that the trace of the
result alongside the numerical results was valuable in determining the “quality” (C9)
of the test, as “having the tracing to see is really important because you obviously
don’t know how the patient performed [during the test]21 (C11). It was also noted
that providing all results in a table format allowed for an easy compare and contrast
of how the patient’s lung function may have deteriorated over time.
An important challenge raised around Scenario 5 was that HCPs generally felt that
spirometry data was more trustworthy if it was recorded within their own department.
However, HCPs also preferred spirometry test results that was recorded by HCPs
which they had a close working relationship with (which could be HCPs in different
departments and organisations). For example, C7 and H2 discussed how they believed
having a stronger working relationship with a particular HCP or service would mean
that the data was more “familiar” (C7) and as such, they would be more confident in
using it for their decision-making. C7 discussed that their close working relationship
with the Hospital HCPs made the spirometry tests performed by them seem more
reliable (compared to tests taken by GP practices), as they were familiar with the
Hospital HCPs’ specialisms and competencies. When discussing using the data within
Scenario 5 for decision-making, C7 described how they placed confidence in test
21Spirometry tests require three forced blows into the spirometer device, and how the patient blows
can affect the reading.
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results from the Hospital over GP practices:
“I can see on this one (pointing to spirometry results on the screen) that
this was done here [in Community Care], and this one at the Hospital, so
you’d be more inclined to use the Hospital data as kind of reliable, that’s
your reliable one, then you can probably work from that as to whether or
not the others were really done properly.” (C7)
In the example above, C7 used the Hospital spirometry test result as a baseline
to compare and contrast the rest of the data with, in order to decide whether the rest
of the data was reliable. This demonstrates how the HCPs place different weights or
“confidence intervals” (H4) on the data depending on its source (despite the type data
being the same). This same thought process was seen with C9, C8 and H5 when
comparing spirometry test results:
“Was that [spirometry test] actually done by the Hospital or Community
Care? In which case, then it’s reliable. Otherwise, it might have been a
GP.” (C9)
“I definitely believe what came from the Hospital over the GPs.” (C8)
“I think it [reliability] is a big issue and it depends on, I know you’ve got
who’s done the trace, so I think that gives you an idea of the reliability of
it.” (H5)
4.5 Discussion
The following sections collate the findings across all stages of the study into three
main discussion points: (1) ‘trusting data for clinical decision-making’, (2) ‘integrating
systems into workflow’, and (3) ‘reflections on evaluation approach’. These discussion
points, grounded in the findings from this study, aim to highlight salient challenges
and opportunities for DSDM technologies to support respiratory care.
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4.5.1 Trusting Data for Clinical Decision-Making
A prevailing theme throughout this study has been the concept of ‘trusting’ data and
how this influences whether HCPs will use certain data for decision-making. That
is, trusting its author (who recorded the data), and its source (what system the data
originated from), which helps to determine data reliability. Trust can be defined as
‘a subjective assessment of the reliability that a person or system will perform an
expected action’ (Knowles, 2016).
Trust and technology has been explored extensively in past research, particularly
in relation to its impact on users’ engagement with digital health technologies or
health information. For example, trust in health information shared and published on
the internet (Crawford et al., 2014; Sillence et al., 2013; Smith and Manna, 2004),
trusting the accuracy of patient-generated data (West et al., 2016), trusting the validity
of data originating from sensors in personal health technologies (Clifford and Bishop,
2011; Jaigirdar et al., 2019; Knowles, 2016), distrust in the advice of non-specialist
HCPs by patients (McNaney et al., 2018), and trusting computer assistance in medical
decision-making (Hartswood et al., 2003b; Yang et al., 2016).
However, my research has discovered how HCPs may distrust data held in their
clinical systems, and data produced by their colleagues and patients. The sections be-
low describe where trusting data was a key concern to HCPs, followed the implications
for the design and deployment of DSDM technologies for respiratory care.
4.5.1.1 Healthcare Professionals as ‘Data Authors’
The trustworthiness of data generated by HCPs depended upon how competent they
were perceived to be in relation to understanding and assessing COPD. When HCPs
were ‘data authors’ (responsible for recording data), their competency levels were de-
termined by their professional role, and how reliable the data recorded from members
of that role have been in the past. Data recorded by the ward staff at the Hospi-
tal (perceived as highly specialised in COPD) was considered the most trustworthy,
131 4.5. Discussion
while data generated by GPs (perceived as less specialised in COPD) considered the
least trustworthy. This concept of trusting data based on professional roles strongly
resonates with findings by Cicourel (1990) and Ellingsen (2003a,b), which discussed
how the source of medical information determines its adequacy for use in decision-
making. More specifically, Cicourel (1990) observed how the perceived credibility of
information was based on social and professional hierarchies within a teaching hos-
pital. For example, diagnostic information from attending physicians was rarely chal-
lenged and perceived to be more ‘objective’ (pg. 228) than that of medical students.
Whereas Ellingsen (2003a) expanded on Cicourel (1990)’s findings, demonstrating
how physicians were reluctant to use information recorded by their trainees due to
perceived inexperience. Both studies show how information recorded by senior and
experienced HCPs can be perceived as more ‘trustworthy’ in hospital contexts.
Adding to these findings by Cicourel (1990) and Ellingsen (2003a), I have discov-
ered that HCPs’ medical areas of specialism can influence the perceived trustworthiness
of data. For example, spirometry tests undertaken by COPD nurses (an expert in their
domain and highly specialised in COPD care) were deemed more trustworthy than
those undertaken by a GP (an expert in their domain but not specialised in COPD). As
the GP’s clinical specialism is not COPD, rather they are experts in general medicine,
they were perceived as less likely to produce trustworthy data about their COPD
patients. GPs may be less likely to be trained in conducting spirometry tests as this
forms a very small part of their role, compared to COPD nurses who may conduct
these daily. Similarly, their lack of specialism in COPD was perceived to make them
less likely to be able to accurately identify a COPD exacerbation. In short, the GP
is thought to be less knowledgeable in COPD care, and although a medical expert,
information that they produced about COPD was considered less trustworthy. This
was also observed in how HCPs perceived the information received by emergency
department staff at the Hospital.
Further to this, some HCPs believed that they could better assess data trust-
worthiness if it was produced by a colleague whom which they had a close working
relationship. When staff have a close working relationship with one another, they are
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able to assess each other’s specific skills and competencies. Though this ultimately
relates back to how trust depends on perceived competencies, it demonstrates an
additional social dimension to this phenomenon. This social dimension inadvertently
produces bias against information produced by the GP, as Community Care and the
Hospital do not collaborate closely with them. This relates to the concept of ‘bio-
graphical familiarity’, which is described by Jirotka et al. (2005) as a ‘predicate’ for
trust. In their work, Jirotka et al. (2005) observed how mammogram readers devel-
oped a sense of familiarity of the strengths and weaknesses of their colleagues, which
affected how they judged and oriented themselves to reading mammograms produced
by those colleagues. They found that contextual information about the production of
the mammogram (such as the reading centre that produced the scan) had relevance
for how the mammogram would be interpreted during reading. In my research, a lack
of biographical familiarity had direct implications for how willing HCPs were to engage
with data produced by staff whose competencies they were less familiar with. The
Hospital and Community Care could better trust each other’s clinical judgements as
they had a close working relationship and shared the common goal of quality care and
admission avoidance for COPD patients. This contrasts with how they perceived data
recorded by the GP or emergency department staff, whom which they collaborated
with less and had different specialisms to.
As I have highlighted, HCPs trust data differently depending on the data author.
This has direct implications for the design of DSDM technologies for healthcare, and
we must be mindful of how to represent such data in DSDM technologies as the same
data may not be weighted equally. In the prototype, I included the ‘source’ of spirom-
etry test results and exacerbation reports, which HCPs felt was crucial metadata to
emphasise next to the collation of this information. However, including the source ac-
commodates these trust concerns, rather than provides a mechanism for alleviating or
eliminating them. It is important to note, however, that this trust observation is social
in nature. Therefore, though this observation has direct relevance for how we design
DSDM technologies, it cannot be ‘fixed’ through a technical solution alone. In a future
where better education and training around COPD can occur, one way to technically
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support collaborating HCPs begin to better trust each other’s data could be through
the use of digital badges, similar to those seen in online communities (Anderson et al.,
2013). These badges could identify, for example, which healthcare organisations have
undergone certified technical training in spirometry tests. These could be displayed
next to data entries recorded by the healthcare organisation. This could support trust
building, by slowly eliminating the ‘blanket approach’ currently undertaken, which is
to question data generated by a particular source.
It is important to acknowledge that this concern around trusting data authors
is a very nuanced problem, which is unlikely to be solved by a number of proposed
design solutions in this thesis. I argue that what we can learn about the existence of
these trust issues, and what this means for DSDM technologies, is the important point
to emphasise here. Though the HCPs in this study strongly believed that collation
of data collected by all HCPs in the patient’s care network would support decision-
making, in reality there were concerns over the reliability of certain data. I raise the
need for the HCI community to become better aware of how trust impacts the use
of cross-organisational and cross-departmental data in healthcare. This is particularly
relevant for care of chronic conditions, whereby there may be many collaborating
HCPs that have different areas of medical specialisms. This will ultimately impact
human-data interaction for DSDM technologies for healthcare, and perhaps digital
healthcare technologies more widely.
4.5.1.2 Patients as Subjective ‘Data Authors’
Patient-generated data was thought to offer a rich perspective about the overall patient
story, which helps to understand the severity of their condition and support individu-
alising their care. However, the Stage 4 evaluations uncovered trust concerns around
patients generating their own data to share with HCPs for decision-making. This con-
cern was specific to the self-assessed data items included in the prototype: ‘increased
breathlessness’, ‘increased cough’, ‘increased sputum’, and ‘sputum colour’. This
trust concern ultimately stemmed from HCPs believing that patients’ self-assessed
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judgements of their symptoms were too ‘subjective’ and contained too much variabil-
ity to use for decision-making. It was a challenge for HCPs to identify whether a patient
was likely to under-report or over-report their symptoms, which would directly impact
how their symptoms were represented in the data. In fact, Nadarajah et al. (2019)’s
study on telemonitoring of COPD patients showed how some patients themselves
had difficulty in responding to ‘subjective’ questions about rating their breathless-
ness and coughing, and would choose to under-report their symptoms unless there
were large deviations from their usual baseline symptoms. Likewise, it is conceivable
that there are patients that would over-report their symptoms in response to dealing
with uncertainty around subjective measurements. This shows that subjectivity in
patient-generated data is a challenge for both COPD patients and HCPs.
One way that HCPs thought variability in patient-generated data could be mit-
igated is by pairing this data with quantitative readings. For example, using pulse
oximeter readings to numerically represent the breathlessness symptom. Pairing self-
assessed data with physiological data to predict respiratory exacerbations has been
used in previous work with promising early results (Anastasiou et al., 2018; Velardo
et al., 2017). For example, by pairing symptom diary data with either pulse oximeter
readings or peak flow readings. Going forward, it is important to work with HCPs
to understand the symptoms that are valuable to track, and map how these may be
recorded to a degree of accuracy that the HCP can use for certain types of decision-
making. The dataset which was used to represent patient-generated data in Scenario
3 was based on data from an existing symptom monitoring app for COPD22, and some
criticisms raised by HCPs in this study will be specific to the type of data explored in
the evaluation. However, the symptoms explored in this study, particularly breath-
lessness, are all measured in COPD clinical assessment questionnaires (Bestall et al.,
1999; Crisafulli and Clini, 2010; Jones et al., 2009; Kendrick et al., 2000) and are
22‘How Are You Today?’ Accessed Februrary 6, 2020 from https://play.google.com/store/
apps/details?id=com.intelesant.copd&hl=en_GB.
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used in formal definitions of what constitutes a COPD exacerbation (Pauwels et al.,
2004). Therefore, discussions about the specific symptoms explored in this study
in Scenario 3 can be used to inform future work around using these indicators for
decision-making.
An area where subjective and variable patient-generated data would be prob-
lematic is for predicting exacerbations, something which HCPs expressed interest
in using this data for. Previous work has shown how clinical data may be used to
predict COPD exacerbations (Amalakuhan et al., 2012; Garcia-Aymerich et al., 2001;
Kerkhof et al., 2015), with the strongest predictor of exacerbation risk thought to be
the frequency of exacerbations the patient has had in previous years (Amalakuhan
et al., 2012; Kerkhof et al., 2015). These predictive systems require patient data
that is recorded in a consistent and standardised format, such as patient data held
within primary care records (Kerkhof et al., 2015). However, when patients are in
charge of generating their own data for this purpose, any subjectivity and variability
in reporting could hinder the accuracy of the predictions made by the systems23. As
such, there would be a requirement to collect data that is perceived to be more ‘ob-
jective’ as part of this process, such as quantitative readings. It is important to note,
however, that quantitative readings can also be subject to inaccuracies or variability,
for reasons such as improper calibration of equipment and differences in device algo-
rithms (Marcengo et al., 2016; West et al., 2016). Information about the context in
which data was recorded is also important to understand situational factors that may
impact readings (West et al., 2016). For example, as raised by one HCP, anxiety can
influence symptoms such as breathlessness (C6, section 4.4.6.3, pg. 120). There-
fore, when using patient-generated data for the purposes of predicting exacerbations,
the data should have minimal variability and account for the context in which it was
collected. Minimising potential inaccuracies can be achieved through the collection
23It is worth noting that data collected by HCPs, particularly about COPD exacerbations, can also be
variable (see section 4.5.1.1).
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of multiple physiological readings which can provide a less ambiguous picture of the
patient’s health. However, this increases burden on the patient to record additional
data (Lupton, 2013). Depending on the COPD patient population who engage with
this technology (e.g. severe patients at high-risk of exacerbation versus mild patients at
low-risk), different levels of engagement with self-monitoring may be considered more
acceptable and worthwhile. Yet, this does not lessen the need to consider the patients’
perspective when designing technologies to predict COPD exacerbations.
Subjectivity in patient-generated data may be somewhat acceptable in particular
clinical scenarios. Accessing this data in clinic with a patient, as “an entry to a
conversation” (C6, section 4.4.6.3, pg. 120), was thought to help explore how a
patient is managing their condition in their everyday life. This insight could help HCPs
identify opportunities where the patient may require extra support, such as improving
education around self-management. Here, the data alone is not used to drive the
decision-making process. Rather, the data becomes a tool that can support patients to
structure storytelling about their symptoms and experiences. The design of Scenario
3 enabled this, as patient-generated data was provided in a standardised format24,
which highlighted to the HCPs any variations in a patient’s symptoms graphically.
This allowed HCPs to quickly identify areas to query the patient about.
This aligns with work by Mentis et al. (2017) about using activity trackers to
understand movement of patients with Parkinson’s disease. Their work showed
that patient-generated data can be an useful resource for HCPs and patients to co-
interpret to identify personalised management strategies and health goals. However,
they discussed the need to support patients to better understand their data prior to
clinic visits to maximise the value gained from the co-interpretation process. This is
important in the context of COPD, as HCPs had noted that patients’ recall of their
24In reality, patient-generated data can only be in a standardised format if COPD patients use the
same monitoring technology. This is not completely out of the question, as healthcare organisations
may look to endorse specific technologies for monitoring chronic conditions (see Chapter 6).
137 4.5. Discussion
symptoms tends to be poor (C7 and H3, section 4.4.6.4, pg. 127). To support
COPD patients to understand their data in preparation for clinic visits, self-monitoring
technologies could prompt patients to optionally input free-text to accompany their
symptom data. Through providing contextual information in addition to monitoring
symptoms, patients can be reminded of any notable events or experiences to discuss
in clinic. However, it is important to recognise the liability concerns that HCPs may
face when viewing free-text notes sent by the patient, as they may perceive themselves
as liable for the content (Marcu et al., 2011). To mitigate this, the patient-generated
data shown to the HCP could be refined to exclude free-text narrative. Alternatively, a
system could operate where these free-text notes would only be made available with
the patient present in a clinic.
4.5.1.3 Patients as Sporadic ‘Data Authors’
A notable practical challenge with patient-generated data is the effort perceived to
be necessary to keep patients generating data consistently, so any patterns can be
accurately identified (Stone et al., 2002, 2003). Thus, sporadic data entry by patients
can create a challenge for using this data in clinical settings as important insights
may be missed, or considered ambiguous due to missing data (West et al., 2018).
However, when exploring Scenario 3 with HCPs, I found that sporadic data was
sometimes considered acceptable. It was raised that being able to identify a patient’s
‘bad days’ was most important, and if the patient consistently entered data when
they felt unwell, this was usable. This was summarised by one HCP as: “what you
don’t want is patients who put greens [days] but don’t put red [days]” (H5, section
4.4.6.3, pg. 123). Further to this, some Community Care HCPs suggested that
the Scenario 3 could be improved by offering functionality that allows HCPs to filter
asymptomatic patients from the collated list. Although understanding that a patient
feels well is of interest to the HCPs, there was a stronger interest to know when a
patient felt unwell, as this requires some action or intervention from the HCP. Adding
customisable filters to patient-generated data views (such as the view in Scenario 3)
could support HCPs to focus on, and prioritise, a subset of patients. However, these
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filters must be designed with caution to ensure that HCPs do not develop tunnel vision
and inadvertently displace attention on patients outside the filtered subset (Dowding
et al., 2015). Visual alerts that remind HCPs of the filter that has been applied to their
current view could help to avoid tunnel vision.
Previous work has noted that sporadic data entries by patients may be concern-
ing, as it may indicate that a patient is too unwell to monitor their symptoms (Bardram
and Frost, 2018; West et al., 2016, 2018). However, West et al. (2018) briefly dis-
cussed how some HCPs believed that incomplete data may not represent a concern,
as it may indicate that patients simply prefer to monitor their symptoms when they
feel unwell. My work has concretised how sporadic patient-generated data can be
considered clinically acceptable for decision-making around COPD, as long as the
patient is consistent with reporting periods of poor health. Sporadic data could there-
fore still provide use in clinic settings. However, if the patient is unpredictable in
how they report data, such as not taking a consistent approach to what they report,
this creates a situation where the HCP (and potentially the patient) cannot easily find
utility in the data. It is likely that sporadic data may be incompatible with scenarios
such as predicting COPD exacerbations, as this would require a higher degree of data
completeness and consistency. By the time the patient decides to report that they feel
unwell, it may be too late to prevent an exacerbation. A closer focus on how sporadic
data might be navigated in clinic settings would enhance knowledge about how this
could be supported in practice through design.
4.5.1.4 Trusting Data Sources
There was a clear awareness of the limitations of certain data sources and as a result,
HCPs felt distrustful relying on data from certain sources. The coding department and
the hospital marker system were two data sources that were cited as unreliable and
HCPs were less trustful about relying on them for decision-making. The reliability of
coded data has been explored in previous work (Axelrod et al., 2011; Burns et al., 2011;
Sunderland, 1985). Particularly around the overlap of clinical codes used to describe a
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single clinical condition (Axelrod et al., 2011), which can introduce uncertainty when
working with this data. The hospital marker system, which was a system specific
to the Hospital and Community Care, had three reasons for why it was perceived
as unreliable: (1) it was a poorly utilised feature within the main clinical system
which meant the data was not complete; (2) the list was maintained by three different
organisations (the Hospital, Community Care, and GP services) which meant some
patients were on the list erroneously and had other respiratory conditions; and (3)
some patients may be missed from the list due to lack of formal diagnosis25. As
shown, both the data from the coding department and the hospital marker system
contained uncertainty, and this uncertainty led to perceptions of low trust.
As medical data is often bound to the context in which it was originally pro-
duced (Berg, 1999), improving the accuracy of data sources requires additional work
to be carried out by the HCPs (Berg, 1999; Berg et al., 1998). In the case of the
hospital marker system, this requires a more consistent use of the flagging system
within and between organisations. Unlike the hospital marker system, coded data is
inherently uncertain due to how codes are attributed to health conditions. How we
can work towards fixing the coding system is beyond the bounds of this thesis, but
it raises the importance of increasing transparency about data sources that are used
to facilitate DSDM technologies. Knowles (2016) suggested that an explicit mention
of a system’s data sources is important for building trustworthy systems. I argue
that being explicit about the data sources used for visualisations can help build trust-
worthy DSDM technologies for healthcare. One way to approach this could be by
visually mapping uncertainties on the system’s interface. For example, heat maps
and icons could be used to represent the degrees of uncertainty in a specific data
source that is being used to facilitate visualisations. Simply being clear about the data
sources used to facilitate visualisations could help HCPs to better incorporate their
local understandings of datasets when interpreting data.
25Recall that HCPs discussed the challenge of COPD misdiagnosis in section 4.4.2.2 (pg. 99).
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4.5.2 Integrating Systems into Workflow
This study raised important practical challenges, particularly in relation to the eventual
deployment of a DSDM technology into clinical practice. Previous studies have shown
the considerations that need to be made when deploying technology into clinical
contexts (Ackerman et al., 2017; Hansen et al., 2006; Zhou et al., 2009). For example,
considering who will maintain the system from a technical perspective (Hansen et al.,
2006), how the integration of the system should occur (Ackerman et al., 2017), where
the system will physically be placed and how this impacts work (Zhou et al., 2009).
I consider these practical questions to be important to the overall discussion on the
role of DSDM in healthcare, in order to move from theoretical thinking to considering
pragmatics. Though the prototype in this study was not deployed in clinical practice,
I have gained insights into potential challenges which surround the deployment of
DSDM technologies. In the sections below, I discuss two main points: ‘actions and
protocols’ and ‘training on systems’.
4.5.2.1 Actions and Protocols
Agreeing sufficient protocols that specify what actions can be taken in response to
the prototype’s data was raised as an important consideration. Recall that when
discussing data priorities in Stage 2 (Priorities and Implementation Challenges), one
HCP stated that there is a requirement to form “agreements with other Trusts about
how we respond to these spikes in admissions” (H3, section 4.4.2.1, pg. 98). For
some scenarios, HCPs highlighted that new organisational arrangements would be
necessary to effectively make use of the insights. This was raised regarding two
areas specifically. The first area is about planning and organising resources to deal
with service demand that may be visualised on the prototype (i.e. simply knowing that
there is a spike in admissions is not adequate, HCPs should be able to react to this data
sufficiently). The second is about responding to remotely received patient-generated
data (e.g. what are HCPs obligated to investigate when viewing this data).
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Both of these areas introduced the HCPs to data which they previously did not
have access to, presenting opportunities for the new information to inform decision-
making. However, there were no existing organisational protocols that outlined how
they should respond to this type of data. One major concern raised by C6 related
to the potential lengthy process of ‘chasing’ patients who were not recording any
data in Scenario 3 (Patient-Generated Data Overview). They felt they had an obli-
gation to investigate the reasons why this may be the case, yet there was a lack of
guidance on how to do so (or when this would be appropriate to investigate). This
highlighted the importance of ensuring relevant (cross-)organisational protocols are in
place to ensure HCPs can effectively use DSDM technologies in practice. However,
as the DSDM technology becomes part of the wider sociotechnical system within the
healthcare organisation (Ackerman et al., 2017), its introduction will have impacts
on the existing organisational and social practices of how clinical work is carried out
(whether intended or unintended) (Dowding et al., 2015).
The challenges involved in introducing technologies into clinical practice has
been observed in previous healthcare research (Ackerman et al., 2017; Bardram and
Frost, 2018; Berg, 1999; Cai et al., 2019; Dowding et al., 2015; Heath and Luff, 1996;
Pine and Mazmanian, 2014; Tentori et al., 2012). Specific to the concept of actions
and protocols, Bardram and Frost (2018) discussed how the deployment of a sys-
tem for HCPs to remotely monitor patients with bipolar disorder required protocols
to govern how the system would be used in practice (including which HCPs would
be involved in, and responsible for, which parts of the process). Whereas Cai et al.
(2019) noted the legal concerns that pathologists raised in relation to using an artificial
intelligence assistant to support prostate cancer diagnosis. They discussed how these
legal concerns would ultimately influence whether the assistant would be adopted in
practice. These studies serve to demonstrate how the wider sociotechnical implica-
tions of introducing new technology into healthcare require careful consideration. As
uncovered by my research, introducing relevant protocols to govern how to respond
to data should be considered prior to system deployment. This could influence how
willing HCPs are to engage a technology, but could also ensure that the intended ben-
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efits of the DSDM technology can be properly realised in practice. This is particularly
relevant in situations where technologies are evaluated in practice, without supporting
HCPs to react to data appropriately then the evaluation metrics about the impact of
the technology are subsequently effected.
Both Reddy et al. (2003) and Ackerman et al. (2017) have suggested that un-
derstanding the impacts of introducing new technology into clinical practice can be
estimated, to some degree, through sociotechnical requirements analysis within the
design process. This can be achieved through actively seeking to understand the
complex work environments in which medical work is carried out, for example by
using ethnographic techniques within the research (Reddy et al., 2003). In addition to
using observational approaches in the research, I stress the importance of adopting a
multi-stakeholder approach to gain insight into potential sociotechnical implications
of technology introduction. Including a diverse stakeholder group can help to bring
together a unique blend of expertise that can help map out potential challenges26 to
the clinical and business workflows. In addition to working with diverse stakeholder
groups to estimate potential sociotechnical challenges, including diverse stakeholder
groups may help to scope any potential protocols which need to be created to govern
the use of the technology, as described previously. For example, if organisational or
policy changes are required, including senior staff across the organisation can help to
consider these possibilities. In some cases this can be a complex process, as depend-
ing on the nature of technology being introduced, changes to clinical pathways and
guidelines may be required (Bardram and Frost, 2018).
26It is important to acknowledge that any practical challenges that may occur due to the introduction
of a technology cannot be completely foreseen. However, this exercise can help to identify more
apparent challenges.
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4.5.2.2 Training on Systems
The time and effort required to train HCPs on new systems was identified as a ma-
jor challenge during this study. System training was not only identified as time-
consuming, but unnecessary by some HCPs who often thought they had the knowl-
edge to quickly master the use of new tools themselves. Despite efforts to train staff, IT
staff reported that these challenges led to HCPs using systems that they had not been
formally trained on (section 4.4.2.1, pg. 197). In some cases, this had reportedly led
to errors in data and disruptions to the workflow. Previous work has noted how a lack
of training can inhibit HCPs from supporting technology interventions (Chung et al.,
2015; Sarcevic et al., 2018; Thieme et al., 2016; West et al., 2016), or even give rise to
unintended and potentially negative consequences of using a system (Dowding et al.,
2015; Kim et al., 2017). For example, Sarcevic et al. (2018) designed a dashboard for
improving team awareness in time-critical trauma resuscitation units. They highlighted
that a key barrier to adoption was around how HCPs could safely use the system, in
terms of how the data is found within the dashboard and subsequently interpreted for
use. Similarly, West et al. (2016) reviewed research about using patient-generated data
in clinical practice and found that HCPs had concerns about being adequately trained
to interpret unfamiliar data provided by patients. These studies demonstrates how a
lack of training on clinical systems can be a barrier for engaging with data and adopting
technologies, and therefore becomes a relevant problem for HCI research.
The barriers around training have direct implications for the deployment of
DSDM technologies in healthcare contexts for two main reasons. First, HCPs will
need some form of standard training if the system becomes deployed to understand
its purpose and how it is used. But second, and more specific to the nature of DSDM
technologies, is how the collation of (possibly unfamiliar) data in new ways will require
HCPs to effectively interpret and understand this information for decision-making. As
described by one HCP, the collation of large datasets can seem “frightening” (C8,
section 4.4.6.2, pg. 117). The lack of digital skills training among HCPs has been
highlighted in previous work (Steen and Mao, 2016), and this remains a challenge
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that can effect if, and how, HCPs engage with DSDM technologies. If HCPs are not
trained to accurately interpret data on DSDM technologies, they may draw wrong
inferences from it, or lack the confidence to use the technology all together as they
cannot generate insights (Ackerman et al., 2017).
This echoes findings by Dowding et al. (2017), who conducted a survey study to
to assess nurses’ numeracy and graph literacy to understand how this may influence
data visualisation on dashboards. They discussed that nurses with low numeracy
may have difficulties interpreting visual information, and suggested that HCPs with
different numeracy and graph literacy may benefit from simple data visualisation
techniques (such as bar graphs and tables). This raises important considerations
about the potentially different levels of data literacy among different HCP groups.
One way that design can accommodate different levels of data literacy is through
supporting alternative views of the same data (e.g. by offering multiple different
visualisation options according to the users’ preference). However, data visualisation
options must be designed with caution to avoid creating visualisations that present
data in a potentially misleading way (Szafir, 2018). In addition to supporting alternative
views of data, when data is collated from multiple sources into a single visualisation27,
dashboards could offer functionality that allows the user to ‘select’ and ‘deselect’
data items to avoid overwhelming the user. This could support the user to build an
understanding of the complete visualisation at their own pace. However, reminders
and alerts would need to be put in place to avoid users forgetting about data items
they have deselected so that they do not displace this data.
In terms of training HCPs to use DSDM technologies more generally, flexible
scenario-based training programmes could provide ways to build confidence in nav-
igating the system and interpreting the data. However, a stronger understanding of
how to support HCPs in effectively interpreting and understanding data on DSDM
27For example, in Scenario 2 visualisations had collated exacerbation data from the Hospital, Com-
munity Care, and GP practices.
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technologies is needed. Until then, it remains a notable challenge to consider when
deploying such technology.
4.5.3 Reflections on Evaluation Approach
The research in this chapter concluded with an evaluation of the scenario-based
prototype of a DSDM technology. There are important elements of the evaluation
stage to reflect on, which can provide valuable lessons about the evaluation of digital
health technologies. Though there are numerous HCI technology evaluation tech-
niques (Barkhuus and Rode, 2007), this section focuses on the approach taken in this
chapter. In the following two sections about ‘using TAM in healthcare technology
evaluation’ and ‘scenario-based evaluation approach’, I discuss the advantages and
limitations of the evaluation techniques used within this study. I argue that this sec-
tion presents valuable insights about my chosen methods that can inform future work
about evaluating DSDM technologies in the healthcare space.
4.5.3.1 Using TAM in Healthcare Technology Evaluation
TAM has been used extensively in healthcare research to predict acceptance of a variety
of digital health technologies (Holden and Karsh, 2010), including telemedicine (Hu
et al., 1999), logistic information systems (Tung et al., 2008), and hospital informa-
tion systems (Nadri et al., 2018). Extended models of TAM have also been used
in healthcare research to establish further determinants that can impact technology
acceptance (i.e. considering how factors such as ‘facilitating conditions’ or ‘social
influence’ can influence technology acceptance) (Holden and Karsh, 2010). In short,
TAM has been used widely within healthcare research as a way to theoretically predict
the acceptance of a range of technologies. However, for this study, adapting the
TAM questionnaire to apply it to context of DSDM technologies was challenging. This
challenge stemmed from attempting to adapt one of the central TAM variables, ‘per-
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ceived usefulness’28 to meaningfully apply to DSDM technologies aimed at supporting
clinical decision-making.
I adapted the TAM questionnaire provided by Davis and Venkatesh (1995) with
Professor Pearson for this study, which was originally used to evaluate a word process-
ing software. As I adapted questionnaire, Professor Pearson advised how notions of
‘improving job performance’, ‘increasing productivity’, and ‘increasing effectiveness’
— which were included in the original questionnaire — did not align with the aims of
clinical decision-making. It may appear that this can be easily explained by the fact I
was adapting a questionnaire that was designed for a different technology and context,
but similar wording has been used in many previous TAM healthcare studies29 (Holden
and Karsh, 2010). This terminology is unsuited to clinical decision-making, as it is
difficult to draw clear inferences about the relationship between how a medical device
is designed and how this impacts clinical outcomes (Sharples et al., 2012). Sharples
et al. (2012) discussed how medical devices tend to be used in combination with other
devices, with multiple actors, within complex situations, which all influences how a
task or procedure is completed. Similarly, it may take some time before the effects
of a clinical decision can be appropriately assessed. This is directly relevant to how
evaluations of DSDM technologies are framed, as technology is likely to be only one
instrument within the process of reaching an intended clinical outcome. Therefore,
attributing a DSDM technology to improving the ‘effectiveness’, ‘productivity’, and
‘performance’ of the HCP is ill-suited.
For the reasons above, associating ‘device’ (in this case the DSDM prototype)
directly with ‘outcome’ (in this case the outcome of clinical decisions) was something
I avoided when framing the TAM questionnaire. Firstly, as discussed, it presumed the
28Defined by Davis et al. (1989) as ‘the prospective user’s subjective probability that using a specific
application system will increase his or her job performance within an organizational context’.
29In some studies reviewed by Holden and Karsh (2010), the exact same wording has been used in
healthcare TAM questionnaires as in Davis and Venkatesh (1995).
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outcomes of medical work are immediately evident, measurable, and can easily be
detached from their complexities and attributed to the DSDM technology. Secondly,
by focusing on influences on ‘effectiveness’, ‘productivity’, and ‘performance’ as a
primary measure, the DSDM technology is consequently framed as some form of
production means in the Marxist sense (Marx, 1959; Rosenberg, 1974). This suggests
the ultimate purpose of the DSDM technology is to enable HCPs to become more time-
efficient and economically valuable workers. This largely ignores the complex nature
of clinical work, placing a disproportionate emphasis on maximising performance and
saving time. As a result of this, during the adaption of the TAM questionnaire the words
‘productivity’ and ‘performance’ were excluded. The term ‘effectiveness’ was used
only to describe how the prototype may contribute in the delivery of more effective
patient care overall30 (acknowledging its part contribution in this process).
The clinical expertise of Professor Pearson helped to ensure that the terminology
in the questionnaire was meaningful for clinical contexts. My pursuit to make the
TAM questionnaire more meaningful to this study’s context follows on from Holden
and Karsh (2010)’s call for researchers to better contextualise TAM to healthcare
to understand its power. When using TAM in healthcare research, the terminology
used in the questionnaire must be carefully considered in relation to the context of
study. Particularly, how the terminology aligns with the value that the technology
intends to bring to the users themselves (rather than how the technology can make
the users more valuable). Additionally, publishing contextualised TAM questionnaire
templates (along with the studies they were used for) helps to build a corpus of valuable
questionnaire templates that are relevant to a variety of clinical contexts for future
research31. Indeed, this could apply to other types of user experience questionnaires
issued within healthcare research studies outside of TAM specifically.
30The exact ranking statement was ‘using Respire may lead to more effective patient care overall’.
Respire was the name given to the prototype.
31I have included the TAM questionnaire template for this study in Appendix G.
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4.5.3.2 Scenario-Based Evaluation Approach
Traditionally the gold standard approach for evaluating the effectiveness of healthcare
technologies has been through randomised control trials (RCTs) (Kaplan, 2001b). For
example, RCTs have been used to evaluate clinical decision-support systems (Bennett
and Glasziou, 2003) and clinical dashboards (Linder et al., 2010). While RCTs are
effective in demonstrating factors such as calculating a system’s accuracy, they are
less suited to assess factors that explain why a system is (or is not) used in practice
by users (Heathfield, 2001; Kaplan, 2001a,b). This is where qualitative evaluation
approaches are valuable and can complement RCT studies (Kaplan and Maxwell,
2005). Through the user-centred and scenario-based approach taken in this research, I
was able to discover a number of important factors relating to how DSDM technologies
can be designed and deployed for healthcare contexts. Specifically, the scenario-based
evaluation allowed participants to envisage important social, cultural, and political
concerns surrounding the use of the DSDM prototype.
Through creating realistic dummy datasets with a biostatistician, I resourcefully
avoided the need to use real-world healthcare data to facilitate a meaningful early
evaluation. Kaplan and Maxwell (2005) have highlighted the importance of uncovering
sociotechnical factors during healthcare technology evaluations, as they influence
system acceptance and actual use. While I do not argue that the approach taken in
this research resembles a formal evaluation process in the same sense as RCTs, it
has provided rich insights into potential criteria impacting use, disuse, and misuse
of DSDM technologies for respiratory care. Scenario-based approaches and Wizard
of Oz approaches have been used throughout HCI research to simulate interactive
systems as a way to accumulate early feedback at a relatively low cost (Bardram, 2000;
Favela et al., 2010; Stiemerling et al., 1998; Weiss et al., 2009). These approaches
can be especially valuable for evaluating DSDM technologies for healthcare, as they
provide an early way to identify potential challenges relating to data before the creation
of a fully functioning system.
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4.6 Study Limitations and Reflections
There are two important limitations arising from this study. The first limitation relates
to the findings from Stage 4 (Evaluation). Stage 4 consisted of the same HCPs who
informed the design of the prototype (with the exception of H5). Involving the same
HCPs in the design and evaluation of the prototype could have introduced positive
bias into the feedback, with participants potentially responding more positively to the
prototype as they were involved in its design (i.e. the ‘IKEA effect’ (Ceil, 2019; Norton
et al., 2012)). I attempted to mitigate this potential bias by activelh trying to recruit
additional HCPs for the evaluation. However, I unsuccessful due to the challenges in
recruiting this participant group (I reflected on this in the methodology: Chapter 3,
section 3.5.2, pg. 57). I could only recruit one new HCP (participant H5). Though I
acknowledge there may be bias present in the evaluation results, I argue there were
important benefits to retaining the same HCPs throughout the entire process. Many
of the important findings arising from this chapter have related to the sensitive topic
of trust in the workplace, and I believe the familiarity built between myself and the
HCPs facilitated the unpacking of this delicate topic. Likewise, involving the same
HCPs throughout the process introduced consistency across each of the different
stages. However, it is still important to interpret the evaluation findings with caution
to account for any potential bias.
Finally, this research was undertaken with multiple HCPs from two NHS or-
ganisations in the north west of England. The local context and ways of working of
both organisations has shaped the findings within this chapter. As a result, this limits
the degree of generalisability across other healthcare contexts. Different healthcare
organisations across the world will have their own organisational structure, resource
constraints, and individual clinical pressures. That is not to say these research findings
cannot transfer outside of this study’s contextual confines, rather, I acknowledge that
these findings are not representative of all respiratory healthcare services. Therefore,
when interpreting the findings of this work, it is important that the reader considers
how these findings may resonate or differ across healthcare settings.
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4.7 Chapter Summary
This chapter explored how DSDM technologies could support HCPs in their decision-
making abound COPD care. Through documenting the design and evaluation of a
DSDM prototype that aimed to support decision-making about COPD, I uncovered the
challenges and opportunities for DSDM technologies to support HCPs in this space.
The study was carried out in four stages with 17 participants, involving the expertise
of different stakeholders at each point. First, I sought to understand the motivations
for a dashboard, challenges with the current clinical systems, and discuss initial data
needs. The second stage involved learning about the different existing clinical systems,
outlining and prioritising data needs for the dashboard, and identifying any potential
feasibility barriers for acquiring this data. The third stage involved working iteratively
with HCPs to create wireframes that incorporated their data needs, before focusing
on a subset of scenarios to include in the digital prototype. The fourth and final
stage involved qualitatively evaluating the prototype with HCPs to explore how they
envisaged it could support their decision-making in practice.
The findings highlighted important considerations for designing and deploying
DSDM technologies for respiratory care. This includes: the concept of trusting data
for clinical decision-making and how this depends on the data source and author;
how to support integrating systems into workflows by considering how HCPs can be
trained on systems and respond to data in practice; and finally reflections on evaluating
DSDM technologies for healthcare settings. These findings take us a step further to
understanding how DSDM technologies could support HCPs in practice.
The next chapter explores a different perspective: the rich lived experiences
of COPD. It explores how technology can support the lived experience of COPD by
engaging the wider chronic respiratory community through a survey, interviews, and
a workshop. This complements the research presented in this chapter, offering the




The Role of Technology in Supporting
the Lived Experience of Chronic
Respiratory Conditions
Some of the data and findings from this chapter have been published as a full paper
in the 2019 EAI International Conference on Pervasive Computing Technologies for
Healthcare (Tendedez et al., 2019b).
5.1 Introduction
This chapter explores the lived experiences of chronic respiratory conditions (CRCs)
and the potential role of technology to support this experience. This chapter mainly
focuses on experiences of self-management and self-care of Chronic Obstructive Pul-
monary Disease (COPD). Practices of self-care and self-management are collaborative
in nature (Nunes and Fitzpatrick, 2015), often involving patients, healthcare profes-
sionals (HCPs), and carers. However, for the purposes of this study I focus on the
perspectives of the person with the respiratory condition. I have chosen to do this to
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build a rich understanding of the embodied experience of living with a CRC to gain a
first-hand understanding about if, and how, technology could offer support.
To achieve the aims of this chapter, I present findings from a survey of 147
respondents, one-to-one interviews with 13 participants, and workshop findings with
11 participants. I present detailed and nuanced findings about the lived experiences
of CRCs, and demonstrate the opportunities and limitations that technology could
have for supporting this experience. I take an open-ended approach to consider
different types of technology. This chapter aims to answer the second research
question: ‘what is the lived experience of COPD, and how can technology support
this experience?’
The key contributions of this chapter can be summarised as follows:
1. Some participants take a ‘reactive’ approach to managing their condition, which
could influence how they choose to engage with technologies for self-management.
2. Participants described how their condition needs evolved over time. Needs
changed in two ways: (1) as they developed experiential experience of living
with the condition and (2) as the condition naturally progressed. However, a
common need when starting the condition journey is adequate information at
diagnosis.
3. Some people with COPD may require additional support and encouragement for
seeking help for their condition, as they experience stigma about their condition
and concerns about ‘burdening’ support networks.
4. As COPD is linked to social deprivation and an older adult population, there is a
strong need for researchers and designers to actively and carefully consider the
accessibility and inclusively of the digital support that they create.
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5.2 Study Design and Methods
This chapter reports on a three stage study involving the CRC community. The majority
of participants had COPD. However, as discussed in Chapter 2 (Background and
Related Work), there is diagnostic uncertainty involved with COPD and it can overlap
with other CRCs (Chapter 2, section 2.1, pg. 15). Therefore, engaging the wider
CRC community was an attempt to be considerate of these challenges and include a
wider perspective. The first stage of the study involved a survey to gather a broad
understanding of the CRC community’s experiences of self-care, experiences using
technology, and their perceptions on using technology for the self-management of their
condition(s). The second stage involved conducting one-to-one interviews to explore
the lived experiences of having a CRC and experiences of using self-management
technologies in richer detail. The interviews allowed me to uncover and explore
insights in greater depth, which was not possible through a survey alone. The third
and final stage involved a workshop with a respiratory support group to further expand
on the insights from interviews. All participants were provided with an information
sheet and consent form to consider before study participation (see Appendix I).
5.2.1 Respiratory Support Groups
A vital part of this study was my engagements with three respiratory support groups
in North West England (described in Chapter 1, section 1.2.2, pg. 7). There are over
230 of these Breathe Easy groups across the United Kingdom (UK)1. The groups are
self-organising and meet at different intervals, for example, some groups meet once
a week and some once a month. Group members are people within the respiratory
1At the time of publishing this thesis, The British Lung Foundation reports that there are over 230
Breathe Easy groups across the UK: https://www.blf.org.uk/support-for-you/breathe-easy
(accessed July 9th, 2020).
154 5.2. Study Design and Methods
community, including family and friends. During group meet ups, they may have
visitors who give health talks (such as healthcare professionals (HCPs) who share
health information or advertise clinical research studies); talks about government
support (such as disability and carers’ allowance); teach lightweight exercise classes
(promoting breathing techniques and an active lifestyle inline with their condition);
and singing classes (which can help symptoms and improve general wellbeing). The
group also carry out more general social activities such as quizzes and raffles.
Figure 5.1: A picture of me presenting my research at one of the support groups.
To better understand and familiarise myself with the CRC community, I spent 12
hours embedded in three different respiratory support groups in North West England.
I did this to prepare for the study, particularly the one-to-one interviews (Figure 5.1).
During this time, I observed group discussions about CRC; participated in group exer-
cise activities (such as armchair exercises and tai chi); participated in social activities at
the group more generally; and shared my research aims with them. The groups were
very welcoming with me, and appeared interested in helping me with my research. I
kept in close contact with two out of the three groups over the course of the research
due to their closer proximity to Lancaster University (where I was located). I was
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invited to join one group’s closed Facebook group where they shared group related
information, such as: summaries of the meetings; updates on members’ health; shar-
ing of photos; and the organisation of any upcoming events. The lead for the other
group would email me their monthly e-newsletters and kept in written contact with
me over the course of the study. As such, in between my visits to the group, I was
updated about the groups’ activities.
5.2.2 Survey
The first stage of data collection was a survey. The survey, hosted on Qualtrics,
consisted of 17 core questions, ranging from free-text responses to selection lists
for user input. It was open for 70 days, and was advertised primarily through a
snowball sampling approach (Johnson, 2014). I distributed the survey link through
email and social networking websites (Facebook, Reddit, and HealthUnlocked). I used
the COPD community forums on HealthUnlocked and Reddit as a way to reach people
with CRCs to participate. I also sent paper versions of the survey to four respiratory
support groups2 in the UK (who then distributed these to their members and posted
responses back to me), to reduce the chance of technology literacy bias in the results
and to ensure the responses reflected both online and offline communities. A full list
of the survey questions is included in Appendix J.
Once the survey had closed, responses were collated and analysed using NVivo
software to better organise, manage, and code the number of survey responses (Welsh,
2002). Details about how I conducted analysis of the survey responses is included in
Chapter 3 (Methodology, section 3.3, pg. 49).
2Three of which I had been visiting to prepare for this study, as described in the previous section.
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5.2.3 Interviews
The second stage of the study involved 13 one-to-one semi-structured interviews with
people with CRCs. Most participants were recruited through the support groups, but
interview recruitment was also advertised online (on Lancaster University’s website
and social networking sites) and through a patient and public involvement lead. I
set out to recruit participants that varied in their age, length of time having been
diagnosed with a CRC, and their experience of using self-management technology for
their condition. This would help to ensure that diverse and rich perspectives were
captured. Table 5.1 outlines details of the 13 interview participants.
Participant Age Gender Condition Diagnosed
Nelly* 63 Woman COPD and Asthma 14 years
Irma 65 Woman COPD 1.5 years
Jin 67 Man COPD 5 months
Amy* 80 Woman COPD and Asthma 50 years
Joti 58 Woman Asthma 43 years
Hedge 69 Man COPD 20 years
Fred 83 Man COPD 5 years
Dan* 82 Man COPD and Asthma 5 years
Seb 66 Man COPD and Asthma 10 years
Mary* 50 Woman COPD and Asthma 3 years
Maggie 74 Woman COPD and Asthma 8 years
Tina* 60 Woman COPD and Asthma 4 years
Ken 66 Man COPD 6 years
Participants denoted with an asterisk (*) were not recruited from support groups and had no
involvement with support groups.
Table 5.1: Chapter 5 interview participants and their assigned pseudonyms.
Before finalising the interview schedule, which would be used to guide the
interviews, I provided the proposed schedule to an experienced patient and public
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involvement lead, Debbie Parkinson, who provided feedback on the questions. Debbie
Parkinson also provided the interview schedule to a COPD patient champion whom
she worked with, who additionally provided feedback on the wording of the questions.
It was important to me to gain feedback on the questions so I could ensure that my
language and the wording of the questions were sensitive and inclusive. Interviews
were then conducted using a semi-structured exploratory approach, which allowed the
questions to change direction (to an extent) to explore interesting ideas and insights
discussed by participants.
Interviews lasted between 30 and 60 minutes and were held at a location local
to participants to account for any mobility challenges. For example, interviews were
held in local libraries, cafes, the venue of their support group, or their homes. During
the interviews, participants were asked to recall their experiences of diagnosis, daily
challenges they experienced, how they self-managed, and experiences using technol-
ogy (for CRC self-management or otherwise). They were then asked if they believed
technology had the potential to support their self-care practices. Participants were
welcome to bring a family member or carer with them to the interview to accompany
them, though only one chose to do so (Fred, who brought his wife). Details about
how the interview data was analysed is provided in Chapter 3 (Methodology, section
3.3, pg. 49).
5.2.4 Workshop
The third and final stage of the study was a workshop held at one of the support
groups that I had been engaging with. The aim of the workshop was to explore two of
the key findings from the interviews in more detail, through detailed discussions with
the respiratory community. These two key themes were (1) the lack of information
from healthcare services, and (2) the value of support networks (a detailed account of
the full findings from the interview stage are in section 5.4). The support groups were
a great avenue to explore the wealth of experience and knowledge that members had
in these areas.
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To organise the workshop, I approached the group lead and proposed a work-
shop plan. The group lead discussed the plan with the members, who then informed
me that they would like to participate. The workshop lasted 90 minutes and was held
during one of their regular meet up slots. There were 11 participants (six women, five
men) aged between 43 and 81 (see Table 5.2). As there were two areas I wanted to
explore (information needs and support networks), I allocated 30 minutes for discus-
sions on each (with the remaining time spent on the consent process, handing out
material, and breaks). I had assistance with running the workshops from Dr Roisin
McNaney and Dr Stephen Forshaw who, alongside me, sat with participants in their
groups during the workshop activities to probe discussions and answer any questions.
At the start of the session, I divided participants into two groups to manage the discus-
sions. The idea was that participants could have smaller discussions in their groups,
and then reconvene to present and discuss ideas together after each activity. This
would give all participants the chance to be heard in their groups.
Participant Age Gender Condition Group
Elliot 69 Man Bronchiectasis Two
Rose 66 Woman COPD Two
Max 80 Man COPD One
Tony 74 Man COPD One
Lisa 74 Woman COPD and Asthma Two
George 68 Man Carer One
May 81 Woman COPD One
Daisy 43 Woman COPD One
Linda 82 Woman COPD Two
Eva 74 Woman COPD Two
Daryl 79 Man Asthma Two
Note that workshop participants discussed the uncertainty around their respiratory diagnoses.
Therefore, the data within the ‘condition’ column represents their formal diagnosis at the time of the
workshop.
Table 5.2: Chapter 5 workshop participants, their assigned pseudonyms, and groups.
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Figure 5.2: A picture of the mock pamphlet used to stimulate discussion around information
needs.
To prepare for the discussions around information seeking, I designed an activity
to help participants structure their experiences and information needs, as if they were
advising a person newly diagnosed with COPD. To do this, I created a mock pamphlet
(Figure 5.2) which asked participants to list three of their top self-management tips
that they believed would help somebody start their journey with COPD. I advised
participants not just to think about practical tips about managing their condition,
but also tips that could help people manage emotionally and mentally. Participants
were welcome to discuss their ideas with their group, but were asked to think of
three individual things by themselves first to ensure that different perspectives were
explored. After they had written their three pieces of advice, they were asked to
discuss their ideas as a group and agree on three of the most important pieces of
advice. The two groups then joined to discuss one another’s advice emphasising its
importance. Figure 5.3 shows participants engaged in the activity.
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Figure 5.3: A picture of the discussions with workshop participants.
The second part of the workshop was focused on discovering what support
networks participants relied on as part of living with their condition. Participants were
asked in their two groups to discuss the different support channels they would use
on a day during which they felt ‘not so good’ either physically or emotionally. I tried
to avoid using the term ‘bad day’ to initially describe the activity as I did not want
participants to reflect too negatively on their condition. However, during the activity,
participants used the term ‘bad day’ themselves, which then normalised the use of
the term during the workshop. The purpose of this activity was to explore the support
participants felt they required to manage their condition, and where they seek this
support. I gave participants the option to note their feelings on different types of
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days (good day, normal day, bad day) on a small sheet of card. However, the cards
were not heavily used during the activity and instead participants preferred to verbally
discuss their ideas in the group. At the end of the activity, I asked both groups to
jointly discuss their ideas out loud while I made notes.
5.3 Survey Findings
147 responses were gathered from the survey. Of these, 114 were online responses
and 33 were paper. Within the 147 responses, 98 self-identified as women, 47 self-
identified as men, and two self-identified in another way. In terms of length of time
having lived with a CRC, 58% of respondents had lived with their condition for 10 or
more years, 13% for six to nine years, and 29% for five years or less. This means that
most respondents had lived with their CRC for a relatively long time. The breakdown
of respondents by age is shown in Figure 5.4, location in Figure 5.5, and CRC in Figure
5.6. Where free-text responses are discussed, respondents are referred to as Rn, with
n representing the respondent’s identifier (e.g. R5 represents respondent 5).
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Figure 5.4: Survey respondents by age group.
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Note: respondents could select that they had more than one CRC.
Figure 5.6: Survey respondents by chronic respiratory condition.
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5.3.1 Device Ownership and Usage
Respondents were asked to select all the devices which they owned from a list that
included: ‘landline telephone’, ‘computer or laptop’, ‘basic mobile phone’, ‘smart-
phone’, ‘tablet’, ‘smartwatches’, and ‘games consoles’. The aim was to understand
the types of mainstream devices which respondents owned and engaged with, to
understand the everyday device usage across the community. In decreasing order
of ownership across the survey dataset, results were as follows: computers and lap-
tops (80%, 117), landline telephone (72%, 106), smartphone (66%, 97), tablet (56%,
83), basic mobile phone (36%, 53), smartwatches (15%, 22), and games consoles
(10%, 14). All respondents (100%, 147) owned at least one of the listed devices.







phone Smartphone Tablet Smartwatches
50 or under 27.78% 88.89% 16.67% 88.89% 72.22% 27.78%
51 to 60 50.00% 75.00% 15.00% 85.00% 70.00% 10.00%
61 to 70 77.59% 81.03% 27.59% 70.69% 58.62% 17.24%
71 to 80 88.37% 76.74% 58.14% 48.84% 48.84% 11.63%


















Figure 5.7: Devices owned by survey respondents broken down by age group.
The most commonly owned device across the entire dataset was a computer or
laptop (80%, 117) and the least commonly owned device was a smartwatch (15%,
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22). With the exception of computers and laptops, newer devices were increasingly
owned by younger respondents. For example, though smartwatches were the least
commonly owned device generally, they were mostly owned by respondents aged
50 or under (with no respondents aged 81 or over owning a smartwatch). Likewise,
landline telephones were owned by 100% of respondents aged 81 or over (with only
28% of respondents aged 50 or under owning landline telephones).
96% (141) of respondents answered that they used ‘smartphones’, ‘computer
or laptop’, and ‘tablets’ for: browsing the internet (89%, 126), sending and receiving
email (89%, 126), messaging family and friends (87%, 122), shopping online (84%,
119), social networking (62%, 88), and playing games (52%, 73). Computers and lap-
tops were the most used device to undertake each of these activities, except messaging
friends and family, where smartphones were more commonly used for this purpose.
5.3.2 Self-Management Experiences
Respondents were asked to select the types of techniques and methods they had used
(either currently or in the past) to manage the symptoms of their condition (Figure
5.8). ‘Taking prescribed medication’ (96%, 141), ‘pulse oximeter readings’ (49%,
72), and ‘following exercise plans’ (48%, 71) were the most popular techniques that
respondents had tried. ‘Keeping a diary of symptoms and reflecting’ was the least
popular technique (13%, 19). Respondents that selected ‘other’ techniques were asked
to specify and noted techniques such as: ‘positive thinking and avoiding conditions
that may lead to infection’ (R62), ‘being a member of the British Lung Foundation [a
respiratory support charity]’ (R109), ‘[visiting] British Lung Foundation, HealthUnlocked
and Public Health Agency website[s]’ (R32), and ‘[practicing] meditation and wellbeing’
(R40).
In terms of technology used for managing CRCs, 61% (91) of respondents re-
ported having experience of using technology for self-management either currently or
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in the past. Of those who had used technology for self-management, 56% had taken
pulse oximeter readings, 14% had used a dedicated mobile health app for their CRC,
12% had used wearable technology such as smartwatches, and 10% had used other
types of technology to manage their CRC. For example, respondents mentioned using
telemonitoring, digital spirometers, peak flow meters, and researching information
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Self-management activities carried out by survey respondents
Figure 5.8: Self-management activities carried out by survey respondents.
5.3.3 Challenges Living with CRCs
The following sections detail the two most prominent themes from the free-text re-
sponses to the question ‘what is the biggest challenge that you face living with your
respiratory condition(s)?’ The themes relate to physical challenges and mental chal-
lenges faced by respondents in their everyday lives.
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5.3.3.1 Mobility, Fatigue, and Breathlessness
Mobility, fatigue, and breathlessness were listed as the most challenging aspects of
living with a CRC in the survey dataset. Combined, these factors were referenced
by 60% (88 times) of respondents in the question around the biggest challenges that
respondents faced living with their CRC. Mobility, fatigue, and breathlessness are all
interwoven and had significant and ‘debilitating’ (R61) effects on the everyday life of
respondents. For example, they effected R9’s ability to ‘complete household chores,
socialise, or provide childcare’ and led to R32 feeling as though they ‘always have
to consider if I can do anything if at all’. Respondents discussed having difficulty
doing seemingly ‘normal things’ (R87, R126, R96, R63, R38, R16), including ‘simple
household chores [which] are a major event’ (R63), ‘going out on my own’ (R35),
‘capacity to care for myself’ (R99), and the feeling that R96 is ‘just sitting on sidelines’.
The challenges of conducting day to day activities also impacted the way respondents
perceived their life, with many noting that ‘there is no ‘normal’ in my life anymore’
(R83), and not ‘being able to breathe well enough to continue leading a ‘normal’ life’
(R81), not being able to live ‘the life I used to lead’ (R21), and generally ‘living a normal
life’ (R43) as a result of ‘not being able to do things I used to do’ (R20) and how the
‘goal posts move due to progression [of the condition]’ (R88).
5.3.3.2 Isolation, Depression, and Anxiety
While 45% of respondents had family as social support and 18% had friends as social
support, 11% of respondents said that they had no social support at all. This ties in
with the themes of mental challenges that emerged as a challenge living with CRC,
which was discussed by 18% (26 times) of respondents in the question around the
biggest challenges that respondents faced living with their CRC. Leading on from
the physical challenges in everyday life noted in the previous section, respondents
discussed how isolation, loneliness, and depression had an impact on their lives. For
example, the ways in which being ‘unable to do simple things can be very isolating’
(R127) and led to respondents ‘rarely leave[ing] the house’ (R83) which ‘severely limits
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social contact’ (R46). In addition to social isolation, some respondents discussed
experiencing anxiety and fear about the future and the ‘the unknown’ (R68, R111,
R112, R138) of living with a progressive chronic condition. One respondent noted
that they faced significant challenges ‘coming to terms with the effect this illness will
have on me and my family in future years’ (R61) while another discussed challenges
associated with ‘on waking every morning, never knowing what I am going to be able
to achieve’ (R82).
5.3.4 Communicating with Healthcare Professionals
The following sections discuss respondents’ free-text answers to the question ‘how
do you currently share details of your symptoms and general wellbeing with your
clinician during appointments?’
5.3.4.1 Communicating Symptoms in Clinic
Most respondents (111, 76%) answered that they simply verbally shared their symp-
toms and level of wellbeing at appointments with their HCPs. Some respondents
(29, 20%) mentioned that their verbal narratives revolve around ‘any ups and downs’
(R42) in their symptoms over a period of time, or putting their recent clinical test
results in context to how their symptoms have been (such as blood tests, chest x-rays,
spirometry tests, six minute walk tests3, or oxygen saturation tests). Respondents
mentioned meeting with various types of HCPs to discuss their symptoms and have
periodic reviews, including respiratory nurses, COPD specialist nurses, general prac-
tice nurses, respiratory consultants, General Practitioners (GPs), and physiotherapists.
3Six minute walk tests require patients to walk as far as they can for six minutes to test exercise
tolerance.
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This is reflective of the multi-disciplinary team approach involved in chronic condition
care (Kuzma et al., 2008; Wagner, 2000).
5.3.4.2 Using External Data to Supplement Discussions
There were 22 references (15%) to respondents bringing extra materials into clinic
to supplement their verbal discussions about their symptoms. For example, some
respondents mentioned bringing in paper and digital diaries to help them recall their
symptoms and experiences, written notes on questions which they want to ask the
HCP, diaries of pulse oximeter readings and trends, printed information found on
the internet about their condition, and mobile health app data. Two respondents
expressed how HCPs tend to be ‘uninterested’ (R21, R17) in their observations and
readings. One respondent felt that diaries ‘do not tell the clinicians anything that I
could not tell them myself. Basically another thing to add to the daily routine and a
waste of time’ (R18).
5.3.5 Summary of Survey Findings
There were a total of five key take-aways from the survey:
1. All respondents owned technology, with younger respondents owning newer
devices. Many respondents used their devices to communicate with people and
browse the internet.
2. The majority of respondents had used technology to self-manage their CRC,
with pulse oximeters being most common device used and wearable technology
being the least common.
3. Taking medication is the most common self-management activity, while keeping
a diary of symptoms being the least common.
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4. CRCs introduce significant physical limitations and uncertainties for the future,
which contributes to social and mental health difficulties.
5. Some respondents use external data to support conversations in clinic, which
they discuss with a diverse range of HCPs.
5.4 Interview Findings
The survey provided a broad picture of technology use, experiences of self-management
techniques and technologies, and communication with HCPs within the respiratory
community. However, the 13 interviews offered a deeper and richer understanding of
how technology could support self-care interventions and make a meaningful differ-
ence to people’s quality of life. Some aspects of the interviews expand on topics from
the survey, while others uncover a completely new account of people’s experiences.
Emergent findings are summarised below under the following themes extracted from
the thematic analysis: (1) ‘building an understanding of chronic respiratory condi-
tions’; (2) ‘challenges living with chronic respiratory conditions’; (3) ‘management
approaches’; and (4) ‘experience of self-monitoring technologies’.
5.4.1 Building an Understanding of Chronic Respiratory Condi-
tions
The following sections discuss key findings that relate to the ways in which participants
had to build their own understanding of what their CRC was, and how it should be
managed. The two key themes within this section are (1) ‘lack of information from
healthcare services’ and (2) ‘building confidence through peer support’.
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5.4.1.1 Lack of Information from Healthcare Services
All participants discussed not having enough information about their condition at the
point of diagnosis, with the exception of Fred. 10 participants described having to do
their own research online to learn more about their condition as they had unanswered
questions about their diagnosis and how to self-manage. For example, there were
concerns over how a diagnosis of COPD impacted existing respiratory conditions,
such as asthma. This effected Nelly, Mary, Maggie, and Tina. They discussed how
understanding “where the asthma and where the COPD came in” (Nelly) could help
understand if symptoms would be any different “if it was just COPD, or just asthma”
(Tina) and “if there’s anything different I need to do to manage” the two respiratory
conditions. For Tina, the only distinction she had regarding her COPD and asthma
was the different inhalers she was told to use “the blue one is for asthma, the pink
one and the green one is for COPD, I do them by colours!” Other participants felt that
COPD was only briefly explained to them at diagnosis, if at all, which left them with
many questions about how to move forward as they had not heard of the condition
before. For example, Seb discussed “how not one person ever told me anything about
it when I was diagnosed. It was just ‘that’s what you’ve got, use this inhaler and go”’,
while Mary was not even told “what it stood for, they just said you had COPD, that
was it, that was literally it”.
Lack of information also led to feelings of fear about participants’ future. They
discussed how the uncertainty around their prognosis had implications for their life
going forward. Some participants felt uncertain about how the condition effected their
life expectancy, for example Nelly questioned “does it mean that my lifespan will be
shorter by 10 years?” Whereas Seb discussed significant impacts on his mental health
as he “thought it was terminal there and then” and self-research left him “depressed”
as he uncovered negative stories online from other people living with COPD. The fear
associated with not understanding the prognosis and how to avoid exacerbations was
highlighted by Jin as being an area which should be better recognised by healthcare
services. He summarised this need by stating “sometimes you get the feeling you’re
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out on your own ... they’ll [the health service] supply you with the medicine but that’s
all you’re gonna get”.
Participants were asked to describe what information they felt would have helped
them at diagnosis. Ideas ranged from information “co-written with people with COPD”
(Mary) to a “welcome to the world of COPD” (Hedge) bag which has “information
about drugs [and] how to take inhalers” (Hedge). The cause of the condition was also
mentioned as important to participants, who felt that they were simply asked “had I
smoked” (Maggie), which was pinpointed as the reason without further investigation.
This frustrated participants, especially those who had not been a smoker, or had
not been a smoker for many years. They discussed needing further explanation to
understand why COPD had developed after so many years, and to “keep out of that
situation [that caused the condition]” (Ken) in case there were other causes that could
exacerbate the condition. Whereas Mary believed that a lack of explanation or further
investigation was “because they [HCPs] held the view that it was our own fault, whether
they’d admit that, whether it was conscious or unconscious, because if they had been
telling you that you had anything else, I don’t think they would have just said that and
sent you away”.
5.4.1.2 Building Confidence through Peer Support
Participants believed peer support helped them in the management of their condition.
Peer support contributed to easing anxieties around the future and built confidence
in day to day living with a CRC. Participants that attended support groups believed
that they were positive avenues to exchange knowledge with others directly effected
by the condition. The information obtained from the groups was perceived to be
the information that should have been acquired from HCPs at diagnosis. Learning
from these peers allowed participants to experiment with new techniques to help
them manage their conditions better at home. For example, Fred discussed accessing
information through the group that he otherwise would not know about: “I was talking
to an old lady [at the group] and she’s got a little fan, she said to me, ‘go and buy one
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of these fans and it helps you to breathe”’. Whereas Jin discussed how practical advice
obtained through the groups helped limit the need for frequent clinic visits: “I can’t
go to the doctor every time I get a little tweak so, [I go to] this group”.
Moreover, support groups enabled participants to build confidence around living
with their condition. Participants discussed how attending support groups made
them feel more hopeful about their condition as “you are not struggling on your own”
(Maggie), a contrast to how they described their feelings when initially diagnosed.
Irma believed that this was due to peers having “lots of experiences and some of them
have had the condition for many years” which meant that people could learn from one
another’s experiences. Seeing people who were in the later stages of the condition,
but were managing effectively, helped Irma to change her outlook about her own
future: “that made me think hang on ... [I can] sit here and let it get hold of me, or I
can turn it all around and be positive and try and manage it the best way that I can”.
Whereas Seb described how attending support groups has made him an “expert” in
COPD, as “there‘s not anything I do not know about my lung condition, and inhalers,
and how to look after myself, diet, exercise, etc. Breathe Easy [the support group] has
taught me all this”. The support groups also exchanged recommendations on available
self-management technologies, where a few members would trial the technology and
then feedback to the rest of the group. For example, Ken discussed how two members
of the group have “tried loads of stuff” and would recommend things to the rest of
the group or say “no that’s not worth it”. For Mary, support groups were perceived
as valuable, but “the majority of support for people with COPD is during the working
hours” which meant they are “not accessible to people like myself” as she had a full
time job.
Peer support groups additionally helped participants build confidence in asking
questions about their condition, such as with HCPs or with one another. Hedge dis-
cussed that being proactive is important in obtaining information about his condition,
and as such, he would “would make a list of things that I had to ask the consultant”
which gave him the information he needed “because I asked the questions”. Likewise,
Fred felt the encouraging atmosphere of support groups gave him the confidence to
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be more proactive in interactions with his HCP:
“We have the doctors from the hospitals coming [to the group] ... it was a
question and answer session ... you can find out things that you wouldn’t
usually find out ... some people asked questions which then gave you the
incentive to ask questions, so if I want to know something now, I would
ask.”
The more emotive aspects of living with a chronic condition were thought to be
easier to discuss and resolve in support groups compared to in discussions with HCPs.
For example, questions such as “why me? I’m not old enough, I’ve never smoked”
(Irma) and “what’s going to happen to me in the future?” (Nelly) were discussed as
being difficult to address with HCPs, particularly as they are “always in too much of
a hurry” (Seb) such that it can be challenging to raise additional questions. However,
through meeting people with similar conditions and experiences, participants felt more
confident and assured. This emphasises the need for support networks to consist of
those with similar conditions, needs or experiences, especially for coming to terms
with more emotive aspects of living with a CRC.
5.4.2 Living with a Chronic Respiratory Condition
The following sections discuss the key themes from the interviews around the chal-
lenges of living with a CRC. There were three themes which relate to (1) ‘physical
oppression’, (2) ‘emotional impact’, and (3) ‘guilt and stigma’. These themes are
unpacked below.
5.4.2.1 Physical Oppression
Participants expressed daily physical challenges of exhaustion and breathlessness,
which was described as “oppressive” (Nelly) as it affected participants’ ability to con-
duct everyday activities such as household chores, socialising, and leaving their home.
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Hedge summarised this challenge by emphasising to me that regardless of having a
good or bad day in relation to his condition, everything he does “is really limited by
the COPD.” This led to participants giving up their hobbies or avoiding certain social
situations, particularly if either situation triggered a flare up of their condition (such
as being around smoke or pets). Amy recalled having to give up her life-long hobby
of playing sports despite strong perseverance to continue, as the effects it had on her
COPD could not be stopped: “I lost control of my breath and I couldn’t get near an
inhaler and I thought ‘why am I putting myself through this?’ I decided then enough
was enough and I finished.” While some participants were able to continue being
active, albeit by pacing themselves and reducing activity levels, others felt unable to
lead an active lifestyle. Jin discussed how his breathlessness had stopped him from
enjoying long walks, which now impacts how often he is willing to leave his house
as “you’re wishing you never came out” due to breathlessness, which “doesn’t do
me any good, all I’m doing is sitting around the house”. The challenges of becoming
increasingly sedentary was also heightened by older age, as Dan noted “you can’t do
much else really at my age really, when you get to this sort of standard, you sit down
and it’s no good for your health, you need to be active, but you can’t be active.”.
5.4.2.2 Emotional Wellbeing
The emotional impact associated with having a CRC was raised as a prominent daily
challenge. Through facing daily physical challenges, participants felt they could not
continue life as ‘normal’ in the same way as before they developed a CRC. Being
unable to keep up with friends, family, maintaining their home and their hobbies made
participants frustrated and upset as they felt the limitations were “taking over” (Joti)
their life. This was particularly challenging for participants who recalled previously
being able to complete certain activities and tasks without any difficulties. For example,
Fred described needing to sit down and rest when out with his family, which was
difficult for him as “I love going out with my grandchildren and you can’t keep up
with them”. Likewise, Nelly described that the physical limitation of being unable
to maintain her home to her own standards was difficult for her emotionally. She
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described finding it more challenging to accept the emotional difficulties as she felt
“depressed” when the physical limitations “builds up and gets you down”.
5.4.2.3 Guilt and Stigma
Guilt and stigma associated with having COPD was experienced by participants. They
believed they were stigmatised as COPD is related to cigarette smoking, leading to
people describing their condition as a “self-inflicted” (Jin) illness. The perceptions of
stigma were evident in the interviews, as participants who had never smoked wished
to emphasise this to me (e.g. “I’ve never smoked, that’s the first question people
ask” (Irma)). Irma described feeling “resentful” towards smokers when she was first
diagnosed, stating that she “wanted to blame people, if I saw people in the street
smoking, I wanted to go up to them and say ‘hey! This is what you could do to yourself
and this is what you are doing to other people”’. She felt that the stigma towards
her was unfair, as she lived “through an age where mum and dad smoked, everybody
around you smoked at work” and effectively was a “passive smoker” through no
choice of her own. Similarly, Mary believed that blame around COPD was not simply
a perception, but is “societal views ... the views that are out there”. She discussed
how people stigmatise the condition but “they’re not thinking about who you were
at the time you started smoking ... impressionable”. There were also references to
participants blaming themselves for their condition, such as Tina, who found it difficult
to quit smoking, and referenced how developing COPD was her “own fault” and how
she believed that she “should have known” that her smoking would lead to a health
condition.
There was also reported stigma experienced in relation to the particular symp-
toms of CRCs, particularly coughing. Participants discussed how they felt uncomfort-
able coughing in public as “people don’t like people coughing in general because they
feel they are passing something on” (Seb). In extreme circumstances, coughing led to
“wetting myself or soiling myself” (Irma) which impacted how willing Irma was to leave
her home and socialise. One way participants felt better about their symptoms was
176 5.4. Interview Findings
when they were around other people with the condition, such as at support groups,
as “people can cough their heads off and no one complains” (Ken) due to a shared
understanding of life with a CRC.
5.4.3 Management Approaches
The following sections provide detail on the approaches and attitudes that participants
described for managing their condition. The two key themes described below are (1)
‘reactive management approach’ and (2) ‘knowing yourself’.
5.4.3.1 Reactive Management Approach
Some participants took a ‘reactive’ approach to self-management. This described an
approach whereby participants did not feel it was necessary to self-manage or monitor
their condition when they felt well, but instead would ‘react’ to feelings of symptoms
or incidents. This was contrasted to other health conditions which participants had,
such as diabetes, where participants felt there was a stronger need to monitor each
day regardless of symptoms. For example, Ken discussed being “more conscious” of
his diabetes and how diabetes management has “all got to be done” each day whether
or not he feels symptoms as “it hits me hard”. Whereas he described the effect of not
taking COPD medication as less immediate, so he may decide not to take his COPD
medication if he feels minimal symptoms and thinks he can cope without it. For Tina,
her “diabetes is easier to monitor” as “you know that if you take your medications that
it’s going to be okay” unlike with COPD. She found regardless of taking medication
and doing “everything you should”, she could “have a bad day” with her COPD as
it was more “unpredictable” which makes COPD less suitable for monitoring in the
way that diabetes is. However, she discussed how, for a short period of time, she
recorded daily peak flow readings at the suggestion of her HCP after experiencing a
COPD hospital admission. During this time, she was motivated to track her breathing
after her hospital admission “so they [the HCPs] could see what was going on ... I
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thought if they could see a pattern that maybe I can’t see, they could give me the
solution, which is why I did it”. Beyond this, she did not engage in self-monitoring
her COPD symptoms and did not believe doing so each day would be valuable for
her.
Some participants took a reactive approach to managing their condition even if
this contradicted advice given by their HCPs; who may prescribe them medication to
take regularly or instruct them to record certain readings. There was acknowledgement
from participants that more consistent self-management and monitoring practices
could alleviate the severity of the bad days, but it was not an approach that they
actively took in practice. For example, Nelly acknowledged that consistent monitoring
of peak flow readings could be beneficial for her COPD yet “I’ve never done that
because my symptoms aren’t so bad that I’ve needed to”, she continued to justify this
by stating “when I’m OK, I don’t do anything, it’s just when things go down I take
action”. Similarly, Dan discussed taking his prescribed oxygen when he felt that he
needed to, in contrast to his HCP’s instructions: “if I need it [oxygen] I’ll take it, if I
don’t then I don’t bother with it, that’s the way I deal with it”. Likewise, Ken described
how he prefers to take certain inhalers if he feels he needs to, rather than taking them
consistently as a preventative measure:
“Sometimes I’ll leave it ... because I think I don’t need it *laughs*, it’s silly
really, but I think I’ll be alright in a minute... I don’t need it. But then 10
minutes later, I’m like, where’s that spray! ... I’ll try not to take it because
I think it [the symptoms] will go away, but it won’t, it doesn’t... I try and
hang on to see if it goes away”.
Participants were asked if they kept diaries or metrics about their condition as
part of the self-managing process, or if they would consider doing so in future. Some
participants believed that their symptoms being under control meant that there was
no need to record this information (Jin, Nelly, Maggie), but may consider this “when
I’m feeling not so good” (Nelly) rather than “when I’m feeling well” (Nelly), as being
well provides no “necessity to monitor it, if I was worse that would be different”
(Maggie). However, Hedge emphasised the importance of a consistent approach to
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self-management instead of waiting “until you’re actually poorly” as “you might be
too poorly by the time you do something, you might have missed the chance”, as
deterioration can “make your symptoms go worse permanently, you can lose some of
your lung function” (Mary).
5.4.3.2 ’Knowing’ Yourself
The notion of ‘knowing yourself’ was discovered with participants. This related to
understanding symptoms and capabilities over time and eventually reaching a point
where additional support is no longer required. Participants recalled the early stages of
their condition, and how they felt that triggers were “unpredictable” (Jin) and how “at
first it was all a mystery and it was terrifying” (Tina) as she was “panicking all the time”
(Tina). Yet, over time, participants began to adjust with life with COPD and began to
“know myself” (Irma), including what their limitations and capabilities were. Hedge
recalled how he was “so well aware” of his condition now that he could “forecast”
exacerbations. Whereas Tina, believed she could now “read into it [her symptoms]”,
as she became “much more aware now with everything that’s going on with my chest”
as her experience living with the condition grew. For Joti, having lived with her asthma
for so many years meant she was well aware of her triggers, and “know[s] for a fact
when I get a cold that’s in, I’m in trouble for 3 or 4 weeks ... I already know that”
The effect of ‘knowing yourself’ over time caused some participants to outgrow
certain self-monitoring practices which they initially adopted to learn their capabilities.
Both Dan and Irma commented on how they abandoned their activity trackers as “you
know how far you can go, you know when to stop” (Dan) and how “the walks I do
are the same walks I did then, so I have an idea of how far I’ve been walking” (Irma)
so “I feel like I’ve been managing without having to use that” (Irma). Whereas Tina
discussed how she did not use her peak flow meter as “I know already my chest is
bad, so I don’t need that little red dial to tell me” and the reading “means very little
to me”. This demonstrates how technology enabled support helped participants to
‘learn’ about themselves, but over time they felt the value obtained from these tools
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was outgrown.
5.4.4 Experience of Self-Monitoring Technologies
Participants who had experience using self-monitoring technology for their CRCs
were asked about them. Amy, Dan, Hedge, and Seb had all used self-monitoring
technologies for their CRC either currently or in the past. They had experience using
the same diary-based smartphone app, called ‘How Are You Today’4. The app was
being promoted by different healthcare services in the region, which explains why
the four participants had experience using it specifically. The app required them to
record data about their symptoms daily for self-reflection, while also providing a set
of recommendations for the day based on what the user reports (such as ‘consider
contacting a healthcare professional’). Each week the data would be shared with the
user’s HCP. Amy was an avid user of the app and had been using it for two years
consistently before being interviewed. Hedge, Seb, and Dan were no longer using the
app and their responses were reflective of their past experience in doing so.
Participants were asked how they engaged with the app throughout their time
using it. Amy, Seb, and Hedge had all used their personal smartphones to engage
with the app each day. Amy noted how her use of the app has become part of her
“routine” just “like getting up, going to the bathroom, cleaning, tea”. However, she
said being symptomatic serves as a strong reminder to record her entries “because
[being unwell] it reminds me, because I am wheezing a bit, I am a bit puffy, I better fill
[the app] in” whereas “if it’s too early [in the day] I can’t tell how I am today, so I leave
it [until later]”. Dan did not have a smartphone or internet connection, so he used
the app by phoning a relative each night who had downloaded the app and input the
answers for him. Dan felt the approach he had to take was ineffective, as it relied on
4‘How Are You Today?’ Accessed February 6, 2020 from https://play.google.com/store/
apps/details?id=com.intelesant.copd&hl=en_GB.
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phone calls each day to have the information recorded. For Dan, smartphones “cost
too much” and he preferred using his basic mobile phone to make phone calls, and
his computer for any other tasks.
5.4.4.1 Linking App Data to Support Networks
The importance of self-monitoring data being linked to specific support networks was
raised in the interviews. Having somebody ‘check in’ with participants and their data
was seen as positive and motivating for participants to continue using an app for
self-monitoring. Amy used a feature within the How Are You Today app to share her
data with her daughter, which she believed was positive for her overall management
as her daughter could oversee her entries and raise any concerns with her. Seb was
using a new diary app each day5 which functioned similarly to the How Are You
Today app, but where data was reviewed every day by respiratory nurses which he felt
was “proactive” as “whenever I’m putting something on there, someone’s reading and
taking notice”, which motivated him to record each day as “if there’s anything wrong,
they ring me”. Hedge strongly believed that self-monitoring data that is sent to HCPs
or carers, who should act on potentially concerning entries, “would be the epitome of
success”. He expanded further by describing a system “that would just flag up or even
send a signal to, it may be a GP or respiratory clinic, that Mrs X’s sats [oxygen saturation
levels] and observations are poor, it might be a good idea to pay her a call” or that “sent
a text to your partner or to whoever you’ve designated as your carer”.
5This was not an app available on the market, but was part of a clinical trial looking at predicting
exacerbations based on self-monitored data.
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5.4.4.2 Keeping Up with Evolving Needs
When discussing reasons for discontinuing the use of the How Are You Today app,
participants mentioned that the app did not keep up with the evolving needs of their
condition. Participants commented that the app was unable to provide them with
new knowledge about their condition, which was seen as important for it to retain
value. Participants raised the point that self-monitoring technology should provide
value to the user beyond simply generating data, and something more than what can
be achieved with just a “piece of paper” (Hedge). Rather, it was discussed that the tool
should provide actionable data back to the user that can be used to inform and adjust
self-management practices, such as predicting exacerbations. Hedge felt that he was
at a stage in his condition where he knew himself when it was time to seek medical
help. Therefore, he felt the recommendations from the app were not valuable when
he was being told to seek professional help: “I don’t need an app to tell me that [I
should go and see my doctor]”. Similarly, Seb felt that the questions asked by the diary
app were out of sync with his current condition stage, noting: “I have emphysema
so I’m going to be breathless [commenting on the alerts raised when he input that he
was breathless]”. Seb eventually abandoned the app when it was clear that it could
not learn that being breathless was normal for him and not the basis of which to seek
help. He felt that the app would be useful for somebody adjusting to life with a CRC,
but he was “too far on this journey for this app to be of any use” and “that it would
be better for somebody in the early stages”. This demonstrates how participants have
different needs according to their condition stage and length of time having had their
condition.
5.4.5 Summary of Interview Findings
Overall, there were five key findings from the interviews:
1. Participants lacked information about CRCs, both at diagnosis and more long-
term.
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2. Participants have experienced stigmatisation due to their condition and its symp-
toms.
3. Some participants adopted a reactive approach to self-managing their CRC.
4. Those at different stages of their condition will find value in different types of
self-management tools, but overall tools must be simple and accessible.
5. Self-monitoring technology that links with a person’s support network is seen
as valuable, and these support networks should ideally respond to concerns
outlined by the data entries.
5.5 Workshop Findings
The workshop with 11 participants (split into two main groups: Group 1 and Group 2)
aimed to build on some of the themes about information needs and support avenues
that were discovered in the interviews. The following sections report on the findings
from the workshop discussions and are split by activity. The first workshop activity
centred on defining information needs, by exploring the self-management advice that
participants would give to a hypothetical friend who was newly diagnosed with a CRC.
The second activity focused on discussions about accessing support, comprising of
discussions around how participants seek support and the respective barriers involved
in doing so.
5.5.1 Feedback on Information Needs
The following three sections present the main findings from the information needs
activity, in which participants were tasked with exploring self-management advice
which they would give to a hypothetical friend that was newly diagnosed with a CRC.
If an excerpt is attributed to a particular group, this indicates that the text has either
been taken from the respective group’s collective pamphlet (i.e. not deriving from a
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single participant, but their joint agreed pieces of advice) or an individual pamphlet
from one of the group members (these were not labeled with participants’ names). A
total of nine themes were identified from the thematic analysis for this activity. Some
themes were not included in the presentation of the findings due to their similarity with
the interview findings, such as ‘lack of information at diagnosis’ or lack of prominence
in discussion, such as ‘the need for accessible language’ (describing how participants
required more accessible language to be used when having their condition described
to them). The remaining themes were then condensed into three key themes around
(1) ‘lack of knowledge from healthcare professionals’; (2) ‘diagnostic uncertainty’; and
(3) ‘learning to understand your illness’.
5.5.1.1 Lack of Knowledge from Healthcare Professionals
Participants believed that an important part of managing their CRC was having mean-
ingful interactions with their HCPs, through which they could learn useful information
about their condition that could help them to improve their self-management. How-
ever, participants discussed their disappointment with the perceived lack of knowledge
that general practice staff had about CRCs (particularly COPD). Participants felt that
this lack of knowledge was the reason they did not obtain adequate information at
diagnosis or have meaningful interactions with general practice staff. One of the
prominent pieces of advice that was drawn out from the information needs activity
was around telling newly diagnosed people to ask general practice staff ‘would an
early referral to a COPD specialist be useful?’ (Group 2). When discussing this advice
in more detail, participants mentioned “we want a specialist in the surgery that knows
the ins and outs of COPD” (Tony), which would “give us a clearer picture of what
we are up against” (George) and “how to handle it” (Lisa), which means “they can
explain exactly what you have, what the prognosis is, what medication you’ll need ... so
that they who have the in-depth knowledge could actually answer all your questions”
(Rose). It was raised that there is a need to “explain exactly what the tests mean
... they don’t really explain what or why they’re doing these things” (Elliot) which is
important for understanding the condition and effectively self-managing. One partici-
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pant, George, even advised that “if you can’t get into your doctors, you can go to the
accident and emergency walk-in centre, and they’re better than the doctors” as a way
to receive appropriate treatment and support for the condition, along with getting in
touch with “respiratory nurses which just deal with respiratory problems” (May). The
group further reflected on their unsatisfactory experiences with general practice staff,
noting that they have been “shown the wrong way” (George) to use their inhalers,
which they had only been corrected when specialist nurses visited the support group
to demonstrate how to use inhalers. Likewise, Daisy (aged 43) mentioned that her
COPD symptoms were dismissed too easily by her GP as she was repeatedly told
“people your age don’t get it”, while Tony stated that “sometimes the information
they [GPs] give is contradictory”. As such, these experiences prompted participants
to advise a newly diagnosed person to ask for a referral to a specialist to ensure they
would receive meaningful advice and appropriate support.
5.5.1.2 Diagnostic Uncertainty
Another prominent theme discovered in the workshop discussions was diagnostic un-
certainty; participants discussed the medical uncertainty around CRCs which resulted
in uncertain diagnoses. Participants discussed their experience of their diagnosis be-
ing formally changed by HCPs over time, and sometimes reverting back to a prior
diagnosis. One participant had included the uncertainty around diagnosis as a node
of caution to a newly diagnosed person: ‘my wife was told she had asthma, and then
she was told she had COPD, later she was told she didn’t have COPD but had asthma.
Conclusion: we need more accurate diagnosis’ (George). This uncertainty was a com-
mon experience across the group, as participants recalled how “they couldn’t make
their mind up if I had COPD or asthma, or both” (Lisa) and “they still can’t figure out
if I’ve got asthma or COPD or not 10 years on. I’ve got bronchiectasis, I’m diagnosed
with that now ... it’s a different thing all together” (Elliot).
Some people perceived their diagnosis to be made without careful considera-
tion: “if you say you’ve been a smoker they tend to say you’ve got COPD without
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really thinking about it” (George). Moreover, there was confusion around exactly
what COPD was, with some participants believing it was “another term” (May) for
emphysema, or a new name for “what they used to call bronchitis” (Lisa), rather than
COPD describing a set of CRCs. The challenge of being unsure about their condition
meant participants felt confused about how to manage their condition appropriately,
the likely cause and triggers of the condition, how to adjust to it, and felt unsure
for their future due to the uncertainty. For this reason, participants emphasised that
newly diagnosed people should ‘be assertive’ (Group 1) with HCPs, and be sure to
‘ask questions’ (Group 1) to seek further clarity on their diagnosis.
5.5.1.3 Learning to Understand Your Illness
An important piece of advice that participants highlighted was around taking the time
to ‘learn to understand your illness’ (Group 2), by learning how it effects each person
individually both physically and emotionally. This was not seen as explicit knowledge,
but a process of ‘trial and error’ (Group 1) arising from embodied experience, with
every case being “really individual” (Tony). However, participants agreed there were
still valuable opportunities to advise a newly diagnosed person on how to begin navi-
gating the discovery process. One of the most important first steps in learning to live
with the condition was to not ‘blame yourself’ (Group 1) or not to “allow yourself to
be told it’s your fault” (George), as “blaming yourself does lead to other problems”
(George) such as mental health conditions, and a reluctance to seek help or help
oneself. The concern about blaming oneself stemmed from the stigma around CRCs,
such as COPD, developing primarily through cigarette smoking (but also environmen-
tal factors such as certain industrial occupations). Daisy reflected on how she would
comfort her mother, who also had COPD, by reinforcing that “you haven’t done this”
as a result of being a smoker. Participants believed that this was an important emo-
tional ‘hurdle’ to overcome when being diagnosed and preparing to adjust to life with
a CRC. They argued that people could become better emotionally equipped to deal
with the condition once addressing any notions of self-blame.
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Learning about physical triggers and symptoms was another area which partici-
pants raised as important for self-management. Group 1 noted that newly diagnosed
people should be told ‘it can’t be cured, but a lot can be done to slow the process’
(Group 1) and ‘there is so much you can do for yourself’ (Group 1) and that this can
help enforce a positive mindset for self-managing the progressive condition. Although
making sure people ‘get the right medication’ (Group 2) that works for them was very
important, participants noted that ‘a pill is not always the answer’ (Group 1) and there
are additional ways in which people can enhance their quality of life through personal
self-care practices. Some participants discussed specific self-care practices that could
be helpful for learning about how their condition impacts them, including avoiding
environments such as “a smoky atmosphere, or if it’s really damp, or very cold” (Rose),
finding ways to exercise such as ‘walking on flat ground if hills are beyond you ... any
exercise is better than none’ (Group 1), ensuring proper breathing as “a lot of people
with COPD do not know how to breathe correctly ... I mean my lungs are seriously
shot to pieces ... but I’ve learnt to breathe.” (Tony), and ‘mindfulness courses’ (Group
1) to help deal with breathlessness and anxiety. It was stressed that this advice can
help newly diagnosed people to experiment with different techniques that can help
them to self-manage their condition, but also ensure they ‘don’t give in to it’ (Group
1) and can ‘meet the challenges’ (Group 1) while trying to ‘carry on as normal’ (Group
1).
5.5.2 Exploring and Accessing Support
The following three sections describe the findings from the discussions around seeking
support. There were a total of five themes arising from the thematic analysis, which I
condensed into three key themes that explored different support avenues. During this
activity, participants made reference to discussions had during the previous activity
around ‘lack of knowledge from healthcare professionals’ and ‘diagnostic uncertainty’,
which I did not include in the findings for this section to avoid repetition. The three
key themes described below are (1) ‘being selective with support’; (2) ‘discovering
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support groups’; and (3) ‘attending support groups’.
5.5.2.1 Being Selective with Support Networks
Participants discussed the ways in which they were selective about who they ap-
proached for support when they felt unwell, as they did not want to cause worry
or concern to certain people. Participants described how their evident shortness of
breath when feeling unwell can make their family members “worry about your breath-
ing” (Elliot), which made participants reluctant to share how they felt as they did not
want cause distress to their family. Some participants discussed how this reluctance
created a barrier to support, as “sometimes you think, I wish I could tell them blah blah
blah, but I don’t want them to know just how bad I am today” (Daisy) and this leads
to feelings that “you have to” (Max) deal with it alone as “if I tell them about it, is that
going to affect them [mentally] as well?” (Daisy). To overcome this, other participants
discussed sharing their concerns with support group members who understand the
condition: “sometimes when I’m not well, and I’m breathless, I’d rather ring some-
body in Breathe Easy [the group] to tell them I’m not well, rather than family, so I don’t
worry them, you know what I mean?” (Lisa). In fact, participants described how they
would telephone one another outside of group meetings or “go ‘round and see how
they are” (Lisa). Being part of the support group, “a community that understands your
problems” (Tony), was seen as valuable for providing emotional and mental support
without the concerns of ‘burdening’ or worrying family about the reality of how they
feel during their ‘bad’ days.
5.5.2.2 Discovering Support Groups
Participants emphasised that support groups were “tremendously” (Rose) conducive
to feeling part of a community, where people could receive support and advice on
an ongoing basis as “unless you come to something like this where you’ve got people
who have gone through it, or who are going through it, you wouldn’t know, I wouldn’t
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have known anything, I’d have been no nearer [in terms of support and advice]” (Rose).
However, participants believed that learning about the existence of support groups
was a challenge among people with CRCs. Many participants found out about the
group through researching online or seeing it “advertised on the wall in the notice-
board at the doctor’s surgery” (Linda), with one participant being referred by their GP
practice (Lisa). However, participants believed that HCPs should be actively informing
people with CRCs about the groups, and not leaving them to discover the groups them-
selves as “there are thousands of people suffering from COPD or breathlessness” and
“they haven’t got enough information” (Max) about the existence of support groups.
Some participants described trying to campaign for better awareness about the groups
through bringing material by the British Lung Foundation into healthcare centres, but
noted “it’s very difficult to get notices put because so many people want to put notices
up” (Linda) and how the GP practices refused to let them leave material as they “would
not allow it ... they just didn’t want them” (Tony). This frustrated participants as they
noted that “it’s the fourth biggest killer [COPD], but it doesn’t get the recognition”
(Daisy) and that leaving material at healthcare services was believed to be the most
effective way of advertising the support groups and awareness to people with, or at
risk of, CRCs.
5.5.2.3 Attending Support Groups
In addition to the challenge of learning about the support groups, participants dis-
cussed that there were challenges related to physically attending them as “there’s lots
of people that would come [to the groups] but they can’t get here, transport is a real
problem” (George). Being able to arrange travel to the groups was highlighted as
extremely difficult for people, particularly as CRCs contribute to limited mobility and
fatigue. Participants talked about how they travelled to the groups, often being driven
by family, friends, or carpooling together. They talked about how some people do
not have this mobility support and “can’t be going out” (Max) alone and may have
anxiety over “what happens if they get serious” (Max) while travelling alone. It was
also suggested that some people may struggle to make “the effort to come” (Max) due
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to challenges with mental health and wellbeing associated with CRCs. Participants
described how sometimes existing members “can’t always get here with health issues”
(Tony) and that they used a closed Facebook group to discuss each meeting and share
information, so that existing members that can “read whats gone on and not feel out
of place [by not having attended the meeting]” (Tony).
5.5.3 Summary of Workshop Findings
Overall, there were five key findings from the workshops:
1. Participants felt HCPs lacked information about CRCs, which was a barrier to
the support they could provide.
2. Learning and developing an understanding of the condition is an individual
process that can be made easier through sharing pointers and experiences across
the CRC community.
3. Some participants were selective with the type of support they used when
sharing experiences of poor health as to not worry or ‘burden’ family.
4. There is difficulty in discovering support channels as there are limited opportu-
nities to advertise them.
5. Physical support groups can be difficult to access for people with CRCs due to
transport issues and challenges associated with leaving the home.
5.6 Discussion
The following sections synthesise the findings from the survey with 147 respondents
(to gather a broad understanding of the CRC community’s self-care experiences, every-
day device usage, and uses of technology for self-care), interviews with 13 participants
(understanding the rich lived experiences of having a CRC), and workshop with 11
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participants (exploring information needs and support avenues). The discussion is
centred around design considerations for CRC self-management and self-monitoring
technologies. The three discussion points focus on (1) ‘designing for reactive manage-
ment approaches’; (2) ‘knowledge acquisition and evolving needs’; and (3) ‘designing
for inclusivity and reach’.
5.6.1 Designing for Reactive Management Approaches
The interviews revealed that some participants took a reactive approach to man-
aging their own care. Participants felt a heightened need to self-monitor and take
medication when they felt unwell, compared to a consistent approach that, in some
cases, was advised by HCPs. Some participants discussed that they believed this
reactive approach would extend to their potential use of self-monitoring technolo-
gies. Likewise, survey findings demonstrated that many respondents did not track
symptoms using a diary for self-reflection or sharing in clinic6. This highlights how
current models of self-tracking, which stress the importance of long-term consistent
data points generated by the user (Pols, 2012; West et al., 2018), may not align with
the symptom transience and gradual fluctuations that can occur with CRCs. The
concept of designing for symptom transience has been explored in HCI research
around Parkinson’s disease (McNaney et al., 2015; Mishra et al., 2019; Nunes and
Fitzpatrick, 2015, 2018) and migraines (Schroeder et al., 2018), highlighting the need
for self-monitoring and tracking tools to support variability in condition state. Par-
ticularly, Nunes and Fitzpatrick (2015), discussed how people with Parkinson’s will
adjust their self-management practices to deal with periods of stronger symptoms,
contrasting with conditions such as diabetes that require more stable and consis-
tent self-management. This resonates with the reactive patterns of management that
was evident with the interview participants, who in some cases, also contrasted this
6This is not to say people would not be willing to do this, just that they routinely did not.
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approach to how they managed their diabetes. There is a need for self-monitoring
technologies to adapt to reactive styles of management. This changes the way we
think about the practice of self-monitoring for CRCs, shifting from a stable process of
self-monitoring rhythmically, to a flexible process that can support more intermittent
habits of monitoring.
Reactive management approaches are not unusual, as consistent self-observation
of one’s condition can be detrimental to their mental wellbeing (Ancker et al., 2015;
Craven et al., 2013; Lupton, 2013; Nunes et al., 2015; Oudshoorn, 2011; Pols, 2014;
Yun et al., 2010). Particularly, Lupton (2013) discussed that the emphasis placed
on self-monitoring and self-surveillance of a person’s chronic condition can be over-
whelming and depressing. For respiratory care specifically, Craven et al. (2013) found
that daily self-monitoring of asthma symptoms (specifically coughing) on an app were
intrusive for a user, making them more conscious of their symptoms, resulting in more
coughing. Similarly, COPD patients in a study by Pols (2014) felt that lung function
readings were counterproductive as they could only be interpreted in unhelpful ways,
which did not improve the situation for the patient. Although tracking this information
may lack value for the patient, Pols (2010, 2014) described how physiological readings
can depict a condition of one’s body in a way that may not be experienced directly
by the patient themselves. Thus, there may be instances where it would be clinically
meaningful to track certain symptoms even if this does not align with what a patient
deems meaningful. However, too much emphasis on the generation of clinically use-
ful data at the expense of the experience of living with the CRC can reinforce Parsonian
notions that the patient is not autonomous and must ‘comply’ with the demands of
the HCP in order to treat their sickness (Parsons, 1975; Storni, 2010).
Identifying this reactive management approach demonstrates how consistent
long-term tracking practices from the individual can interfere with how some individ-
uals organically routinise, organise, and manage their everyday life to accommodate
living with a CRC (Lupton, 2014c). More passive approaches to monitoring could be
a more promising approach for people that adopt a reactive style of management. For
example, using audio sensors to detect wheezing (Chatterjee et al., 2019) or the use
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of smart inhalers (such as reliever inhalers) and peak flow meters which record usage
and detect increased use (Chen et al., 2020; Perez, 2015). Heightened use of tools
and objects that are designed to help with self-management could be an indication of a
struggle or a decline in health, which could prompt user engagement to monitor when
necessary. For example, the survey data showed that medication and pulse oximeters
were most commonly used by the community to self-manage. Therefore, increased
contact with them could suggest a change in health condition, which could be used
to generate data points without overburdening people for day to day additional data
input.
I do not argue that technologies that require more explicit user input lack value
for people with CRCs. Instead, I argue there may be specific periods or stages of the
condition where explicit user input is more acceptable and more valuable to people
with CRCs. For example, Anastasiou et al. (2018) built an asthma exacerbation pre-
diction system aimed at predicting severe exacerbations of patients from their homes.
Through capturing daily peak flow readings, an asthma questionnaire response, and
medication use, the system was able to predict asthma exacerbations seven days in
advance. This may suit periods when individuals with CRCs are unwell over a long
period of time, such as those who are in the acute stages of their condition or are
recovering from a recent hospitalisation. Outside of these scenarios, some individuals
may feel that they ‘know themselves’ and their symptoms well enough that they do
not require day to day support. This does not suggest that these technologies have
no place or value in CRC self-management, or that these reactive approaches apply
to all individuals with CRCs. Rather, I wish to emphasise that it would be useful to
consider how self-monitoring practices may be a temporary practice that some people
choose to take in certain situations and circumstances. This is in contrast to viewing
the process of self-monitoring as something that begins and ends indefinitely, without
consideration of the condition stages and experiences that individuals with CRCs are
living with.
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5.6.2 Knowledge Acquisition and Evolving Needs
The concept of outgrowing certain self-care practices was explored, as interview
participants eventually learnt more about their condition and capabilities as time
progressed. This relates to the chronic illness trajectory (Corbin and Strauss, 1991),
whereby individuals experience different phases of their illness as their condition
progresses (Mccorkle and Pasacreta, 2001). During the interviews, participants raised
the concept of ‘knowing yourself’, in which they abandoned activity tracking devices
that supported knowledge building around their capabilities once this knowledge
had formed. This was also evident with interview participants that had lived with
the condition for many years, who expressed that their development of experiential
knowledge about their condition warranted new needs (such as no longer learning
about their condition but forecasting potential exacerbations). For instance, we saw
how one interview participant felt the value provided by a symptom monitoring app
did not align with the advanced stage of his condition. The concept of abandoning
technology after reaching certain goals has been explored in previous self-tracking
work (Epstein et al., 2015).
More specific to concerns around designing for different life stages, Kelley et al.
(2017) discussed the ways that self-monitoring tools for mental wellbeing in young
adults should be designed for their different life stages. Similarly, Pollack et al. (2016)
explored how technology should support hospitalised patients to self-manage grad-
ually as to not overwhelm them with information before discharge, while also ac-
counting for how their needs change and vary over time. As CRCs are progressive
conditions, there is a need to design tools that consider the different stages of the
condition but also the length of time having lived with the condition (which are two
different axes on the illness spectrum). If self-monitoring technologies are flexible
enough to follow the progression and experiences of the person with a CRC, it could
offer more value to the individual. As CRCs progress over time, the experience of living
with the condition also matures, thus progression of the condition and progression of
the experience changes an individual’s needs over time. However, progression of the
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condition and progression of the experience do not necessarily advance at the same
pace.
Participants from both the interviews and the workshop lacked enough informa-
tion about what their condition was, what it meant for their life (also evident in the
survey data, section 5.3.3.2, pg. 167), and how to self-manage when being diagnosed.
They lacked what Pols (2012) described as ‘clinical knowledge’ (knowledge accumu-
lating from multiple sources including scientific literature, test results, and patient
reports) and ‘practical knowledge’ (knowledge of living and dealing with the condi-
tion through embodied experience7). They felt that both types of knowledge were
important for understanding and self-managing their condition; and expected clinical
knowledge to help facilitate the development of practical knowledge. However, the
lack of information about CRCs provided at diagnosis and the lack of knowledge of
general practice staff, combined with uncertain (and changing) diagnoses, interfered
with their self-management journey and how they made sense of their condition.
Medical literature has also reported on the ambiguity in diagnosing COPD due to
changes in the agreed thresholds for spirometry results (Pellegrino et al., 2008), simi-
lar characteristics to other lung conditions (Soler-Cataluna et al., 2012), having more
than one CRC at the same time (Barrecheguren et al., 2020), and lack of training in
delivering spirometry tests and interpreting results (Bolton et al., 2005). To deal with
the dissatisfactory encounters with general practice staff, workshop participants talked
about the value of being referred to respiratory specialists, who provided a route to
better clinical and practical knowledge about their condition.
Some forms of practical knowledge arise through the learning process of living
with a condition (Pols, 2012). Knowledge that develops through embodied experience
can be somewhat incommunicable (Williams and Ryan, 2017). However, workshop
participants emphasised how some tips and advice are transferable and valuable for
7Note that HCPs can still contribute practical knowledge to the patient by providing self-management
advice based on the patient’s reported problems.
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starting and carrying out the journey of living with a CRC. Pols (2012) talked about
‘know-how knowledge’ (knowing how to do something embedded through techniques
and methods) and ‘know-now knowledge’ (knowing and interpreting what to do in
a new, unseen situation). The workshop participants discussed being able to share
experiences of both know-how and know-now knowledge during meet ups, which
greatly improved the inventory of knowledge that participants had about living with
their condition. For instance, being aware that certain environments can exacerbate
the condition (to inform know-now knowledge) or breathing techniques they had
learnt that helped with breathlessness (to inform know-how knowledge).
Clinical and practical knowledge are clearly important components for being
able to best manage and navigate life with a CRC. Though interview and workshop
participants felt this knowledge was generally lacking, its existence within defined
groups was acknowledged (specialist respiratory HCPs, experienced support group
members, etc). The challenge was in accessing these defined groups where the
knowledge exists, with participants noting that a change in attitude can help them
to obtain this knowledge (by being assertive with HCPs about information needs and
actively asking questions) or by physically locating this knowledge themselves (through
searching the internet and physically attending support groups). In some cases,
there can be challenges in discovering this knowledge in the first place (discovering
information about specialist respiratory HCPs and support groups). Further physical
barriers to accessing knowledge occur when considering the significant mobility and
fatigue challenges faced by many participants (evident across the survey, interview,
and workshop data). This can impact how far individuals can physically go to obtain
needed knowledge (such as attending healthcare centres and classes, and support
groups).
These challenges present an opportunity for digital solutions to aid in providing
sources of information on starting and maintaining the self-care journey. Previous
work has looked at the ways in which technology can provide digital support for peo-
ple with CRCs. For example, Pols (2012) described how COPD patients collaboratively
developed and shared practical knowledge through webcam meetings to overcome
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limitations imposed by mobility difficulties. This demonstrates the value that technol-
ogy can provide in remotely bringing together communities for information sharing
and strengthening self-efficacy. More specific to online information provision, pos-
itive stories and information sharing have been shown to enhance and strengthen
knowledge of asthma, expanding on the ‘basic’ information provided by healthcare
professionals (Sillence et al., 2013). McNaney et al. (2018) engaged the Parkinson’s
community in the co-creation of health information resources, allowing information
needs to be designed by the community themselves. This resulted in the creation of a
radio channel which involved clinical and personal perspectives about the condition.
Collaborating with respiratory support groups to co-create their own information re-
sources could be a beneficial way to build practical knowledge. It could also help to
build a widespread sense of community which traditionally exists in physical support
groups.
Through providing an online platform for people with CRCs to co-produce and
share practical knowledge (such as know-how and know-now knowledge), advice
on gaining more meaningful support from healthcare services (such as being as-
sertive, asking questions, suggesting referrals), pointers to additional avenues for
support (such as physical support groups), and feedback and recommendations on
self-management technology (which reportedly occurs in support groups), people of
different physical abilities can be better supported in acquiring important information
and knowledge that they need to (self-)manage their condition. This also supports
information provision and helps build confidence in people that face mental health
challenges associated with CRCs who may find it challenging to seek this support.
Considering many survey respondents used the internet to browse for information
(88% of all respondents), and some used the health related websites and forums,
online information provision can be seen as an accessible and useful way to support
the CRC community.
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5.6.3 Designing for Inclusivity and Reach
The following sections below discuss ‘reaching out for support’ and ‘accessible solu-
tions over novelty solutions’ in relation to designing for reach across the CRC com-
munity.
5.6.3.1 Reaching Out for Support
Facing stigma in association with a CRC has been reported in previous work, par-
ticularly relating to smoking and wider societal blame (Berger et al., 2011; Halding
et al., 2011; Johnson et al., 2007a), feelings of embarrassment about symptoms such
as coughing, breathlessness, and increased sputum (Berger et al., 2011; Snadden
and Brown, 1991), and not wanting to ‘burden’ others with the condition (Berger
et al., 2011; Earnest, 2002). This stigma can negatively impact people’s illness experi-
ence, cause feelings of defensiveness, and contribute to disengaging with healthcare
services (Berger et al., 2011). I found that participants experienced stigma in their
everyday lives about their CRC, this was experienced from HCPs (who were perceived
as being dismissive with participants if they admitted being current or former smok-
ers), society more widely (who perceived the condition to be self-inflicted), and even
self-blame in some cases (believing COPD was a form of punishment for smoking).
Experiencing stigma created barriers for some participants to accept and adjust to
life with the condition, creating difficulties in fostering a positive outlook for self-
management. Examining how design can accommodate stigmatised conditions has
featured in previous HCI work, for example around Type 1 diabetes (on how to de-
sign more discreet medical devices) (McCarthy et al., 2017) and HIV (designing for
(non)disclosure on sex-social apps) (Warner et al., 2019). However, the stigma I have
found in context to CRCs reportedly affected how participants’ felt they could seek
support for their condition (opposed to how they engaged with specific technology
and devices). In addition to stigma, workshop participants expressed wanting to avoid
‘burdening’ family members about their condition, leading to them being hesitant to
reach out to family for support (section 5.5.2.1, pg. 187). This is important to note as
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a lack of social support can have a negative effect on chronic illness self-management
behaviours (Gallant, 2003), and the reluctance to seek help. Stigmatisation could also
potentially impact how individuals with CRCs practice self-care.
Interview participants discussed that technology that linked their personal health
data to peer support networks (such as HCPs, family members, and carers) was a mo-
tivation to track their symptoms and would be a valuable safety net for collaboratively
discovering periods of difficulty. The importance of understanding self-care as a col-
laborative activity between people and their carers has been raised by Corbin and
Strauss (1984) and more recently by Nunes and Fitzpatrick (2015) in the context of
using technology for self-care of chronic illness. However, the feelings of guilt around
‘burdening’ family members could influence how people may report data about their
symptoms, in a similar way noted by Dahl et al. (2018), who reported that COPD
patients under-reported their symptoms when engaging telemonitoring technology
to avoid ‘burdening‘ HCPs. This raises the importance around how self-monitoring
technologies that provide links to support networks are designed and how support
networks are appropriately chosen. Previous work on COPD monitoring technology
has incorporated features that allow data to be uploaded onto Facebook (Pereira et al.,
2016). However, although the survey data showed people with CRCs used technology
for social networking (60% of all respondents), data relating to CRC health is highly
personal and people are selective with whom they wish to share this type of data.
Therefore, there needs a stronger consideration about what channels people with
CRCs would wish to share their health data with. Going forward, the ways in which
personal health data is represented to different people in the patient’s support network
should be considered. For example, differing levels of information granularity for data
sent to HCPs, family, and friends. For example, people with CRCs may wish to alert
HCPs to small changes in their health but may feel that they are burdening or worrying
friends and family by indicating this small change. It is important to be mindful of
the way that personal health data is communicated to different people, and providing
people with CRCs the option to customise this could be a positive step in encouraging
and supporting people to share this data with their support networks.
199 5.6. Discussion
5.6.3.2 Accessible Solutions over Novelty Solutions
In the context of empowering8 patients through the use of technology, Skinstad and
Farshchian (2016) have argued that some researchers may be more focused on achiev-
ing concept novelty than promoting empowerment in their development of technical
solutions for health. Pols (2014) stressed the redundancy of handing patients technol-
ogy that they cannot find ways to conveniently fit into their lives. Moreover, asking
users to engage with a device which is not part of their existing lives and routines
can be burdensome (Pols and Moser, 2009). The survey results showed that all re-
spondents owned some digital technology, and that computers and laptops were the
most commonly used device across all respondent age groups, with newer technology
such as smartwatches being less commonly owned overall (but most likely owned by
younger respondents). However, it is important to acknowledge that the use of tech-
nology in everyday life is not necessarily indicative of willingness to use and acquire
technology to manage health conditions. Evidence suggests that respiratory condi-
tions such as COPD are linked to social deprivation (Burney et al., 2014; Fullerton
et al., 2011; Naess et al., 2007; Torres-Duque, 2017; Townend et al., 2017), as such
it is important to note that those within the CRC community may not have access to
costly technology for support.
It may be tempting to argue that as generations grow more technology profi-
cient, older adults will engage more with a wider range of technologies. However,
research by Knowles and Hanson (2018a,b) has shown that older adults may ‘always’
have a conscious rejection of newer technology due to their unique values inherent
to their generational cohort (e.g. valuing face-to-face interaction over digitisation
of services (Knowles and Hanson, 2018a)). This serves as a node of caution about
assumptions that future generations will be more willing to engage with newer tech-
8Patient empowerment has been defined as ‘a mechanism to facilitate self-led behaviour change’ (An-
derson and Funnell, 2010).
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nologies. As generational values will change over time, the increasing digitisation of
healthcare services and support may become a notable tension in future years. Partic-
ularly for people with chronic health conditions, where access to healthcare support
would be required more frequently.
This introduces two important lessons for designing technology for people with
CRCs: the first is ensuring that the design of digital solutions are community inclu-
sive, the second is ensuring that solutions align with the values of the community.
For example, Pereira et al. (2016) suggested that expanding their COPD exercise app
onto newer devices, such as smartwatches, can increase users. However, expanding
technology concepts onto newer technologies can exclude a large and older propor-
tion of the CRC community. This is not to say that those with CRCs will not own
newer devices, but raises the importance of considering the community inclusivity
of the platforms that we design. Moreover, this approach of designing onto newer
technologies to increase users is usage-focused compared to value-focused (i.e. first
and foremost focusing on increasing user base rather than increasing value to users).
In contrast to this, Yun and Arriaga (2013) demonstrate inclusive design when they
created an education tool for children with asthma, which looked at improving asthma
health outcomes through daily short message service (SMS) messages. They noted
that using SMS messages, used heavily among pediatric patients at the time of the
study, improved the response rate over the course of the study. Moreover, this de-
cision was conscious: the fact that SMS messages were easy to use and something
which pediatric patients engaged with in their daily lives motivated their decision for
using them for the study. This demonstrates how favouring inclusive and considerate
approaches to design, over the creation of ‘novel’9 concepts on newer technologies,
can better support members of the CRC community.
9I am not arguing against novelty, rather, I am against putting novelty over patients’ actual needs.
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5.7 Study Limitations and Reflections
The most significant limitation to raise about this study is about self-selection bias
and generalisability. I could only conduct research with participants who were will-
ing to participate, which means my findings reflect a sample of participants who
were willing to share their experiences and stories for research. I also actively used
non-probabilistic sampling10 to try to recruit interview participants who had used
technology to self-manage their CRC, and then arranged a workshop with an existing
support group to understand support channels and information sharing. This has
implications for the generalisability of my results, as my findings cannot be said to
reflect the entire CRC community.
Further to this, interview and workshop participants were mainly older adults,
living in North West England, and were mostly white. Older adults are the demo-
graphic most likely to be diagnosed with a CRC like COPD, but there are people living
with CRCs who are not older adults (Raherison and Girodet, 2009). Likewise, how
people adapt to, and live with, any health condition will be influenced by their cultures,
beliefs, and environment. I have not captured this diversity in this study, though I
note its important for building a rich understanding of the lived experiences of CRCs
(and the potential role of technology for support). This ultimately places limitations
on the degrees of generalisability of this research.
Another important limitation is the lack of carers’ perspective. Nunes and Fitz-
patrick (2018) highlighted that, in some ways, carers can be thought as living with the
chronic condition by being able to observe its effects in the person they are caring
for. However, data was captured from only one carer in this study. Some workshop
participants had CRCs while also caring for others with CRCs. One benefit of focusing
10In qualitative research, non-probabilistic sampling relates to identifying and recruiting people within
your sample population that have the characteristics relevant to the phenomena you wish to study (Mays
and Pope, 1995).
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research on people living with the condition is that this approach can ensure research
outcomes can provide greater benefit for the people with the condition (Nunes et al.,
2015). However, this leaves a gap in my research, and creates an opportunity for
future work in this area to incorporate the perspectives of carers.
I kept participants informed about this research while it was ongoing and after
it had concluded. This was very important to me, because I had personal discussions
with participants about important and sensitive topics about their life. I wanted to
actively show them how their contribution to my research was being used. Whenever
I was presenting a talk or writing a research paper, I would let them know. I consider
this to be good practice in human subjects research, but it really struck me just how
important it was after one of my last visits to a support group. One member wrote to
me and thanked me for my continued updates and visits, noting: ’over the 16 years
that I’ve led the group, a number of people have sought information from our members
to support various projects and studies, but sadly most of them thank everyone on the
days of their visits, then we never hear from them again’11. Of course, a researcher’s
involvement on a project will always end in some way. However, I believe showing
participants the value of their contributions is more than just ‘good practice’ and
instead an important step in the research process.
Researchers in HCI are becoming increasingly aware of the ethical and practical
challenges associated with research with communities, specifically what happens to
relationships and technology when a research project finishes (Race et al., 2020; Taylor
et al., 2013). This can be particularly difficult in healthcare HCI research, where they
may be nothing tangible to show or give (in terms of technology) to participants at
the end of the study. Therefore, keeping participants informed about the outcome of
the research is an important way to demonstrate to them how their contributions are
being used. Keeping participants informed could also help to encourage communities
to participate in future research which could ultimately benefit them.
11Quote included with full consent.
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5.8 Chapter Summary
This chapter has documented the rich lived experiences of CRCs and explored how
technology could support this experience. Through carrying out a series of research
engagements with the CRC community, I uncovered the challenges and opportunities
involved when designing technology to support this lived experience. There was a
total of 171 participants in this study. First, I conducted a survey with 147 respondents
from the CRC community to understand: the everyday challenges they faced with their
condition; how they used technology in their day to day lives; and their experiences
of using technology to self-manage their condition. Next, I conducted 13 one-to-
one interviews to build a richer understanding of the everyday challenges associated
with living with a CRC, how people self-managed their condition, and their in-depth
experiences of using technology to do so. Finally, I conducted a workshop with 11
participants to understand their information needs about their condition and explored
different support avenues that were important to them.
The findings provided rich insights about the lived experiences and needs that
people with CRCs have, followed by what this means for designing technology to
support them. This includes: the reactive management approaches that some partic-
ipants take to self-manage their condition (which is rooted in their perception of their
condition and their individual needs); the need for technology to better support knowl-
edge acquisition and the evolving needs of the condition (both in terms of clinical and
practical knowledge about the condition); and the need to design technologies that
are inclusive and accessible to the CRC community (particularly those who struggle
physically and emotionally to seek support).
The next chapter builds on the previous two research chapters. It uses a case
study approach to explore the lived experiences of self-monitoring COPD symptoms
and sharing this data with HCPs. It explores the perspectives of both COPD patients
and HCPs. It completes the perspectives explored in the previous two research
chapters, by uniting HCPs and people with COPD to understand the opportunities for
data supported decision-making through self-monitoring.

Chapter 6
Exploring the Lived Experiences of
Self-Monitoring for Chronic
Respiratory Care
Some of the data and findings from this chapter have been published as an extended
abstract in the companion proceedings of the 2019 ACM Conference on Computer
Supported Cooperative Work and Social Computing (Tendedez et al., 2019a)
6.1 Introduction
This chapter explores the lived experiences of self-monitoring COPD symptoms and
sharing this personal health data remotely with healthcare professionals (HCPs). When
HCPs and patients are both connected in the self-monitoring process, Bardram and
Frost (2018) have called this as ‘double loop’ technology. This compares to ‘single
loop’ technology, which only involves the patient in the self-monitoring process for
their own self-management. I use an exploratory case study approach to uncover
patients’ and HCPs’ experiences of engaging with a self-monitoring mHealth app,
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designed for generating digital diaries about COPD symptoms. This chapter aims
to answer the third research question: ‘what is the lived experience of using self-
monitoring technology to share symptom data between COPD patients and healthcare
professionals?’
The key contributions of this chapter can be summarised as:
1. Sharing personal health data remotely with HCPs can cause undesirable ‘shifts’
in the responsibilities of care between the patient and the HCP. These give rise
to prominent accountability concerns for the HCPs.
2. The opacity of algorithms used within self-management technologies can cause
users to distrust the technology as they struggle to understand its outputs.
3. Self-assessed data about COPD symptoms can be perceived as too ‘subjective’
to rely on for understanding a patient’s symptoms and overall condition.
4. Technologies that give self-management suggestions to patients must align with
the local healthcare organisations which support its use. Otherwise, the tech-
nology can become a source of conflict for patients.
5. Self-monitoring technology for COPD should offer personalisation capabilities
to adapt to patients’ individual needs and contexts, which may change as the
condition progresses.
6.2 Study Setting
This study took place with a community care respiratory service (referred to as ‘Com-
munity Care’ henceforth), which is described in the methodology chapter (Chapter
3, section 3.4, pg. 50) and in Data Supported Decision-Making (Chapter 4, section
4.2.2, pg. 70). To recap, Community Care offer services that aim to support pa-
tients with COPD to self-manage their condition. The main aim of the service is to
help patients avoid COPD hospital admissions through offering support within the
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community. They provide a number of services including: intensive home support,
pulmonary rehabilitation (PR) services, and patient clinics.
Intensive home support provides COPD patients with clinical support in their
own homes, including home visits to check on the patient and provide them with
medication and monitoring if needed. Patients may be on intensive home support
services if they are acutely unwell or have recently been discharged from hospital after
a COPD exacerbation. PR is an eight week group programme that consists of exercise,
education, and breathing support classes. It is held at the Community Care site and
requires patients to travel to the site twice a week to attend the classes. Patients are
usually referred to PR after an exacerbation of COPD (which may have led to a hospital
admission) or if the patient’s General Practitioner (GP) believes they need support in
learning about and managing their condition.
As Community Care provide support for COPD patients to self-manage their
condition, they were interested in exploring new ways to support and educate pa-
tients. Particularly, they were interested in the role that digital technology could
have for assisting patients to self-manage their condition and become better aware
of their symptoms. They believed that the use of technology could alleviate some of
the resource strains and pressures currently experienced by their service. Through
providing a digital medium that patients could engage with to help manage their condi-
tion, they believed patients may become ‘more empowered’ and capable of managing
independently. They believed mHealth apps were an inexpensive option to explore
these motivations (Iribarren et al., 2017). They were familiar with, and wanted to
explore using, the ‘How Are You Today’ app (described later in this chapter) as it was
being used by other healthcare services in North West England.
6.2.1 Community Care
This section provides brief details on the daily work of the Community Care team. I
spent half a work day (approximately four hours) at the Community Care site observing
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their work practices. This was a context building activity aimed to learn about their
working day in more detail. The nurses begin working at 8.30am when they start
providing phone support to patients with COPD. They have a list of patients to contact
on a spreadsheet and will typically spend all morning going through the list. They will
contact patients registered on their service, such as patients on intensive home support
or enrolled in PR. They also check on patients that have recently been discharged from
the nearby hospital (described in Chapter 4, Data Supported Decision-Making, section
4.2.1 on pg. 69). They may receive phone calls from patients, and when they do, they
typically structured their phone calls around a number of triage questions including
asking the patient if they are short of breath, if they have increased sputum production,
if they feel wheezy, and if they have chest pains (Figure 6.1). When calling patients,
they will ask questions like ‘how is your course of antibiotics?’, ‘have you had your
nebuliser this morning?’, followed by encouraging comments such as ‘you need to
give your medication more time’ and ‘don’t give up hope yet!’ A summary of each
phone call is then recorded on the patients’ electronic care record.
Figure 6.1: The questions that HCPs will ask when answering phone calls from COPD
patients.
Nurses will also discuss their case load informally in the office. They share
important contextual information about patients to help the team improve their un-
derstanding of patients’ individual circumstances (Weiner, 2004). For example, as
well as discussing when a patient’s last clinic visit was or their comorbidities, they
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may discuss other very individual and contextual factors about a patient that affects
their respiratory condition. For example, the temperature in a patient’s house (which
they know from home visits), when a patient’s holiday is scheduled for, how many
grandchildren the patient has, and which window in the patient’s house they routinely
keep open that produces too strong of a breeze. This important contextual information
helps to paint a stronger picture of a patient’s life so they can orient the support they
provide. In the late morning (at approximately 11am), the nurses will then prepare
for, and then conduct, home visits to patients that are on their intensive home support
service. While this occurs, the physiotherapists and assistant practitioners will prepare
for, and run, clinics or PR classes.
6.2.2 ‘How Are You Today’ App
This study involved the use of an mHealth app called ‘How Are You Today’1 (referred
to as ‘the app’ henceforth). The app had been commissioned by various National
Health Service (NHS) respiratory services across North West England2. I was told by
Community Care that the app was designed by HCPs and tested with patients. The
app was based on pre-existing COPD paper diaries that were also designed by HCPs
(see Figure 6.2). These paper diaries were offered to COPD patients in community
care settings in North West England to support their self-management. To date, there
is a lack of public information available about exactly how the app was designed and
tested. The app’s description on Google Play and the App Store simple states that it
was created and tested with HCPs and patients. To the best of my understanding, this
is the first systematic in-the-wild study that explores the app’s use.
1‘How Are You Today?’ Accessed February 6th, 2020 from https://play.google.com/store/
apps/details?id=com.intelesant.copd&hl=en_GB.
2The How Are You Today app had been commissioned across healthcare services in North West
England as it had been developed with, and by, HCPs working in this region.








































































































































































































211 6.2. Study Setting
To start using the app, the patient requires a referral from their HCP. The app
company then contact the patient and register them onto the app. This requires the
patient to download the app onto their phone. After registration, the patient can start
inputting symptom data, which is shared with their HCP as a weekly report.
Patients are required to fill out a short survey each day on the app, which
consists of five questions (one action related question shown in Figure 6.3 (A) and
four symptom related questions shown in Figure 6.3 (B-E)). The action related question
asks the patient if they have taken any respiratory medication3 on the prior day or
contacted their healthcare team, then the four symptom related questions ask about
potential increases in cough, sputum (phlegm) production, breathlessness, or changes
in sputum colour. Once the patient completes the survey, the app labels the ‘type’ of
day that the patient is having based on their input, and suggests a management action
(Figure 6.3 (F)). There were four different day types that the app could categorise: ‘no
symptoms’ (good day), ‘bad day’, ‘flare up’, and ‘danger day’.
Typically in the event of a ‘bad day’, the app would recommend the patient
increases their inhaler intake and contact their HCP if they feel concerned about their
health. It will also provide tips to the patient, such as using relaxation techniques
to improve the way they feel. During a ‘flare up day’, the app would suggest the
patient makes contact with their healthcare service (the same service which referred
the patient onto the app). It may also suggest that the patient needs antibiotics (e.g.
if their answers indicate that the patient may have a respiratory related infection).
Whereas in the event of a ‘danger day’, the app would recommend the patient to
seek emergency support (i.e. call an ambulance). Each week a record of the patient’s
entries is securely sent to the HCP by the app company through a portal.
3Such as their reliever, nebuliser, steroid tablets, or antibiotics.
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A-E detail the daily questions asked by the app.
F indicates an example daily suggestion provided by the app based on the user’s answers to A-E.
Figure 6.3: The ‘How Are You Today’ app questions.
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6.3 Study Design and Methods
This chapter reports on a three stage study with COPD patients and HCPs using the
How Are You Today app. Patients were asked to answer the questions on the app
every day for a period of 30 consecutive days. They were informed that if they had
forgot to fill the app in one day, they could retrospectively answer the questions when
they remembered (and if they wanted to). In other words, I did not ask patients to
maintain strict adherence by filling in the app each day at the same time. During the
study, HCPs were asked to review the patient-generated data weekly when it was sent
by the app company. They were only asked to engage with this data in the same way
which they would outside of the study’s context. That is, they were not required to
do anything specific with the data as part of the study.
Qualitative data was captured from both HCPs and patients through one-to-one
interviews, phone calls, and focus groups. I collected data from the HCPs twice
during the study, first at the beginning (a focus group exploring their motivations for
the study) and then at the end (interviews to understand their experiences on the
study). I collected data from patients three times during the study, first at the start
of their involvement on the study (an interview that explored their motivations and
expectations for the study), then a short phone call with them halfway through their
time on the study (to check in on how they were getting on with the process of self-
monitoring), and finally at the end of their 30 day self-monitoring period (an interview
to understand their experiences on the study). Though the app company were not
explicitly involved in this research, they were aware of the study, as Community Care
contacted them about using the app for a pilot study. They agreed to provide basic
information about how many diary entries the patients’ made throughout the study
(so that I could review their engagement with the app when interpreting the findings).
However, I did not have access to the patients’ diary entries.
Patients were informed that they were free to continue using the app after the
study, or had the option to delete their account and uninstall the app. Deleting their
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account would lead to the deletion of the data generated throughout the study4. They
were informed to contact the app company if they required any support about the app
beyond the study.
6.3.1 Participant Recruitment
The following sections describe the process undertaken to recruit the HCPs and patient
participants onto the study.
6.3.1.1 Healthcare Professional Recruitment Process
Four HCPs were recruited onto this study (Table 6.1). Three of them (NURSE, PHYSIO,
AP1) were already known to me through their involvement in Chapter 4 (Data Sup-
ported Decision-Making). The fourth one, AP2, was invited to participate by NURSE,
due to their involvement with COPD patients through running and assisting PR classes.
The HCPs all had direct involvement with the care of COPD patients within the Com-
munity Care service. PHYSIO is the lead physiotherapist at Community Care, they
are highly experienced and manage a team of physiotherapists, lead PR classes, and
run one-to-one physiotherapy clinics. NURSE is a lead COPD nurse, they are highly
experienced in their role and manage a team of specialised COPD nurses. They also
run spirometry clinics (where patients are given annual or diagnostic spirometry tests),
nurse clinics (where patients receive specialised management support), and conduct
home visits and phone calls to patients. AP1 and AP2 are assistant practitioners, they
assist the running of PR classes, educate patients about managing their condition, and
more generally support the wider healthcare team where needed.
4This was arranged through the app company and I had no involvement in this process. This was
the standard process for any patient using the app, whether on this study or not.
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Participant Job Role




Table 6.1: Chapter 6 HCPs participants.
6.3.1.2 Patient Recruitment Process
This study involved recruiting COPD patients from Community Care’s PR programme.
The HCPs explained that patients on their PR programme were a good target group
for the study, as they were already receiving education and support to help them
self-manage their condition. Therefore, it was thought that these patients would be
motivated to participate in the study as they were currently learning about, and working
on, ways to better self-manage their condition. Patients that expressed interest in the
study were provided with an information sheet with my contact details, and were
advised to contact me if they wished to participate (see Appendix K). Patients required
access to a smartphone and the internet to download and use the app.
Recruitment was open from May to November 2018. As discussed in detail
in the methodology chapter (section 3.5.1.2, pg. 55), patient recruitment was very
challenging for this study. The HCPs approached eligible participants in clinics and at
the start and end of weekly PR classes. As PR was an eight week rolling programme,
HCPs would only encounter new patients every few weeks. Therefore, they did not
have the opportunity to approach new eligible patients on a daily or weekly basis. In
the end, four patients contacted me to express interest in participating.
6.3.1.3 Patient Participants
A total of four COPD patients (three men and one woman) were enrolled onto the
study (Table 6.2). The first patient was recruited in August 2018 and the last in October
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2018. All patients were enrolled in the PR programme at the time of their recruitment.
They all had their own smartphones and internet access for the study, except Chris,
who was loaned a smartphone and SIM card with 5GB of data (see Chapter 3, section
3.5.1.2, pg. 56). Once each patient contacted me to express interest in participating,
I met with them to take their full informed consent, and then proceeded to interview
them. After this, I informed the HCPs by email that I had enrolled the patient onto the
study. The HCP then contacted the app company to provide them with the patient’s
contact details to set them up on the app (following the standard referral process).
The app company registered the patients onto the app between one and six days after
their enrollment on the study. After this time, the patients could start inputting their
symptom data onto the app.
Participant Age Gender Diagnosed Comorbidities
Petros 66 Man 1 year Abdominal hernia
Robert 65 Man 1.5 years Suspected heart condition
Lia 68 Woman 10 years None reported
Chris 76 Man 16 years Bowel cancer
Table 6.2: Chapter 6 patient participants and their assigned pseudonyms.
6.3.2 Exploring Healthcare Professionals’ Motivations
The first method of data collection for the study was a focus group lasting 36 minutes
with NURSE and PHYSIO. The aim was to understand their motivations for introducing
a COPD self-monitoring app into their service. I asked questions such as: ‘in what
ways can the introduction of a self-monitoring app for COPD benefit your patients?’,
‘in what ways can the introduction of a self-monitoring app for COPD benefit your
service and your staff?’, and ‘does the introduction of a self-monitoring app for COPD
support your organisational goals?’ I chose to capture this data through a focus group
to draw on the HCPs’ joint expertise and experience of working in Community Care,
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followed by providing the opportunity for them to learn about one another’s thoughts
and perspectives. It was not possible to coordinate a time where AP1 and AP2 were
also available, so I prioritised collecting this data from NURSE and PHYSIO who were
senior HCPs. The focus group insights were used to prompt the questions in the follow
up interviews later in the study, scoping whether expectations had been met.
6.3.3 Exploring Patients’ Motivations
I conducted one-to-one interviews with patients at the start of their involvement
on the study, lasting between 30 and 60 minutes each. The interviews sought to
understand their experiences of self-management, expectations of using technology
to self-monitor their symptoms, and expectations of sharing this data with HCPs. I met
participants in their homes or after their PR classes (at the Community Care site) for
their convenience. I informed patients that they could have a family member or carer
present during any interviews if they wished, and only Chris chose to include his wife.
Chris’ wife was heavily involved in his care, and also contributed to the interview data
(with full informed consent). After the interview had occurred, I showed participants
how to download the app and talked them through how to use it. I also provided
them with written instructions.
6.3.4 Checking in with Patients
I had prearranged a call with each patient after approximately 14 days of them having
used the app, to check in on how they were finding the experience of self-monitoring
and to answer any questions that they may have5. The discussion centred around one
main question which was ‘so far, how are you finding the experience of monitoring
5Patients were made aware that they could contact me at any time during the study if they had any
questions. However, nobody did.
218 6.3. Study Design and Methods
your symptoms each day’? Phone calls lasted between 5 and 15 minutes, and were
not audio recorded. Instead, I made detailed notes during and after each phone call.
During the calls, I also asked patients to schedule their concluding interview on the
study (to occur approximately 14 days after the phone call took place).
6.3.5 Understanding Patients’ Experience
30 days after the initial interview, I conducted a final interview with patients to un-
derstand their experience of self-monitoring each day. I met Chris and Robert on
the 30th day of them monitoring themselves using the app. However, I could only
arrange to meet Lia 10 days after the 30th day elapsed and Petros 30 days after the
30th day elapsed due to practical reasons (Lia had been away on holiday and Petros
was hospitalised). However, all patients had been self-monitoring up until the day
they were interviewed (they had freely chosen to do this). I met Robert, Chris, and
Lia face-to-face for the interview, either in their homes or after their PR class for their
convenience. However, I conducted the interview with Petros over the phone as he
was unwell and felt more comfortable with this option. Petros had still been using the
app up until the concluding interview (thus he was not recalling his experience of using
the app from over 30 days ago). I asked the patients questions such as ‘how would
you describe your overall experience using the app to self-monitor your condition?’,
‘how did you interact with the app throughout the study?’, and ‘would you consider
using a mobile health app in future to manage other aspects of your health?’ Interviews
lasted between 30 and 90 minutes.
6.3.6 Understanding Healthcare Professionals’ Experience
Once each patient had concluded their involvement in the study, I conducted follow
up interviews with each HCP (Table 6.1) to learn about their experiences supporting
patients’ use of the app and receiving personal health data generated by them. I also
explored challenge areas about the study to the HCPs, such as recruitment difficulties.
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Interviews were held at the Community Care site, and lasted between 30 and 45
minutes each. Interviews were held in January and February 2019, which was a
challenging season6 for the HCPs due to the increase in patients with COPD that are
unwell and require support. Hence, it was difficult for HCPs to find availability for the
interviews. It would not have been practical to delay the interviews until HCPs had
longer periods of availability, as I wanted to ensure HCPs could recall their experiences
of the study as accurately as possible. I asked questions such as ‘how did you find
the study overall?’, ‘how did you engage with the weekly patient reports?’, ‘what have
you learnt from being involved this study?’, and ‘were there any specific benefits or
drawbacks you found as part of the study?’
6.4 Findings
The following sections present the findings from both the patients and the HCPs. The
first two sections discuss the patients’ and HCPs’ motivations for the study, with the
final sections focusing on their experiences on the study.
6.4.1 Healthcare Professionals’ Motivations
The following two sections describe the HCPs motivations to introduce a self-monitoring
app into their service, arising from the focus group held with NURSE and PHYSIO.
These motivations are divided between ‘Organisational Benefits’ and ‘Individual Pa-
tient Benefits’ and are described in detail below.




The HCPs discussed that introducing a self-monitoring app for COPD within their ser-
vice provided a way that they could give “the patient the autonomy and the empower-
ment to manage their condition” (NURSE). Teaching and promoting self-management
is a core priority for Community Care to support patients in living with their chronic
condition. NURSE and PHYSIO both discussed how the organisation were looking to
improve how self-management is promoted and sustained among the various different
COPD patients that engage with their service, as they believed that they needed to
adopt a more “proactive” (NURSE) approach to help those patients who engage less
with their service but still require support.
For example, they recalled how they used to offer a three month review to
patients after they have completed PR to check in on their self-management, but
found that “it’s kinda a waste of time” (PHYSIO) as “the patients who comply and do
well come, the ones who don’t, don’t” (PHYSIO). In light of this, they were undertaking
“quite a lot of development work” (PHYSIO) in how they run their PR programme as
a starting point. This included restructuring the sessions and the content within the
sessions, and following up each week with patients to reinforce the lessons learnt
in the previous week. For this reason, PR was thought to be a “really good place to
get something like that [the app] instigated” (PHYSIO) as “you’re seeing the patient
then for six weeks” (PHYSIO). This face-to-face contact could help familiarise patients
with the HCPs, who could in turn encourage them to engage with self-monitoring
during a period where they are enrolled into a programme focused on enhancing
self-management techniques.
In addition to this, using an app was perceived to be a less “expensive” (NURSE)
and thus a more accessible approach to support patients in self-managing, compared
to telemonitoring practices whereby the organisation provides equipment to patients
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in their home7. NURSE described how the HCPs could “look at data over the phone,
and if the patients saying they don’t require a visit from us at least we’ve got some kind
of back up in the sense of knowing that”. This was thought to be an another area
where the app could support reducing resources where appropriate.
6.4.1.2 Individual Patient Benefits
There were also benefits that the HCPs believed self-monitoring could bring to indi-
vidual patients on their service. Specifically NURSE discussed how “patients who are
newly diagnosed or quite early in the disease” could benefit from learning “to under-
stand the implications and the symptoms and deterioration” of their condition through
the process of self-monitoring, as “quite often patients are unaware of their symptoms
until they start to use technology to identify when things are getting worse” (NURSE).
For PHYSIO, the process of self-monitoring would help the patient in “learning to look
after yourself and manage your condition better” through reflecting on the symptom
data each day as “patterns of self-reporting is useful, trends, and being able to see
whether it’s something new that day or actually has this been going on for a few days”,
and “it [the app] does prompt them” (PHYSIO) to take appropriate action.
Though the HCPs felt the app was primarily “a self-management tool that is
for them to identify when they should be ringing us” (NURSE), HCPs could “identify
patients that don’t like to bother us, they leave things until it’s too late ... there’s this
kind of understanding that from a certain cohort of patients that they’re bothering us
or they don’t think it’s appropriate to ring us” (NURSE) and that these patients could
be supported and “managed earlier” (NURSE) if there was a way of better identifying
them through the “weekly patient reports” (NURSE).
7Telemonitoring has been described as ‘the use of communications technologies to monitor and
transmit items related to patient health status between geographically separated individuals’ (Maric
et al., 2009).
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Both NURSE and PHYSIO discussed being eager to hear the “patient experience
and what they’d want on it if we were to change it [in future]” (NURSE) so they could
decide “whether or not we continue with the app or move on to something else”
(NURSE) that could provide self-management support to patients.
6.4.2 Patients’ Motivations
The two sections below describe the patients’ two key motivations to engage with
self-monitoring and to participate in the study, which was collected through the four
interviews with the four patients on the study (Petros, Robert, Lia, and Chris). The two
key themes that patients discussed as their reason for participating in the study are (1)
‘sharing data with healthcare professionals’ and (2) ‘self-monitoring for self-reflection’.
These are described in detail below. Petros and Robert described themselves as being
confident with technology, having worked in the information technology sector in
the past. Lia described herself as moderately confident in using technology. Chris
described himself as having a low level of confidence in using technology.
6.4.2.1 Sharing Data with Healthcare Professionals
The main motivation described by patients to engage with the self-monitoring process
was to work with HCPs to optimise their self-management strategies. Having the HCPs
involved in the monitoring process was perceived to be “putting another arrow in your
bow” (Robert) in the process of managing a progressive chronic condition, and “rather
than saying ‘oh I’ll try this, I’ll try that”’ (Robert) they can be better “guided” (Robert) by
the HCPs. For example, collaboratively analysing the data and identifying “trends and
how you’ve got around it [difficult periods], and see what works and what didn’t work”
(Petros) because “every person is different, their lifestyle, the weather, their home, their
diet, and drinking, whatever the case may be” (Chris) and better understanding these
individual factors can help in the process of creating more effective self-management
plans.
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Patients also believed that being connected to their HCPs through the self-
monitoring process would help them obtain timely help in the case of health decline,
as “we only tend to contact them when we go to [PR] class” (Petros) or, outside
of the PR programme, “once a year to see how you are getting on with the nurse”
(Chris).
For patients, sharing self-monitoring data and viewing trends could help obtain
the support needed outside of those periods as “sometimes if you’re not feeling *too*
bad you’re reluctant to ring up ... whereas if they are getting feedback of how I’ve
been over the week, maybe they might see something” (Petros) and help to overcome
situations where “I didn’t feel confident enough to say ‘I’m really poorly”’ (Chris). The
collaborative approach of collecting symptom data and sharing this with HCPs for
decision-making was thought to be important, as Lia believed that it would be “a bit
pointless” if HCPs were not connected in this process to incorporate their perspective
of the generated data. Likewise, Robert believed collaboration between the HCP and
patient is needed to create and alter self-management strategies as if it is “just done by
the nurses then you’re talking down on the patient, and their motivations are not taken
into account” yet “if the patient is doing it by themselves, then they are not taking note
or they’re not taking on board the professional advice which is available.”
6.4.2.2 Self-Monitoring for Self-Reflection
Self-monitoring to aid the process of self-reflection about symptoms was the second
motivation highlighted by participants. This reflection process was thought to help
patients in being able to personally adapt their strategies for self-management as a
response to the insights provided by the self-monitored data. They had acknowledged
the limitations that their condition placed on their lives, and expressed being willing
to engage with different types of research conducted by their healthcare organisations
if it could “help in any way shape or form” (Lia) as “I want to be able to improve
my COPD” (Chris). For example, Lia described how having a diary of her symptoms
“might make me more aware of actually recognising when there’s any differences [in the
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days], and make me think twice before I do nothing about it like last time.” Likewise,
Petros was motivated to use the app to reflect on his symptoms over time, comparing
this to how he began using Fitbit to track his steps and sleeping since they became
effected by his COPD. Whereas Robert discussed that he could use the data collected
over time to make correlations with his symptoms and his behaviour, such as “the
weather is such and such, I must take medication, or if I’m going to do a certain activity,
take medication before or after I do it ... but that will come with time.”
In addition to the perceptions of being able to adjust self-management behaviours
to manage symptoms, Chris and Robert discussed hopes that insights from their data
could help them to restore their health in the instance of a flare up without the
need to take extra medication. For example, Robert described his approach to taking
medication as follows “I tend to take it when I need it, the medical professionals say
‘no you carry on with it’, but I think I know my body better than somebody writing
prescriptions”. Both Chris and Robert raised concerns about taking antibiotics in
response to exacerbations8, noting “I don’t like taking antibiotics because next time
will that antibiotic work as well as it should? ... *are* they the solution?” (Chris)
and “I don’t want it [antibiotics], personally my body can cope without it ... If it was
spreading and I can’t breathe and this that or the other, yeah then I’ll pop in and ask
for help. But otherwise I feel it’s unnecessary, that’s my personal reasoning” (Robert).
They both raised the perception that it is important to try different strategies to deal
with a flare up before resorting to taking antibiotics, as they had concerns about the
health effects and possible resistance.
8Recall that during periods of exacerbations a patient may be prescribed antibiotics, as discussed in
Chapter 2, section 2.1.1, pg. 17.
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6.4.3 Healthcare Professionals’ Experiences
The HCPs noted that patients engaged well with the app, even approaching the HCPs
at the PR classes saying “’I’ve filled my app out today’, they wanted to tell you about
it, ’I’ve had two good days!”’ (AP2) and that at the time of the interviews with
the HCPs, they noted “the reports that we are getting in now show they are still
filling it in” (AP2). The following sections describe the key themes which arose
from the analysis of each interviews with the HCPs (NURSE, PHYSIO, AP1, and AP2)
where they reflected on their experiences on the study. There were five main themes
identified from the thematic analysis: (1) ‘concerns around failure to act’; (2) ‘concerns
around overreacting’; (3) ‘misalignment with local practice’; (4) ‘opacity of the app’s
algorithm’; and (5) ‘blurring of role boundaries’.
6.4.3.1 Concerns Around Failure to Act
The simple action of receiving patient-generated data around daily symptoms created a
feeling of a “professional obligation to act on that [data]” (NURSE) for the HCPs, which
is “one of the issues with that sort of data” (PHYIO) that is sent to HCPs remotely and
“there’d be the expectations that you were checking it” (PHYSIO). They had perceived
themselves as implicitly accountable for taking immediate action based on the weekly
reports that they were sent.
This led to them disengaging with viewing the reports after the second week
of the first patient being enrolled, and would only access the data if “somebody rang
in and then we could refer to it and have a look at their data”9 (PHYSIO) or “when
we’ve got time really ... [as] every bit of our day is planned up” (AP2). This arose from
concerns that patients may depend on them to immediately detect and subsequently
act on any signs of health decline surfacing from the data. NURSE highlighted the
9They informed the patients of their decision to do this.
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difference between telemonitoring and the app, which was “more a self-management
tool”, yet receiving the patient-generated data on the app blurred the boundaries
between telemonitoring and self-management and made them feel that they “should
be” checking the data consistently.
For example, NURSE mentioned that if the reported data “doesn’t go anywhere
[i.e. automatically to the Community Care service]” then it better facilitates self-
management as the patient is “responsible” to make necessary contact with their
healthcare team and could optionally share data at that point. This was echoed by
AP1 who felt that if the data is being sent to the HCPs then there must be some sort
of action required on their behalf: “it’s like doing somebody’s blood pressure and it
being raised and not acting on it, isn’t it? It’s like what is the point in having done
the blood pressure in the first place if you’re not going to do something with that
information?” Whereas AP2 described viewing the weekly data and seeing that one
patient had not input for a few days, and had “wonder[ed] why they’ve not filled it in”
and felt that it could be a cause for concern, but when contacting the patient they had
been “struggling logging in” to the app, hence the lack of entries. AP2 highlighted that
the potential concerns around missing reports is “something to think about” in future
discussions around how HCPs should respond to missing data entries, as it could lead
to HCPs needing to make contact with the patient. This was noted as being unfeasible
at scale, and even with the four patients on the study, was “generate[ing] more work
for the team” (NURSE) which the app was meant to alleviate.
6.4.3.2 Concerns Around Overreacting
The HCPs voiced how continuous symptom monitoring using only subjective scoring
could lead to both themselves and patients overreacting to the data. For example,
it was highlighted that breathlessness was rated by the patient subjectively on the
app without any objective measurement, such as a pulse oximeter reading. This had
implications for the consistency of the patient-generated data as a whole. PHYSIO
noted that two patients with similar levels of breathlessness “could give you two
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completely different answers” when being asked to rate “breathlessness from one to
10” as “their perception of how unwell they are is very different and that effects things”
and “that could lead to us needing to visit more patients which isn’t a bad thing but
then that increases demand on service because that patient doesn’t have the equipment
to check their own [vital] signs” (NURSE).
It was further noted by the other HCPs that it is not uncommon for COPD patients
to mistake feelings of breathlessness as a flare up of their condition. For example,
patients may perceive breathlessness caused by anxiety or tiredness as a worsening
of their COPD symptoms, and it is important to distinguish “are they feeling not so
good today from a medical point of view or an anxiety point of view ... they might have
seven bad days but they are not unwell, that’s just their condition ... what distinguishes
from a bad day when you’ve got a long-term condition?” (AP2) and “something that
would allow some sort of identification of baseline” (PHYSIO) would generate more
reliable data, or justification of the rating such as “if there was an opportunity where
they could say ‘increased sputum’ or ‘shortness of breath on exertion’ you know there
doesn’t have to be war and peace, just something to justify the X” (AP1).
When this distinction was faced in regular clinical practice, the nurses would
coach the patients over the phone to better recognise the root cause of their breath-
lessness and reassure them that they are not experiencing a COPD exacerbation
because “using an inhaler isn’t going to help somebody who is anxious” (AP1). How-
ever, the app relied solely on the patients’ subjective measure of breathlessness and
would label the day type accordingly. The HCPs would not be able to distinguish the
cause of the breathlessness from the data alone, and felt accountable to immediately
follow up with the patient.
Moreover, it was noted that the suggestions from the app may further cause
patients to believe they are exacerbating, which can be “quite a frightening thing”
(PHYSIO) and may trigger “more anxiety” to the patient (PHYSIO). For example, AP2
noted that the app would still reflect that the patient may be exacerbating when they
are recovering from a recent exacerbation as “it takes longer to recover, so if they are
then putting in more bad days but they’ve just been on treatment, would it then say
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you need more treatment when actually they’re just having bad days because they have
an infection?”
In addition to this, NURSE and AP2 reflected on how the app was reported to
use the term Ventolin (the brand name of the inhaler medication Salbutamol), which
caused confusion as one patient phoned Community Care concerned, stating “it’s
telling me to take my Ventolin but I don’t have Ventolin, I’m on Salbutamol, so do I
need this new inhaler?” (AP2) and having to tell the patient “no, actually what you are
on is correct, it’s just using a different [drug] name” (AP2).
6.4.3.3 Misalignment with Local Practice
The daily recommendations that were generated by the app were highlighted by HCPs
as lacking alignment with the “model of management” (PHYSIO) in their local Com-
munity Care practice. They noted how the app provided generic management advice
to patients, when their approach was to “individualise care” (PHYSIO) depending on
patients’ lifestyle, condition stage, and particular needs. PHYSIO expanded on this
by stating the advice from the app was “too simplified” and that “there’s [national]
guidelines but that will be implemented individually to the patient”.
For example, advice on frequency of inhaler10 use was noted as being specific
to each individual patient, where they “would be advised on an individual basis in
what circumstances to take their inhalers” (PHYSIO) with some patients “advised to
use them on a regular basis” (PHYSIO) and some advised to “use them when needed”
(PHYSIO). Additioally, “somebody might take one puff twice a day of a particular
inhaler” (PHYSIO) and “another person will have two puffs twice a day” (PHYSIO) and
“you can’t give standard advice even about that” (PHYSIO).
10Be reminded that the app might suggest for the patient to increase their inhaler usage when
reporting certain symptoms (see Figure 6.5 (F)).
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Therefore, PHYSIO noted “I’ve got a reluctance or scepticism about that sort of
advice being generated by an app.” Likewise, AP1 and AP2 felt that the app focused
more strongly on medication specific actions when “there’s not always a medical so-
lution, it could be a therapeutic one initially [before resorting to increased medication
use]” (AP1) such as asking the patient “have you tried your breathing techniques?”
(AP1) or “the use of different [body] positions” (PHYSIO) before “just relying on medi-
cation” (AP2). It was acknowledged that the app did provide therapeutic tips with daily
reports, but these were not presented as headline actions for the patient (whereas the
medication suggestions were, see Figure 6.3 (A)). Whereas NURSE was concerned
that the app suggested to patients that they may need to take antibiotics11, and could
result in patients who have rescue packs12 at home who might “initiate that treatment”
too quickly at the app’s suggestion or “patients who would go ‘alright I’ll go get some’
[medication]” (AP2) and visit their GP. The challenge associated with the misalign-
ment of the app’s advice and local practice led to a patient calling Community Care
to establish which guidance to follow. As such, HCPs had to verify which advice to
follow. This was thought to be “doubling up on work” (AP1) that HCPs have to do, and
causing the potential for patients to get “confused” (NURSE) about their management
advice.
6.4.3.4 Opacity of the App’s Algorithm
The HCPs also raised concerns around the opacity of the algorithm used to generate
the daily suggestions to patients. NURSE highlighted that as “we [Community Care]
weren’t involved in that process” of designing the algorithm and agreeing on “the
11Recall that this would be suggested on a ‘flare up day’.
12A rescue pack is a small supply of steroids and antibiotics that COPD patients keep at home for
use when a flare up occurs. Whether a patient is issued them or not is at the discretion of the HCP and
local practice guidelines.
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wording” of the recommendations, they were less “confident” in the daily suggestions
and as such, less confident in recommending the app to patients. Likewise, PHYSIO
described that being part of the design of the app would make “you more engaged
[with it] because you’ve actually got a stake in it, you’ve been involved in the setting
up” and can vouch for its validity and robustness.
AP1 and AP2 acknowledged that the app was created by HCPs but stated that
“we don’t know what the algorithm is or what it does” (AP1) and queried “when was
that algorithm developed? Is it [based on] old information?” (AP1). Their concern was
that “advances in medical science” (AP2) may not be reflected in the app, as “everything
has changed, inhalers have changed haven’t they? Techniques have changed” (AP2)
and they were uncertain that the algorithm was kept “up to date” (AP2).
For AP1 and AP2, knowing what HCP had developed the algorithm and knowing
“it had come from someone related to respiratory” (AP2) with “a specialism” (AP1)
would have given them “more confidence in it” (AP2). It was clear that as the HCPs
were not aware of how the algorithm worked and what evidence it was based on,
their confidence in its outputs were compromised. Moreover, a lack of confidence in
how the app works meant that that HCPs “are going to be less confident in promoting
it to patients” (PHYSIO), and “if we’re going to do something like this in future, then
that would be the first thing to make sure everyone is fully on board because then if
they are they’re confident promoting it to patients” (PHYSIO).
6.4.3.5 Blurring of Role Boundaries
One notable problem (faced mostly by the assistant practitioners) was having to
answer patient queries about the app, both technical and medical. For example,
as AP1 and AP2 were primarily involved in patient recruitment for the study, when
patients faced a problem with their daily suggestions or using the app, they would
call or approach them specifically for help as “in their mind the only person to contact
would be us because we recommended it [the app] ... [they presumed] we’ve created
it and if there was a problem we’d sort that out” (AP2). This was an unintended
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consequence of the study, and patients were made aware initially that they should
contact the app company for all technical enquiries (e.g. difficulties logging onto the
app or using the app). However, one patient approached AP2 for support logging into
the app, noting “obviously we would always help them, but when they couldn’t log
in, and stuff like that, that was nothing to do with us, but then we ended up helping
them with that”, which was challenging as “it’s more work for us ... we’re already
stretched.”
Patients were also asking the assistant practitioners for medication advice over
the phone, which was challenging as assistant practitioners are not “not medication
trained” (AP2) and “luckily there was a staff nurse next to me” (AP2) to answer the
patient’s question, but there “needs to be more defined boundaries as to who is
responsible” (AP1) to reassure patients over the phone and answer their queries.
Overall, with having to deal with technical questions about the app and advice on the
daily suggestions created a situation with the assistant practitioners where “something
that necessarily wouldn’t be our role had turned into our role” (AP1). AP1 argued
that to support such an app in future practice, a HCP that is qualified in providing
medication support will need “protected time to go and review the data”, whereas
NURSE supported this viewpoint by stating that it needs to be clear what type of HCP
is suitable “to interpret that data” generated by the patient.
6.4.4 Patients’ Experiences
The following sections combine the data from the interviews with patients (which
occurred after 30 days of them using the app) and the phone calls with them (which
occurred approximately 14 days into their use of the app). A total of eight themes arose
from the thematic analysis, which were condensed into five themes: (1) ‘engaging
with self-monitoring’; (2) ‘personalising questions and suggestions’; (3) ‘applicability
of questions and suggestions’; (4) ‘uncovering insights in reported data’; and (5)
‘monitoring as a safety net’.
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According to the data from the app company, the levels of engagement from
the patients during the 30 day period were as follows: Petros monitored 25/30 days,
Robert monitored 30/30 days, Lia monitored 29/30 days, and Chris monitored 27/30
days. These can be considered relatively high levels of engagement. Recall that Petros
and Lia monitored beyond this 30 day period, as they were voluntarily continuing to
self-monitor up until their final interviews. Therefore, although the original aim of
the study was for patients to recall their experiences of self-monitoring for a period
of 30 days, their experiences detailed below are indicative of a longer period of
engagement.
6.4.4.1 Engaging with Self-Monitoring
Patients reported a positive overall experience using the self-monitoring tool, but
noted that the process “would bring more benefit” (Lia) and be more “valuable” (Lia)
during more challenging periods, such as during bad weather or flare ups. All patients
described filling in the app once they “felt it was right to fill it in, as to what my
expectations of the day was or has been, rather than just going through the process of
filling it in” (Robert). Patients described needing time “to let the whole day pass before
you can really judge [your symptoms]” (Lia) and think “about it, what I’d actually done,
what I’d actually achieved” (Chris) to provide a true indication of the day. This meant
that patients typically filled in the app in the late afternoon or evening. However, for
Petros and Robert, when they filled in the app did vary depending on the severity of
their symptoms. For example, Petros reported that when his symptoms are bad that
he will fill the app in at a later time, as he would be too preoccupied dealing with
his shortness of breath. Whereas Robert reported the opposite, stating that if he felt
particularly symptomatic he would be reminded to fill the app in “very early”, and use
the suggestion to plan his day.
There were occasions where patients forgot to record their symptoms on the
app, and suggested the use of reminders to help them to remember. Periods when
patients forgot to fill in the app were usually during busy days and holidays, where
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they “had better things to do” (Lia) than take their mobile phones out and reflect on
their condition. The ability to provide delayed reports was perceived as useful so that
patients could return to the app once they had remembered, which all patients had
experience of doing. However, for Petros, he had not filled in the app for one week
due to being acutely unwell and having a respiratory related hospitalisation. He had
highlighted that completing reports retrospectively when unwell was challenging, as
“you’ve got to remember what it was like... what did I take [medication wise]?” on
the previous days, and “if you’ve not done it for a few days, then you don’t remember
what you were last like”, and as he “lapsed so much, it affected how much I used it”
as it was difficult to pick up where he had left off.
6.4.4.2 Personalising Questions and Suggestions
All patients described that they would prefer more personalised questions to be asked
by the app, with a strong emphasis on personalised feedback in the daily suggestions.
For some patients, desire for personalisation seemed to become more apparent as their
time on the study increased, as Petros described how “at first it met my expectations
but as I said you don’t get any personalised feedback ... I started filling it in and it was
okay, but then I just found it a little bit laborious for one thing, you’re putting the same
thing [each day]”, while Chris stated “it just needs more answers in there [in the daily
suggestions] that say ‘well stop doing this!’ That becomes a bit more personal then,
doesn’t it?” Robert described how “a generalised app would be mundane” and that
he wanted “an app for Robert, not for Mr X”, that is “reactive” and not “pre-written
and one message applies to all”, but in the same way that “the conversation we are
having now is a reactive conversation, I’m making a statement and there’s a response
forthcoming, and the whole response is relevant”.
One of the main reasons that personalised questions and feedback was felt
to be important was due to the fact that COPD “gradually gets worse, so the app
needs to be personalised and change, and help people manage their condition so it
doesn’t get worse” such as “whereby the app would recommend this person is on
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such and such of a dosage, that would indicate how bad that particular person is and
it would be geared towards that” (Robert). Whereas Lia, Chris and Robert noted that
COPD symptoms are heightened under certain circumstances, such as being exposed
to “alternate surroundings or atmospheres” (Lia) or the “weather ... if it’s damp or
wet outside” (Chris), and certain “activities” (Robert), which should be factored into
the daily questions and subsequently the daily recommendations. One way that the
suggestions could become more personalised and useful is “filling it in twice a day
... when you start your day off ... then you would fill it in again, and it would review
whether it was correct or not and it makes self-improvements” (Robert). By doing this,
the app may begin “predicting what kind of treatment or activities I should be doing
for that particular day” (Robert), or say “look you’re still poorly, call an ambulance, or
call your COPD nurse or specialist, you can perhaps help yourself a bit more better”
(Chris) as Chris’ wife mentioned “it’s no good saying with him sit down, because that’s
what he’s doing most of the time anyway”.
6.4.4.3 Applicability of Questions and Suggestions
Patients had some concerns about the perceived applicability of the app’s daily ques-
tions and suggestions. Lia, Petros, and Chris reported that the app’s questions, and
in some cases suggestions, did not feel applicable to them individually. For example,
Lia discussed that the question that asks about “the change in sputum colour ... that
only applies if you manage to cough it up, because that’s the only time you see the
colour, it’s quite difficult to actually say”, which meant that she could not often tell if
her sputum had changed colour in order to answer the question accurately13. She also
discussed perceiving expectoration as a positive sign for her, contrasting with how the
app portrayed it to be negative, by stating “suppose some people would describe that
13It may be the case that Lia would be expected to select that this was ‘normal’ when picking her
answer, but it evidently was not communicated clearly to her.
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as a bad day in a way, but actually it’s a good day because it’s getting rid of the damn
thing ... I’d call coughing up good not bad [discussing how the app labels this as a ‘bad
day’]”.
When reflecting on her experience of receiving daily suggestions, she recalled
the app suggesting for her to “increase [taking] two products, one I’d never heard
of” and on another occasion to phone Community Care as she may need antibiotics,
which she felt “was a bit overreacting to say the least” and she was “sensible enough
not to react to that and panic” but the app should provide explanations and “some
kind of index of jargon”. Once making contact with Community Care, she described
how one of the HCPs was “quite taken back that they’d actually said after one incident
I needed antibiotics”. This experience also resonated with Petros, who described how
reporting a small increase in any of his symptoms lead to the app to labelling him as
having a ‘bad day’, which he did not agree with and was not positive to read.
Whereas Chris felt confusion around the action-related question (‘which action
did you take yesterday?’) which asked him if he “took more nebuliser” or took “steroid
tablets” each day, neither of which he owned. He interpreted that the question was
suggesting that he should have a nebuliser and steroids at home and that he was
missing something that is part of his everyday care. He summarised this concern as “I
don’t know whether people with COPD have got steroids to take, whether they’ve been
prescribed them ... so no it doesn’t apply to me, but whether it applies to other people,
I don’t know”. Once I had explained to Chris that the question was not necessarily
an indication that he should have these things at home, he noted that “maybe the
question is correct [in being asked], but it’s not correct for me”, and wondered if by
not selecting these options (as they did not apply) it would impact his overall day type
by suggesting he had not felt the need to undertake these actions.
6.4.4.4 Monitoring as a Safety Net
Patient-generated data being shared remotely with HCPs was felt to be a valuable
safety net for patients. They felt value in knowing that HCPs could look at their data
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and see any patterns such as “two or three days, or even two or three weeks, that you’ve
been coughing badly” (Petros) or “if I was constantly putting in having problems that
obviously something would happen to help me sort that out” (Lia), and that “they’d
give you a ring to say ‘are things okay?”’ (Petros) or “whenever there’s a red flag ...
somebody would address it” (Robert).
Though Robert did not require assistance from the HCPs during the study, he
envisaged the procedure of addressing declines in health recorded by the app as being
similar to when he once took a blood test and “[the test] went to the hospital for
analysis, they say how high it was, they rang up the GP practice, and the doctor rang
me, all within four to five hours”. For Lia and Chris, they believed that having HCPs
connected to their data would help them overcome their reluctance to seek help when
it is needed. Lia reflected on a previous exacerbation which led to a hospitalisation
(before her time on the study), noting that she did not seek help because “I’m not a
complainer ... I don’t like making a fuss”. Yet she acknowledged that “that situation
would have been avoided had I had that [app] then” as “whereas I didn’t think I was
that bad, I was blue lighted into hospital” and “someone would come to see me based
on the app at that point in time”.
Likewise, Chris and his wife felt that having a HCP in the loop would help to
overcome his strong reluctance of “disturbing anyone” about his health problems. In
fact, Chris’ wife recalled that one strategy she takes to convince Chris to visit the
doctors when he is unwell is to “call the doctor to say Chris is really poorly, will you
call him and tell him you want to see him?” (Chris’ wife), so the fact that the app
is automatically connected to “a specialist” (Chris) who can get in touch could make
a positive difference to his management approach. In addition to being a safety net,
the app had a day to day benefit of being a “reassurance tool” (Robert) whereby “it
was giving me reassurance that what I’m doing is correct” (Robert) and helped in “in
deciding whether I should go and see the doctor ... [before using the app] the chances
are I would have ignored it and suffered” (Robert) and “at the end tells you to something
... it tells you if you’ve been a good boy, or you’ve been a naughty boy, or whatever
the case will be” (Chris).
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6.4.4.5 Uncovering Insights in Reported Data
An important part of the self-monitoring process was the ability to view and reflect on
any “ongoing patterns” (Lia) within the data that is collected over time. Patients felt
that, alongside weekly reports, the collected data would be useful in clinic settings with
their HCP for “analysis purposes and perhaps that would add value to my treatment”
(Robert). This could support HCPs to see “if they can diagnose that you are doing
something wrong” (Chris) in terms of self-management, and take action such as
suggesting “maybe change the inhaler”. Chris had changed his inhaler throughout the
study, and felt the app data reflected that he felt better. He felt this was particularly
important as he is often advised to have his annual COPD review “in the summer
month when you’re not on no antibiotics, you’re living a normal life” and visualising
his symptoms over time could be beneficial for demonstrating what his symptoms are
like across the year, and if “there’s too much in the red, or in the black, or in the green,
there should be a methodology of saying ‘this is what we’ve got to do”’ (Chris).
In addition to clinic settings, it was important that patients could obtain insights
into their data themselves. Lia and Petros raised the need for “a sort of picture of
a continuum” (Lia) of their “personal judgement [of their condition] based on your
own experience” (Robert), with Petros highlighting “you can only look at it day by day,
you’re not getting statistics off it” and there should be “a chart that says ‘in January
you had 15 days where you were clear and then 10 days where you were breathless or
coughing”. Aggregated insights about symptoms was thought to “give you a bit more
of an interest to use it [the app]” (Petros) as it could identify if “there was pattern as to
when as to when things got bad” (Lia) which would provide longer-term benefit.
6.5 Discussion
The following sections present a discussion on the lived experience of self-monitoring
COPD symptoms and sharing this data remotely with HCPs as observed within this
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case study. I synthesise the findings from both the patient and HCP experience,
creating three core points about: (1) ‘safety nets and accountability’; (2) ‘trusting data
and algorithms’; and (3) ‘considering local and individual contexts’.
6.5.1 ‘Safety Nets’ and Accountability
Accountability directly stems from the notion of responsibility, which has been defined
by Bivins (2006) as ‘a bundle of obligations associated with a job or function’, including
moral and professional obligations. Accountability is ‘blaming or crediting someone
for an action’. In healthcare research accountability has been explored in the context
of hospital staff addressing inaccuracies in patient records (Murphy and Reddy, 2017),
accessing healthcare data and holding HCPs accountable for its use (Gajanayake et al.,
2011), accountability for information provided by medical artificial intelligence sys-
tems (Academy of Medical Royal Colleges, 2019), and creating transparency around
cost and quality of care to patients (Hendee, 2008). This study has extended the notion
of accountability in healthcare contexts by showing how it arises when HCPs receive
patient-generated data remotely as part of the COPD self-monitoring process.
The findings from this study have demonstrated the value that patients placed
in sharing their self-monitoring data with HCPs remotely, which was perceived as a
‘safety net’ in case of health decline. This is consistent with findings in the telemoni-
toring space, where COPD patients have reported feeling comforted by being virtually
connected to HCPs (Brunton et al., 2015; Dahl et al., 2018; Nadarajah et al., 2019).
Yet in this study, the patient perception of the app as a safety net clashed with how
the HCPs were willing to engage with the patient-generated data. While the HCPs’
overall motivations to support patients to use this app was centred around improving
patients’ self-management and independence, in reality it created a situation which
resembled supported self-management. Bardram et al. (2005) described the process
of home-based monitoring as a ‘collaborative activity system’ between the patient and
the HCP, which can transform the collaborative work of both actors in the system,
having consequences for care practices and divisions of labour. The self-monitoring
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process observed within this study also embodies a collaborative activity system, as
both patients and HCPs collaborate together in the monitoring process (albeit with
contrasting perceptions of how this should be realised). We can use the concept of the
collaborative activity system (Bardram et al., 2005; Engestrøm, 1993) as a theoretical
lens to understand the effect that this double loop self-monitoring activity had on both
the patient and HCP.
Bardram et al. (2005) demonstrated how the introduction of a home-based
monitoring system for hypertension transformed responsibilities within the existing
collaborative activity system. They noted how the activity of taking blood pressure
readings transformed from an activity that is driven by the GP, to one that is driven by
the patient (a change in division of labour). In the context of this study, changes to the
divisions of labour were also observed as a result of the self-monitoring process.
However, there was a notable clash in the perceived desirability of this change.
Outside of the study’s context, HCPs perceived patients to be responsible for actively
informing them about declines in health (i.e. an activity intended to be driven by the
patient). However, remotely sharing patient-generated data created an unintended
and undesirable shift in the responsibilities of care (a form of labour division14). In this
instance, HCPs felt responsible, and subsequently accountable, to identify declines in
patients’ health based on the data. They also felt accountable to actively investigate
why a patient has not input their data in situations where there are gaps in data
entry. This had a notable impact on assistant practitioners, who began to take on
responsibilities which were perceived to be outside the bounds of their role, including
care responsibilities (taking phone calls from patients querying medication suggested
by the app) and technical activities (helping patients with difficulties using the app).
However, as the assistant practitioners were the ‘familiar face’ that recommended
the app and who patients saw during PR classes (where the study was advertised),
14This can be thought of as a see-saw effect, when the perceived responsibilities of the patient
within the self-monitoring activity decreases, the perceived responsibilities of the HCP increases (and
vice-versa).
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questions were directed to them.
This concept of shifts in responsibility of care has been explored by Nunes and
Fitzpatrick (2015) around how patients and carers collaborate for self-care. They noted
that carers may begin to perform a larger share of self-care activities as the patient’s
condition advances (thus their ‘share’ of the division of self-care increases). Here,
I highlight unwelcomed shifts in responsibility of care between the patient and the
HCP arising from the introduction of a new mediating technology. This undesirable
consequence has been observed in previous research into double loop technologies
for monitoring of bipolar disorder (Bardram and Frost, 2018) and telemonitoring in
COPD (Brunton et al., 2015; Fairbrother et al., 2013). Though they did not explore or
unpack concepts of accountability and shifts in responsibility explicitly, Bardram and
Frost’s (2018) work reflected on how patients believed monitoring their symptoms
was useful, as it was tied to the belief that HCPs would be monitoring the data and
acting as a ‘life jacket’ (pg. 181). In practice, they found that this could not scale to a
large number of patients and became challenging for the nurses who were reviewing
the data.
Whereas research by Fairbrother et al. (2013) briefly noted how the process of
telemonitoring created a situation where COPD patients actively relied on HCPs to
be responsible for managing the patient during periods of illness (particularly patients
that were severely unwell). In my study, the patients were not deemed to have severe
COPD and there were no reports that patients had actively deferred responsibility
to HCPs (although patients had noted that a benefit of the app would be that HCPs
could notice health declines). Instead, HCPs felt that shifts in responsibility were
inherent and implied through the nature of receiving patient-generated data remotely.
Unlike traditional telemonitoring, there were no pre-established agreements within
this study where HCPs would be jointly responsible with the patient for actively
detecting exacerbations. This observation highlights how remotely receiving patient-
generated data can give rise to accountability concerns that create an undesirable shift
in responsibilities of care. Until now this observation had only been explored in the
context of telemonitoring for COPD.
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Previous work has explored how boundaries can become blurred in HCPs’ work
due to technology that mediated contact between them and patients (Brunton et al.,
2015; Cheng et al., 2015). Cheng et al. (2015) discussed how professional boundaries
became blurred during a mobile trial that sought to integrate patient-generated data
about preterm infants and their parents into the clinical workflow. They described how
clinical support staff had prominent concerns over liability and responsibility related
to giving health advice about preterm infants during the trial, as the HCPs were not the
primary caregivers for the infants which they received data about. Whereas Brunton
et al. (2015) also discussed blurred responsibilities, however, this was in the context
of HCPs being required to undertake technical tasks to support COPD telemonitoring.
They discussed how studies about COPD telemonitoring showed that there was an
increase in HCPs having to undertake technical tasks, such as setting up equipment in
the patients’ home and investigating equipment failure. These findings about blurring
the boundaries of work by Cheng et al. (2015) and Brunton et al. (2015) draws parallels
with my study, as assistant practitioners began to take on the roles of the medical and
technical ‘advisors’, helping to clarify app recommendations to patients and resolve
technical problems. It is important to acknowledge how undesirable changes to the
HCPs’ role can arise when supporting remote monitoring contexts. These role changes
do not just increase work for HCPs, but also creates tension as the HCP reluctantly
becomes responsible for new activities. These changes can impact how willing a HCP
is to accept and support particular interventions.
6.5.2 Trusting Data and Algorithms
Previous work has noted a plethora of challenges raised by HCPs about using patient-
generated data within, and outside of, clinic settings. For example, challenges relating
to how HCPs interpret patient-generated data captured from a multitude of differ-
ent devices (Abdolkhani et al., 2019; West et al., 2016, 2017) and in different for-
mats (Chung et al., 2015), interpreting the meaning of this data more generally (Kim
et al., 2017) especially sporadic entries (West et al., 2018), finding adequate time to re-
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view patient-generated data within and outside of clinic (Chen et al., 2014; Schroeder
et al., 2017), and tensions around what patients want to track versus what HCPs
believe is meaningful to track (Zhu et al., 2016). My research has uncovered how
subjectivity in patient-generated data, paired with the perceived opacity of the algo-
rithm15 used within the app, created trust concerns for HCPs. HCPs felt distrustful
of the patient-generated data for two reasons. The first reason was because the daily
reports were created using patients’ ‘subjective’ perceptions of each symptom mea-
sure. The second reason was because there was a lack of clarity about how the app
generated the daily suggestions to give to the patient. It was also observed that some
patients began to question the applicability of the questions and daily suggestions,
calling for personalisation capabilities.
6.5.2.1 Trusting Subjective Patient-Generated Data
Concerns around the subjectivity of patient-generated data and how this impacts clin-
ical reliability is not a new concept (Bardram and Frost, 2018; Kaptein et al., 2009;
Mohan and Sethi, 2014; Troosters et al., 2013). For example, it has been observed
that there is a difference between actual activity levels and perceived activity levels
in COPD patients (Pitta et al., 2005; Troosters et al., 2013). This demonstrates how
relying on patients’ perceptions of their behaviour and symptoms may not produce
clinically reliable data16. Although previous COPD clinical trials have used symptom
diaries and scores which rely on patients’ own judgement of their symptoms (Casanova
et al., 2015; Ghobadi et al., 2012; Leidy et al., 2011, 2014), this data is not specifically
15Recall an algorithm was used to categorise the patient’s day type according to their data entries
and provided suggestions for management.
16I do not argue that patients’ perceptions of their condition is not important. I argue that perceptions
may differ from reality, and depending on the context, this can create challenges for using the patient-
generated data for decision-making.
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designed for remote monitoring purposes. Where data is captured for remote moni-
toring of COPD, telemonitoring studies have employed ‘objective’ measures that aim
to mitigate the concern around reliability (Sanchez-Morillo et al., 2015; Tabak et al.,
2012; Velardo et al., 2017).
For example, to mitigate variability in patient-generated data, Velardo et al.
(2017) used pulse oximeter readings alongside self-assessed breathlessness ratings
for remote monitoring of COPD. Whereas Sanchez-Morillo et al. (2015) dealt with
variability in patient-generated data by calculating a three day moving average of the
latest entries, which is then given a score that is presented to HCPs. In this case study,
the HCPs felt strongly that rating breathlessness without any objective measures and
additional context could present a potentially misleading account of the patient’s
condition. The HCPs knew that the experience of breathlessness can be inherently
subjective, and can be influenced by factors such as anxiety or fatigue (Bailey, 2004;
Carel, 2018; Heinzer et al., 2003; Maurer et al., 2008; Xu et al., 2008). Previous
work has also noted that the similarity between COPD symptoms and features of
panic attacks can make it challenging for patients themselves to properly identify
the reasoning for altered bodily functions such as breathlessness (Dowson et al.,
2004a). This in itself is not the core problem as the COPD team are used to helping
patients manage their breathlessness regardless of how it arises. However, in remote
monitoring settings when the patient is absent, navigating ambiguity in the data can be
challenging (Andersen et al., 2011). This can be contrasted with clinic settings where
the patient and HCP can collaboratively interpret the patient-generated data (Mentis
et al., 2017). As the app relied solely on subjective assessments of symptoms, there
were concerns that the HCPs and patients may overreact to the data when the app
labels the patient as having a ‘bad day’ or ‘flare up’. Overreacting in this context refers
to perceiving a patient to be more unwell than they clinically are, and subsequently
acting on this perception.
Previous studies in telemonitoring contexts have shown that COPD patients have
consciously opted to under-report their symptoms to avoid ‘burdening’ HCPs (Dahl
et al., 2018). Patients also noted under-reporting their symptoms in situations where
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they were unsure how their current symptoms compared with their usual base-
lines (Dahl et al., 2018; Nadarajah et al., 2019). This can lead to underreacting,
in other words, perceiving a patient to be in better health than they clinically are.
As patients may not have medical backgrounds, they can be led to a false sense of
security if the app provides incorrect information based on them under-reporting. Un-
derreacting can also occur in situations when algorithms mistakenly provide incorrect
information to the patient (i.e. not as a result of the patient under-reporting their
health) (Becker et al., 2014; Wolf et al., 2013). As shown, underreacting can occur as
a result of the way a patient reports their data or as a flaw in the algorithm. However,
my study has highlighted the concept of unintentional overreacting due to subjectivity
in patient-generated data, and the subsequent impact this can have on patients and
HCPs.
In my study, due to the uncertainty around the reported symptoms which are
remotely shared, the HCP would have to make contact with the patient for clarifica-
tion. This has implications for what Bardram and Frost (2018) described as ‘social
scalability’, a feasibility dimension of technology deployment that must be consid-
ered alongside technical scalability. When Bardram and Frost (2018) introduced this
term, they were discussing the challenges that nurses faced when reviewing remotely
received patient-generated data about bipolar disorder. They discussed the ways in
which nurses were uncertain about how they should act on the data, as how patients
rate their mood can vary considerably. They observed how nurses felt they needed to
know each patient’s context to support data interpretation, which has significant chal-
lenges for social scalability. This demonstrates how the type of data that is collected
and its context is a crucial step to supporting social scalability of remote monitoring
contexts. Though these factors are also important for interpreting patient-generated
data in clinic settings (West et al., 2016), the absence of the patient in remote moni-
toring contexts magnifies this challenge.
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6.5.2.2 Trusting Opaque Algorithms
In addition to the challenges of subjective patient-generated data, understanding how
the app’s algorithm functioned was another concern highlighted by HCPs. The HCPs
questioned various elements of the algorithm, including: who designed the algo-
rithm (did they have a specialism in COPD?), how the algorithm made decisions on
what to suggest to the patient (how did it convert the patients’ responses into daily
suggestions?), and how up to date this information was (was it based on the latest
clinical guidance?) The uncertainty around this made HCPs distrust the app’s daily
suggestions, particularly when the app suggested that a patient may need antibiotics,
something which both the patient and HCPs did not agree with (section 6.4.3.3, pg.
229). Hartswood et al. (2003b) and Yang et al. (2019) both discussed how users’
perceptions of the reliability of evidence that is generated by decision support tech-
nology affects their trust and acceptance for its use in practice. In Hartswood et al.’s
(2003b) work on computer assisted mammogram readings, they argued the impor-
tance of mammogram readers being aware of how the algorithm works. This would
help readers understand why the technology makes the suggestions that it does, so
that readers can better understand how to rationalise its outputs.
Whereas, research by Yang et al. (2019) demonstrated that HCPs require an un-
derstanding of how algorithms used within decision support tools have been clinically
validated and how they technically work. This was perceived as central to accepting
these tools in practice. Both studies by Hartswood et al. (2003b) and Yang et al. (2019)
highlight the importance of transparency about algorithms used as part of healthcare
technologies. This case study contributes to this understanding by demonstrating how
trust concerns arise when the algorithms used within health monitoring technologies
are perceived to be opaque. Indeed, these concerns could also arise when HCPs
make decisions about what technologies to recommend to patients for self-managing
their condition (i.e. even with single loop technology when the HCP is not part of the
monitoring process). This contribution, taken together with the studies by Hartswood
et al. (2003b) and Yang et al. (2019), uncover key requirements for researchers to sup-
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port the reduction of these trust concerns. In turn, this could support building more
trustworthy technologies for healthcare. Below I discuss two opportunities to support
HCPs to build trust and familiarity with double loop technologies for healthcare.
First, it is important to ensure that HCPs are confident about how algorithms
used in healthcare technologies function before the start of the study or real-world
deployment. This can be achieved through involving HCPs in the algorithm design.
For example, through employing participatory approaches to algorithm design, such
as human-centred algorithm design (Baumer, 2017). In this approach, HCPs would
be actively involved in designing the algorithm and deciding how it should perform.
HCPs can incorporate their expertise on the latest clinical guidance and, if necessary,
tailor the outputs towards their local practice guidelines17. Patients could also be in-
volved in later stages of this approach to assess how they understand advice produced
by the technology. Explainable artificial intelligence18 techniques should be employed
to avoid the ‘black box’ effect (Holzinger et al., 2017; Rai, 2020; Wang et al., 2019), so
that future users independent from the design process can understand the algorithm’s
decisions and outputs. For example, providing transparency about the medical guid-
ance being used to drive suggestions and how up to date this information is. It is also
important to be transparent about how combinations of symptoms are categorised
and map to management recommendations.
Second, it is important to provide HCPs with the opportunity to understand how
the algorithm works under certain conditions, with the ability to make amendments
during the development phase. This can be achieved through the team of HCPs using
the technology themselves for a short period of time before the study officially begins
(as a type of autoethnography). During this time they could input data imitating a
17Note that this could introduce scalability challenges, but the importance of understanding the local
context of clinical work and how this is relevant to design is discussed in the following section (6.5.3).
18Explainable artificial intelligence refers to methods that promote visibility about how artificial
intelligence systems make decisions and execute their actions (Rai, 2020).
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‘patient user’ and subsequently view this data as the ‘HCP user’. Following this activity,
a debriefing session could be conducted with the researchers to discuss and unpack
any potential findings, with opportunities for amendments to the technology. This
supports building an understanding of not just what the algorithm technically ‘does’
step by step, but how this is realised in practice. Autoethnography has been used in
previous HCI studies to develop empathy for the user experience of engaging with a
variety of technologies (Bergman, 2000; O’Kane et al., 2014). However, in this context
I describe using autoethnography as a strategy to develop a deeper understanding
about how double looped technologies perform under empirical use.
Both strategies discussed above can support the better inclusion of end users
within the design of double loop technologies. This can in turn support end users to
develop stronger trust in these technologies.
6.5.3 Considering Local and Individual Contexts
Similar to how we think about generalisability of scientific work, building generalisable
healthcare technology allows solutions to specific problems to transfer across a variety
of contexts which encounter similar challenges (Briand et al., 2017). The Community
Care service within this case study will not be the only healthcare service that are
interested in how technology can support the COPD self-management process. How-
ever, the Community Care service has local practices and protocols that have been
shaped over time, which are specific to their organisation. For example, how they
organise their caseload, how (and if) rescue packs are prescribed, and how they coach
patients to better understand their own symptoms. Understanding the individual and
‘particular’ features of different users and contexts is important for designing for real-
world contexts. Bertelsen et al. (2018) argued that by making generalisable solutions
the goal of research, researchers risk losing sight of important design questions that
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occur in the real world19. This case study has highlighted the importance of appreciat-
ing the particular features of the Community Care service and COPD patients, which
has implications for the design of digital health technologies that aim to support this
space.
Hartswood et al. (2000, 2003b) argued that as technology becomes interwoven
with everyday work, the design challenge becomes less about creating tools and
more about how tools can integrate with existing and localised work practices. In
this case study, localisation and personalisation of technology was highlighted as an
important requirement by HCPs and patients. One concern that HCPs raised about
the daily recommendations provided by the app was their standardised nature, which
contrasted with Community Care’s individualised and localised approach to patient
care. Individualising patient care is an important approach to better consider how
unique and contextual factors about a patient are relevant to how they are cared
for (Weiner, 2004). This contrast was evident when the advice from the app was felt
to have conflicted with what the HCPs had advised the patient in the past (such as
increasing inhaler usage and suggestions around antibiotics). As a result, the HCPs
became distrustful of the app and its recommendations.
Storni (2011) explored the notion of conflicting health information during their
study about diabetes self-care. Storni noted that the variety of people involved in
a patient’s life (such as family, friends, support group members, online mentors,
etc) may offer suggestions and advice about a patient’s condition. The challenge
for the patient is that information from different sources does not always align and
can cause the patient to feel conflicted. While Storni (2011) raised an important
point about how people can be sources of conflicting health information, this case
study highlights how self-management technology can be the source of this conflict.
This is particularly challenging when technology is being designed to support the
19Note that Bertelsen et al. (2018) do not suggest research on the particular is mutually exclusive
with generalisability.
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self-management journey, as these technologies should be perceived as reliable and
safe sources of support and information. If self-management technologies provide
health information that conflicts with advice from HCPs, this could cause patients to
make decisions or hold beliefs about their condition which are inaccurate and possibly
harmful. It is important to note that there were no instances of patients being exposed
to harm in this study. However, the concerns about technology providing information
that conflicts with the advice of HCPs makes this an important point to raise.
Patients raised a need for more personalised solutions to self-monitoring that
applied to their individual context. They expressed that a more tailored and adaptive
approach that can learn about users could better support effective self-management.
In fact, a lack of personalisation can render the app useless for some patients due to the
lack of individual applicability. This was observed with one participant who noted that
the app’s suggestions were not always helpful for the patient: “it’s no good saying with
him sit down, because that’s what he’s doing most of the time anyway” (Chris’ wife,
section 6.4.4.2, pg. 234). Whereas there were also instances where patients felt the
questions were not relevant to their situation, or that the suggestions from the app did
not align with how they preferred to manage their condition (recall that some patients
raised concerns about using antibiotics as a first resort, see section 6.4.2.2, pg. 224).
Without some level of personalisation, the app can only produce suggestions based
on hard coded assumptions about the patient’s capabilities, needs, or circumstances.
As experienced, these assumptions can be incorrect and subsequently influence the
perceived usefulness of the technology.
Axelrod et al. (2009) emphasised the importance of considering the real lives of
people living with a certain condition when designing technology to support them.
Their study focused on assistive technologies to support people who have had stroke.
They highlighted the importance of dismantling the utopian vision of how users will
engage with assistive technologies for stroke, by taking into account the lived reality
of people who have suffered from stroke. They discussed the importance of personal-
ising approaches to assistance that take into account the person’s physical needs and
motivations to best embed support into their lifestyle. Similarly, Storni (2011) dis-
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cussed the challenges of designing universal solutions to diabetes self-management, as
these solutions do not consider the individual circumstances and lives of each patient.
In response to this challenge, Storni (2011, 2014) created a system to support dia-
betes journalling which allows patients to personalise the data they track. The system
involves patients creating ‘tags’ to track data about their different self-management
practices. The findings from both Storni (2011) and Axelrod et al. (2009), paired with
the findings from my case study, present a strong case for self-management technolo-
gies to better support personalisation. I discuss two opportunities for self-management
technologies to support personalisation for patients with COPD below.
The first opportunity for self-management technology to support personalisa-
tion is through providing customisation. Technology that allows individual patients
and their HCP to collaboratively customise and tailor the technology to the individ-
ual patient’s needs and circumstance may be promising. A similar approach was
used in previous research around personalisation of self-management technology for
autism (Simm et al., 2016). In their work, adults with autism were able to physically
and functionally customise wearable technology bracelets that collected data about
anxiety to support self-management and reflection. The technology was built with
the intention for it to be customised at the user’s end to support individual needs.
This approach could help to mitigate patients’ concerns that there is a “one message
applies to all” approach to support (Robert, section 6.4.4.2, pg. 233). In addition
to supporting customisation for individual patients, customisation capabilities could
also be offered to HCPs to support localisation. For example, HCPs could be offered
the opportunity to tailor the information provided by the app to align with their local
healthcare practice. One way this could be achieved is through block based program-
ming approaches, which allows users to customise the functionality or outputs of the
app (see an example in Figure 6.4). Block based programming approaches have been
used in previous work to teach people how to program, making it an effective way
for technology non-experts to tailor the functionality of technology (Dasgupta and
Resnick, 2014; Maloney et al., 2010; Weintrop and Wilensky, 2015).
251 6.5. Discussion
In this example the HCP can customise the messages and thresholds for the patient. This image was
created using Scratch (https://scratch.mit.edu).
Figure 6.4: An conceptual example of using block based programming to customise the
functionality of self-management technologies to support localisation and individualisation.
The second opportunity for self-management technology to support personali-
sation is by learning about the patient over time. Artificial intelligence techniques, for
example, could support building a stronger and more individualised understanding of
the patient’s capabilities and limitations. This would ensure that the technology pro-
vides individualised support to patients and does not suggest actions that are beyond
the bounds of what can be achieved. For example, patients could specify their condi-
tion stage or capabilities (which should be modifiable as the condition changes over
time), and this information should influence the management suggestions that are
provided by the technology. It is important to note that as technology supports COPD
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patients in self-managing their condition, the way that potential declines in health
are visualised by the technology must be communicated sensitively (Lupton, 2013;
McNaney et al., 2015). As we envisage technology that could adapt to patient’s needs
and capabilities, it is likely that declines in health may be reflected by the technology,
as COPD is a progressive condition.
Both opportunities described above can help to support building and customis-
ing double loop technologies for COPD care. However, these opportunities could
extend to other digital health technologies that support patient monitoring and offer
self-management advice. Through offering stronger personalisation for patients and
localisation for healthcare services, these technologies can improve the value they offer
for COPD care. This could also contribute to the sustained use of these technologies
in practice.
6.6 Study Limitations and Reflections
An important limitation about this study relates to the extend to which the findings can
be generalised. There was a total of eight20 participants (four HCPs and four patients)
with a total of 18 data items (1 focus group, 12 interviews, 4 phone call discussions, 1
set of summarised app engagement statistics on each patient). Though the sample size
is small, my intention is not to argue that the findings will apply to every instance of
patients sharing data remotely with HCPs. Instead the study has taken an exploratory
approach to document the real-world lived experiences of using an mHealth app to
self-monitor and share data about COPD symptoms. Through doing so I have been
able to devise rich conceptual and empirical findings that can inform future work in
this space.
20There were nine participants if participant Chris’ wife is included as a participant. However, she
was not involved in the same way as the other eight participants.
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Moreover, Crabtree et al. (2013) have argued that the underlying social arrange-
ments of interaction can serve as a basis of generalisability across a cohort – even in
single cases. The collaborative monitoring process in this study can be considered as
a form of social arrangement between patients and HCPs. Through situating my find-
ings within previous literature on self-monitoring, I have built a case that prepares my
insights for potential transferability across cases of similar research (Yin, 1994). The
in-the-wild approach for this study adds to the study’s ecological validity, enhancing
their reliability (Flyvbjerg, 2006). Therefore, I argue this research provides valuable
insights despite the sample size being small.
A second important limitation is the self-selection bias with patient recruitment.
Recruitment was a significant challenge for this chapter. The patients who participated
had an interest in exploring how technology could support their self-management.
Moreover, they were recruited from the PR programme. It has been shown that lack
of motivation, lack of confidence, and perceived limited benefit of PR are among some
of reasons why patients drop out of PR — or decline the intervention altogether (Fis-
cher et al., 2009, 2007; Keating et al., 2011). Therefore, by recruiting from PR, I was
already selecting from a patient sample that were motivated and engaged with the
Community Care service. This means I do not capture the perspectives and experi-
ences of those who may be less confident or motivated to self-manage their condition
using technology. This should be taken into account when interpreting the study
results.
Finally, I wish to reflect on a practical ethical challenge relating to returning
loaned smartphones at the end of the study. Participant Chris was loaned a smart-
phone for the study and reported enjoying the process of self-monitoring, feeling that
it was positive to his self-management. As per the study protocol which Chris con-
sented to, he was required to return the smartphone at the end of the study. This
meant he could not continue using the app after the study (unlike the other patient
participants who had their own smartphones). As part of their focus on practical
ethical concerns that arise with research in-the-wild, Race et al. (2020) and Taylor
et al. (2013) discussed the challenges associated with taking equipment away from
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communities that have participated in research. Taylor et al. (2013) highlighted the
importance of expectation management and making it clear at the beginning of the
study if the participant will be able to keep the study equipment.
I had made Chris aware both verbally and in writing before he consented to
the study that the smartphone would need to be returned after the study — and
he understood this. Chris had no problems returning the smartphone to me but
expressed feelings of disappointment about no longer being able to participate in a
process he found valuable. Likewise, I felt as though I was taking away a valuable self-
care practice from him. Though it is not always possible for participants to keep study
equipment, researchers should consider gifting the study equipment to participants
(where safe and possible) to avoid any disappointment around the conclusion of the
study. If it is not possible, other ways to provide value back to the participant should
be considered. For example, providing them with hard copies of visualisations of their
health data that they can use after the study21.
6.7 Chapter Summary
This chapter explored the lived experiences of self-monitoring COPD symptoms and
sharing this data with HCPs. I examined the experiences of four patients who self-
monitored their symptoms using an mHealth app for 30 days, and four HCPs who
were sent the symptom data. First, I conducted a focus group with two senior HCPs to
understand their motivations for introducing a self-monitoring app onto their service.
Then, four patients were recruited onto the study and participated in interviews. The
interviews scoped their motivations for using a mHealth app to self-monitor their
symptoms and share this data with HCPs. After this interview, the patients began
self-monitoring their symptoms. Approximately two weeks into the process, I phoned
21I was unable to do this, as I did not have access to patients’ personal health data from the app.
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patients to check in on their experiences. After 30 days of self-monitoring, I conducted
final interviews with patients to understand their experiences on the study. After each
patient completed the study, I conducted interviews with all four HCPs to understand
their experiences of receiving patient-generated data on the study.
The findings uncovered the challenges and opportunities involved when using
self-monitoring technologies for COPD and sharing symptom data remotely. This
included: highlighting tensions around safety nets and accountability (where pa-
tients and HCPs had conflicting perceptions about sharing symptom data remotely
as part of COPD care); HCPs’ concerns about using COPD symptom data that is
perceived as too ‘subjective’; the requirement for digital health technologies to offer
greater transparency and explainability about how their algorithms work; the need for
self-monitoring technologies to localise their management suggestions to the health-
care services which support its use (otherwise conflicting advice may be given to
the patient); and the importance of self-monitoring technologies offering person-
alised approaches to self-management that support individual patients’ needs and
contexts.
The next chapter presents an overall discussion on the findings from each re-
search chapter (4, 5, and 6). It synthesises the research findings to draw out the
main contributions of this thesis about the role of data supported decision-making





The previous three chapters explored the role of data supported decision-making
(DSDM) technology for respiratory care with healthcare professionals (HCPs) and
people with Chronic Obstructive Pulmonary Disease (COPD). This chapter provides
an overall discussion on my contributions to knowledge, drawing on the findings
from each research chapter. First, I review the original aims of this thesis and out-
line how I explored them. Then I present a discussion about my key contributions
across all research chapters, comparing and contrasting them with pertinent related
work. Finally, I conclude this chapter by providing a brief summary of how my over-
arching contributions can be positioned within the current state of knowledge in this
space.
7.1 Review of Research Aims
The role of DSDM technology in healthcare is an increasing area of interest in medical
and computer science research, particularly as we enter an age of advanced technolo-
gies, big data collection, and a growing global population with various health needs.
This thesis was driven by the need to explore how DSDM technologies could support
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the care for people with COPD. It was important to explore this from the key per-
spectives of people with COPD (who live with the condition each day) and respiratory
HCPs (who provide ongoing care for people with COPD). Including both perspectives
builds a strong understanding about the possibilities for DSDM technologies to sup-
port chronic respiratory care — both now and in future. To do this, I went beyond
simply involving people as ‘users’ in requirements gathering phases of research about
DSDM technologies. Instead my thesis aimed to include a deep consideration of
people’s needs and contexts at each stage, while exploring how DSDM technologies
could support their everyday lives and work.
My thesis aimed to answer three research questions about the role of DSDM
technology in chronic respiratory care: (1) how can technology support healthcare
professionals in their decision-making for COPD care? (2) what is the lived experience
of COPD, and how can technology support this experience? and (3) what is the
lived experience of using self-monitoring technology to share symptom data between
COPD patients and healthcare professionals? I explored these research questions
by first identifying gaps in the current literature relating to technologies for DSDM
and COPD self-management (Chapter 2). Then I carefully crafted a mixed methods
research methodology and reflected on the ethical and methodological challenges in
this space (Chapter 3). Finally, I conducted three novel pieces of research to answer my
research questions (Chapter 4, 5, and 6). I discuss and summarise my contributions
to knowledge arising from this thesis in the sections below. These contributions are
relevant to the fields of Human-Computer Interaction (HCI) and Health Informatics.
However, some contributions may also have relevance to other healthcare research
communities and the practices of healthcare staff.
7.2 Discussion of Research Contributions
This section provides a discussion on the main research contributions from this thesis.
I situate these contributions among key literature to demonstrate how my research
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adds to the body of knowledge on DSDM technologies for chronic respiratory care.
Figure 7.1 depicts a visual representation of how each research contribution (arising
from the research chapters) maps to each research question, ultimately informing
our understanding about the role of DSDM technology in respiratory care. These
contributions are discussed in detail in the following sections.
Trust in data ‘authors’, data ‘sources’ and
algorithms (4, 6)
The need for training and resource allocation
to support DSDM (4, 6)
The use of the Technology Acceptance Model
for DSDM technology evaluation (4)
Reactive management approaches to
self-management (5)
The lived experience of COPD as a personal
and evolving journey (5, 6)
The ‘safety net’ paradigm involved
with remote monitoring of COPD  (4, 6)
The challenges around ‘subjective’ data
about COPD symptoms (4, 6)
The need for DSDM technologies to
support local contexts (6)




What is the lived experience of using self-monitoring
technology to share symptom data between COPD 
patients and healthcare professionals?
Research Question 2:
What is the lived experience of COPD, and
how can technology support this experience?
Research Question 1:
How can technology support healthcare
professionals in their decision-making for COPD 
care?
Note: the numbers in brackets indicate which research chapter the finding has emerged from.
Figure 7.1: How each research chapter contributes to each research question.
Trustworthiness of data and algorithms plays a central role in how DSDM tech-
nologies can support HCPs in their decision-making.
‘Trust’ and its impacts on decision-making was a prevailing theme across both Chapter
4 (Data Supported Decision-Making) and Chapter 6 (Self-Monitoring and Collabora-
tion). I have shown that data and algorithms used as part of DSDM technologies
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must be perceived as trustworthy for their use in the decision-making process. As
discussed by Hartswood et al. (2003b) and Jirotka et al. (2005), trust and transparency
in healthcare technology is important for a user to make sense of its contributions and
understand how it should inform decision-making. In this thesis, I expanded on this
understanding about the importance of trust and transparency by uncovering how it
influences decision-making about COPD care. In Chapters 4 and 6, I demonstrated
why data that is used to facilitate DSDM technologies should not be left opaque to
users (and concerns that emerged when it was). More specifically, I have contributed
new understandings about the ways that lack of trust in data authors (Chapter 4 and 6),
data sources (Chapter 4 and 6), and algorithm transparency and explainability (Chapter
6) can present significant challenges for how willing HCPs are to engage with DSDM
technologies.
Who the data authors1 were had significance for how the data was perceived,
as HCPs needed to factor in any potential variability within the data to judge its
reliability. Though Cicourel (1990) first discussed the ways that information reliability
was influenced by professional hierarchy in healthcare contexts, I have unearthed for
the first time how differing areas of clinical specialism also impacts perceived reliability.
I took this concept further to understand how it influences how users engage with
DSDM technologies. For example HCPs discussed that they would engage more with
spirometry data depending on its author: “I definitely believe what came from the
Hospital over the GPs [general practitioners]” (Chapter 4, section 4.4.6.5, pg. 129).
This trust issue became particularly pertinent when collating data from different HCPs
and healthcare organisations, which lessened HCPs’ confidence in its reliability. It is
important to acknowledge that this challenge cannot be resolved by technology alone.
These trust concerns stem from challenges relating to spirometry training and lack of
consistent understanding about COPD. However, these concerns do have implications
1Recall that data authors are anybody that records the data being used for decision-making (in this
research it was patients and HCPs). This concept was introduced in Chapter 4 (section 4.5.1, pg. 130
onwards).
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for how data is visualised and presented for decision-making. When collating data
from multiple different HCPs, providing clarity about who2 has recorded the data
is an important feature for visualisation. In future, as concerns about spirometry
training are addressed, digital badges could be used alongside the data to indicate
which organisations have completed adequate training (Anderson et al., 2013). This
is one way that digital techniques could be used to support the trust building process
about data from specific authors (both considering their clinical specialisms and their
professional roles (Cicourel, 1990)).
Data sources3 used across the organisations in Chapter 4 had flaws well known
to HCPs. This meant that transparency about the data sources used within DSDM
technologies was important, so HCPs could account for these flaws during decision-
making. Repurposing existing data sources for use in DSDM technologies can have
implications for data interpretation, as some healthcare data can be perceived as
bound to the context of its production (meaning it cannot be effectively interpreted
outside of the original context it was produced) (Berg, 1999). Whereas I have shown
that when repurposing existing data for DSDM support, failure to specify the original
source can hinder the data interpretation process. The HCPs needed to factor in
known uncertainties about data sources when considering its use and potential weight
in the decision-making process. For example the Hospital marker system required
manual flagging of COPD patients, so its use to determine the number of COPD
patients in hospital is unreliable as it is not a “true list ... there will be patients
that probably slip through the net” (Chapter 4, participant C7, section 4.4.6.1, pg.
116). While data sources that lack complete accuracy are unideal, HCPs could use
2That is, clarifying their role, not naming the specific individual, as this would be considered too
“political” (Chapter 4, participant BI2, section 4.4.2.2, pg. 100).
3Recall that data sources refer to databases or systems in which data is pulled from for the purposes
of collation and visualisation on DSDM technology. For example, the Hospital marker system from
Chapter 4 is an example of a data source (Chapter 4, section 4.4.2.3, pg. 100).
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their local understanding of the data sources and professional vision to interpret its
utility (Goodwin, 1994). One way to promote transparency about data sources used
in DSDM technologies is by clearly visualising to the user where the data originates
from. Taking this a step further, visualising uncertainties4 in the data can help to
inform its reliability. Future work should carefully consider the potential effects of
using particular data sources for DSDM support in clinical settings.
The concept of algorithm transparency and explainability was highlighted in
Chapter 6, when HCPs raised trust concerns about the outputs of the ‘How Are You
Today’ app used within the case study. There was a strong need to understand how
the algorithm worked to understand its potential contributions to decision-making
and management of patient care. As highlighted in the previous two paragraphs,
who designed the algorithm and what data it was based on was important criteria for
explainability. For example, whether the algorithm designer was a respiratory spe-
cialist and whether the algorithm reflected the latest clinical guidance was important.
This knowledge helps the HCP to judge the suitability and validity of the outputs for
decision-making. It also gives HCPs the confidence to recommend the app to their
patients, knowing that they can trust and justify the outputs.
Explainability can help facilitate the trust building process between HCPs and
DSDM technology, providing them with key knowledge required for its initial accep-
tance. Jirotka et al. (2005) noted that workers establish trust with technology in similar
ways as they establish trust with human colleagues: by understanding its respective
strengths and weaknesses. Algorithm explainability is recognised for its importance
for healthcare technologies (Adadi and Berrada, 2020; Ahmad et al., 2018; Bussone
et al., 2015; Holzinger et al., 2017). One way to design DSDM technologies that
promote explainability is to incorporate participatory algorithm design activities when
designing the technology (Baumer, 2017). This could include involvement of medi-
4For example, uncertainties about the completeness or quality of the data. If data is pulled from the
coding department in the hospital for example, it should be communicated that this data is provisional.
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cal experts during algorithm design, providing them with the opportunity to decide
where and how explainability should be communicated. For example, Chapter 6 un-
covered the need to include information about the designers of the app’s algorithm
and information about what clinical guidance the data is based on. Additionally, when
designing technologies which are both HCP and patient facing, like in Chapter 6, in-
cluding patients when testing the algorithm’s outputs can provide confidence that the
outputs are understood by patients as intended. It is also important to understand how
algorithms ‘behave’ beyond their written step by step instructions. To explore this,
HCPs could take an autoethnographic approach to trial the technology so they can
assess its behaviour under empirical use5 (Bergman, 2000; O’Kane et al., 2014).
There is a wider acknowledgement about the importance of providing trust-
worthy technologies for healthcare services (and patients). Hence organisations are
seeking to provide platforms that can showcase a library of reviewed and accredited
health apps (NHS Digital, 2018; ORCHA, 2018). It is important that these platforms
carefully consider how explainability and transparency has been offered and assessed,
considering the points described above, as part of their judgement criteria. This will
become particularly relevant as healthcare technologies grow to be more complex and
sophisticated in nature.
To support existing work and care practices, DSDM technologies must provide
support that is applicable to the local healthcare context.
Both Chapter 4 (Data Supported Decision-Making) and Chapter 6 (Self-Monitoring
and Collaboration) highlighted the need for DSDM technologies which conformed
to, and integrated with, local ways of working and providing care. The co-design
5I discussed this approach in Chapter 6 as being specifically useful for double loop technologies, so
that HCPs could understand how the ‘patient’ input influences the outputs that are shown to them and
the patient (Chapter 6, section 6.5.2.2, pg. 247).
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process in Chapter 4 accounted for the various local arrangements of both the Hospital
and Community Care, to create support that would align with their collaborative
needs. Whereas in Chapter 6, integrating a standardised symptom monitoring app
into clinical practice clashed with Community Care’s requirement for localisation.
Though healthcare organisations will follow evidence based best practices6, how they
carry out their work will be influenced by their local preferences, demands, and
regional guidelines. For example, HCPs from different organisations may have different
medication prescribing habits (Davies et al., 2014; Hemminki, 1975; Robinson, 2018).
Likewise, the local arrangements that healthcare services have with one another will
influence how work is organised (as seen in Chapter 4 and Hartswood et al. (2003a)).
This is not to say that DSDM technologies cannot be designed for more than one
context at a time. Rather, this point emphasises that local differences can impact
how DSDM technologies are (dis)used and (un)valued (Berg, 1999; Hartswood et al.,
2003b).
Chapter 6 showed how HCPs felt the management suggestions provided to
patients by the standardised app misaligned with the advice given from their local
healthcare service (Chapter 6, section 6.4.3.3, pg. 228). As a result, HCPs on one
occasion had to ‘correct’ the advice provided by the app, which created broader con-
cerns about accountability and increasing their workload (Chapter 6, section 6.4.3.2,
pg. 228). This highlights the importance of considering local needs and ways of work-
ing when designing DSDM technologies to support patient care. This is particularly
relevant for technologies which may be recommended to patients by healthcare ser-
vices to support self-management of their condition. In addition to following clinical
guidelines when providing advice to patients, HCPs may wish to personalise manage-
ment advice based on individual patient needs (Savard, 2013; Weiner, 2004). This
was summarised in Chapter 6: “there’s [national] guidelines but that will be imple-
6For example, in the United Kingdom, the National Health Service (NHS) will follow guidance set
out by the National Institute for Health and Care Excellence. See https://www.nice.org.uk/about
(Accessed May 5th, 2020).
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mented individually to the patient” (section 6.4.3.3, pg. 228). If guidelines given from
the healthcare service and the technology conflict, this can create difficulty for the
patient’s self-management – and potentially cause harm. This is particularly important
given that the lived experience of COPD reported in Chapter 5 (Technology and the
Lived Experience) already details the perceived lack of adequate information about
self-management and self-care (Chapter 5, section 5.4.1.1 and 5.5.1, pg. 170 and
182). Therefore, this contribution highlights how localisation and personalisation are
important capabilities for technologies which support patients and HCPs.
To ensure that standardised support provided by DSDM technologies does not
create discordance with local contexts, front-end customisation capabilities could be
offered to healthcare organisations. I discussed in Chapter 6 (section 6.5.3, pg. 250)
that customisation capabilities could be provided based on block based programming
approaches (Dasgupta and Resnick, 2014; Maloney et al., 2010; Weintrop and Wilen-
sky, 2015). This could allow users to engage with a simple graphical user interface to
tailor functionality of the system (see a conceptual example in Figure 6.4, pg. 251).
Customising digital health technologies in this way has been explored by Simm et al.
(2016) in the context of managing anxiety in adults with high functioning autism. My
research demonstrates how customisation should enable localised support on patient
and service levels. However how customisation capabilities that support localisation
may be offered to HCPs, and realised in practice, requires further investigation.
Integrating DSDM technologies into healthcare practice requires training and
resources for HCPs to make effective use of them.
Supporting decision-making extends beyond the process of designing, developing,
and deploying a particular DSDM technology into clinical practice. There is a need for
the wider sociotechnical system within the organisation to accommodate the role of
the technology and the decisions that can be informed by it. Moreover to effectively
evaluate and measure the outcomes of introducing a DSDM technology in clinical
practice, it must be introduced in an environment that appropriately supports its
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intended benefits. My research in Chapter 4 (Data Supported Decision-Making) and
Chapter 6 (Self-Monitoring and Collaboration) showed that for DSDM technologies
to support HCPs, there is a need for appropriate (cross-)organisational protocols and
policies to accommodate and resource ways for staff to respond to the data. This
particularly applies to scenarios where the DSDM technology introduces HCPs to
data that has been previously unavailable to them in practice.
For example, current organisational protocols may not include activities such
as responding to patient-generated data (e.g. patients’ symptoms sent remotely to
HCPs explored in Chapter 6) and types of service level data (e.g. data about COPD
hospital admission rates explored in Chapter 4). This type of data, which was explored
in Chapters 4 and 6, was seen to have a more important purpose than simply being
‘informative’. The HCPs believed that this type of data should be acted upon where
appropriate, such as when data shows a patient is struggling with their health (“you’ve
got to do something with this data” – Chapter 4, participant C6, section 4.4.6.3, pg.
123) or COPD hospital admissions rates are suddenly increasing (“[we need] agree-
ments with other Trusts about how we respond to these spikes in admissions” – Chapter
4, participant H3, section 4.4.2.1, pg. 98). To that end, healthcare organisations must
consider and accommodate the decisions that users can (and should) make based on
the technology’s insights. If the protocols around the use of the DSDM technology
are not clearly communicated, HCPs may disengage with the technology over con-
cerns about liability or futility arising from its use (Bardram and Frost, 2018; Cai et al.,
2019). This is an example of the ways in which DSDM technologies can influence how
healthcare work is carried out, an area which Dowding et al. (2015) noted required
further understanding.
However, before considering how these technologies may be used in practice, it
is crucial to consider how HCPs can be appropriately trained to use DSDM technologies.
Chapter 4 revealed that conventional information technology (IT) systems used in
practice were often navigated on intuition alone due to time pressures and perceived
lack of need for training (section 4.4.2.1, pg. 97). However DSDM technologies
may require HCPs to correctly interpret and analyse data that they are “not used to
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seeing” (Chapter 4, participant C8, section 4.4.6.2, pg. 117). Therefore a lack of
training could result in HCPs making incorrect assumptions about, and based on, the
data. A lack of understanding about how to safely use DSDM systems can be a key
barrier to their adoption (Sarcevic et al., 2012). To an extent the challenges relating
to training on clinical systems can be alleviated through intuitive system design. Yet
as DSDM technologies become more sophisticated in their data visualisation and
capabilities, HCPs may require more formalised methods of training to effectively
learn about the system. However as the healthcare domain continues to benefit from
new technologies, data analysis skills may become increasingly important for the HCP
workforce (Steen and Mao, 2016).
To minimise the time burden required for user training, careful consideration
of how the data is presented and articulated on DSDM technologies is crucial. In
Chapter 4, I suggested offering alternative views of data to support different levels of
data literacy among HCPs (section 4.5.2.2, pg. 144). Different professional roles and
expertise must be considered when designing data visualisation, to account for the
potentially different levels of analysis and data comprehension skills among healthcare
staff (Dowding et al., 2017; Gaissmaier et al., 2012; Islam et al., 2016). Understanding
the most effective way to engage HCPs in training on DSDM technologies remains an
important topic for future work. For example, considering how flexible and scenario-
based training could be feasibly designed to support the safe and effective use of
DSDM technologies in practice.
Carefully considering the use of the Technology Acceptance Model in healthcare
to evaluate DSDM technologies.
In Chapter 4 (Data Supported Decision-Making), I used a scenario-based evaluation
approach and a technology acceptance model (TAM) questionnaire7 to evaluate the
7Recall that TAM intends to predict if a user will accept a new technology (Davis et al., 1989).
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DSDM prototype (section 4.3.6, pg. 90). I reflected on how the scenario-based eval-
uation provided a resourceful way to capture rich qualitative data about factors that
can influence the (dis)use of a DSDM technology. These insights can complement
the traditional quantitative data captured by randomised control trials, which seek to
evaluate the effectiveness of DSDM technologies in practice (Kaplan, 2001a). How-
ever, in addition to my reflections about the benefits of the scenario-based approach, I
have contributed an important reflection about using TAM for the evaluation of DSDM
technologies in healthcare.
Researchers have used TAM as a tool to evaluate various healthcare technologies
(as shown in Holden and Karsh (2010)). I found that the language used within
published TAM questionnaires focused strongly on technologies that ‘improve job
performance’, ‘increase productivity’, and ‘increase effectiveness’ of the user in their
job. This was the case with healthcare studies using TAM also (Holden and Karsh,
2010). These concepts do not align well with the process of clinical decision-making,
as it can be difficult to draw clear inferences about how the design of a medical
device8 influences clinical outcomes (Sharples et al., 2012). Therefore, evaluating
the DSDM prototype in Chapter 4 based on its ability to improve the ‘effectiveness’,
‘productivity’, and ‘performance’ of the HCP was inappropriate.
To deal with these existing challenges within TAM, I worked iteratively with a
Professor of Respiratory Medicine to adapt the TAM questionnaire provided by Davis
and Venkatesh (1995) to ensure it was applicable to DSDM in healthcare. This in-
volved changing the language of the statements to ensure that the responses were
more pertinent and meaningful to DSDM. I actively avoided positioning the DSDM
technology as a tool that would make HCPs more ‘productive’ workers, as this ig-
nores the complex nature of clinical decision-making. The result of this process was
8Not all clinical dashboards are considered medical devices (GOV.UK, 2018). However, the chal-
lenges of associating a medical device with a clinical outcome can also exist when associating software
with a clinical outcome.
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a TAM questionnaire that was more relevant for evaluating DSDM technologies in
healthcare. Holden and Karsh (2010) noted that researchers should better contex-
tualise TAM quesionnaires for healthcare. As such, I contribute my critiques about
TAM in healthcare and provide a contextualised TAM questionnaire used Chapter 4 in
Appendix G.
Understanding and supporting reactive management approaches through de-
sign.
Chapter 5 (Technology and the Lived Experience) documented a rich account of the
lived experience of chronic respiratory conditions (CRCs). This chapter discovered
the ways that some people with COPD took a reactive approach to managing their
condition, which contrasts with approaches that are more consistent and preventative
in nature (Chapter 5, section 5.4.3.1, pg. 176). A statement by one participant
summarises this phenomenon well: “when I’m OK, I don’t do anything, it’s just
when things go down I take action” (Chapter 5, participant Nelly, section 5.4.3.1,
pg. 177). Reactive approaches involved taking prescribed medication according to
personal preferences instead of following instructions from HCPs, and having a desire
to monitor symptoms only when feeling unwell. This approach was also seen with
one patient in Chapter 6 (Self-Monitoring and Collaboration) in relation to taking
antibiotics and the concerns about potential overuse (“I know my body better than
somebody writing prescriptions” – Chapter 6, participant Robert, section 6.4.2.2, pg.
224). Though patients self-monitored consistently in Chapter 6, with no evidence of a
reactive management approach taken, observing this phenomenon within that study’s
context would have been a challenge. This is because the study was small-scale
(short duration and small number of participants) and any potential observer effect
could have resulted in altered self-monitoring behaviour on the study (Sedgwick and
Greenwood, 2015).
However, participants in Chapter 6 did report that the self-monitoring process
would be more valuable during challenging seasonal periods or condition flare ups,
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when there may be an increased motivation to self-monitor due to risks of poor health
(Chapter 6, section 6.4.4.1, pg. 232) (Johnston et al., 2017; McManus et al., 2008;
Sama et al., 2017). This reinforces the concept that engaging with self-monitoring
technologies is perceived as more valuable during periods of flare ups, which may
be infrequent. Overall the reasons for adopting a reactive management approach
appeared to be related to the perceived unpredictability of the condition occurring
regardless of taking medication (“[you can do] everything you should ... [and still] have
a bad day”, Chapter 5, participant Tina, section 5.4.3.1, pg. 176), lack of perceived
need to consistently take medication or monitor due to the condition appearing under
control (“if I was worse that would be different”, participant Maggie, section 5.4.3.1,
pg. 177) or believing that the severity of the condition does not warrant the medication
prescribed (“personally my body can cope without it” – Chapter 6, participant Robert,
section 6.4.4.2, pg. 224).
These findings around reactive management relate to behavioural research on
how people self-manage COPD. Behavioural research has shown that health beliefs
strongly influence how people self-manage and live with COPD (Arnold et al., 2011;
Chambers et al., 1999; Dowson et al., 2004b; Kaptein et al., 2008, 2009; Rand, 2005;
Restrepo et al., 2008; Salimi et al., 2013). According to the Health Belief Model used to
explain health-related behaviours, ‘perceived severity of the condition’ and ‘perceived
benefits’ (of taking action) are two theoretical constructs that are thought to influence
health-related behaviour (Strecher and Rosenstock, 1997). Both constructs relate to
the reasons why participants took reactive approaches to managing their COPD. From
a medical perspective, reactive management approaches may contribute to worse
health outcomes (e.g. if patients are not taking medication as prescribed (Makela et al.,
2013)). However, this style of managing may not be as problematic for the practice of
self-monitoring symptoms. Though this depends on the purpose of the self-monitoring
activity.
It is not entirely surprising that some people with COPD may not want to mon-
itor their symptoms during asymptomatic periods, as this may emphasise or remind
people about ill health (Ancker et al., 2015; Craven et al., 2013; Lupton, 2013; Pols,
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2014). In Chapter 4 (Data Supported Decision-Making) it was noted that the consis-
tent monitoring of COPD symptoms may contribute to “medicalising their condition”
(Chapter 4, participant C6, section 4.4.6.3, pg. 122). This demonstrates that HCPs,
too, may have concerns about the effects of self-monitoring COPD symptoms each
day. However instead of viewing self-monitoring as an activity that must be consis-
tently and indefinitely ‘complied’ with, we can begin to consider how digital support
could accommodated desires to reactively self-monitor symptoms.
In Chapter 5 I discussed how smart devices could support the generation of
data points without the need for explicit user input (section 5.6.1, pg. 191). For
example, smart inhalers could detect increased use and interpret this to mean that
the patient feels unwell (Chen et al., 2020). Similarly, smart capabilities could be
built into different devices or objects that users engage with when feeling unwell.
Chapter 4 demonstrated some promise that a reactive approach to self-monitoring
could generate clinically useful data. When discussing accessing patient-generated
data on the prototype, HCPs discussed that “there will also be patients who just
don’t put data in until they are unwell” but the challenge would be if patients report
“greens [days of good health] but don’t put the red [days of poor health]” (Chapter
4, participant H5, section 4.4.6.3, pg. 123). This demonstrates that some HCPs
would still find value in viewing patients’ symptomatic days, even if asymptomatic
days were not consistently captured. However, further studies are required to explore
how technology could support capturing ‘reactive’ data and how this could generate
reliable datasets that can be used for COPD care.
Designing for a personal and evolving condition journey.
As the related work in Chapter 2 showed, COPD is a complex chronic condition that
introduces many physical and emotional challenges into peoples’ lives. In Chapter 5
(Technology and the Lived Experience), I was able to explore how these challenges
are experienced by people with COPD in their everyday lives. It became clear that the
COPD journey is one that is highly personal and evolves due to the progressive nature
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of the condition. Chapter 5 discussed the need to support the evolving needs of the
condition, demonstrating how needs evolve in two main ways: (1) as individuals learn
more about the condition through experiential knowledge and (2) as the condition
progresses to a later stage in terms of severity (Chapter 5, section 5.4.3.2, 5.4.4.2,
and 5.5.1.3).
Starting the condition journey required obtaining adequate ‘clinical knowledge’
and ‘practical knowledge’ about the condition (Pols, 2014). This knowledge was
perceived to be an important aspect of being able to accept, and live with, COPD.
Diagnostic uncertainty and lack of information from general practice staff marked the
first point in the condition journey where many participants felt unsupported. Some
participants believed that the lack of information from healthcare services was due to
the stigma9 around COPD: “if they had been telling you that you had anything else, I
don’t think they would have just said that and sent you away” (Chapter 5, participant
Mary, section 5.4.1.1, pg. 171). Chapter 2 discussed the challenges relating to
accurately diagnosing COPD in practice, including its similarities with asthma and the
changes in medically agreed thresholds for spirometry results (Bellia et al., 2003; Buist,
2003; Fletcher and Pride, 1984; Murphy, 2019; Pellegrino et al., 2008; Tinkelman et al.,
2006). Uncertainty around COPD diagnoses was also highlighted in Chapter 4 (Data
Supported Decision-Making) relating to how some general practice staff formulate a
diagnosis without conducting a spirometry test or may not be adequately trained to
deliver these tests (section 4.4.2.2, pg. 99). Chapter 5 showed that these clinical
uncertainties about COPD have an impact on how the patient is able to understand
their condition. It is likely that as diagnostic tools and medical understanding about
COPD improves in future, diagnoses and information about the condition will be
more certain. However amidst the current uncertainty there is still a need to support
patients’ understanding of their condition.
9Recall that COPD was discussed as being a stigmatising condition due to its relations to cigarette
smoking (Chapter 5, section 5.4.2.3, pg. 181).
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Though participants felt that general practice staff did not provide them with
enough information about their condition, it was noted that clinical knowledge needed
to understand the condition could be obtained from COPD specialists. For example,
specialists could provide detailed information about the condition and advice about
how it should be managed. Specialists could “explain exactly what the [clinical] tests
mean” (Chapter 5, participant Elliot, section 5.5.1.1, pg. 183) and “could actually
answer all your questions” about the condition (Chapter 5, participant Rose, section
5.5.1.1, pg. 183). Referral to a COPD specialist, however, was not automatically
offered as part of participants’ care pathway. Therefore, participants discussed that it
became their responsibility to actively seek this referral. This was a prominent point
that led to workshop participants in Chapter 5 advising10 a newly diagnosed patient to
ask their GP ‘would an early referral to a COPD specialist be useful?’ (Chapter 5, Group
2, section 5.5.1.1, pg. 183). Though this demonstrates the value that participants
placed in receiving support from a COPD specialist, it also highlights the power of
sharing collective experiences and advice across the CRC community to support the
condition journey.
In fact, many participants in Chapter 5 credited practical knowledge sharing
across the respiratory community as the reason that “there’s not anything I do not
know about my lung condition, and inhalers, and how to look after myself” (Chap-
ter 5, participant Seb, section 5.4.1.2, pg. 172). Participants who attended support
groups discussed them as a key avenue to obtain practical knowledge and ongoing
emotional support about the condition – which was perceived as lacking from health-
care services11. There was, however, an acknowledgement that support groups are
not accessible to everybody (Chapter 5, section 5.4.1.2 and 5.5.2.3, pg. 172 and
10Recall that in Chapter 5, workshop participants engaged in an activity about outlining important
needs for the condition (section 5.2.4).
11It is important to note that as I recruited heavily from support groups in Chapter 5, the perceived
benefits of these groups may be over-represented in my data.
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188). It was thought that the reasons for this were: (1) lack of knowledge about the
groups and barriers to advertising it; (2) being unavailable during the time of the group
meetings12; and (3) being unable to physically attend the groups due to anxiety and
mobility issues.
These challenges present an opportunity to consider how digital support could
facilitate the dissemination of practical knowledge “cowritten with people with COPD”
(Chapter 5, participant Mary, section 5.4.1.1, pg. 171). Previous work has engaged
the Parkinson’s community in the co-creation of health information resources – with
information needs being commissioned from the community themselves – resulting
in the creation of a radio channel which involved both clinical and personal perspec-
tives (McNaney et al., 2018). Involving respiratory support groups in a similar way to
co-create their own information resources could be a promising way to share practical
knowledge. Moreover, this could help build a sense of community which traditionally
resides in physical support groups. Collaborating with the CRC community in this way
also ensures that community inclusive digital platforms are given precedence to.
I have discussed the importance of clinical and practical knowledge acquisi-
tion, particularly relating to starting the condition journey. However supporting the
personalised and evolving needs of the condition was also discussed in relation to
self-management technologies. Chapter 5 and Chapter 6 (Self-Monitoring and Col-
laboration) highlighted that people with COPD had a desire for technology to be
personalised and adaptive to their condition journey. When recalling experiences of
using the ‘How Are You Today’ app in Chapter 6, patients discussed the need for the
mananagement advice generated by the app to relate to their personal context and
capabilities. For example, providing insights and advice that relate to the specific be-
haviours of the patient rather than “one message applies to all” (Chapter 6, participant
Robert, section 6.4.4.2, pg. 233). This was also raised in Chapter 5, as participants
12Recall participant Mary stating “the majority of support for people with COPD is during the working
hours” (Chapter 5, section 5.4.1.2, pg. 172).
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discussed abandoning self-management technologies when they no longer provided
novel insights about their health (Chapter 5, section 5.4.3.2, pg. 178). As participants
began to develop experiential knowledge about their condition they encountered dif-
ferent needs. For example, shifting from learning to understand the condition to
predicting and preventing exacerbations. The need for technology to align with the
evolving needs of the condition was summarised as “[COPD] gradually gets worse, so
the app needs to be personalised and change, and help people manage their condition
so it doesn’t get worse” (Chapter 6, participant Robert, section 6.4.4.2, pg. 233).
Understanding how self-management technologies could support and accom-
modate the evolving needs of COPD has not been explored in previous work. Most
previous research in this space has focused on supporting specific activities, such as re-
habilitative exercises, monitoring the environment, or self-monitoring symptoms (Kim
and Paulos, 2009; Pereira et al., 2016; Spina et al., 2013; Taylor et al., 2011). Though
these are important activities for managing COPD, an opportunity exists to under-
stand how technologies that aim to provide long-term support could be personalised
and adaptive13. Johnston et al. (2009) acknowledged that this was an important area
for future work as individual characteristics of people with COPD may shape differ-
ent preferences to self-monitoring and management. Future research should work
collaboratively with the CRC community to map out the condition journey to under-
stand core needs at different stages14. This thesis contributes a starting point for this
process, as I have identified a common challenge experienced by participants about
starting their condition journey after diagnosis. This relates specifically to the need
13Algorithm transparency and explainability, as discussed in section 7.2.1, would be crucial in this
context so that patients understand how the technology is personalised and adaptive
14It is important to note that people’s lived experiences of COPD will be different. However, there
may be common experiences across the community which could be supported by technology. For
example as seen in Chapter 5, at early stages of COPD, people may be interested in self-monitoring to
understand their symptoms. Whereas at severe stages of COPD, people may want to self-monitor and
share this data with support networks to predict and prevent exacerbations.
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for clinical and practical knowledge about the condition to help equip participants in
their self-management and acceptance of the condition.
The ‘safety net’ paradigm involved with remote monitoring, and the challenges it
introduces for HCPs.
Participants with COPD in Chapter 5 (Technology and the Lived Experience) and
Chapter 6 (Self-Monitoring and Collaboration) highlighted a strong desire to share
their symptom data with HCPs as part of their ongoing care and self-management.
Sharing patient-generated data with HCPs in clinics and appointments was not some-
thing commonly reported by participants in Chapter 5. However it was discussed that
participants would welcome this as part of self-monitoring their symptoms so that
HCPs could be informed about their health outside of the clinic (Chapter 5, section
5.4.4.1, pg. 180). I discussed how including support networks in the self-monitoring
process could help to alleviate reluctance that patients face in seeking help due to
stigma and perceived burden (Chapter 5, section 5.6.3.1, pg. 197). This was rein-
forced in Chapter 6 as HCPs and patients themselves discussed how remotely sharing
data about COPD symptoms could support seeking timely help (Chapter 6, section
6.4.1.2 and 6.4.2.1, pg. 221 and 222)
However in instances where HCPs were connected to data about patients’ symp-
toms15, they perceived themselves as accountable and responsible to monitor patients’
health and identify health decline. This concept was discussed in Chapter 6 as ‘shifts in
responsibility of care’, which HCPs felt occurred when they received patient-generated
data remotely (Chapter 6, section 6.5.1, pg. 238). Detecting health decline was con-
sidered the responsibility of the patient as part of their self-management. However
when HCPs are remotely connected to patients’ symptom data, they felt detecting
15HCPs were connected to data about patients’ symptoms in one scenario in Chapter 4 (Data
Supported Decision-Making) and in Chapter 6 with patient-generated data from the case study.
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health decline became their joint responsibility with the patient. As one HCP de-
scribed in Chapter 4, having access to live symptom data means “fundamentally they
[the patients] aren’t fully self-managing under this sort of scenario” (Chapter 4, par-
ticipant C6, section 4.4.6.3, pg. 122). While HCPs voiced that the implicit joint
responsibility of detecting health decline was undesirable, patients described this as
being a motivator to collect and share this data. Previous work has also identified that
having HCPs connected to COPD symptom data is a strong motivator for patients to
record this data (Brunton et al., 2015; Dahl et al., 2018; Nadarajah et al., 2019).
Previous telemonitoring studies observed how COPD patients actively deferred
the responsibility of identifying health decline to HCPs (Fairbrother et al., 2013).
Though this was not observed in Chapter 6, these concerns led to HCPs feeling reluc-
tant to engage with the remotely received patient-generated data. In addition to this
concern HCPs discussed the additional work that would be required to support this
responsibility. In Chapter 4 HCPs raised concerns about how they would be expected
to interpret missing data entries (Chapter 4, section 4.4.6.3, pg. 122). Whereas in
Chapter 6 HCPs raised concerns about failing to act on potentially concerning data
entries when occupied with other clinical duties (Chapter 6, section 6.4.3.1, pg. 225).
A further challenge to note relates to how HCPs in Chapter 6 found themselves under-
taking additional technical and medical duties to support the patients’ use of the app
(section 6.4.3.5, pg. 230). This was also seen as an undesirable outcome of engaging
with technology that mediates data exchange between patients and HCPs.
Recall that self-management is understood as an ‘individual’s ability to manage
the symptoms, treatments, physical and psychosocial consequences and life style
changes inherent in living with a chronic condition’ (Barlow et al., 2002). However
self-management is also represented as a collaborative activity in the literature, involv-
ing varying levels of input from patients themselves, carers, and HCPs (Corbin and
Strauss, 1984; Nunes and Fitzpatrick, 2015; Unruh and Pratt, 2008). When designing
technology to support self-management activities, it is important to carefully consider
the degrees of involvement that support networks should directly have. Increasing
the responsibilities that support networks may traditionally have could clash with the
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concept of self-management – in the sense that it is moving away from the ‘individ-
ual’s ability’ (Barlow et al., 2002). In some situations increasing the responsibilities
of support networks may be necessary, such as when a patient’s abilities are pro-
gressively limited due to their condition (Nunes and Fitzpatrick, 2015). For example,
the HCP may take on additional responsibilities such as calling the patient frequently
to check on them. However, at this stage there becomes a transition away from
‘self-management’ as its described by Barlow et al. (2002). This raises an important
question about the line where self-management ‘ends’ and a model that resembles
more collaborative care ‘begins’. The challenge in Chapter 6 was that this line was
ambiguous.
Therefore it is important to consider the purpose of technologies that serve
as a platform for patients to collect and share symptom data. For example is the
intention of the technology to promote self-management or enhance collaborative
care? If the former, how can these technologies be designed to keep the management
responsibility on the patient? If the latter, how can these technologies be designed to
alleviate the HCPs’ concerns about potentially missing data entries and failing to act?
To answer these questions it is important to work with patients, carers, and HCPs to
co-create technology that considers the boundaries of responsibility. This presents an
important opportunity for future work in this space to explore how we can design for
the differences in self-management and more collaborative models of care.
Subjectivity and variability in personal health data can hinder decision-making.
To use personal health data to inform decision-making about patients’ care, the data
must be considered clinically reliable. Chapter 4 (Data Supported Decision-Making)
and Chapter 6 (Self-Monitoring and Collaboration) unearthed challenges relating to
the generation of reliable data about COPD symptoms. These concerns were mainly
about the subjective nature of symptoms and how patients can vary in their judge-
ment of their own symptoms (Chapter 4, section 4.4.6.3, pg. 124 and Chapter 6,
section 6.4.3.2, pg. 226). Reporting the symptom ‘breathlessness’ was raised as the
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most prominent cause of subjectivity as it can be influenced by anxiety and illness
perceptions (Bailey, 2004; Carel, 2018; Heinzer et al., 2003; Maurer et al., 2008).
However Chapter 6 also showed that increases in other symptoms such as ‘sputum’
and ‘cough’ may be judged variably and understood differently across patients (e.g.
“I’d call coughing up good not bad” – Chapter 6, participant Lia, section 6.4.4.3,
pg. 235). This demonstrates how there can be variability and subjectivity in COPD
symptom data.
In clinic contexts it may be possible to decipher the root cause of certain symp-
toms when the patient is present to support the data interpretation process (Mentis
et al., 2017). For example it was discussed that patient-generated data could be used
in the clinic as “an entry to a conversation” to help the patient understand the cause
of their symptoms (Chapter 4, participant C6, section 4.4.6.3, pg. 120). Though
interpreting patient-generated data in the clinic has its own challenges (West et al.,
2016, 2018; Zhu et al., 2016), when viewing this data remotely the patient is not
present to support the interpretation process. Therefore subjectivity and variability in
reports is more challenging to deal with. To seek clarification about remotely shared
symptom data HCPs may be required to call the patient to discuss the data (Brunton
et al., 2015). As highlighted in Chapter 4, contacting the patient to clarify observa-
tions in the data can generate “a whole heap of work” as “you ring them up and they
don’t answer. Really common ... at some point, you are gonna have to send them
a letter or do something else” (Chapter 4, participant C6, section 4.4.6.3, pg. 123).
Though this point by C6 was discussed in relation to clarifying missing data entries,
it is relevant to the discussion about how HCPs can clarify uncertainties in remotely
shared patient-generated data.
To combat the challenges relating to variability in subjective symptom report-
ing, Sanchez-Morillo et al. (2015) calculated a three day moving average of symptom
reports instead of displaying them day by day. Likewise it was discussed in Chapter
4 that “an agreed parameter where there was three days of red” before the patient
was highlighted as needing attention would help to establish when HCPs should take
action (Chapter 4, participant H2, section 4.4.6.3, pg. 122). Considering how specific
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thresholds in patient-generated data could be established to help HCPs manage their
caseload should be explored in future studies. However it is also important to consider
how minimising the variability and subjectivity in symptom reporting can be achieved
through more reliable data capture. When unreliable data collection techniques are
used, this gives rise to challenges relating to overreacting and underreacting to the
data (Chapter 6, section 6.5.2.1, pg. 244). Pulse oximeter readings were discussed in
Chapter 4 and 6 as providing a reliable baseline to compare and contrast patients’ re-
ported breathlessness. However Chapter 4 and Chapter 5 (Technology and the Lived
Experience) showed that COPD introduces emotional and mental challenges that are
important to share with support networks. Chapter 4 highlighted that there was clini-
cal value in accessing subjective data about quality of life, as understanding the overall
patient experience of the illness is important (Chapter 4, section 4.4.6.3, pg. 126).
Patients may not be exacerbating but psychological difficulties may influence them to
believe that they are (Dowson et al., 2004a). There is an important balance required
to capture subjective data on “what they [the patient] feel or experience” and objective
data on “what is actually happening” (Chapter 4, participant H4, section 4.4.6.3, pg.
126).
To capture objective and subjective aspects of breathlessness patients could
record pulse oximeter readings and rate their experience of breathlessness on a clini-
cally reliable scale. In instances where patients are reporting that they feel breathless
across both scales, HCPs could interpret this as a potential sign of poor physiologi-
cal health. In instances where patients have acceptable pulse oximeter readings but
subjectively report feeling breathless, this could indicate that the patient requires psy-
chological support. However it is important to highlight that increasing the amount
of data that the patient is required to record can be burdensome (Ancker et al., 2015;
Lupton, 2013). Different patient groups may have different levels of tolerance for
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recording this data16. For example patients that are more severely unwell may feel
the effort required to record this data is worth the benefit. However there is a still a
need to consider what patients believe is important to track (and how) as part of the
self-monitoring process. Future work should focus on co-designing self-monitoring
technologies that incorporates both COPD patients’ and HCPs’ needs in terms of data
collection (considering what data should be tracked and how). This can help work to-
wards building support that considers the needs from both groups – avoiding tensions
about chosen parameters to track (Zhu et al., 2016).
7.3 Positioning of Contributions
This section briefly summarises how my contributions can be positioned within ex-
isting research narratives in this space. I revisit the current body of relevant research
from Chapter 2 (Background and Related Work) and briefly outline where I have added
knowledge.
RQ1 - How can technology support healthcare professionals in their decision-
making for COPD care?
The literature around DSDM in healthcare demonstrated a wealth of research focused
on the development and quantitative evaluation of technologies that aim to support
clinical decision-making. Dashboards featured strongly in previous work due to their
ubiquity across healthcare settings (Dowding et al., 2015). Many studies on DSDM
technologies focused on randomised control trials or evaluation studies, which aimed
to assess the clinical effectiveness of DSDM dashboards. This strong focus prompted
16In Chapter 4, HCPs highlighted that the ‘right’ patient group would need to be identified to
participate in collaborative self-monitoring. For example, patients who have just been discharged from
hospital and require short-term monitoring (Chapter 4, section 4.4.6.3, pg. 120).
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several scholars to call for approaches that better explored the (dis)use of these
technologies from the user’s perspective (Hartswood et al., 2003b; Heathfield, 2001;
Kaplan, 2001a,b). There were a limited number of qualitative studies which involved
HCPs during the design and evaluation of DSDM technologies to understand their
true needs (Bardram and Nørskov, 2008; Sarcevic et al., 2018). However there was
generally a lack of HCI research that sought to provide a rich understanding about the
factors that influence how DSDM technologies are designed for, and used in, clinical
settings. This understanding is crucial for providing insights that can support the
design and deployment of DSDM technologies for real-world use in healthcare.
Though the challenges involved when innovating in the digital health space are
well-researched (as shown in Fitzpatrick and Ellingsen (2013)). Prior to this thesis,
these challenges were not specifically contextualised to technologies which support
clinical decision-making. Through working with HCPs to design and qualitatively eval-
uate a DSDM ‘dashboard’ prototype in Chapter 4 (Data Supported Decision-Making),
this thesis contributed this much needed contextualisation. I have provided rich in-
sights about how we can approach the design of DSDM technologies that support
respiratory care, taking into consideration the real-world challenges of clinical prac-
tice. This has progressed our understanding about the ways that DSDM technologies
can support HCPs in their decision-making for COPD care.
RQ2 - What is the lived experience of COPD, and how can technology support
this experience?
There were a relatively small number of studies that focused on building technologies
that aimed to support COPD patients to manage their condition. However, prior to
this thesis, there was very limited published work which had systematically engaged
the CRC community to understand their lived experiences and how technology could
support these experiences. Though there was existing research into the experiences of
COPD and self-managing the condition (e.g. Cicutto et al. (2004); Cicutto and Brooks
(2006); Giacomini et al. (2012); Pols (2010); Pols and Moser (2009); Seamark et al.
(2004)), the findings from these studies had not been positioned within HCI litera-
282 7.3. Positioning of Contributions
ture to inform how self-management and self-care technologies should be designed.
Chapter 5 (Technology and the Lived Experience) and Chapter 6 (Self-Monitoring and
Collaboration) marked a starting point for HCI researchers to consider people’s needs
and lived experiences when designing technologies to support the COPD journey.
Therefore, this thesis contributes a novel experience shared with the HCI community
that heightens our understanding about designing for, and with, people with COPD.
This thesis continues the turn in HCI research which considers the non-medicalised
aspects of self-care by focusing on people’s lived needs (Nunes and Fitzpatrick, 2015;
Nunes et al., 2015). As such, this research has made an important step in advancing
knowledge about how technology can support the lived experience of people with
COPD (and CRCs more widely).
RQ3 - What is the lived experience of using self-monitoring technology to share
symptom data between COPD patients and healthcare professionals?
The literature review showed that the practice of self-monitoring one’s health and
sharing this data with HCPs is thought to support care and decision-making (Chung
et al., 2016; Mentis et al., 2017; Schroeder et al., 2017; Zhu et al., 2016). Though
this topic is of great interest to the HCI and medical community, most research
about the patient experience of self-monitoring COPD focused on telemonitoring
contexts (Brunton et al., 2015; Dahl et al., 2018; Huniche et al., 2013; Nadarajah
et al., 2019). This is relatively unsurprising given that telemonitoring revolves around
the practice of sending symptom data remotely to HCPs. However recording personal
health data and sharing this with HCPs is not exclusive to telemonitoring, and it
can occur as part of different social arrangements between patients and their HCPs.
Overall there was a limited body of research in this space that sought to understand
both the patients’ experience of self-monitoring their COPD and the HCPs’ experience
of receiving this data. These joint experiences are crucial to report, and reflect,
on so that digital support can incorporate the key needs of both groups. This is
important for considering how these technologies can be used in the real world to
support COPD care. I contributed to this gap in the literature through Chapter 6
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(Self-Monitoring and Collaboration), where I explored the lived experiences of self-
monitoring COPD symptoms and sharing this data remotely with HCPs. Taking this
a step further, I provided novel design considerations that directly result from the
reported experiences of both participant groups.
7.4 Chapter Summary
This chapter presented the overall discussion about my contributions to knowledge,
drawing on the findings from each research chapter (4, 5, and 6). First, I reviewed the
original aims and objectives of this thesis and outlined how I approached them. Then
I demonstrated how the findings from the individual research chapters contributed
to the overall understanding about the role of DSDM technology for respiratory care.
Following this I presented a detailed discussion where I synthesised all the contri-
butions of each research chapter. I concluded this chapter by summarising how my
overall contributions can be positioned within existing research in this space, by briefly
revisiting key research from Chapter 2 (Background and Related Work).
The next chapter is the final chapter of this thesis, which concludes this explo-
ration of the role of DSDM technology for respiratory care. The chapter provides a
high-level summary of the thesis contributions, opportunities for future work in this





This thesis has taken a user-focused approach to provide a rich understanding about
the needs of those involved in Chronic Obstructive Pulmonary Disease (COPD) care.
Particularly, this thesis has aimed to explore opportunities for data supported decision-
making (DSDM) technology to support these needs and experiences. I have spent the
past three years working in partnership with people directly impacted by COPD, so
I could meaningfully explore this space and achieve the aims and objectives of this
research. This chapter concludes my exploration of this area by providing a summary
of my contributions to the fields of Human-Computer Interaction (HCI) and Health
Informatics. Additionally, I outline opportunities for future work to further enhance
understanding about the role of DSDM technologies for respiratory care. This thesis
closes with concluding remarks that reflect on the research as a whole.
8.1 Summary of Contributions
Prior to this thesis there was a lack of understanding about the role that DSDM
technologies could have for COPD care. The gaps in knowledge, identified from
reviewing previous research (Chapter 2), led to the exploration of three research
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questions in this thesis. These questions were: (1) how can technology support
healthcare professionals in their decision-making for COPD care? (2) what is the lived
experience of COPD, and how can technology support this experience? and (3) what
is the lived experience of using self-monitoring technology to share symptom data
between COPD patients and healthcare professionals? Below I summarise the main
findings which have contributed to these three research questions:
1. My research in partnership with respiratory healthcare professionals (HCPs) and
other healthcare stakeholders in Chapter 4 (Data Supported Decision-Making)
has contributed the following:
• A rich account of the daily challenges faced by HCPs relating to their
decision-making about COPD care;
• Insights into the trust concerns that HCPs have about certain data, which
effects their confidence in its use for decision-making. Specifically, HCPs
expressed distrust in certain data generated by other HCPs, patients, and
data from particular clinical systems;
• An understanding of the practical challenges of integrating DSDM tech-
nologies into existing clinical workflows. Particularly, understanding how
HCPs should be trained on DSDM systems, how they should respond to
data and insights, and what organisational protocols must accommodate
the use of the new technology;
• Critical discussion on the use of the Technology Acceptance Model for
evaluating DSDM technologies in healthcare. This involved highlighting
concerns about the criteria to which DSDM technologies for healthcare are
judged;
• Reflections on the strengths of scenario-based evaluations for DSDM tech-
nologies in healthcare. Particularly, how this technique can enable the
capture of important sociotechnical factors which influence technology de-
sign and deployment.
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2. Through my research engagements with the chronic respiratory conditions
(CRC) community in Chapter 5 (Technology and the Lived Experience), I have
contributed:
• A rich understanding of the lived experiences of COPD, including the ev-
eryday challenges involved with self-care;
• Insights about, and reasons for, the ‘reactive’ approaches that some people
take to manage their CRC;
• An identification of the need for self-care technologies to accommodate
the gradual and evolving nature of the COPD experience, helping people to
acquire the right support relative to their condition and experience stage;
• Awareness about the need to design self-care technologies that can help
and encourage people who face difficulties reaching out for support;
• A recognition of the need to design and develop self-care technologies
which are community inclusive and accessible. This is opposed to striving
for concept ‘novelty’ that cannot fit into people’s everyday lives.
3. The case study in Chapter 6 (Self-Monitoring and Collaboration) involved COPD
patients self-monitoring their symptoms and remotely sharing the data with
HCPs, which showed:
• The ‘safety net’ paradigm that arises as patients feel comforted by HCPs
viewing their symptom data, consequently creating concerns about ac-
countability for the HCPs;
• The trust concerns that HCPs have about patients’ ‘subjective’ symptom
reporting, and how this can negatively impact decision-making for both
themselves and patients;
• The strong need for algorithm transparency and explainability for HCPs to
trust, and engage with, algorithms used in digital health technologies. Par-
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ticularly, information about: who designed the algorithm, how it worked,
what information it is based on, and how up to date this information is;
• The need for digital health technologies to adapt to local and individual con-
texts through personalisation. Specifically, considering the needs of local
healthcare practices who support the technology and individual patients
who use them.
8.2 Future Work
This section outlines the leading opportunities for future work in this space, which
directly build on the findings and main limitations of this thesis.
8.2.1 Going Beyond ‘Envisioning’ Data Support
I used a scenario-based prototype in Chapter 4 (Data Supported Decision-Making) to
explore how technology could support HCPs in their decision-making about COPD.
This study provided important contributions about potential factors which influence
how HCPs engage with DSDM technologies. Though I argue the scenario-based eval-
uation was a strength of this work, the evaluation focused on how HCPs could envisage
using the prototype to support their decision-making. It is important to acknowledge
that there is much more to learn here, particularly about how DSDM technologies are
engaged with in clinical environments. The evaluations in this study were conducted
in a quiet room that did not resemble the environment the technology would realisti-
cally be used in. As discussed in this thesis, there are notable challenges relating to
integrating new technologies into healthcare systems. However, there are alternative
approaches to further explore this space without integrating a fully functioning system
into clinical practice (Favela et al. (2010) discuss a number of alternative methods
which aim to strengthen the ecological validity of prototype evaluations).
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Future work should explore how the scenarios in Chapter 4 may be used in
clinic settings by introducing them within clinic appointments1. This would involve
populating the scenario with real patient data (compared to dummy data used in
Chapter 4), and observing how it is engaged with in clinic settings. This would
help to understand how the technology may provide support in the environment it is
designed to be used in. It would also provide insights about the real-time factors that
influence its use and intended benefits. It may be challenging to adopt this approach
for some scenarios explored in Chapter 4, such as Scenario 1 (an overview of COPD
patients that are currently in hospital with a COPD related admission). However,
exploring certain scenarios in clinic contexts is a useful starting point for furthering
our understanding in this space. Ultimately, the goal is to understand how these
technologies can be designed and deployed to support real-world use. Future work
in this area would bring researchers and designers a step closer to building systems
which achieve this.
8.2.2 Improving Personal Health Data Capture about COPD
Chapter 5 (Technology and the Lived Experience) explored the lived experience of
COPD and how technology could support this experience. As part of that, there
were discussions about how technology could support capturing personal health data
about COPD for self-reflection, or sharing with trusted support networks. This study
highlighted the need to design DSDM technologies that: operate on platforms inclu-
sive to the CRC community; support reactive management approaches; evolve and
personalise to the individual; and consider different levels and granularities of data
sharing. However, an important next step is to explore how technologies which in-
corporate these factors are developed and used by people with COPD in practice.
1These clinic appointments could be organised as a research activity. They would still involve real
patients and data.
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Future research should build on these findings by conducting studies that test these
concepts in-the-wild with people with COPD. Exploring how reactive data capture
can be accommodated as part of self-monitoring would be particularly valuable. This
would help to form an understanding about how this may support the lived experience
of COPD without causing burden for user input.
As shown in Chapter 2, there have been a number of studies which have built
novel technologies for COPD self-management (Anastasiou et al., 2018; Chatterjee
et al., 2019; Fernandez-Granero et al., 2018; Merone et al., 2016; Nathan et al.,
2019b). However, only a limited number of these studies have involved people with
COPD in their research. Studies which expand on the research in Chapter 5 will be
grounded in real needs observed within the CRC community. This will help grow the
current limited body of HCI research working in partnership with, and for, people with
CRCs to understand how technology can support them.
8.2.3 Exploring Personal Health Data about COPD in the Clinic
A prominent area that has not been explored in this thesis is how personal health data
can be used in clinic appointments to inform COPD care. Chapter 6 (Self-Monitoring
and Collaboration) explored the lived experiences of recording personal health data
and sharing it remotely with HCPs. However, sharing data remotely and sharing
in clinic contexts will introduce different challenges and opportunities for DSDM.
A challenge when interpreting patient-generated data that is sent remotely is that
the patient is absent from the interpretation process (Chapter 6, section 6.5.2.1, pg.
243). Observing how patients and HCPs collaboratively interpret COPD symptom
data in clinic settings can provide important insights about how this data can inform
care. Moreover, observing this collaborative activity provides insights about what is
missing when HCPs interpret this data without the patient present (i.e. in remote
contexts).
Understanding how patient-generated data is used and navigated in clinic set-
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tings has been explored in previous HCI research (Chung et al., 2016; Mentis et al.,
2017; West et al., 2016, 2018). However, these studies have not looked at patient-
generated data about COPD specifically. Exploring COPD symptom data is important,
as this thesis has demonstrated the potential complexities of this data for decision-
making. For example, Chapter 4 (Data Supported Decision-Making) and Chapter 6
highlighted the challenges relating to the subjectivity of COPD symptoms. Whereas
Chapter 5 (Technology and the Lived Experience) discovered the reactive management
approaches that people may take when managing their condition. These factors have
direct consequences for how symptom data should be collected and used for DSDM.
Future work should seek to explore how data about COPD symptoms can be effec-
tively used in clinic settings to support decision-making. Particularly, exploring what
impact ‘reactive’ data capture has on decision-making in clinic settings.
8.2.4 Incorporating Carers’ Perspective
Carers are a crucial pillar of support for patients with chronic conditions (Cameron
et al., 2016; Corbin and Strauss, 1984; Nunes and Fitzpatrick, 2015; Seamark et al.,
2004; Spence et al., 2008). In this thesis I focused on exploring the lived experiences of
having COPD. Though I argue I was able to document a rich understanding of this lived
experience, I acknowledge that carers’ perspectives are largely missing from my work.
There was a total of two carers who contributed data to this research. One participant
in Chapter 6 (Self-Monitoring and Collaboration) was supported by his wife during
the case study (section 6.3.3, pg. 217). She was able to provide valuable insights into
the challenges that the participant faced living with COPD, including reflecting on his
reluctance to seek help when needed. It is clear that carers can contribute a wealth of
knowledge about COPD needs that may not be explicitly recognised, or admitted, by
the person with the condition.
In addition to this, feelings of stigma and limited mobility could result in people
with COPD feeling reluctant to participant in research. This potentially limits our
understanding of the lives of people who could benefit from improved support. How-
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ever, carers may be willing to share their experiences supporting people who face
barriers to research participation. This can help build a wider understanding of the
challenges and needs across the CRC community. Many participants with CRCs re-
cruited in this thesis were members of support groups. Individuals without access to,
or the desire to be part of, support groups require stronger representation. Therefore,
future work could actively seek to incorporate carers’ perspectives to build on this
thesis2.
8.3 Concluding Remarks
This thesis presented three novel pieces of research exploring the potential role of
DSDM technology for respiratory care. I achieved this by working in partnership with
people with COPD and respiratory HCPs. My findings have drawn on existing research
within medical sciences, social sciences, and computer science to provide a rich
understanding of what encompasses living with COPD and providing care for people
with COPD. As a result, I have contributed an initial understanding of what influences
decision-making about care in this space. From this, I have created a starting point
for how DSDM technologies can be appropriately designed, deployed, and supported
in practice. My methodological approach contributes to existing literature that has
sought to demonstrate the power of qualitative research within digital health: taking a
human-focused approach that complements the vast body of traditionally quantitative
research in this space (Ackerman et al., 2017; Berg, 1999; Hartswood et al., 2003b;
Kaplan, 2001a,b; Kaplan and Maxwell, 2005; Nunes and Fitzpatrick, 2015).
My work aimed to provide a rich understanding of my three research questions.
Through doing so I encountered and explored various aspects of healthcare work
2It is important to note that recruiting carers is not a replacement for recruiting those who face
barriers to participation. However, it can help to capture different perspectives (as well as offering
perspectives specific to carers themselves).
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and experiences of living with a chronic health condition. To an extent my research
holds potential to contribute to digital health beyond the concept of DSDM. For
example, my reflections and evaluation approach taken with HCPs in Chapter 4 (Data
Supported Decision-Making) and Chapter 6 (Self-Monitoring and Collaboration) may
inform how digital health technologies can be evaluated to truly appreciate their
value and limitations. Likewise, my findings about respiratory self-care in Chapter 5
(Technology and the Lived Experience) and Chapter 6 could contribute to studies about
COPD care pathway design. These would be considered secondary contributions of
this thesis, which have not been my intended focus.
As I conclude this thesis it is important to re-emphasise that this has been a
very challenging space to plan and conduct research, as discussed in detail in the
methodology (Chapter 3). There were numerous challenges to navigate: obtaining
ethical approvals; recruiting participants; conducting research activities; and practical
ethical implications evident on reflection. These types of challenges are inherent with
conducting research in the healthcare space, a domain that is less tolerant to errors
and risk. The challenging nature of conducting research in this space is partly why
it can take many years for research to translate into clinical practice (Liddell, 2007;
Morris et al., 2011; Topol, 2019). As such, this PhD marks an important starting
point for understanding the role of DSDM technology for respiratory care — laying
the foundations for future work to further enhance this understanding. There remains
a vast amount of knowledge to discover that can bring us closer to the successful
intersection of medicine and computer science, in a way that supports the care for a
growing population of people (Barnes, 2007).
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Chapter 4: Participant Information
Sheet and Consent Form
This section includes the participant information sheet and consent form used to
recruit participants for Chapter 4.
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Participant	  Information	  Sheet	  
	  
Project	  Title:	  Co-­‐Designing	  Health	  Systems	  	  
Researchers:	  Helena	  TendeDez	  
Principal	  Investigator:	  Prof	  Jon	  Whittle,	  Head	  of	  Department,	  School	  of	  Computing	  and	  
Communications,	  Lancaster	  University.	  Email:	  j.n.whittle@lancaster.ac.uk	  
	  
About	  the	  research	  
Connected	   Health	   Cities	   is	   a	   project	   designed	   to	   unite	   local	   health	   data	   and	   advanced	  
technology	   to	   improve	   health	   services	   for	   citizens	   in	  North	  West	   England.	   As	   part	   of	   this	  
project,	   at	   Lancaster	   University,	   we	   are	   working	   on	   co-­‐designing	   software	   systems	   with	  
clinicians,	  which	  will	  utilize	  NHS	  data	  to	  aid	  better	  clinical	  decisions	  to	  be	  made.	  The	  systems	  
that	  are	  designed	  will	   support	   clinicians	   in	   the	  North	  West	  of	  England	   to	   improve	  patient	  
and	  experience.	  
	  	  
About	  the	  team	  
The	  researchers	  in	  this	  team	  are	  part	  of	  the	  School	  of	  Computing	  and	  Communications	  at	  
Lancaster	  University.	  	  
	  
Why	  have	  you	  been	  approached?	  
You	  have	  been	  approached	  to	  take	  part	  in	  this	  project	  because	  you	  are	  a	  clinician	  who	  has	  
experience	  with	  patients	  who	  suffer	  from	  chronic	  obstructive	  pulmonary	  disease	  (COPD),	  or	  
have	  an	  interest	  in	  improving	  care	  or	  services	  for	  these	  patients.	  For	  this	  reason,	  we	  would	  
like	  to	  interview	  you	  or	  invite	  you	  to	  a	  focus	  group	  to	  discuss	  this.	  You	  have	  the	  opportunity	  
to	   contact	   the	   researchers	   during	   or	   after	   the	   study,	   face	   to	   face	   or	   via	   email,	   for	   any	  
reason.	  
	  
What	  does	  ‘Informed	  Consent’	  mean?	  
Before	  the	  study	  commences,	  you	  will	  be	  asked	  to	  sign	  a	  consent	  form	  to	  confirm	  that	  you	  
have	  read	  and	  received	  this	  information	  sheet	  and	  that	  you	  are	  willing	  to	  volunteer	  in	  this	  
research.	  You	  do	  not	  have	  to	  take	  part	  in	  this	  study	  if	  you	  do	  not	  want	  to.	  You	  have	  the	  right	  
to	  terminate	  the	  interview	  at	  any	  point	  and	  you	  are	  not	  obliged	  to	  answer	  questions	  if	  you	  
do	  not	  wish	  to.	  You	  may	  withdraw	  from	  the	  research	  without	  any	  negative	  consequences.	  If	  
you	  wish	  to	  withdraw	  from	  this	  research,	  please	  do	  so	  within	  two	  weeks	  of	  the	  interview,	  so	  
that	  the	  interview	  material	  can	  be	  excluded	  from	  the	  analysis.	  	  
	  
Recording	  sound	  
We	  would	  like	  to	  take	  audio	  recordings	  of	  the	  interviews,	  group	  discussions	  and	  workshops.	  
These	   audio	   recordings	   will	   be	   transcribed.	   Parts	   of	   the	   recordings	   may	   be	   used	   in	  
publications,	   such	   as	   newspapers,	   written	   reports,	   public	   presentations,	   and	   on	   the	  
Lancaster	   University	   website	   and	   respective	   social	   media	   channels.	   Your	   name,	   email	   or	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contact	   addresses	   will	   not	   be	   used	   without	   your	   explicit	   consent.	   In	   addition,	   we	   are	  
committed	  to	  withhold	  any	  data	  that	  could	  be	  used	  to	  identify	  you,	  such	  as	  employer	  name,	  
address,	  etc.	  Therefore,	  no	  one	  will	  be	  able	  to	  identify	  you.	  
	  
Photographs	  
We	  would	  like	  to	  take	  photographs	  of	  workshops	  and	  discussions.	  If	  you	  agree,	  photographs	  
may	  be	   used	   in	   publications	   such	   as	   newspapers,	   essays,	   reports,	   public	   presentations	   or	  
websites	  including	  the	  Lancaster	  University	  website	  and	  its	  social	  media	  channels.	  
	  
Confidentiality	  and	  anonymity	  
All	  information	  collected	  from	  you	  will	  be	  treated	  with	  confidentiality.	  This	  means	  that	  only	  
the	   research	   team	  will	   have	  access	   to	   any	  of	   the	   raw	   information	   that	   can	  be	   specifically	  
associated	  with	  you.	  Any	  information	  that	   is	  shared	  beyond	  this	  team	  will	  be	  anonymised.	  
Your	   name	   and	   address	   will	   be	   removed,	   and	   we	   will	   use	   a	   pseudonym	   to	   refer	   to	   you	  
instead.	   This	  will	   apply	   to	   any	   publication	   or	   presentations	   or	   any	   discussions	  with	   other	  
colleagues	  in	  the	  University.	  Data	  that	  can	  be	  used	  to	  identify	  you	  will	  also	  be	  removed.	  We	  
will	   keep	  personal	   details	   (such	   as	   your	  name	  and	   contact	   email,	   if	   you	  provide	   this)	   and	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Chapter 4: Stage 1 Requirements
Document
This section presents the document that I created about the early data requirements
from the Stage One one-to-one interviews held in Chapter 4.
375
Stage One  
Problem Scoping Interviews 
 
 
This document outlines the high-level data requirements discussed in the stage one interviews between HT and 
H3, H4 and C6. The requirements have been divided into data requirements (Table 1), functional requirements 
(Table 2), and non-functional (Table 3) to provide structure to the document. 
 
Data requirements refer to specific data that participants mentioned they would like access to when using the 
dashboard.  
Functional requirements refer to the what the system should do (the behaviour of the system)1.  
Non-functional requirements refer to how the system should work from a quality perspective 2.  
 
 
Table 1. Data requirements 
 
No. Requirement Supporting statements 
1 Hospital admission data.  “For forward planning.” [H3] 
“We don’t know how many patients are at any one point in the 
hospital, if we don’t know how many are admitted, be it COPD 
or any other disease associated ... we want to flag that up.” 
[H3] 
“Once we know from a secondary care perspective, we can see 
what can be done to avoid admissions.” [H4] 
“See how admissions are changing over time.” [H3] 
2 Flu jab data for different locations.  
 
Having updates on areas that have/have no had flu jabs, 
reported by various schemes already. This would allow the 
targeting of areas that have slow or low uptake in flu jabs to 
plan for action. [C6] 
3 Information on clinic letters such as symptoms and 
flare ups for individual patients  
 
“There’s information relating to symptoms and flare ups that 
are collected in clinic letters, on GP systems, as well but we 
don’t really have access at the moment.” [H3] 
4 Weather, pollen and pollution data.  “Would be incredibly useful” and is collected by the MET office 
[C6]. 
5 Patient generated data around symptoms.  Through using mobile health apps that allow patients to collect 
data on their symptoms [C6]. 
6 Patient smoking status across different locations.  Smoking status and smoking rates would be useful to collect 
[C6].  
7 Indicators of COPD status at both a population level 
and individual patient level basis. 
“Ideally we’d like to be able to look at population data, what’s 
happening for specific indicators as it were, then be able to go 
down to individual GP practice, organisation, down to 













1 Dabbagh, Mohammad & Lee, Sai. (2014). An Approach for Integrating the Prioritization of Functional and Nonfunctional Requirements. 




Table 2. Functional requirements 
 
No. Requirement Supporting statements 
1 Present data in summary form.  “I just want to know what is common with people 60+ female? 
Looking at this [month/days] admissions, etc., that’s what I 
expect to get from the dashboard. Is it 60+ females? What’s 
the average length of stay, when have we intervened, has this 
reduced their stay? That’s my vision.” [H4] 
2 Visualise trends and patterns in COPD data.  “Looking at patterns... is it more in weekends or weekdays? Is 
there a pattern or if it’s just a scatter of data then we need to 
crack out heads again and figure out what’s causing them 
coming into hospital?” [H4] 
“Looking at a pattern and then look into what will cause that 
pattern.” [H4] 
“If there is a pattern that there is issues with the way things 
are being managed, or admissions or whatever from a 
particular practice – we can look down to see the issues there.” 
[H3] 
3 Collate COPD data held by different organisations.  “I have to physically ask the GP to fax, why can’t I see the 
[spirometry test investigation] on my screen if there is one? If 
it’s all in a cloud somewhere I can tap into those resources and 
see that information which will help me make further decisions 
when it comes to A&E that is not available at the moment” 
[H4] 
4 Highlight potential deficiencies in service. “If one month we aren’t doing so well on smoking cessation, 
we can think, well, why is that? Is there a reason? Is a member 
of staff off? Is there been a change in the way we approach 
that target?” [H4] 
5 Utilise existing data sources to visualise routinely 
collected data.  
It would be “extremely helpful” to utilise existing data sources 
to avoid having to collect and input new data [C6]. 
“So there’s information collected in clinic letters, when a 
patient has seen their GP as well, so that’s information relating 
to symptoms and flare ups that’s collected in clinic letters, on 
GP systems as well but we don’t really have access at the 
moment.” [H3] 
6 Have a responsive way of checking that beds are 
free.  
Clinicians have to make phone calls sometimes to find out if a 
hospital is full as can’t access this information online which is 
“incredibly time consuming.” [C6] 
Check if number of beds are going up or down as this data is 
often obtained one month later and needs to be checked on 




















Table 3. Non-functional requirements 
 
No. Requirement Supporting statements 
1 Visualise data in a user-friendly format for decision-
making. 
“Being able to look at the data in a user-friendly format across 
the health economy will help us identify areas that we need to 
work on.” [H3] 
“Most systems aren’t user-friendly. They’re quite clunky and 
you have to go through lots of processes to get where you 
want really.” [H3] 
“Visualising data in an easy way will absolutely help me do my 
job” [C6] 
2 Dashboard should be pervasive. Clinicians are often not in one place, so being able to access 
the dashboard from different places is helpful [C6]. 
“I am not a very IT person, I am not comfortable with that, I 
prefer desktop. The only other way to go would be on a mobile 
computer that we use on the wards.” [H4] 
3 Inform decisions that can make a meaningful 
change for patients.  
“We are hoping this [dashboard] will make a meaningful 
change to the patients.” [C6] 
4 Minimise extra work associated with data input.  
 
“Data entry is incredibly manual and takes too much time for 
admin ... it’s important to be realistic, they do not have time to 
manually input data.” [C6] 
5 Utilise data in real time. “Be more proactive instead of waiting for data to come through” 
[H3] 
“A lot of the data we have, or the information we have is 
retrospective. So months behind. But in order to be able to act 
when things are fast moving, particularly in the winter months 
when things are busy for us as well so we can really focus on 
particular aspects of care or particular systems in the 
organisation - if that happens in a real time way, so we can see 
that on a day to day or week to week basis.” [H3] 
6 Visualise data quickly to help assess whether 
interventions are effective.  
“[Certain] knowledge will help us manage better.” [H4] 
“I think having a dashboard would mean we are able to assess 
any quick interventions that we put in, so any change we make, 
PDSA cycle, if we have something that reacts to whatever we 
put in the patient’s pathway, in terms of detecting any changes 
in admissions or whatever it might be then it would help 
forward planning a bit more and help with how we develop the 
services further.” [H3] 
7 Minimise duplication of data to keep report writing 
procedures efficient and less time consuming.  
 
Reporting information about beds for example could be 
minimised with a live dashboard displaying this information 
[C6].  
A system that minimises duplication and can match up data.  
[C6] 
8 Visualise service data to allow decision-making 
based on data and metrics. 
“Identifying the specifics is quite difficult, we need to focus on 
the details ... the way we are set up is quite fragmented ... 




Chapter 4: Stage 2 Priorities
Workshop Document
This section presents the document that I created that summarises the data from the





This document outlines the discussions around data priorities for the dashboard from the priorities workshop 
with H3, H4, C9, IT1, BI1 and BI2. 
Table 1. Focus Group One 
Priority Aim Label Supporting Statements 
Access to admissions 
data, with the ability to 
identify periods where 
there are spikes in 
admissions. 
To decrease the number 
of admissions by 
identifying periods of 
spikes and acting upon 
those spikes (by 
deploying more 
community nurses, etc.)  
Use the dashboard to 
understand if admissions 
rates are lowered as a 




“I think spikes in admissions, being able to 
track spikes in admissions, and being able to 
deploy the services, so get in reach from the 
community team and for us to be able to 
focus our efforts in the trust to a particularly 
area, that’s quite a big priority I think for us 
as a trust, to be able to decrease the number 
of admissions we are getting in, so, if we are 
able to do that I think that’s a high priority.” 
[H3] 
Access to data behind 
the admissions 
numbers, such as: are 
the admissions 
reoccurring for certain 
patients, where an 
admission has come 
from geographically, 
are admissions 
occurring from a 
particular practice.  
Understanding what 
practices most 
admissions are coming 
from will allow 
assessments of that 
practice/location to take 
place to understand why 




“The patterns around it would be interesting 
as well. So, if we get a spike, what is it about 
those patients that are coming in, are they 
patients who have had reoccurring 
admissions that are all coming from a 
particular area of the city, or particular 
practice?” [H3]  
 
Access to spirometry 
data, such as 
spirometry test results 
and diagnosis data.  
The respiratory clinicians 
are currently unsure 
about the quality of 
spirometry tests carried 
out in primary care so 
repeat these tests when 
they see a patient.  
Medium 
priority  
“We have issues with diagnostics at the 
moment around spirometry and things, so 
that should be fairly soon really, be able to 
access disease specific data if you like, so 
spirometry data as part of this.” [H3] 
“There’s been a big change in the way people 
are trained to deliver spirometry and we don’t 
really have any idea about quality of 
spirometry across the patch and also 
equipment upkeep and servicing type of 
stuff.” [H3]  
“Because of the data sharing we may or may 
not get a photocopy of some spirometry, 
when a patient comes to the clinic, but also 
it’s about the quality of that data, I can’t 








reported data to 
understand symptoms 
and predict 
admissions.   
Access to patient 
reported data on a 
mobile health app or 
similar device to help the 
clinicians predict 
potential admissions and 
better understand how a 
patient is managing.  
Blue sky 
thinking  
“The other thing that’s quite exciting, I think, 
going forward, it’s probably blue sky 
actually... patient reported data? And how to 
link that into all of this, so the data that 
patients record around symptoms, either on 
paper or electronically using the app.” [H3] 
“It may be doable in 3-5 years, but I think we 
have a long way to go to be able to get 
patients to record the data, I think that’s 
going to be the issue. I think the cohort of 
patients that we deal with are generally not 
very electronic, kind of savvy, as it were. So 
using smart phones and things but that will 
change... you know... people get older... using 
patient reported data to, and whether that 
could predict any of these admissions and so 
on.” [H3] 
“I think the key to identifying these 
admissions and things is around the patient 
reported data because we know patients do 
delay and put off seeing their doctor in case 
they go to hospital and there’s research to 
show that, if we can push that back then we 
can potentially make quite a big impact.” [H3]  
Identify patients 
reaching end of life 
(last 12 months of their 
life) and share their 
priorities with GPs on a 
digital system.  
 
End of life patient 
discussions happen in 
meetings and are 
recorded on paper. This 
makes it difficult to 
share a patient’s 
priorities as they reach 
end of life with their GP 
and others. Building this 
into a system would be 
helpful to share this data 





“Our expanding cohort of patients with very 
severe disease who are in the last 12 months 
of their life, being able to effectively have 
their data available to everybody so that’s 
viewable in the community and hospital etc 
and we can effectively respond to their needs 
as well.” [H3] 
“We are identifying patients proactively who 
reaching the last 12 months of their life and 
are trying to manage them more effectively, 
so I think if we can look at that as well. We 
could go all standard frameworks, patients 
who – I don’t know if you have heard of that, 
if you hit certain disease in generic criteria 
which predicts that they are in the last 12 
months of their life, and that will enable us to 
maybe focus on slightly different priorities for 
the patients maybe.” [H3] 
“There is data, the data that is generated in 
our meetings where we discuss all the 
patients are just on paper at the moment, it 
gets photocopied and mailed out to GPs, so if 
that could be built into Quadramed [our main 
system] we could do that as we go along in 
the meeting and that could be fed into this 
and that would be really helpful” [H3] 
 
381
Table 2. Focus Group Two 







misdiagnoses take place will 
allow practices to be 
targeted for support. This 
will in turn help to improve 
how patients are diagnosed 




“I’m not a clinician, but in the few 
conversations that I’ve had, about spirometry, 
there does seem to be some consensus that 
the quality of spirometry depends on where 
the patient has attended that test, is higher in 
some areas than others. And when the quality 
isn’t particularly high, that’s where you end up 
with patients that are misdiagnosed.” [BI1] 
“If we could just look at that, that in itself 
would make a massive difference, not just to 
the number of inappropriate referrals that 
we’d have to accept anyway because they 
technically they’ve been diagnosed with COPD, 
but also from the patient perspective as well 
because it then puts the patient on the 
pathway that they might not need to be on.” 
[BI1] 
Understand pulmonary 
rehabilitation rates and 
which practices are 
referring patients to that 
service.  
Identifying practices that are 
not referring patients into 
pulmonary rehabilitation can 
enable them to be targeted 
and educated about the 
benefits of referring patients 
(and the available resource). 
Understanding the number 
of patients being referred 
can help with planning 





“Yes, there is [the desire to see which patients 
are being referred into PR], from us, not with 
current funding. We’ve just had a recent 
resurgence in referrals because there’s been 
pressure applied to surgeries who haven’t 
previously referred, it’s difficult to manage, 
we’re just managing.” [C9] 
“Who is delivering treatment, those patients 
that should have been referred to PR that 
haven’t been, what resources are needed to 
see these patients in total that haven’t been 
referred. If you can visualise it all, it would 
help commissioners as well to a degree 
because they’d be able to visualise what 
happens now but what needs to happen.” 
[BI1]  
“I think overall management, like you know 
pulmonary rehab would come there and 
number of admissions they had in the last one 
year so that we can target them specifically 
you know their ongoing management towards 
that, unfortunately it’s a progressive condition 
so if I start seeing that there are more and 
more admissions or more and more 
complications then it tells me that I need to 






 Spirometry test results  Secondary care clinicians 
cannot see spirometry test 
results that were taken in 
primary care, often having to 
repeat them due to this 
inaccessibility of data.  
High 
priority  
“We can’t see it, you have to beg borrow and 
ask somebody to contact what is the 
spirometry? You can’t see that unless they 
have had a spirometry as part of their 
investigation in chest clinic for which we will 
have some data but you know, I think it’s 
being done, it’s just we can’t see it, even when 
the GP sends somebody’s care records, even 
then we can’t see it, we have to ask them 
specifically what was their spirometry.” [H4] 
“[I want] the graphs which would give us the 
information and the values as well, it depends 
on the age for that patient, what is the 
percentage predicting, etc.” [H4] 
“Definitely to see a trend to say that things are 
getting worse and we need to do something 
about it now because it is a progressive 
disease and once we start seeing the downhill 
then we need to know we need to put more 
services on, more into the actual management 
of the patient.” [H4] 
Create disease specific 
predictions about the 
patient population and 
individual patients based 
on current data 
Use machine learning to 
predict patient outcomes 
based on different 
management techniques to 
allow for more effective 






“I think it’s sometimes scary to even dream of 
this... to be able to visualise pictorially what is 
happening to our COPD service, I think that is 
my dream goal, by then I’ve done my 
immediate diagnostics I got everything right, 
most of it right, and managed them, so I can 
kind of predict 5 years down the line this is 
what my COPD patient population will be, for 
planning it would be like ‘wow this is what I 
need’.” [H4] 
“Because you know at the end of the day I 
want it down to that patient Mr Smith but 
strategically or from a service point of view 
how many Mr Smiths are in this area or in this, 
you know, population that is what datasets, to 
me, that is what the dataset is doing, it’s 
telling me how many similar patients that are 
in that situation and in this area so that I can 
target my intervention in that particular area 
so that I can get the management right in that 
place, to me all this dataset is trying to help 




Chapter 4: Early Annotated
Wireframes
This section presents early versions of annotated wireframes used in the development
process of the prototype in Chapter 4.
384
D.1 Wireframe for Scenario 1: Respiratory Ward Overview












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D.4 Wireframe for Scenario 4: Example Patient’s Exac-
erbation History
D.5 Wireframe for Scenario 5: Example Patient’s Spirom-
etry Results
Appendix E
Chapter 4: Scenario Dummy
Datasets
This section presents information about the schema for the dummy datasets that I
created for the prototype in Chapter 4.
390
Scenario 1 Dummy Dataset 
This dummy data set was created based on hospital admissions data. The ‘COPD Flag’ column is 
based on the Hospital’s marker system, and relates to if a patient is on the marker system or not. 
 






















Patient0 1 1234 1 5432 01/01/19 1 Respiratory Hospital1 COPD 
 
Scenario 2 Dummy Dataset 
Dummy dataset A breaks down infective and non-infective exacerbations recorded by the three 
sites, Community Care, Hospital, and GP.  
 
I created approximately 180 dummy data points for dataset A, 344 dummy data points for dataset B, 
and 180 dummy data points for dataset C. The rationale behind the numbers was simply to simulate 
















01/01/19 1 3 0 6 2 9 
 




Patient Admission Date COPD Flag Admission Reason 
Patient0 01/01/19 1 COPD 
 




Year Month Flu_Vaccinations_Administered 
Patient0 January 5 
 
Scenario 3 Dummy Dataset 
This dummy data set is based on patient-generated data from the smartphone app ‘How Are You 
Today’ (for monitoring of COPD). The ‘Day_Type’ column is generated as a result of the user’s input. 
The ‘Action_Taken’ column indicates what the user has done that day in relation to their COPD (e.g. 
taken their medication). ‘SymptomReport3’ is a rating of their breathlessness, ‘SymptomReport4’ is 
a rating of their cough, ‘SymptomReport5’ is a rating of their sputum, and ‘SymptomReport6’ is a 
report of their sputum colour.  
 
I created five dummy patients for this scenario. For each individual patient, I created approximately 























Scenario 4 Dummy Dataset 
This dummy dataset breaks down the date of an exacerbation, which healthcare service managed it, 
the type of exacerbation (infective or non-infective) and the outcome. 
 
For this scenario, I created 8 dummy data points to simulate a realistic exacerbation history that one 
patient might have. 
 
Date Managed_By Exacerbation_Type Outcome 
01/01/19 Hospital Infective Hospital Admission 
 
Scenario 5 Dummy Dataset 
This dummy dataset includes a patients’ spirometry test results, followed by the date, and the 
source of the test (Community Care, Hospital, GP Practice). 
 
For this scenario, I created 4 dummy data points to simulate a realistic spirometry test history that 
one patient might have. 
 
Date FEV1 Predicted FVC Predicted FEV1:FVC RV% Source 





Chapter 4: Scenario Usefulness
Ranking Results
This section presents the results from the scenario usefulness ranking survey provided






























































































































































































































Chapter 4: TAM Questionnaire




Perceptions of Dashboards 
 
1. Using data dashboards to improve patient care, management and service provision is a 
good idea. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly 
Agree          Disagree 
 
2. Using data dashboards to improve patient care, management and service provision would 
be beneficial for how I manage patient care. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly 




1. Using respire would give me more evidence – and so help improve my decision making.   
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly 
Agree          Disagree 
     
2. Using Respire would save me time compared to my current practices. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  
Agree          Disagree 
 
3. Using Respire may lead to more effective patient care overall.                          
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  
Agree          Disagree 
 
4. Respire would be of practical use for my work. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly 
Agree          Disagree 
 
 
Perceived Ease of Use 
 
5. My interaction with Respire is clear and understandable. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  
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Agree          Disagree 
6. Interacting with Respire does not require a lot of my mental effort. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  
Agree          Disagree 
 
7. I find Respire easy to use. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  
Agree          Disagree 
 
8. I find it easy to get Respire to do what I want it to do. 
 
Strongly  +3  +2 +1 0 -1 -2 -3  Strongly  





Chapter 4: Scenarios Included for
Evaluation
This section includes details of the five scenarios shortlisted for inclusion in the digital
prototype as part of the Chapter 4 evaluation.
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H.1 Scenario 1: Respiratory Ward Overview
H.2 Scenario 2: Admissions and Exacerbation Reports

H.3 Scenario 3: Patient-Generated Data Overview
H.4 Scenario 4: Example Patient’s Exacerbation His-
tory




Chapter 5: Participant Information
Sheet and Consent Form








Participant Information Sheet 
 
Project Title: How Are You Today?   
Researchers: Helena Tendedez, Roisin McNaney, Maria-Angela Ferrario 
Principal Investigator: Roisin McNaney, Lecturer in Digital Healthcare Technologies School 
of Computing and Communications, Lancaster University.  
 
About the research 
Connected Health Cities is a project designed to unite local health data and advanced 
technology to improve health services for citizens in North West England. As part of this 
project, at Lancaster University, we are working on co-designing software systems with 
clinicians, which will utilize NHS data to aid better clinical decisions to be made. The systems 
that are designed will support clinicians in the North West of England to improve patient 
and experience. 
  
About the team 
The researchers in this team are part of the School of Computing and Communications at 
Lancaster University.  
 
Why have you been approached? 
You have been approached to take part in this project because you have an understanding 
of chronic obstructive pulmonary disease (COPD) or other respiratory conditions, the care of 
these conditions and the lives of people affected by the condition. For this reason, we would 
like to interview you or invite you to a focus group to discuss this. You have the opportunity 
to contact the researchers during or after the study for any reason.  
 
What does ‘Informed Consent’ mean? 
Before the study commences, you will be asked to sign a consent form to confirm that you 
have read and received this information sheet and that you are willing to volunteer in this 
research. You do not have to take part in this study if you do not want to. You have the right 
to terminate the interview at any point and you are not obliged to answer questions if you 
do not wish to. You may withdraw from the research without any negative consequences. If 
you wish to withdraw from this research, please do so within two weeks of the interview, so 
that the interview material can be excluded from the analysis.  
 
Recording sound 
We would like to take audio recordings of the interviews, group discussions and workshops. 
These audio recordings will be transcribed. Parts of the recordings may be used in 
publications, such as newspapers, written reports, public presentations, and on the 
Lancaster University website and respective social media channels. Your name, email or 
contact addresses will not be used without your explicit consent. In addition, we are 
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committed to withhold any data that could be used to identify you, such as employer name, 
address, etc. Therefore, no one will be able to identify you. 
 
Photographs 
We would like to take photographs of workshops and discussions. If you agree, photographs 
may be used in publications such as newspapers, essays, reports, public presentations or 
websites including the Lancaster University website and its social media channels. We will 
not be publishing photographs of participants without their explicit consent. 
 
Confidentiality and anonymity 
All information collected from you will be treated with confidentiality. This means that only 
the research team will have access to any of the raw information that can be specifically 
associated with you. Any information that is shared beyond this team will be anonymised. 
Your name and address will be removed, and we will use a pseudonym to refer to you 
instead. This will apply to any publication or presentations or any discussions with other 
colleagues in the University. Data that can be used to identify you will also be removed. We 
will keep personal details (such as your name and contact email, if you provide this) and 
research content (e.g. interview transcriptions) in separate encrypted and password 
protected files. 
 
How will the data be used and protected?  
We will treat data that you have provided in accordance with the Data Protection Act 1998. 
This means that any personal information stored in physical format (paper, readily playable 
recordings) will be stored in a locked filing cabinet in a locked office in Lancaster University 
premises. Any personal information that is stored electronically will be stored on a secure 
and password protected server. Any personal information that is transported electronically 
on a mobile device (such as a laptop) will be encrypted and/or password protected. The 
information collected will be used to inform the development of further research and may 
be included in publications, presentations and PhD theses. Only anonymised information 
will be retained indefinitely for on-going research purposes. We will keep the raw data for 
up to 10 years after the data is collected, after that, the data will be destroyed.  
 
Who has reviewed the project? 
This study has been fully reviewed by the Faculty of Science and Technology Research Ethics 
Committee. If you have more questions please contact Helena Tendedez, School of 
Computing and Communications, Room C20, C Floor, InfoLab21, Lancaster University, 
Lancaster LA1 4WA, via email at h.tendedez@lancaster.ac.uk. 
 
Issues or complaints 
If you have any concern about this study wish to speak to someone outside study, you may 
contact: Prof. Nicholas Race, Director of Research, School of Computing and 
Communications  
D33, InfoLab21,  
South Drive, Lancaster University,  
Lancaster LA1 4WA,  
UK Tel: +44 (0)1524 510123  





Participant Consent Form 
 
Project Title: How Are You Today? 
 
Name of Participant:  _______________________________________ 
 
Pseudonym to be in research:  _______________________________________ 
(Please leave blank if you prefer the  
researchers to select a pseudonym) 
 
The purpose of this consent form is to check that you understand what till be required of 
you, if you agree to take part in this research, and how any information you give will be used 
in the study. 
 
1. I confirm that I have read and understood the Participant Information Sheet for the above 
study. 
 
2. I have had the opportunity to consider the information, ask any questions about the 
research and have had these questions answered satisfactorily. 
 
3. I agree to participate in this study. I understand that my participation is voluntary and I can 
choose to opt-out of the study at any time as described in the Participation Information 
Sheet.  
 
4. I understand that I have the right to withdraw, without giving any reasons for this, at any 
point during the study.  
 
5. I agree for any interviews I give to be audio recorded. 
 
6. I agree that photographs of me can be taken. 
 
7. I agree that any quotations from what I say during an interview can be used in publications.  
I understand that my quotations will be used anonymously. 
 
8. I understand that any personal data I provide will be retained and processed by the 
researcher in accordance with the Data Protection Act 1998. 
 
9. By providing contact details, I understand that I will be contacted further by the team with 
updates about the study.  
 
 
Participant email/phone number: ___________________________________  (optional) 
 
Participant’s signature:  ___________________________________ 
 
Researcher’s signature:  ___________________________________ 
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Chapter 5: Survey Questions
This section provides the survey questions used in Chapter 5.
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1) What chronic respiratory conditions do you have? 
Asthma COPD Bronchiectasis Bronchitis Emphysema I’m not sure 
Other, please specify  
 
2) How long have you lived with a chronic respiratory condition? 
Less than one year 1-5 years 6-9 years 10+ years 
 
3) What gender do you identify with? 
Woman  Man  In another way 
 
4) What is your age range? 
40 or under  41-55  46-50  51-55 
56-50  61-65  66-70  71-75  
76-80  81-85  80 or over 
 
5) Where do you live? 
Scotland  Wales   Northern Ireland South East England 
Ireland  North West England North East England South West England 
Midlands  Other, please specify 
    
6) Which of the following devices do you own? 
A basic mobile phone (with limited capabilities) Landline telephone (home phone) 
A smartphone (such as an iPhone or Android phone) A computer or laptop 
Game consoles (such as PlayStation or Xbox)  A tablet (such as an iPad)   
Smart watch (such as Fitbit or Apple watch)  I don’t own any of these devices 
 
7) What do you use the following technologies for? 
 

















A smartphone (such 
as an iPhone or 
Android) 
       
Laptop or computer        
Tablet (such as iPad)        
 
 
8) What is the biggest challenge that you face living with your respiratory condition(s)? 
 
9) What social support do you have available to you? 
Paid carer Family  Friends  Support group members   
The community team at my local healthcare service I have no social support
 Other 
 
10) What techniques or methods do you use (or have you tried in the past) to manage the 
symptoms of your respiratory condition? Please select all that apply  
Taking prescribed medication including inhalers 
Following an exercise plan or attending exercise classes  
Keeping a diary of your symptoms and reflecting on the diary  
Attending support groups (such as Breathe Easy groups) 
Taking readings through a peak flow meter and reflecting on these readings 
Taking readings through a pulse oximeter and reflecting on these readings 
Attending pulmonary rehabilitation groups / classes 
Other, please specify 
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11) How many times in the past two years have you been admitted to hospital for your respiratory 
condition? 
None     1-2 times   3-5 times 6+ times 
 
 
12) How do you currently share details of your symptoms and general wellbeing with your clinician 
during appointments?  For example do you show them diary notes that you have made on how 
you've been feeling, oximeter readings, mobile health app data you've collected, or just 
verbally discuss how you've been feeling?  
 
13) How confident would you say you are using technology?  
Not confident at all Somewhat confident Very confident   I’m not sure 
 
14) Have you ever used any form of technology to help manage your respiratory condition? Please 
select all that apply.  
Yes, I've used a dedicated smartphone app  
Yes, I've taken pulse oximeter readings  
Yes, through wearable technology such as a smart watch 
 Yes, through another way (please specify)  
 No 
 I’m not sure 
 
15) Have you ever used any form of technology to manage your health outside of your respiratory 
condition? 
Yes, please specify No I’m not sure 
 
16) Would you be motivated to use technology to manage your respiratory condition if you knew 
that the data could then be viewed by your clinician to provide you with more personalised 
care?  
Yes, if the technology was right for me    
Yes, even if I was not confident with the technology I would try to learn 
No, please specify why 
I’m not sure 
 
17) How often would you be willing to record data about your respiratory condition for self-
reflection or sharing with your clinician?  
Once a day, if it was quick to do     Once a week 
Once a day, I would set aside time to do it    A few times a week 
Over an agreed period of time decided by my clinician  Never, please specify 





Chapter 6: Participant Information
Sheet and Consent Form
This section provides the participant information sheet used to recruit the COPD
patients for Chapter 6.
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Participant Information Sheet 
 
Project Title: How Are You Today 
Researchers: Helena Tendedez, Roisin McNaney, Maria-Angela Ferrario 
Principal Investigator: Roisin McNaney, Lecturer in Digital Healthcare Technologies School 
of Computing and Communications, Lancaster University.  
 
About the research and the team 
Connected Health Cities is a project designed to unite local health data and advanced 
technology to improve health services for citizens in North West England. As part of this 
project, at Lancaster University, we are focused on understanding how people with chronic 
obstructive pulmonary disease (COPD) self-manage their condition using self-management 
technologies, such as through mobile phone health apps. We are interested in participants’ 
experiences and perceptions of self-managing using a mobile health application that has been 
developed by Intelesant Ltd in partnership with [anonymised] (NHS). The researchers in this 
team are part of the School of Computing and Communications at Lancaster University 
working on a PhD project that is part of Connected Health Cities. The researchers conducting 
this study have full insurance cover through Lancaster University. 
 
Why have you been approached? 
You have been approached to take part in this project because you have some understanding 
of chronic obstructive pulmonary disease (COPD) or other respiratory conditions, the care of 
these conditions and the lives of people affected by the condition. For this reason, we would 
like to invite you to take part in our study that looks at how people with COPD can self-manage 
their condition through technology.  
 
Your participation 
This project involves using a mobile health smartphone application as a personal symptom 
diary for 4 weeks alongside your pulmonary rehabilitation involvement at [anonymised]. The 
smartphone application that you will be using has been developed how Intelesant Ltd in 
partnership with [anonymised]. The mobile health application will ask a series of five 
questions each day relating to your symptoms for you to answer. This will generate a diary 
entry each day on your smartphone. You will have the opportunity to contact the researchers 
during or after the study, face to face or via email, for any reason.  
 
Your participation in the project can be outlined in three stages, and the project will run 
alongside your usual pulmonary rehabilitation programme. This project will not change the 
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Stage 1: At the start of the study, the researchers would like to interview you to understand 
your experiences living with a respiratory condition and perceptions of using technology to 
self-manage. The interview will last approximately 30-60 minutes. After this interview, you 
will begin using the mobile phone application to self-manage your condition for 4 weeks. 
Once you start using the mobile phone app, you will have access to help and support in using 
it from a dedicated team at Intelesant Ltd. They will describe the app’s Privacy Policy and 
Terms and Conditions to you. You will also have the researchers’ telephone number and email 
address should you have any questions about the research. After this interview, you have two 
weeks to decide if you wish to withdraw from the study. There is no consequence to 
withdrawing from the study.  
 
Stage 2: Two weeks into the use of the smartphone app, the researchers would like to 
telephone you to ask how you are finding the process of using the application to self-manage 
your condition, and will answer any questions you have about the research. This telephone 
call will last approximately 20-30 minutes. 
 
Stage 3: After four weeks have passed, you will be at the end of the study. The researchers 
would like to invite you to a closing interview where you will discuss your diary entries and 
experiences with the researcher and a COPD nurse. This meeting will solely be to discuss your 
diary data and experience, not your personal health records or any further aspects of your 
care. The meeting will be held at a clinical site. You will open the diary app on your phone and 
you will be discussing your experience of logging your symptom data on an app and discuss 
any challenges that were encountered. This interview should last between 60-90 minutes. 
 
What happens with the app after the study? 
You are free to decide whether you wish to keep the How Are You Today app on your phone 
and continue using it under the guidance of your community team, or you may choose to 
delete the app. If you decide to delete the app, both the app and the data accumulated 
throughout the study will be deleted from your smartphone. If you want further information 
about this, please contact the researchers or Intelesant Ltd, who can give you the relevant 
advice. Please note after the study has commenced, if you wish to seek advice on the app, 
you should contact Intelesant Ltd or your community team. 
 
What does ‘Informed Consent’ mean? 
Before the study commences, you will be asked to sign a consent form to confirm that you 
have read and received this information sheet and that you are willing to volunteer in this 
research. You do not have to take part in this study if you do not want to. You have the right 
to terminate the interview at any point and you are not obliged to answer questions if you do 
not wish to. You may withdraw from the research without any negative consequences. If you 
wish to withdraw from this research, please do so within two weeks of the interview, so that 
the interview material can be excluded from the analysis.  
 
Recording sound 
We would like to take audio recordings of the interviews. These audio recordings will be 
transcribed. Parts of the recordings may be used in publications, such as newspapers, written 
reports, public presentations, and on the Lancaster University website and respective social 
media channels. Your name, email or contact addresses will not be used without your explicit 
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consent. In addition, we are committed to withhold any data that could be used to identify 
you, such as employer name, address, etc. Therefore, no one will be able to identify you. 
 
Confidentiality and anonymity 
All information collected from you will be treated with confidentiality. This means that only 
the research team will have access to any of the raw information that can be specifically 
associated with you. Any information that is shared beyond this team will be anonymised. 
Your name and address will be removed, and we will use a pseudonym to refer to you instead. 
This will apply to any publication or presentations or any discussions with other colleagues in 
the University. Data that can be used to identify you will also be removed. We will keep 
personal details (such as your name and contact email, if you provide this) and research 
content (e.g. interview transcriptions) in separate encrypted and password protected files. 
 
How will the data be used and protected?  
We will treat data that you have provided in accordance with the Data Protection Act 1998. 
This means that any personal information stored in physical format (paper, readily playable 
recordings) will be stored in a locked filing cabinet in a locked office in Lancaster University 
premises. Any personal information that is stored electronically will be stored on a secure and 
password protected server. Any personal information that is transported electronically on a 
mobile device (such as a laptop) will be encrypted and/or password protected. The 
information collected will be used to inform the development of further research and may be 
included in publications, presentations and PhD theses. Only anonymised information will be 
retained indefinitely for on-going research purposes. We will keep the raw data for up to 10 
years after the data is collected, after that, the data will be destroyed.  
 
Who has reviewed the project? 
This study has been fully reviewed by the Faculty of Science and Technology Research Ethics 
Committee. If you have more questions please contact  
Helena Tendedez 
School of Computing and Communications,  
Room C20, C Floor,  
InfoLab21,  
Lancaster University, Lancaster LA1 4WA,  
 
Or via email at h.tendedez@lancaster.ac.uk or telephone  
 
Issues or complaints 
If you have any concern about this study wish to speak to someone outside study, you may 
contact: Prof. Nicholas Race, Director of Research, School of Computing and 
Communications  
D33, InfoLab21,  
South Drive, Lancaster University,  
Lancaster LA1 4WA,  
UK Tel: +44 (0)1524 510123  
Email: n.race@lancaster.ac.uk  
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Participant Consent Form 
 
Project Title: How Are You Today  
 
Name of Participant:  _______________________________________ 
 
Pseudonym to be in research:  _______________________________________ 
(Please leave blank if you prefer the  
researchers to select a pseudonym) 
 
The purpose of this consent form is to check that you understand what till be required of 
you, if you agree to take part in this research, and how any information you give will be used 
in the study. 
 
1. I confirm that I have read and understood the Participant Information Sheet for the above 
study. 
 
2. I have had the opportunity to consider the information, ask any questions about the 
research and have had these questions answered satisfactorily. 
 
3. I understand that I have the right to withdraw, without giving any reasons for this, at any 
point during the study. 
 
4. I agree for any interviews I give to be audio recorded. 
 
5. I agree that any quotations from what I say during an interview can be used in publications.  
I understand that my quotations and audio recording will be used anonymously. 
 
6. I understand that any personal data I provide will be retained and processed by the 
researcher in accordance with the Data Protection Act 1998. 
 
7. By providing contact details, I understand that I will be contacted further by the team with 
updates about the study.  
 
8. I agree for my GP to be notified by [anonymised] that I am taking part in this study. 
 
9. I agree to participate in this study. I understand that my participation is voluntary. 
 
 
Participant email/phone number: ___________________________________   
 
Participant’s signature:  ___________________________________ 
 
Researcher’s signature:  ___________________________________ 
 
Date:     ___________________________________ 
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